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Cyathostomins are potentially life threatening parasitic nematodes of adult horses 
and are highly prevalent worldwide. Infected animals may be asymptomatic or show 
clinical signs of weight loss, diarrhoea and colic. Third and fourth stage larvae spend 
a large proportion of their lifecycle encysted in the large intestinal wall where they 
cannot currently be detected ante mortem. Mast cells are commonly found at 
interfaces to the external environment, such as the rectum, and these cells and the 
proteinases they produce have been implicated in protective host immune responses 
against nematode infection in animals. Previous studies have demonstrated an 
increase in caecal mast cell proteinase expression during cyathostomin infection. 
Prior to this study, there were two known equine mast cell proteinases, which had 
been purified and characterised from a mastocytoma (equine tryptase [eqTRYP] and 
equine mast cell proteinase-1 [eqMCP-1]). However, as many mammalian species 
express multiple closely-related chymases it was hypothesised that other equine mast 
cell proteinases exist that have not yet been characterised and which may be more 
closely associated with the level of worm burden. The primary objective of this study 
was to investigate the recruitment of mast cells to the large intestine in cyathostomin 
infected horses and the expression of mast cell proteinases in response to infection. A 
further aim was to evaluate the potential of associated mast cell proteinase assays or 
rectal biopsy mast cell enumeration for utility in diagnostic tests to estimate 
cyathostomin mucosal burden. A secondary objective was to explore the existence of 
further mast cell proteinases and the relationship of these enzymes to cyathostomin 
mucosal burden. Optimised sampling protocols, parasitological, histological and 
immunohistochemistry techniques were performed to enumerate cyathostomin 
mucosal burden and to characterise the mast cell populations in the caecum, right 
ventral colon (RVC) and rectum of naturally infected horses (n=28). Mast cell 
populations correlated throughout the intestine, providing further evidence of the 
common mucosal system. EqMCP-1 and eqTRYP labelled mast cells were identified 
throughout the large intestine. Significant positive linear relationship existed between 
rectal proteinase-labelled mucosal mast cell populations and both the combined total 
cyathostomin mucosal burden (CTMB; eqMCP-1, p=0.018; eqTRYP, p=0.048) and 
 
 x 
the combined total luminal burden (CTLB; eqMCP-1, p=0.009; eqTRYP, p=0.007). 
Concentrations of eqMCP-1 and eqTRYP in (i) serum, (ii) local serum from venous 
blood draining the large intestine, and (iii) large intestinal tissue homogenates were 
assessed using ELISA. There was no significant correlation identified between local 
and peripheral serum proteinase concentrations suggesting that peripheral serum 
proteinase levels are not representative of the local proteinase response. There was 
however a significant negative relationship between peripheral serum eqMCP-1 
concentrations and the CTMB, which could relate to the activation and sequestering 
of proteinases within the gut lumen. Concentrations of eqMCP-1 and eqTRYP 
measured in local serum did not significantly positively correlate with cyathostomin 
mucosal burden. There was a significant association observed between intestinal 
tissue levels of eqMCP-1 and eqTRYP and the CTMB in the RVC (p<0.023), 
providing support for their role in the immune response. Four proteinase sequences, 
equine tryptase (TLP1), Granzyme B-like (GZMBL), putative equine Mast Cell 
Proteinase-1 (CLP1) and Granzyme(BGH)-like (GZM(BGH)L), were sequenced and 
the local transcription levels of each of these enzymes assessed using quantitative 
reverse-transcription PCR. The expression of TLP1 was closely correlated with 
GZMBL expression, and there was a significant positive relationship observed 
between TLP1 and GZMBL transcript levels and combined total mucosal burden in 
the RVC. Both GZM(BGH)L and CLP1 transcript levels were also positively 
correlated with each other, but the levels of these transcripts were not statistically 
correlated to any of the cyathostomin parasitological measures assessed here. 
This work has provided the basis for further rectal biopsy studies to examine the 
important dynamics of the mast cell response to cyathostomin infection. The results 
from this thesis, with the demonstration of novel proteinases, are encouraging for 
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1 General Introduction 
1.1 Equine Gastrointestinal Parasites 
Equine parasites have been recognised as a cause of clinical disease for many 
centuries (Kaplan and Nielsen 2010). The introduction of the anthelmintic interval 
dosing strategies in the 1960’s (Kaplan and Nielsen 2010), designed to primarily 
target Strongylus species, combined with the availability of benzimidazole 
anthelmintics (McKellar and Jackson 2004), was successful in reducing large 
strongyle nematode populations. This strategy was so effective that by the 1980’s 
small strongyles, cyathostomins, frequently accounted for virtually 100% of faecal 
egg counts (FECs) (Drudge and lyons 1966; Herd, Miller et al. 1981; Herd and Gabel 
1990; Kaplan 2002; Kaplan and Nielsen 2010). Despite the concern that strict 
interpretation of the selective therapy regimen, based on the anthelmintic treatment 
of horses with FECs above a pre-determined threshold (Duncan and Love 1991), 
could be associated with an increase in prevalence of Strongylus vulgaris (Nielsen, 
Vidyashankar et al. 2012), cyathostomins are still considered the principal parasitic 
pathogen of horses over the age of six months (Love, Murphy et al. 1999; Kaplan 
and Nielsen 2010; Kornas, Cabaret et al. 2010; Hinney, Wirtherle et al. 2011). 
Anoplocephala perfoliata is the most common equine cestode and is prevalent in 
populations worldwide (Gasser, Williamson et al. 2005). This tapeworm has been 
implicated in various types of colic, including caeco-caecal intussception (Edwards 
1986; Owen, Jagger et al. 1989), spasmodic colic (Proudman, French et al. 1998) and 
intestinal obstruction (Slocombe 1979); however, recent studies have questioned 
these findings by demonstrating no association between colic and A. perfoliata 
infection (Trotz-Williams, Physick-Sheard et al. 2008). In foals, the principal 
parasite is the small intestinal nematode, Parascaris equorum, which can cause 
weight loss and gastrointestinal disease (Reinemeyer 2009). However, patent 
infection is rare and of less importance in adult horses, as protective immunity to this 
parasite is thought to develop by the age of six months (Clayton and Duncan 1979; 
Laugier, Sevin et al. 2012).  
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1.2 Cyathostominae 
Cyathostomins (family Strongylidae, subfamily Cyathostominae) pose a major threat 
to the health and welfare of equidae worldwide (Mfitilodze and Hutchinson 1990; 
Love, Murphy et al. 1999). Their prevalence and pathogenicity make them the most 
important equine nematodes (Love, Murphy et al. 1999). The vast majority of 
grazing horses will be exposed to cyathostomin infection to varying degrees 
throughout their lives, the control of which relies heavily on anthelmintic treatments 
(Matthews 2011). Of the fifty or so cyathostomin species described, over forty have 
been reported in horses (Lichtenfels, Gibbons et al. 2002); however, the majority of 
animals have burdens mainly comprised of ten common species (Torbert, Klei et al. 
1986; Lyons, Tolliver et al. 1999). These species are reported by Ogbourne (1976) 
as; Cylicostephanus longibursatus, Cyathostomum catinatum, Cylicostephanus goldi, 
Cylicocyclus nassatus, Cyathostomum coronatum, Cylicostephanus calicatus, 
Cylicostephanus minutus, Cylicocyclus leptostomus, Cyathostomum pateratum and 
Cylicocyclus insigne (Ogbourne 1976). Similar species’ prevalence have been 
reported by Reineymeyer et al. (Reinemeyer, Smith et al. 1984), Torbert et al. 
(Torbert, Klei et al. 1986) Lyons et al. (Lyons, Tolliver et al. 1996; Lyons, Tolliver et 
al. 1996) and, more recently, Traversa et al. (Traversa, Milillo et al. 2010). In a 
comparative study between populations in Germany, Italy and the UK, a reverse line 
blot (RLB) macroprobing assay (Traversa, Iorio et al. 2007) was performed to assess 
the distribution of 13 common cyathostomin species (Traversa, Milillo et al. 2010). 
These species were the ten listed above with the addition of Coronocyclus labiatum, 
Coronocyclus labratum and Cylicocyclus ashworthi (Traversa, Iorio et al. 2007). Of 
the three countries, Italy had the highest proportion of horses with a low number of 
species; 12% of yards had 2-3 cyathostomin species compared to 5% in the UK and 
none in Germany. Germany in comparison had the highest proportion of horses with 
the most diverse number of species; 40% of yards had 10-13 cyathostomin species 
compared to 25% in Italy and 27% in the UK (Traversa, Milillo et al. 2010). The 
differences between countries may be due to selection pressure imposed by differing 
anthelmintic treatment approaches; the clinical significance of this variation is not 
yet known (Traversa, Milillo et al. 2010).  
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1.2.1 Life cycle 
Cyathostomins have a direct, non-migratory life cycle (Figure 1.1). After ingestion 
from pasture, third stage larvae (L3) penetrate the wall of the large intestine, 
predominantly the caecum and the right ventral colon (Ogbourne 1976). Within the 
intestinal wall, larvae go through a number of developmental stages, initially as L3 
and then fourth stage larvae (L4). The L4 emerge from the intestinal mucosa and 
continue development in the gut lumen to L5 and subsequently adults, the female of 
which produce eggs after mating, which are passed into the environment in faeces. 
The eggs hatch and release first stage larvae (L1) and these develop in the faeces into 
second stage larvae and then the infective L3 (Matthews 2008). Cyathostomin 
development in faeces is dependent on temperature and moisture (Nielsen, Kaplan et 




Figure 1.1: Cyathostomin life cycle. Developing larvae (DL) include late L3, early L4 and late L4 in 
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1.2.2 Mucosal Larval Stages 
The pre-patent period from ingestion of L3 to release of eggs in faeces has been 
stated as approximately 6-12 weeks (Love and Duncan 1992); however, L3 can 
encyst in the gut wall for a longer period of time (inhibited development) lasting 
from months to years (Gibson 1953; Murphy and Love 1997). A consequence of this 
is that larvae can potentially accumulate in the mucosa of the intestinal tract to the 
order of several million (Smets, Shaw et al. 1999; Dowdall, Matthews et al. 2002). 
These encysted larvae play an important role in the epidemiology and pathogenesis 
of cyathostominosis (Giles, Urquhart et al. 1985) as the natural period of larval 
maturation appears to coincide with clinical cases of larval cyathostominosis. The 
exact mechanisms controlling this inhibited state are poorly understood. 
Epidemiological risk factors associated with the diagnosis of cyathostminosis have 
been demonstrated through multivariate analysis of assigned parameters using 
logistic regression (Reid, Mair et al. 1995). It was highlighted that the disease is 
more probably a cause of chronic diarrhoea in horses younger than six yrs. Those 
animals that have received anthelmintic treatment within the previous two weeks 
have an increased likelihood of cyathstominosis diagnois by three and a half times. 
Also, animals affected in the winter months are nearly five times more likely to have 
cyathostominosis than animals presenting with diarrhoea in the summer (Reid, Mair 
et al. 1995). In the UK and other temperate climates, larvae tend to encyst during the 
cooler winter months and may emerge en masse in the spring (Giles, Urquhart et al. 
1985). In the case of tropical climate the reverse is seen, where larvae emerge in the 
autumn following inhibition during the hot summer period (Baudena, Chapman et al. 
2000). It is also not clear as to what causes the encysted larvae to re-emerge. A 
reduction in the luminal cyathostomin population due to, for example, treatment with 
an anthelmintic may trigger mucosal emergence (Eysker, Boersema et al. 1997; Cobb 
and Boeckh 2009). Seasonal effects, host immunity, the magnitude and duration of 
challenge have all also been suggested (Murphy and Love 1997; Love, Murphy et al. 
1999; Chapman, French et al. 2002; Matthews 2008).  
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1.2.3 Current Control Strategies  
Anthelmintics are currently the main method of helminth control in horses (Stratford, 
McGorum et al. 2011). The anthelmintics currently available in the UK are divided 
into three classes; the benzimidazoles (BZs: fenbendazole, oxbendazole), 
tetrahydropyrimidines (THPS: pyrantel salts) and the macrocyclic lactones (MLs: 
ivermectin and moxidectin). The MLS approved for use in the horse are ivermectin 
and moxidectin, an avermectin and a milbemycin, respectively (Gokbulut, Nolan et 
al. 2001). These anthelmintics are thought to exert their effects by binding to gamma-
aminobutyric acid (GABA) and glutamate-gated channels and paralyse parasites 
(Shoop, Mrozik et al. 1995; Cobb and Boeckh 2009). Both MLs have proven 
efficacy against adult worms (Xiao, Herd et al. 1994; Molento, Nielsen et al. 2012); 
however, there are reported differences in efficacies against inhibited third stage 
larvae. In some studies ivermectin has been reported to have little to no efficacy 
against inhibited third stage larvae (Eysker, Boersema et al. 1992; Klei, Chapman et 
al. 1993; Xiao, Herd et al. 1994). However, others have reported a significant 
reduction (>75%) in mucosal larvae following treatment with oral ivermectin paste 
compared to untreated controls (Love, Duncan et al. 1995). Reports for moxidectin 
vary in efficacies against encysted third stage cyathostomin larvae ranging from 
insignificant (Xiao, Herd et al. 1994; Monahan, Chapman et al. 1995) to greater than 
90% (Bairden, Brown et al. 2001; Bairden, Davies et al. 2006). The discrepancies in 
observations for ivermectin and moxidectin efficacy may be related to experimental 
design (Love, Duncan et al. 1995). In particular, differences in the nature of 
experimental, compared to natural, infections may have an effect (Monahan, 
Chapman et al. 1996). Also in the case of moxidectin, which demonstrates persistent 
activity resulting in a long egg reappearance interval (Demeulenaere, Vercruysse et 
al. 1997; Vercruysse, Eysker et al. 1998), necropsies performed at different time 
points after treatment may lead to difficulty in interpretation of efficacy on various 
encysted stages (Eysker, Boersema et al. 1997; Bairden, Brown et al. 2001).  
To date, specific targeted administration of anthelmintics based on encysted larval 
burdens has been hindered by a lack of knowledge of an individual’s current 
infection status. FECs provide a rough estimate of adult luminal worms, but give no 
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indication of encysted larval burdens (Giles, Urquhart et al. 1985; Dowdall, 
Matthews et al. 2002). Mucosal larval stages, i.e. early L3, late L3 and developing 
L4, can constitute the major proportion of an individual’s cyathostomin burden 
(Duncan, Bairden et al. 1998; Collobert-Laugier, Hoste et al. 2002; Dowdall, 
Matthews et al. 2002). Therefore, whilst FECs may be a good indicator of an 
individual’s capacity to contaminate pasture and may also facilitate a reduction in 
selection pressure for anthelmintic resistance (Lester, Bartley et al. 2013), they do 
not give an accurate estimation of the encysted larval burden (Duncan, Bairden et al. 
1998; Klei and Chapman 1999; Dowdall, Matthews et al. 2002). Due to the severity 
of the disease and the consequences of untreated infection, the use of regular blanket 
treatment against encysted cyathostomin larvae with moxidectin has been advocated 
(Bairden, Brown et al. 2001). Such non-targeted and frequent treatments are likely to 
be a significant risk factor for the development and spread of anthelmintic resistance 
(Matthews 2011).  
 
1.2.4 Anthelmintic Resistance 
A feature of growing concern with regards to equine cyathostomin infection is the 
development of anthelmintic resistance (Love and Mckeand 1997). Cyathostomins 
have demonstrated signs of resistance to all three available drug classes (Molento, 
Antunes et al. 2008; Traversa, von Samson-Himmelstjerna et al. 2009). A reversion 
to susceptibility does not seem to occur in parasitic nematodes in general (Jackson 
and Coop 2000; Slocombe, Cote et al. 2008) and the fact that resistance is essentially 
everlasting is a further incentive to encourage new, more sustainable, approaches to 
control (Sangster 1999; Kaplan 2004). As there are no new equine anthelmintics 
currently under development, it is important to preserve the efficacy of those 
presently available (Kaplan and Nielsen 2010; Lester, Spanton et al. 2013). 
Benzimidazole resistance in cyathostomins is well documented and widespread 
(Dorny, Meijer et al. 2000; Kaplan 2002; Matthews 2008) and resistance to the 
pyrantel salts has also been demonstrated (Kaplan, Klei et al. 2004; Slocombe and de 
Gannes 2006; Traversa, Castagna et al. 2012). The situation in Brazil is of great 
concern, where resistance to all three anthelmintic classes was reported after all 
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tested products failed to reduce FEC by 95% and gave inadequate cyathostomin 
control up to 28 days after treatment (Molento, Antunes et al. 2008; Molento, 
Nielsen et al. 2012). There is further evidence of multi-class resistance, as reduced 
efficacy of both fenbendazole and pyrantel have been reported (Kaplan 2004; 
Traversa, Klei et al. 2007; Traversa, Castagna et al. 2012; Relf, Lester et al. 2014).  
The egg reappearance period (ERP), the time between administration and resumption 
of strongyle egg detection in faeces (Duncan 1985), is considered an early indicator 
of resistance (Sangster 1999). Evidence of a shortened ERP after ivermectin 
treatment has been reported in the Netherlands (Borgsteede, Boersma et al. 1993), 
and with moxidectin in Kentucky (Rossano, Smith et al. 2010) and the UK (Relf, 
Lester et al. 2014). The responsible use of moxidectin is of particular importance due 
to its reported efficacy against encysted larval, as well as adult stage cyathostomins 
(Vercruysse, Eysker et al. 1998; Bairden, Brown et al. 2001; Schumacher and 
Taintor 2008). Moxidectin’s value in killing encysted larvae and its persistent 
activity resulting in a longer egg reappearance period are factors that differentiate it 
from other anthelmintics (Eysker, Boersema et al. 1992; Cobb and Boeckh 2009; 
Corning 2009). Should resistance to this drug continue to develop, there will be no 
efficacious treatment for control of encysted cyathostomin stages (Matthews 2008).  
 
1.2.5 Clinical Significance 
Although horses acquire an incomplete age-related resistance to cyathostomin re-
infection (Klei and Chapman 1999), individual animals vary in their susceptibility to 
infection and this generally persists throughout an animal’s life (Nielsen, Monrad et 
al. 2006). Cyathostomin populations are over-dispersed, with the majority of 
parasites often present in the minority of the host population (Matthews 2008). 
Although the vast majority of grazing horses are exposed to cyathostomin 
populations, most animals harbour sub-clinical infections that do not result in overt 
clinical signs (Matthews 2010). Cyathostomins are pathogenic at their luminal and 
mucosal stages and horses with high levels of infection can develop clinical signs. A 
large adult worm population within the intestinal lumen can cause weight loss and 
debilitation (Murphy and Love 1997; Corning 2009), but of main concern, is the 
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potential damage that can be caused by the larval stages. Mucosal damage can occur 
when larvae first enter the gut wall and encyst in the host tissue (Murphy and Love 
1997). However, it is the mass emergence of encysted larvae, sometimes to the order 
of several million (Smets, Shaw et al. 1999; Dowdall, Matthews et al. 2002), that can 
cause significant intestinal damage. This life threatening inflammatory enteropathy is 
termed larval cyathostominosis (Giles, Urquhart et al. 1985; Bodecek, Jahn et al. 
2010). Cases of clinical larval cyathostominosis have been reported most frequently 
in temperate climates in late winter and early spring (Giles, Urquhart et al. 1985) and 
susceptibility to cyathostomin infection or larval cyathostominosis is life long and 
varies between individuals (Hodgkinson, Lichtenfels et al. 2003). A number of 
clinical signs have been ascribed, including weight loss, anorexia, diarrhoea, colic, 
oedema and pyrexia (Love, Murphy et al. 1999; Smets, Shaw et al. 1999; Bodecek, 
Jahn et al. 2010). Experimental infection has been observed to disrupt normal 
intestinal motility (Bueno, Ruckebusch et al. 1979) and this could be associated, 
along with additional mechanisms such as intestinal mucosal oedema and stimulated 
local production of vasoconstrictive substances, with clinical signs of colic (Mair and 
Pearson 1995; Murphy, Keane et al. 1997). Most animals with larval 
cyathostominosis will develop a neutrophilia and hypoalbuminaemia (Giles, 
Urquhart et al. 1985; Murphy, Keane et al. 1997). However, in practice, disease 
related to cyathostomin infestation is challenging to diagnose because there are no 
pathognomonic haematological, biochemical or clinical features, and horses can 
present with a wide range of symptoms (Love, Murphy et al. 1999; Hodgkinson 
2006; Bodecek, Jahn et al. 2010). In cases of larval cyathostominosis, aggressive 
therapy and additional supportive care, including fluid therapy, is necessary (Love 
and Mckeand 1997). In conjunction with oncotic and nutritional support the use of 
anti-inflammatory doses of corticosteroids is also recommended (Church, Kelly et al. 
1986; Murphy, Keane et al. 1997; Peregrine, McEwen et al. 2006). Euthanasia may 
be advocated due to the poor prognosis of the condition (Giles, Urquhart et al. 1985; 
Bodecek, Jahn et al. 2010). In Europe, despite intensive treatment, approximately 
50% of larval cyathostominosis cases do not survive (Giles, Urquhart et al. 1985; 
Murphy, Keane et al. 1997). 
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1.3 Mast cells in Gastrointestinal Parasitism 
1.3.1 Mast Cell Overview 
Mast cells are immune cells containing an abundance of lysosome-like secretory 
granules (Puri and Roche 2008) containing ‘mast cell mediators’ (Pejler, Ronnberg et 
al. 2010). These mediators can be classified into three broad categories; pre-formed 
secretory granule-associated mediators, lipid-derived mediators and cytokines 
(Metcalfe, Baram et al. 1997). Mast cells are derived from haematopoietic bone 
marrow stem cells (Tertian, Yung et al. 1981) and normally circulate in an immature 
form (Urb and Sheppard 2012). The migration of mast cell progenitors to the 
intestine is constitutive and requires both adhesive interactions and directed 
migration (Gurish and Boyce 2006). In the mouse the recruitment of mucosal mast 
cells is controlled by the c-kit pathway and ɑ4ß7 integrins (Gurish, Tao et al. 2001) 
which are expressed by mast cell progenitor cells (Gurish and Boyce 2006). The 
integrin, ɑ4ß7, interacts with mucosal addressin cell adhesion molecule 1 and 
endothelian vascular cell adhesion molecule 1 for transendothelial migration 
(Abonia, Austen et al. 2005). Terminal differentiation and maturation, including 
development of mature granules, occurs locally once the precursors reach their 
destination (Nakano, Sonoda et al. 1985; Metz and Maurer 2007); this is governed by 
cytokines, including stem-cell factor, secreted by endothelial cells and fibroblasts 
(Urb and Sheppard 2012). Despite the fact that mast cells share many characteristics, 
they represent a heterogeneous population in the human, rodent and horse (Welle 
1997; Pickles, Mair et al. 2010) comprised of specific subpopulations in different 
tissues (Befus, Pearce et al. 1982; Friend, Ghildyal et al. 1996; Scudamore, 
McMillan et al. 1997; Pemberton, McEuen et al. 2001). Mast cells have historically 
been classified as connective tissue mast cells (CTMC) or mucosal mast cells 
(MMC). These two populations are phenotypically different, as well as having 
differences in function and proteinase content (Metcalfe, Baram et al. 1997). Mast 
cells have also been classified according to their proteinase content into mast cells 
that contain tryptase only, mast cells that contain chymase only and mast cells that 
contain both proteinases (Weidner and Austen 1993; Kube, Audigé et al. 1998; 
Küther, Audigé et al. 1998; Pejler, Ronnberg et al. 2010; Pickles, Mair et al. 2010). 
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Mast cells have a complex array of functions, they are widely regarded as key 
immune effector cells and are also involved in allergic responses. Mast cells play an 
important role in host defence (Urb and Sheppard 2012); however, mast cell 
mediated inflammation can be deleterious or protective (Caughey 2007). For 
example, in the human, mast cells in the lung display direct antimicrobial activity to 
Streptococcus pneumoniae (Cruse, Fernandes et al. 2010) and they are believed to 
have a protective role in acute septic peritonitis in the rodent (Echtenacher, Mannel 
et al. 1996; Malaviya, Ikeda et al. 1996). Also, in response to venom proteins in 
rodents, mast cells have the capability to detoxify harmful proteins via the action of 
their proteinases (Metz, Piliponsky et al. 2006). However, intestinal mast cells are 
implicated in ulcerative colitis (Tremaine, Brzezinski et al. 2002; Hamilton, 
Sinnamon et al. 2011) and the involvement of mast cell derived mediators in rodent 
inflammatory bowel disease is suggested due to the mucosal pathophysiological 
changes observed in these conditions (Scudamore, Jepson et al. 1998). Also, in 
response to venom proteins in rodents, mast cells have the capability to mediate a 
fatal anaphylactic reaction (N. K and K. G. A 1952; Dutta and Narayanan 1954; 
Caughey 2007). Human and murine mast cells are known for their well-established 
roles in innate or in T helper 2 (Th2) and IgE associated immune responses (Galli, 
Nakae et al. 2005) and can be activated in numerous ways (Urb and Sheppard 2012). 
The best documented of these in humans and rodents is activation through IgE bound 
to high affinity IgE receptor (FcRI) expressed on the mast cell surface (Kinet 1990). 
Other than crosslinking of IgE receptors, mast cells can also be stimulated by direct 
injury or by activated complement proteins (Erdei, Andrásfalvy et al. 2004), the 
constitutive expression of C3 and C5 on human skin mast cells has been 
demonstrated (Fukuoka, Hite et al. 2013). They can also be activated directly by 
pathogens through pattern recognition receptors (Urb and Sheppard 2012), such as 
the Toll-like receptor family (McCurdy, Lin et al. 2001). Non-FcRI dependent mast 
cell activation has been demonstrated in rats to occur through polybasic molecules 
such as Polymyxin B (Lagunoff and Benditt 1960; Kruger and Lagunoff 1981), 
lectins and dextrans (Lagunoff, Martin et al. 1983) and a number of peptides, 
including the neuropeptide substance P (Lorenz, Wiesner et al. 1998; Li, Guo et al. 
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2012). In addition, in humans, adenosine (Polosa, Rorke et al. 2002) and cell-to-cell 
contact with T-lymphocytes (Bhattacharyya, Drucker et al. 1998) have also been 
demonstrated to cause mast cell activation. Activated mast cells release preformed 
mediators, (for example histamine and serine proteinases), from granules by 
exocytosis (Blank 2011); a process dependent on cellular calcium regulation via 
calcium channels (Barnes 1983; Tshori and Razin 2010). The released mediators lead 
to a rapid inflammatory response and recruitment of leucocytes and additional mast 
cells (Brooks and Bailey 2010). Time-lapse photography has shown that mast cells 
can recover following activation and the repeated release of mediators post-recovery 
has been demonstrated (Xiang, Block et al. 2001). One of the consequences of mast 
cell activation is self-amplification and further recruitment of mast cells (He, Gaca et 
al. 1998). In humans, tryptase is a stimulus for histamine release from tonsillar mast 
cells (He, Gaca et al. 1998) and histamine has also been demonstrated to modulate 
tryptase release from large intestinal mast cells (He and Xie 2004). This self-
amplification is of particular interest as stabilisation of mast cell populations, via 
histamine receptor antagonists, tryptase inhibitors and calcium channel antagonists, 
with the aim of preventing this self-amplification, is a potential therapeutic approach 
for conditions such as inflammatory bowel disease in humans (He, Xie et al. 2005) 
and laminitic horses (Owen 2009).  
 
1.3.2 Mast Cells in Nematode infections 
Mast cells are resident within tissues that interface with the external environment and 
play a sentinel role in host defence (Kumar and Sharma 2010) as well as regulating 
epithelial function (Scudamore, Jepson et al. 1998). The “common mucosal immune 
system” is based on observations that stimulation of one mucosal region can lead to 
activation of mucosal responses at sites distant to the initial region of exposure (van 
Ginkel, Nguyen et al. 2000), and is primarily mediated by the migration of mucosal 
immune cells from the site of stimulation to other distant mucosal sites. The mucosal 
immune system is the first line of defence against foreign antigens (Kiyono, Kweon 
et al. 2001). Organised sites of gut associated lymphoid tissue (GALT) in the 
intestine, such as the mesenteric lymph nodes and Peyer’s patches, comprise the 
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largest mass of lymphoid tissue in humans (Salminen, Bouley et al. 1998). One of the 
major mucosal effector sites is the lamina propria, where T cells and B cells are 
found in abundance alongside macrophages, eosinophils and mucosal mast cells 
(McGhee, Mestecky et al. 1992). With respect to the common mucosal system, mast 
cell numbers increase with proximity to the epidermis and increase with distance 
from the centre of the body, with mast cells in human skin displaying a 
proximal/distal and central/peripheral gradient (Weber, Knop et al. 2003). This 
supports the theory of their role as sentinel cells at these sites (Metz and Maurer 
2007) and their ability to directly respond to pathogens and send signals to allow the 
modulation of both innate and adaptive host immune responses (Urb and Sheppard 
2012).  
Intestinal nematode infections have been associated with the development of IgE-
mediated (Type-1) hypersensitivity responses in the gut (Jarrett and Miller 1982; 
King, Jia et al. 1997). Experiments using Trichinella spiralis and Nippostrongylus 
brasiliensis have demonstrated that the population of mucosal mast cells expands 
during T-cell dependent responses to these parasites (Mayrhofer and Fisher 1979 
{Ruitenberg, 1976 #483). In rats, following infection with both T. spiralis and N. 
brasiliensis, mucosal mastocytosis was demonstrated to be maximal at day 12, with 
parasite expulsion by day 15 and 16, respectively (Woodbury, Miller et al. 1984). 
Mast cell infiltration in the large intestine of horses with cyathostomin infection has 
also been demonstrated (Pickles, Mair et al. 2010). Horses acquire immunity to 
cyathostomin infection, but this is incomplete and poorly understood (Klei and 
Chapman 1999; Chapman, French et al. 2002). Mature horses, kept under similar 
treatment and maintenance protocols as younger animals, have lower FECs (Lind, 
HÖGlund et al. 1999). In general, younger horses also demonstrate a shorter egg 
reappearance period (Klei and Chapman 1999). These differences are believed to be 
a consequence of the larger mucosal populations harboured by younger animals, 
which are less susceptible to anthelmintic treatment, compared to luminal parasites 
(Herd 1986; Herd and Gabel 1990; Klei and Chapman 1999). Following treatment, 
these mucosal stages may emerge from the mucosa, in greater numbers in younger 
animals (Klei and Chapman 1999). Along with a weaker immune response allowing 
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a higher level of re-infection, this greater mucosal population could explain the age-
related differences (Klei and Chapman 1999). Variable worm burdens ranging from 
18,700 to 825,900 have been demonstrated in horses of the same age group (one to 
two years) grazing together, suggesting that an aspect of the host immune status 
determines the magnitude of the total burden (Bairden, Brown et al. 2001). Studies 
performed over a three-year period demonstrated consistencies in individual FECs; 
with low shedders remaining low despite a lack of treatment and high FEC shedders 
remaining in this category despite selective therapy (Nielsen, Haaning et al. 2006).  
Large intestinal mucosal mast cells (Pickles, Mair et al. 2010), CD4+ T helper cells, 
eosinophils (Collobert-Laugier, Hoste et al. 2002) and mucosal Th2 cytokines 
(Davidson, Hodgkinson et al. 2005) increase during cyathostomin infection. Th2 
cytokines, such as interleukin-4 (IL-4) and IL-10, activate and stimulate mast cells 
during Th2-mediated inflammation, resulting in intestinal mast cell hyperplasia 
(Shelburne and Ryan 2001), though the direct/causal relationship in horses has not 
been demonstrated. These Th2 cell cytokines, IL-10 and IL-4, have been 
demonstrated to show significant correlation to cyathostomin burden (Davidson, 
Hodgkinson et al. 2005) and the phenomenon of a Th2 driven immune response 
correlates with results observed in nematode models in mice (Lawrence, Paterson et 
al. 1998; Schopf, Hoffmann et al. 2002). The development of the appropriate Th 
response by CD4+ T helper cells is critical to the successful resolution of infection 
with the caecal intestinal nematode Trichuris muris (Else, Finkelman et al. 1994). A 
dominant Th1 response, with the production of interferon-gamma, IL-2 and tumour 
necrosis factor-beta (TNF-ß) (Romagnani 1999), is associated with susceptibility to 
the parasite; in contrast, a Th2 driven response, characterised by production of IL-4, 
IL-5, IL-6, IL-9, IL-10 and IL-13 (Romagnani 1999), is associated with host 
protection (Else and Grencis 1991; Else, Hültner et al. 1992; Else, Finkelman et al. 
1994). Also, in support of this, mice deficient in IL-10 and IL-4 fail to expel T. muris 
(Schopf, Hoffmann et al. 2002). The findings in horses to date are supportive of a 
Th2 type immune response to cyathostomin challenge (du Toit, McGorum et al. 
2007), however, the precise role of these cytokines in the horse has not been defined. 
Whilst it is hypothesised that they are protective in the host immune response to 
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parasites the factors driving these cytokines and their downstream mechanisms have 
yet to be thoroughly investigated (Davidson, Hodgkinson et al. 2005). 
 
1.3.3 Mast Cell Serine Proteinases 
The term “mast cell proteinase” is used to describe a proteinase that is transcribed in 
mast cells and stored in their secretory granules (Pejler, Ronnberg et al. 2010). The 
three main mast cell proteinase types are tryptase, chymase and carboxypeptidase-A. 
Each of these is diverse in form, activity and pattern of expression (Caughey 2007). 
These mast cell proteinases are expressed and stored at exceptionally high levels 
(Schwartz, Irani et al. 1987). Carboxypeptidase-A is a zinc-dependent 
metalloproteinase that hydrolyses C-terminal amino acid residues (Arolas, Vendrell 
et al. 2007; Pejler, Knight et al. 2009). Tryptase and chymase are classed as serine 
proteinases, because of the nucleophilic serine residue at the active site (Hedstrom 
2002). Tryptases and chymases are found in both mammals and bacteria and despite 
the fact that these proteinases are often found together within in the same mast cell 
granules, they appear to share no established common ancestor or evolutionary 
association (Gallwitz and Hellman 2006; Gallwitz, Reimer et al. 2006; Trivedi, Tong 
et al. 2007; Trivedi and Caughey 2010). Serine proteinase specificity is conferred by 
the topology of the substrate specific binding site, which is adjacent to the catalytic 
triad (Hedstrom 2002). This catalytic triad, part of a wide hydrogen bonding 
network, consists of Histidine-57 and Aspartate-102 at one side of the active site 
cleft and Serine-195 on the other (Hedstrom 2002). Two different loci encode the 
mast-cell expressed enzymes in mammals (Reimer, Samollow et al. 2010). There are 
a range of mast cell granule serine proteinases and these have distinct specificities 
and vary among mast cell subsets and between mammalian species (Table 1.1). 
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Species Mast Cell Subclass Chymases Tryptases* 
Human  MCT  α 
   ß (I, II, III) 
 MCTC h-chymase α 
   ß (I, II, III) 
Mouse MMC mMCP-1  
  mMCP-2  
 CTMC mMCP-4 mMCP-6 
  mMCP-5 mMCP-7 
  mMCP-9†  
Horse MMC eqMCP-1 eqTRYP 
 CTMC eqMCP-1 eqTRYP 
Table 1.1: Table of human, mouse and horse mast cell subclasses (adapted from Pejler, Ronnberg et 
al. 2010). *Refers to tetrameric, secreted tryptases. †Preferentially expressed in uterine mast cells 
(Hunt, Friend et al. 1997). (MMC: mucosal mast cell; CTMC: connective tissue mast cell; h-chymase: 
human chymase; mMCP: mouse mast cell proteinase; CPA: carboxypeptidase A; eqMCP-1: equine 
Mast Cell Proteinase-1; eqTRYP: equine Tryptase). 
 
Different mammals express varying numbers and types of tryptases and chymases 
(Caughey 2007). Multiple closely-related chymases are expressed by many 
mammalian species (McAleese, Pemberton et al. 1998; Miller and Pemberton 2002). 
Heterogeneous expression of mast cell proteinases was first described in rodents 
where antibodies specific to different mast cell proteinases demonstrated that the rat 
mucosal mast cell lacked the basic beta chymase (RMCP-I) but expressed the highly 
soluble beta chymase (RMCP-II) (Gibson and Miller 1986; Miller and Pemberton 
2002). Two equine mast cell proteinases have been purified from equine 
mastocytoma tissue and identified as equine tryptase and equine mast cell proteinase-
1 (eqMCP-1) (Pemberton, McEuen et al. 2001). The high salt mastocytoma extract 
was a highly concentrated source of mast cell serine proteinases and contained 
approximately 3% equine tryptase and 7% eqMCP-1 (Pemberton, McEuen et al. 
2001). After purification and N-terminal amino acid sequencing, the tryptase was 
found to be very similar to the sequence for human tryptase-ß (85% identity over 20 
residues), had a similar subunit molecular size (34-36 kDa as demonstrated by SDS-
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PAGE) and showed similar activity in substrate cleavage specificity (Dacre, 
McAleese et al. 2006). The 32 kDa chymotrypsin-like component, eqMCP-1, was 
found to be very similar to human granzyme H (95% over 19 residues) and 
immunolocalised to intestinal mucosal and submucosal mast cells (Pemberton, 
McEuen et al. 2001). 
Mast cell proteinase expression also varies between tissues in horses. Tryptase-
positive mast cells are abundant in equine lung and the predominant pulmonary mast 
cell type is tryptase-positive and chymase-negative (Pemberton, McEuen et al. 2001; 
Dacre 2005). In contrast, studies on equine intestinal cells demonstrated that the 
predominant mast cell type is chymase-positive and tryptase-negative (Pickles, Mair 
et al. 2010). Studies of the equine endometrium during the puerperal period 
identified two potential sub populations of mast cell, one that is chymase-negative 
and tryptase-positive and another that is hypothesised to be both chymase- and 
tryptase-negative (Welle, Audige et al. 1997).  
 
1.3.3.1 Tryptase  
Tryptases are trypsin-like serine proteinases that cleave peptide substrates on the 
carboxyl side of lysine and arginine residues (Little and Johnson 1995). The 
enzymatically active form is a tetramer of 120-140 kDa that consists of four tryptase 
monomer subunits of 31-34 kDa in a ring-like structure with a central pore (Pereira, 
Bergner et al. 1998). The active site is protected and largely inaccessible to 
endogenous mammalian proteinase inhibitors (Pejler, Ronnberg et al. 2010). The 
multigene tryptase locus encodes mast cell tryptases and also a number of tryptase-
like proteinases that are active in other tissues but are not mast cell related (Reimer, 
Samollow et al. 2010). This locus is structurally similar in humans and mice and can 
be divided into two regions; one encoding Group 1 tryptases (membrane-bound 
tryptase-like proteinases) and the other encoding soluble mast cell-derived Group 2 
tryptases (Wong, Yasuda et al. 2004). Analysis of data available from the dog, 
bovine, opossum and platypus genomes along with orthologs from bird, fish and frog 
species, has shown that this locus is well conserved with an indication that the 
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present genes within the multigene tryptase locus are mammalian specific (Reimer, 
Samollow et al. 2010).  
Tryptase is stored almost exclusively in mast cells (Walls, Jones et al. 1990) and is a 
widely used marker of systemic mast cell activation and mastocytosis (Schwartz, 
Metcalfe et al. 1987; Schwartz 2001; Akin, Soto et al. 2007). In the mouse, tryptase 
contributes to the immune response to T. spiralis through eosinophil recruitment 
(Shin, Watts et al. 2008). Tryptase also plays a role in self-amplification with its 
release inducing further mast cell activation and degranulation (He, Gaca et al. 
1998). Cloning and sequencing of equine mastocytoma-derived tryptase has been 
performed (Dacre, McAleese et al. 2006). Observations made using the 
chymotrypsinogen numbering system, based on the alignment of amino acid 
sequences with chymotrypsinogen (Hartley and Neurath 1970; Hedstrom 2002), 
indicated that the sequence is the same length as (245 amino acid mature protein) and 
shares >70 % identity with other mammalian tryptases (Dacre, McAleese et al. 
2006). Many features were found to be characteristic of trypsin-like proteinases 
including the characteristic aspartate residue at position 189 which governs substrate 
specificity (Perona, Hedstrom et al. 1995), the activation site region IVGG (residues 
31-34) and cysteine residues at positions 191 and 220 (Czapinska and Otlewski 
1999; Dacre, McAleese et al. 2006). Residue 216 is important in determining 
substrate specificity (Perona, Hedstrom et al. 1995) therefore it is interesting that 
equine tryptase has alanine at this position, instead of glycine. The biological 
significance of this difference is not known (Dacre, McAleese et al. 2006).  
 
1.3.3.2 Chymase  
Chymases, one of the major mast cell granule constituents, are monomeric and have 
chymotrypsin-like cleavage specificity and cleave substrates on the C-terminal side 
of aromatic amino acids (Andersson, Karlson et al. 2008). The chymase family can 
be subdivided into two groups, alpha and beta chymases, based on their phylogenetic 
analyses (Chandrasekharan, Sanker et al. 1996). This family has a range of substrate 
preferences and activity (Trivedi and Caughey 2010). The mast cell chymase locus 
has been mapped for a number of species and, in all cases, the locus contains a 
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minimum of one mast cell chymase alpha gene, two T and Natural Killer (NK) cell-
expressed granzyme genes and one gene for neutrophil cathepsin G (Reimer, 
Samollow et al. 2010). In humans, chymase and cathepsin G belong to a family of 
serine proteinases which include factor D of the complement system, elastase, 
proteinase-3 and the lymphocyte and NK cell derived human granzymes A, B, H and 
M (Trivedi and Caughey 2010). Many placental mammals demonstrate dramatic 
expansion of this locus (Reimer, Samollow et al. 2010) but it is unknown why some 
mammals express more chymases than others (Trivedi and Caughey 2010). The large 
dimensions of the rodent chymase loci are partly due to gene families that have no 
homologues in the human (Gallwitz and Hellman 2006; Gallwitz, Enoksson et al. 
2007). The genome of the rat contains 13 closely-related functional chymases 
(Gallwitz and Hellman 2006), compared to at least 14 in mice (Gallwitz and Hellman 
2006) and four in humans (Caughey, Schaumberg et al. 1993; Gallwitz and Hellman 
2006). Apart from ruminants, where two very similar alpha-chymase genes have 
been described (Gallwitz, Reimer et al. 2006), in all other species investigated a 
single alpha-chymase has been found (Andersson, Karlson et al. 2008). The mouse 
locus is almost three times larger than the human equivalent and also contains three 
times the number of functional genes (Gallwitz and Hellman 2006). Two 
subfamilies, beta chymases and mouse mast cell proteinase-8 (mMCP-8), have been 
found in the mouse but not in the human genome (Lützelschwab, Huang et al. 1998). 
The rat chymase locus has also undergone considerable expansion (Puente and 
López-Otín 2004) and despite a high number of pseudogenes, it has a similar number 
of functional genes to the mouse (Gallwitz and Hellman 2006). Rat mast cell 
proteinase I is a chymase that is primarily found in the connective tissue (Woodbury, 
Everitt et al. 1978; Rouleau, Garbarg et al. 1994). However, the chemically and 
antigenically distinct rat mast cell proteinase II, another chymase, is localized to 
respiratory and intestinal mucosal mast cells (Woodbury, Gruzenski et al. 1978). Rat 
MCP-II, has been demonstrated to be released systemically following N. brasiliensis 
challenge and has been measured using an enzyme linked immunosorbent assay 
(ELISA) (Miller, Woodbury et al. 1983). The translocation of this proteinase to the 
gut lumen in parasitised rats challenged with worm antigen has been demonstrated 
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(King and Miller 1984). In vitro studies have demonstrated that the action of this 
chymase increases epithelial permeability and alters the distribution of tight junction 
proteins (Scudamore, Jepson et al. 1998). The role of chymases in parasite infection 
has been investigated with the use of knockout strains of mice deficient in certain 
proteinases (Pejler, Ronnberg et al. 2010). The absence of mMCP-1 has been 
demonstrated to affect the kinetics of N. brasiliensis infection (Wastling, Knight et 
al. 1998). This knockout also had a negative effect on the clearance of T. spiralis 
(Knight, Wright et al. 2000) and the intestinal inflammation associated with this 
helminth was ameliorated suggesting that this chymase plays a significant role in this 
process (Lawrence, Paterson et al. 2004). T. spiralis infection is associated with an 
increased paracellular permeability of the jejunum, a phenomenon which is blocked 
in the absence of mMCP-1 and could potentially be a reason for the inability of the 
deficient mice to efficiently expel the parasites (McDermott, Bartram et al. 2003). 
As with equine tryptase mentioned above, the cloning and sequencing of the equine 
mastocytoma derived eqMCP-1 has been previously investigated (Dacre 2005). 
When attempting to clone and sequence the chymase sequence from equine tissue the 
deduced amino acid (aa) sequence for the putative equine mast cell proteinase-1 
(referred to in this thesis as Chymase-like Proteinase -1, CLP1) had an N-terminal aa 
sequence that differed from the mastocytoma derived eqMCP-1 by two aa. Also, 
peptide masses predicted by trypsin digestion of the cloned putative aa sequence 
corresponded poorly with the fingerprint of mastocytoma derived eqMCP-1 (Dacre 
2005). Due to these differences it was hypothesised that a similar but novel 
proteinase was cloned and sequenced.  
Both CLP1 and eqMCP-1 sequences shared similar identities with the lymphocyte 
derived human granzyme H (Dacre 2005). Granzymes are members of a 
chymotrypsin related family of serine proteinases produced by cytotoxic T-cells and 
NK cells (Trapani 2001). Granzymes can be grouped according to their specificity; 
their subfamilies have tryptase-like, chymotrypsin-like and elastase-like properties. 
Eight granzymes have been identified in the mouse (granzyme A-G and granzyme 
M) compared to five in the human (granzyme A, B, H, M and granzyme 3) (Trapani 
2001). The subfamily with chymotrypsin-like specificity is grouped on the chymase 
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locus and includes mouse granzyme B, C, D, E, F and G and granzyme B and H in 
the human (Trapani 2001). 
 
1.3.4  Mast Cell Serine Proteinases in Nematode Infections 
There is evidence of local mast cell activation at the site of parasite infection 
(Metcalfe, Baram et al. 1997) and mast cells and their associated proteinases have 
been implicated in the protective host immune response against nematode infection 
in mammals (Miller 1996; Wastling, Scudamore et al. 1997; McDermott, Bartram et 
al. 2003). Mast cells can reversibly alter their proteinase phenotypes depending on 
host disease state (Ghildyal, Friend et al. 1993; Friend, Ghildyal et al. 1996). 
Activation of innate immune responses relies on the recognition of pathogen-
associated products (Marshall and Jawdat 2004) and mast cells have been implicated 
in this process (Heib, Becker et al. 2008).  
In rodents, the mast cell serine proteinases, tryptase and chymase, contribute to 
innate immunity and tissue remodelling, through proteolysis of matrix proteins, to 
aid nematode expulsion (Miller and Pemberton 2002). In the rat, mucosal mast cells 
have a functional role in immune elimination of the intestinal T. spiralis and N. 
brasiliensis with systemic secretion of rat MCPII maximal at the time of parasite 
expulsion (Woodbury, Miller et al. 1984). Murine mast cell serine proteinase 
expression has been shown to be reversibly modified through infection with T. 
spiralis (Friend, Ghildyal et al. 1996; Friend, Ghildyal et al. 1998). Furthermore in 
the mouse, ablation of the murine chymase mouse mMCP-1 compromises expulsion 
of T. spiralis (Knight, Wright et al. 2000; McDermott, Bartram et al. 2003). 
Differential mast cell proteinase expression has been demonstrated during the 
inflammatory response to nematode infection as the cells migrate towards the 
mucosa (Friend, Ghildyal et al. 1996; Friend, Ghildyal et al. 1998). In one four-week 
study of mice infected with T. spiralis, jejunal mast cells in the submucosa, lamina 
propria and epithelium were shown to exhibit sequential changes in their granule 
ultrastructure and chymase phenotype. At 2-3 weeks post infection (pi), the mucosal 
mast cell population increased more than 25-fold relative to non-infected mice 
(Friend, Ghildyal et al. 1996). These cells expressed the chymase mouse mast cell 
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proteinase 2 (mMCP-2), ceased expressing mMCP-5 and finally expressed mMCP-1, 
as the cells progressed respectively through the tissues. In the recovery phase, four 
weeks post infection (pi), as the cells reached the tips of the villi, the base of the villi 
and the submucosa, they ceased expressing mMCP-1, expressed mMCP-5 and finally 
ceased expressing mMCP-2, respectively (Friend, Ghildyal et al. 1996).  
In the equine case the two neutral serine proteinases previously extracted from 
equine mastocytoma tissue, eqTRYP and eqMCP-1 (Pemberton, McEuen et al. 2001) 
have been used to investigate the intestinal immune response to cyathostomin 
infection (Pickles, Mair et al. 2010). Polyclonal antibodies against these proteinases 
were raised in rabbits (Pemberton, McEuen et al. 2001) and these antibodies were 
subsequently purified and their specificity validated (Dacre, McGorum et al. 2007). 
Immunohistochemical labelling of equine formalin-fixed large intestinal sections 
using these reagents identified increased numbers of tryptase-positive mast cells in 
cyathostomin infected horses despite the use of a tissue fixative that is not ideal for 
immunohistochemical staining (du Toit, McGorum et al. 2007). More recent studies 
using Carnoy’s fixed tissue (Pickles, Mair et al. 2010) demonstrated a strong positive 
linear relationship between cyathostomin burden and the presence of equine tryptase 
and eqMCP-1 within the caecal wall of naturally infected horses. The majority of 
mast cells labelled for eqMCP-1 however, the strongest relationship with 
cyathostomin burden was with tryptase-labelled mast cells. Total cyathostomin 
burden was estimated to account for 57 % of the variation in tryptase-labelled mast 
cells counts in the caecal mucosa in this study (Pickles, Mair et al. 2010).  
 
1.4 Diagnostic Approach to Cyathostomin Infection 
The development of a minimally invasive diagnostic test to provide information on 
an individual’s encysted larval cyathostomin burden has the potential to improve 
horse welfare and health. Knowledge of an individual’s encysted larval burden 
would be beneficial to inform strategic and targeted treatments, especially in young 
horses that are more susceptible to clinical disease (Traversa, Milillo et al. 2010). 
Serum is relatively easy to obtain, hence it is an attractive potential sample for 
diagnostic testing. Previous work has identified two antigen complexes (20 and 25 
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kDa) in somatic antigen preparations of larval cyathostomins that may have 
diagnostic potential (Dowdall, Matthews et al. 2002; Dowdall, Proudman et al. 2003; 
Dowdall, Proudman et al. 2004). The majority of work to date has concentrated on a 
protein present in a 25 kDa antigen complex specifically detected in the encysted 
larval stages. This antigen is known as cyathostomin gut associated larval antigen 
(Cy-GALA) (McWilliam, Nisbet et al. 2010). A diagnostic IgG(T) ELISA using 
recombinant versions of this protein generated from a number of common 
cyathostomin species is currently being assessed (Matthews 2011). The serum half-
life of circulating IgG(T) antibodies has been measured as 21 days in horses 
(Sheoran, Timoney et al. 2000) and the dynamics of antigen specific IgG(T) 
responses, particularly following treatment, are a concern when considering the 
utility of a diagnostic assay, as levels of parasite-specific IgG(T) may persist 
following clearance of active infections. Concurrent measurement of a biomarker 
indicating active mucosal infection would be a useful and complimentary diagnostic 
tool (McWilliam, Nisbet et al. 2010).  
Mast cell tryptase, is frequently used as a biomarker for mast cell activation and 
mastocytosis (Schwartz, Metcalfe et al. 1987; Schwartz 2001; Akin, Soto et al. 
2007). ELISAs have been used with success to measure the systemic release of mast 
cell proteinases into blood in rats (Miller, Woodbury et al. 1983; Woodbury, Miller 
et al. 1984), mice (Huntley, Gooden et al. 1990) and sheep (Huntley, Gibson et al. 
1987) with nematode infections. An increase in caecal mast cells expressing 
proteinases has been demonstrated during cyathostomin infection (du Toit, 
McGorum et al. 2007; Pickles, Mair et al. 2010) and measurement of these enzymes 
in serum has diagnostic potential as a biomarker of active infection. An optimised 
mast cell proteinase ELISA has potential to identify active cyathostomin infections, 
which would be of significant benefit to veterinary practitioners as larval 
cyathostominosis can present with a wide range of clinical signs which, as previously 
stated, are not pathognomonic for the disease (Love, Murphy et al. 1999). Also, a 
further potential benefit of a serum diagnostic would be to assess the level of 
encysted burden to inform strategic targeted anthelmintic treatments. 
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Biopsies of rectal mucosa are taken routinely by veterinarians in practice as a 
diagnostic aid for evaluation of intestinal disease, in particular inflammatory bowel 
disorders (Lindberg, Nygren et al. 1996). They are relatively non-invasive, cheap and 
easy to perform. The presence of cyathostomins in rectal tissue taken from rectal 
biopsy has been documented (Church, Kelly et al. 1986; Ricketts 1996), but this 
finding is rare. As indicated above, the common mucosal immune system has the 
potential to evoke mucosal immune responses throughout the gut, including the 
rectum (Lycke 2012). Mast cells are commonly found at interfaces to the external 
environment such as the rectum (Knight, Wright et al. 2000; Heib, Becker et al. 
2008), leading to the hypothesis that mast cells could be recruited throughout the 
large intestine and rectum in numbers positively associated with cyathostomin 
burden, such that rectal biopsy may have diagnostic potential for prediction of total 
cyathostomin burden. 
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1.5 Thesis aims 
The work presented here aims to examine three complementary hypotheses.  
There is a positive association between mast cell numbers and cyathostomin 
burden throughout the large intestine such that rectal biopsy may have a 
diagnostic potential for estimation of total cyathostomin burden. 
 
Serum and large intestinal tissue mast cell proteinase concentrations are 
positively associated with mast cell number and proteinase expression, and 
with cyathostomin burden, such that they have diagnostic potential for 
prediction of total cyathostomin burden. 
 
There are novel equine mast cell proteinases that have not yet been identified. 
The release of these novel proteinases may be more closely related to worm 
burden. 
 
Research in these areas will improve the understanding of the role of mast cells and 
their proteinases in cyathostomin infection. This thesis will further investigate the 
involvement of these cells in naturally infected horses. The primary aim is to 
evaluate the potential for mast cell proteinase assays or rectal biopsy methods to be 
used in minimally invasive diagnostic tests to assist in estimating the total (i.e. 
including mural stages) cyathostomin burden. A secondary aim is to explore the 








Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Two: Investigation into Recruitment of Large Intestinal Mast Cells in 
Response to Cyathostomin Infection  25 
2 Investigation of Recruitment of Large Intestinal Mast Cells 
in Response to Cyathostomin Infection 
2.1 Introduction 
A central element of the cyathostomin lifecycle is the arrested period during which 
encysted larvae are believed to inhibit development in the equine gut wall. 
Cyathostomin mucosal larval populations can persist at high levels (over 3 million 
larvae have been enumerated in some individuals (Dowdall, Matthews et al. 2002), 
which are thought to put the individual at risk of life-threatening intestinal damage 
(Matthews, Hodgkinson et al. 2004). Equine larval cyathostominosis, in which there 
is mass emergence of encysted cyathostomin larvae from the intestinal wall, results 
in severe diarrhoea, weight loss and ventral oedema, and has up to a 50% mortality 
rate (Love, Murphy et al. 1999). The biological factors underlying cyathostomin 
inhibition are not well understood and it is not known what makes certain individuals 
more susceptible to high numbers of encysted larvae. Factors associated with the 
emergence of these larvae are also not well described. It has been hypothesised that 
season, feedback from luminal mature worms, host immunity and the magnitude of 
challenge may all play a role in development of larval cyathostominosis (Love, 
Murphy et al. 1999; Chapman, French et al. 2002; Matthews 2008). There are 
currently no specific diagnostic tests for the assessment of an individual’s mucosal 
cyathostomin burden. Virtually all grazing equids will be exposed to cyathostomins 
and are therefore at risk (Matthews 2011). Whilst most horses have low level 
infections (Matthews 2008; Traversa, von Samson-Himmelstjerna et al. 2009), 
current recommendations are for the annual administration of anthelmintics effective 
against cyathostomin mucosal stages to prevent the accumulation of large encysted 
larval populations (Lester, Spanton et al. 2013). As there are no new anthelmintic 
classes currently in development, the responsible and targeted use of those that are 
available is of paramount importance. There is also a requirement for the 
development of robust diagnostic assays that will enable identification of horses at 
risk of severe parasitic disease, in conjunction with informing strategic anthelmintic 
targeting protocols.  
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Mast cells are commonly found in large numbers at mucosal interfaces (Kumar and 
Sharma 2010). The role of the mast cell as a key element to the pathogenesis of 
immediate-type hypersensitivity reactions including urticaria, bronchial asthma and 
allergic rhinitis is well established (Welle 1997). Pronounced hyperplasia, 
differentiation, and activation of mucosal mast cells occurs in the intestine during 
nematode infections (Woodbury, Miller et al. 1984; Miller 1996) and it is proposed 
that equine mast cells play a key role in the immune response to equine cyathostomin 
infection. A previous study reported a positive relationship between total adult 
cyathostomin burden and mucosal mast cell counts in the caecum and dorsal colon 
and between the percentage of encysted L3 and mucosal mast cell counts in the 
ventral colon of aged horses, i.e. those older than 10 years (Collobert-Laugier, Hoste 
et al. 2002). A further study has shown a significant positive linear relationship 
between total larval cyathostomin burden and the number of Toluidine Blue (TB) 
stained mast cells in the mucosa and submucosa of the caecum of naturally infected 
horses (Pickles, Mair et al. 2010). The investigation into the role of mast cells in 
cyathostomin infection is continued in this chapter through the characterisation of 
parasite burden and mast cell enumeration in 28 naturally infected horses.  
The aim of the work presented here was to examine the first hypothesis: 
There is a positive association between mast cell numbers and cyathostomin 
burden throughout the large intestine such that rectal biopsy may have 
diagnostic potential for estimation of total cyathostomin burden. 
Specifically, an optimised protocol for cyathostomin larval enumeration was 
developed and the resultant larval burdens compared with the mast cell numbers in 
individual horses from a population comprising of 28 horses. The relationship 
between mast cell populations in the mucosa and submucosa in the intestine at the 
level of the caecum, right ventral colon (RVC) and rectum were also compared. 
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2.2 Materials and Methods 
2.2.1 Sampling Protocol  
Samples were collected for parasite enumeration, histological evaluation, mast cell 
enumeration and proteinase expression between November 2010 and September 
2012. The protocol was optimised for the sampling sites, the equine abattoir 
(Cheshire Equine Services, Nantwich, UK) and the Royal (Dick) School of 
Veterinary Studies (R(D)SVS, Edinburgh, UK). 
 
2.2.2 Abattoir Sampling Protocol  
Samples were collected and processed in the gut room of the abattoir (Figure 2.1). 
Following slaughter, the equine gastrointestinal organs were passed through to the 
gut room for disposal. Large intestinal tracts were selected at random following 
confirmation that the full tract, including the rectum, was present to ensure that all 
necessary samples could be collected. The abattoir processes equine tissue for human 
consumption. Regulations require that horses slaughtered for human consumption 
should not have been treated with anthelmintics for at least 35 (ivermectin) or 64 
(moxidectin) days prior to slaughter. If these regulations have been met this cohort 
should not have been treated close to sampling, however, due to the nature of the 
slaughter process it was not possible to access reliable clinical history, age of horse 
or recent anthelmintic administration for individual animals.  
 
2.2.3 R(D)SVS Sampling Protocol 
Samples were collected and processed in the post mortem suite at the R(D)SVS 
(Figure 2.1). Apart from individual DV3, a clinical case of larval cyathostominosis, 
only horses with no known gastrointestinal pathology were selected. Horses from the 
R(D)SVS were sampled immediately (within 30 min) following euthanasia. The 
clinical histories, ages and prior anthelmintic administration for horses from 
R(D)SVS were recorded where possible. 
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Figure 2.1: Schematic of protocol for processing of samples including tissue, serum and faeces collected from the R(D)SVS and equine abattoir. (FEC: Faecal Egg 
Count; RVC: Right ventral colon; DL: Developing larvae; EL3: Encysted third stage larvae; TMI: Transmural Illumination; TB: Toluidine Blue; MC: Mast Cell; IHC: 




































Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Two: Investigation into Recruitment of Large Intestinal Mast Cells in 
Response to Cyathostomin Infection  29 
2.2.4 Serum Samples 
Left or right colonic vein blood samples were collected post mortem as a source of 
local serum draining the site of interest. Blood was collected by syringe and needle 
aspiration and left to clot overnight at 4 °C. Serum was collected after centrifugation 
at 1,730 x g for 10 min at 4 °C and stored in aliquots at -20 °C and -80 °C. A 
peripheral blood sample was also collected from either the jugular vein or lower limb 
vessels from horses sampled at the R(D)SVS. Due to the nature of the slaughter line 
process it was not feasible to collect peripheral blood samples from the horses 
sampled at the abattoir.  
 
2.2.5 Faecal Samples 
Approximately 50 g of faecal matter was taken from the rectum and placed in a grip 
seal bag. Air was removed from the bag which was then placed in a chill box for 
transport. Once transferred to the laboratory, faecal samples were stored at 4 °C for a 
maximum of two days until a faecal egg count (FEC) was performed. Smaller faecal 
samples of approximately 3 g were also sampled and snap frozen and transported on 
dry ice. Samples were then transferred to -80 °C. 
 
2.2.6 Rectal Samples 
Rectal biopsies (8 per horse) were taken using endometrial biopsy forceps (Equivet 
uterine biopsy forceps, Kruuse). The rectum was orientated anatomically such that 
biopsies could be taken in a similar manner and position to those taken for diagnostic 
purposes in the live animal. Biopsies were taken 20 cm cranial to the anus, which 
corresponds to the level described previously for collecting equine rectal mucosal 
biopsies to aid differential diagnoses (Traver and Thacker 1979). A gloved hand was 
introduced through the anal sphincter and a fold of mucosa palpated. The biopsy 
instrument was advanced and the jaws of the forceps closed onto the mucosa to 
obtain a biopsy sample. The biopsies were taken avoiding the 12 o’clock position to 
avoid the dorsal vasculature. Two biopsies were placed in glass bijous of Carnoy’s 
fixative for subsequent immunohistochemistry. After ≥ 24h in Carnoy’s fixative, 
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these samples were transferred to 70 % ethanol until further processing into paraffin 
blocks and sectioning. Two more biopsies were placed in a plastic bag and snap 
frozen on dry ice for transfer to -80 °C and storage for ELISA experiments. Two 
biopsies were placed in a plastic bijoux containing RNAlater (Sigma-Aldrich). These 
samples were stored overnight at 4 °C and then the tissue transferred to -80 °C 
storage. The final two biopsies were put in a plastic bag and stored in a cool box until 
transferred to storage at -20 °C for pepsin digestion and larval enumeration. Rectum 
from horses from the equine abattoir was incised and a large sample of rectal mucosa 
(approx 15 cm2) dissected. These sections were stored at -20 °C for pepsin digestion 
and larval enumeration. Two rectal sections (approx 1 cm2) were harvested from 
horses from the abattoir (horses AB1-AB16) using dissecting scissors and placed in 
glass bijoux of Carnoy’s fixative, as previously described. Taking rectal biopsies 
requires the use of biopsy forceps which use a pincer motion to extract a sample. 
There is potential to damage the tissue through crushing and cutting and therefore 
may not produce a representative sample. To examine this effect, rectal sections were 
taken from all the abattoir cases (horses AB1-AB16) and processed in the same 
manner as the biopsy sections for comparison. Microscopy was performed without 
knowledge of the sampling technique, horse sampled or cyathostomin burden. These 
sections were taken to compare the biopsies with tissue sections to ensure that the 
biopsy method did not damage the tissue. 
 
2.2.7 Luminal Contents for Parasite Enumeration 
The caecum was identified and isolated by tying off the distal ileum and caecocolic 
junction with lengths of string. The RVC was isolated by identifying the pelvic 
flexure and placing a string tie halfway between the caecocolic junction and the 
pelvic flexure to separate right and left ventral colons. The caecum and RVC were 
separated from the rest of the gastrointestinal tract using a dissecting knife and 
placed into separate buckets. The organ was opened along a taenial band and the 
contents emptied into a measuring bucket. Any gross pathology was noted. The 
caecum was examined for evidence of Anoplocephala perfoliata, paying particular 
attention to the caecal wall, caecal base and ileocaecal valve (Fogarty, del Piero et al. 
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1994; Williamson, Gasser et al. 1997). The caecal mucosa was washed with 1 L tap 
water twice to remove any attached luminal parasites. The total volume of contents, 
including washings, was recorded. The contents were stirred thoroughly and a 100 
ml sample collected. The sample was stored in a cool box and preserved with an 
equal volume of 10 % neutral buffered formalin. This process was repeated for the 
RVC. 
 
2.2.8 Tissue Samples for Parasite and Mast Cell Enumeration and 
Mast Cell Proteinase Quantitation 
The opened organs were examined visually and any attached parasites or gross 
pathology noted. The caecum was placed in an empty bucket on top of a set of wash 
down scales (Digital Retail Scale WBZ 6, Adam Equipment Co. Ltd) and the mass 
recorded. Using scissors, a 5 % by mass longitudinal sample from base to apex was 
harvested for transmural illumination (TMI), avoiding taenial bands. This section 
was stored in a cool box and transferred to –20 °C until further processing. A further 
5 % by mass sample was taken and stored in the same manner for pepsin digestion. 
Six adjacent approximately 1 cm2 sections were obtained using dissection scissors. 
Two sections were put in a plastic bag on dry ice to be stored at –80 °C for ELISA 
experiments. Two sections were placed in glass bijoux of Carnoy’s fixative as 
described for mast cell enumeration and immunolabelling. The final two sections 
were placed in RNAlater solution (Invitrogen). This process was repeated for the 
RVC. All equipment was cleaned thoroughly between horses to avoid contamination. 
 
2.2.9 Faecal Egg Count 
Faeces collected from the rectum post mortem were stored at 4 °C for a maximum of 
two days. A FEC was performed in duplicate using a salt floatation method modified 
by Bartley at al. (2006) originally described by Christie and Jackson (1982) and 
accurate down to one egg per gram (EPG).  
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2.2.10 Luminal Cyathostomin Enumeration  
The 100 ml caecal and RVC samples were stored in 100 ml of 10 % neutral buffered 
formalin at 4 oC until enumerated. To aid enumeration, iodine was added to the 
luminal contents (15 ml per 100 ml). The stained contents were washed over a 53 µm 
aperture sieve (Fisher) to remove formalin and excess iodine and re-suspended in 
water. The samples were screened using scored Petri dishes and a stereomicroscope 
(Leica S8 APO, Leica Microsystems) at x 10 magnification. All stages of larvae 
enumerated were classed as luminal cyathostomins. 
 
2.2.11 Transmural Illumination to Detect Mural Cyathostomins 
Developing mucosal larvae, late L3 (LL3) and developing L4 (DL4), were 
enumerated using TMI following a method similar to that described by Reinemeyer 
and Herd (1986). The frozen samples were re-weighed and then defrosted in tepid 
water. Once thawed, the mucosa was stripped from the serosa and the serosa 
discarded. The mucosa was cut using dissecting scissors into sections of 
approximately 5 cm2. Each small section was enumerated individually on a scored 
Petri dish illuminated from below using a dissecting microscope (Leica S8 APO, 
Leica Microsystems). The mucosa was stretched out across the surface of the Petri 
dish, serosa side down, using a small amount of water to aid stretching. The 
developing larvae were identified according to Lichtenfels (1975) and enumerated at 
x 12.5 magnification with the aid of a grid.  
 
2.2.12 Peptic Digestion  
2.2.12.1 Peptic Digestion Method and Larval Enumeration 
Caecal, RVC and rectal biopsy samples were digested using a modification of 
techniques described by Duncan, Bairden et al. (1998) and Dowdall, Matthews et al. 
(2002). Five percent, by weight, frozen samples were re-weighed and then defrosted 
in tepid water. Once thawed, the mucosa was manually stripped from the serosa and 
the serosa discarded. The tissue was digested in a solution of 1 % (w/v) 1:10,000 
pepsin/1.5 % (v/v) concentrated hydrochloric acid (Fisher Scientific) in warm tap 
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water with up to 25 g of tissue per 100 ml digest solution. The digest was performed 
at 37 °C using a magnetic stirrer to constantly agitate the mixture of tissue and 
solution. Every 45 to 60 min, a ‘milking’ procedure was performed, as described by 
Murphy and Love (1997). The digest solution and mucosa was passed through a 2 
mm aperture sieve (Cole-Palmer Instrument co. Ltd) and undigested material was 
returned to the same conditions in 200 ml of fresh digest solution. To stop the 
digestion process, the solution containing digested material was centrifuged at 450 × 
g for 2 min in 50 ml Falcon tubes and the pellet recovered and made up to a volume 
50 ml of 7 % (v/v) formal saline. This process was performed a total of 2-3 times, 
every 45-60 min. Digestion was continued until no host tissue remained in the sieve. 
The entire pellet was recovered and made up to a volume 50 ml of 7 % (v/v) formal 
saline. Two, 0.5 ml aliquots of the re-suspended pellet (above) were examined at x 80 
magnification (Leica S8 APO, Leica Microsystems) to count inhibited third stage 
larvae (EL3) (Dowdall, Matthews et al. 2002). These were extremely small and 
uniform in size and morphology as described by Duncan et al. (1998). Larval counts 
were aided by the addition of 0.5 ml iodine. The total organ count was calculated 
from the percentage by weight of the sample and multiplied to allow for dilution of 
the pellet after centrifugation. Developing larvae (DL) were identified according to 
Lichtenfels (1975) and also counted in the aliquots. This was done to compare the 
digest method with the TMI method for enumeration of DL. 
 
2.2.13 Mast Cell Staining 
Tissue samples were fixed in Carnoy’s fixative. The samples were kept in solution at 
room temperature for 24 h prior to being transferred to 70 % ethanol before paraffin 
embedding. Slides were prepared in duplicate for each organ, one from each of two 
separate tissue samples taken adjacently. Tissue sections were cut to 8 µm thick and 
mounted onto Superfrost Plus slides (Fisher Scientific). Sections were de-waxed with 
xylene, rehydrated through graded alcohols and water and then immersed in 0.5 % 
Toluidine Blue (VWR International) in 0.5M HCl, pH 0.5. Slides were left in this 
solution overnight. Sections were then briefly washed with tap water and counter 
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stained by immersion in 1 % eosin (VWR International) in 70 % ethanol for 3 sec. 
Slides were again washed with tap water and then dehydrated and mounted.  
 
2.2.14 Mast Cell Enumeration 
All histological counts were performed without knowledge of cyathostomin burden. 
Sections were observed using an Olympus BX50 microscope and photographed 
using an Olympus U-CMAD digital camera and AnalySIS Five software (Soft 
Imaging System GmbH, Münster, Germany). Positively-stained cells were identified 
and enumerated using a calibrated graticule over five mucosal and submucosal fields 
of view per slide (giving a total of 10 per field for each organ) under x 400 
magnification. Total area per graticule field at this magnification was 0.0625 mm2. 
Mast cells were expressed as MC per mm2. 
 
2.2.15 Haemotoxylin and Eosin Staining 
Caecal, RVC and rectal tissue samples from horses DV6-DV12 inclusive were 
collected for haemotoxylin and eosin (H&E) staining and eosinophil enumeration. 
Tissues samples of approximately 1 cm2 were taken adjacent to those samples stored 
in Carnoy’s and preserved in 10% neutral buffered formalin before paraffin 
embedding. Tissue sections were cut to 8 µm thick, mounted onto Superfrost Plus 
slides and dewaxed in xylene and rehydrated to water. The tissue was then stained 
with Eosin followed by Haematoxylin Z (both Cellpath) and washed with tap water. 
Unfortunately, background staining was too high in Carnoy’s fixed tissue. 
 
2.2.16 Carbol Chromotrope Staining  
Tissue sections from the caecum, RVC and rectum were fixed in either 10% formal 
saline or Carnoy’s fixative. The tissue samples in Carnoy’s were kept in solution at 
room temperature for 24 hs and then transferred to 70% ethanol. Sections were 
dewaxed in xylene and rehydrated with water. The tissue was then stained with 
Haematoxylin Z (Cellpath) and washed with tap water. Following this, sections were 
destained in acid/alcohol, washed in Scott’s tap water substitute and washed again in 
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tap water. Sections were stained overnight at room temperature in Carbol 
Chromotrope stain (0.5% Chromatrope (Sigma) in 1% Phenol). The following day 
sections were washed in tap water, dehydrated and mounted.  
 
2.2.17 DAB Staining for Eosinophils 
Tissue samples from the caecum, RVC and rectum were fixed in 10% Formal Saline 
or Carnoy’s fixative. Sections were de-waxed with xylene and rehydrated through 
graded alcohols and water. Slides were then transferred to Sequenza slide carriers 
(Thermo Shandon) and washed through with phosphate buffered saline (PBS). 
Following washing, 100 µl of 3,3’-diaminobezidine (DAB) (Envision kit, Dako Ltd) 
were added to each section for 8 min to visualise the eosinophils through peroxidise 
staining reaction (Kingston and Pearson 1981). Slides were washed with distilled 
water, counterstained with Haematoxylin Z (Cellpath) and then dehydrated and 
mounted.  
 
2.2.18 Enumeration of Eosinophils 
All histological counts were performed without knowledge of cyathostomin burden. 
Positively-staining cells, which were pink with H&E and Carbol Chromotrope and 
brown with DAB (Kingston and Pearson 1981), were identified and counted as per 
mast cell enumeration. Eosinophils were expressed as eosinophil cells (EC) per mm2. 
 
2.2.19 Data Analysis 
As data were not normally distributed, non-parametric tests were selected. For 
optimal graphical representation log transformed (log10+1) data is sometimes 
presented. Statistical analyses and graphical displays were performed using the 
statistical computer package R Studio (V 0.97.551), Minitab 15 statistical software 
and GraphPad Prism5. For investigating parasitological relationships, correlations 
were assessed using the Spearman rank test in R. Correlations were also investigated 
between mast cell counts, using the same test also in R. For comparison of paired 
data the Wilcoxon Signed rank test was selected and for unpaired, the Mann-Whitney 
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test using GraphPad Prism5. Standard linear regression analysis was used to explore 
the relationships between log10+1 transformed mucosal and submucosal mast cell 
counts and log10+1 transformed combined total mucosal burdens using Minitab 15. 
The presence of A. perfoliata was added as a confounding variable. Results were 
considered statistically significant at p<0.05. 
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2.3 Results 
2.3.1 Sample Cohort 
Samples were collected for parasite enumeration, histological evaluation, mast cell 
enumeration and proteinase expression from the equine abattoir and the R(D)SVS. 
2.3.1.1 Equine Abattoir 
Sixteen horses were sampled from the equine abattoir. On post mortem there was 
evidence of A. perfoliata infection from gross examination in 6 of the 16 horses 
(37.5%) (Table 2.1). Luminal cyathostomins were found in 75% and 88% of the 
horses in the caecum and the RVC, respectively (Table 2.1). 
 
Horse Av FEC 
(EPG) 














AB 1 21 Y N Y 0 1,800 
AB 2 7 N Y Y 263 0 
AB 3 0 N N N 0 0 
AB 4 16 N Y Y 975 3,375 
AB 5 0 N N N 0 138 
AB 6 13 Y N Y 1,750 27,750 
AB 7 10 N N N 4,020 46,340 
AB 8 39 N N N 0 1,320 
AB 9 29 N N N 2,520 400 
AB 10 17 N Y Y 70 5,120 
AB 11 290 N Y Y 8,600 81,300 
AB 12  141 N Y Y 9,780 16,600 
AB 13 315 N N N 1,260 19,590 
AB 14 186 N N N 100 2,700 
AB 15 36 N N N 540 760 
AB 16 16 N Y Y 115 1,200 
 
Table 2.1: Results of non-mucosal cyathostomin enumerations and tapeworm observations from 
abattoir horses, AB1-16. (Av FEC: Average Faecal Egg Count; EPG: Eggs Per Gram; PM: Post 
Mortem; RVC: Right ventral colon). 
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Developing larvae enumerated by TMI were found in 14 of the 16 (88%), and 15 of 
the 16 (94%) horses in the caecum and RVC, respectively (Table 2.2). This finding 
was consistent with the enumerations performed by peptic digestion. Of all the 16 
abattoir horses only one, AB3, had no detectable parasites. 
 
















AB 1 2,536 14,000 143,746 312,653 146,281 326,653 
AB 2 21,002 41,804 32,085 77,878 53,087 119,683 
AB 3 0 0 0 0 0 0 
AB 4 1,075 670 3,880 664 4,954 1,334 
AB 5 21 20 2,079 1,015 2,100 1,035 
AB 6 29,198 88,919 102,807 80,684 132,004 169,603 
AB 7 3,665 3,818 216,994 226,746 220,659 230,564 
AB 8 3,670 5,849 3,266 9,333 6,935 15,183 
AB 9 199 393 20,670 23,794 20,869 24,187 
AB 10 2,452 8,554 94,623 109,315 97,075 117,870 
AB 11 8,043 17,085 46,246 86,360 54,289 103,445 
AB 12  4,240 7,326 31,799 71,712 36,039 79,038 
AB 13 18,911 14,166 95,589 55,714 114,499 69,880 
AB 14 1,098 1,934 19,238 25,483 20,335 27,417 
AB 15 4,786 1,209 12,733 4,491 17,519 5,700 
AB 16 0 446 0 7,910 0 8,355 
 
Table 2.2: Results of mucosal cyathostomin enumerations from abattoir horses AB1-16. (RVC: Right 
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2.3.1.2 R(D)SVS 
Twelve horses were sampled at the R(D)SVS over the period 28/01/11 to 
05/09/2012. Where possible, gender, age and the reason for euthanasia for each case 
were reported, as detailed in Table 2.3.  
 
Horses Sample Date Age (year) Gender Reason for Euthanasia 
DV 1 28/01/2011 15 Male Poor performance 
DV 2 09/02/2011 22 Female Elective  
DV 3  05/04/2011 3 Female Larval cyathostominosis 
DV 4  11/05/2011 14 Male Lame 
DV 5  18/05/2011 >15 Female Laminitis 
DV 6 13/12/2011 4 Female Elective  
DV 7 31/05/2012 4 Male Elective  
DV 8 07/06/2012 >15 Male Elective  
DV 9 04/07/2012 5-15 Male Elective  
DV 10 09/07/2012 5-15 Male Elective  
DV 11 11/07/2012 25 Female Hyperadrenocorticism 
DV 12 05/09/2012 1 Male Elective  
 
Table 2.3: Data collected from R(D)SVS horses DV1-12 including sample date, age, gender and 
reason for euthanasia.  
 
On post mortem there was evidence of A. perfoliata from gross examination in 1 of 
the 16 cases (Table 2.4). No horses had evidence of tapeworm on FEC, though this 
methodology is not validated for these worms. Luminal cyathostomins were found in 
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Horses Av FEC 
(EPG) 














DV 1 0 N N N 0 0 
DV 2 89 N Y Y 500 188 
DV 3  0 N N N 400 570 
DV 4  16 N N N 120 1,200 
DV 5  0 N N N 0 0 
DV 6 0 N N N 0 0 
DV 7 7 N N N 0 120 
DV 8 396 N N N 230 19,000 
DV 9 155 N N N 600 11,160 
DV 10 1 N N N 0 0 
DV 11 1 N N N 0 0 
DV 12 26 N N N 90 0 
 
Table 2.4: Results of non-mucosal cyathostomin enumerations and tapeworm observations from 
R(D)SVS horses, DV1-12. (Av FEC: Average Faecal Egg Count; EPG: Eggs Per Gram; PM: Post 
Mortem; RVC: Right ventral colon). 
 
Developing larvae were enumerated by TMI and found in 5 of the 12 (42%) and 8 of 
the 12 (67%) horses in the caecum and RVC, respectively. In the case of encysted 
larvae, EL3 were found in 4 of the 12 (33 %) and 7 of the 12 (58%) horses in the 
caecum and RVC, respectively. Three of the R(D)SVS cases (25%), DV1, DV5 and 
DV6, were found to be strongyle free. Horse DV3 had a markedly higher 
cyathostomin burden with more than 1.7 million larvae in the caecum and more than 
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DV 1 0 0 0 0 0 0 
DV 2 187 87 0 1,947 187 2,035 
DV 3  96,928 51,124 1,676,119 2,002,927 1,773,046 2,054,051 
DV 4  0 19 0 643 0 662 
DV 5  0 0 0 0 0 0 
DV 6 0 0 0 0 0 0 
DV 7 0 75 0 0 0 75 
DV 8 40 334 0 656 40 990 
DV 9 2,323 6,380 23,853 109,791 26,177 116,171 
DV 10 0 0 0 656 0 656 
DV 11 0 39 640 0 640 39 
DV 12 699 1320 665 656 1364 1976 
 
Table 2.5: Results of mucosal cyathostomin enumerations from R(D)SVS horses, DV1-12. (RVC: 
Right ventral colon; DIG: Digest; TMI: Transmural Illumination; TMB: Total Mucosal Burden). 
 
 
2.3.2 Comparison of Location of Sample Collection 
The two different sampling sites, the R(D)SVS and the abattoir, represent two 
distinct cohorts. Individual value plots (Figures 2.2 and 2.3) are presented of the 
luminal and total mucosal burden. The two cohorts were different in their luminal 
(p=0.007) and total mucosal (p=0.005) burdens with the abattoir cohort having 
significantly greater burdens than the R(D)SVS population. 
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Figure 2.2: Individual value plot of (log10+1) transformed total luminal cyathostomin counts from 
abattoir and R(D)SVS horses for comparison of sample location. Luminal counts for the abattoir 
horses were significantly higher than the horses sampled from the R(D)SVS, p=0.007 (Test: Mann-
Whitney). The non-axis horizontal line indicates the median. 
 

























Figure 2.3: Individual value plot of (log10+1) transformed CTMB counts from Abattoir and R(D)SVS 
horses for comparison of sample location. CTMB counts for the abattoir horses were significantly 
higher than the horses sampled from the R(D)SVS, p=0.005 (Test: Mann-Whitney). The non-axis 




Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Two: Investigation into Recruitment of Large Intestinal Mast Cells in 
Response to Cyathostomin Infection  43 
2.3.3 Cyathostomin Recovery 
2.3.3.1 Larval Recovery Techniques 
The peptic tissue digest method was optimised for enumeration of EL3 (Figure 2.4: 
black arrow). Developing larvae were also observed in the digested matter (Figure 
2.4). These larvae displayed evidence of morphological damage which increased 
with digest time (Figure 2.5: black arrow). 
 
 
Figure 2.4: Image of large developing larvae (large black arrow) and encysted third stage larvae below 
it (small, eye lash shaped – small black arrow) following tissue digest for comparison of difference in 










Figure 2.5: Images of larvae released from tissue. A: Image of encysted third stage larvae released 
from caecal tissue and stained with iodine, following peptic digestion. B: Image of developing larvae 
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2.3.3.2 Evidence of Empty Cysts on Transmural Illumination 
In a number of cases, evidence of previous larval damage was observed (Figure 2.6). 
Areas suggestive of the recent presence of larvae were noted on TMI in 10 out of the 
28 horses (36%). These areas of fibrous capsules surrounding a more translucent 
empty cyst-like structure have previously been documented as potential areas of 
larval damage (Steinbach, Bauer et al. 2006; Pickles, Mair et al. 2010; Stancampiano, 
Gras et al. 2010). Horse AB3 was negative for cyathostomins on TMI but had a large 







Figure 2.6: Image from Transmural Illumination of areas suggestive of empty cysts. A: AB16 




2.3.3.3 Evidence of Encysted Larvae in Rectal Mucosa 
Two rectal biopsies were taken from each of the 28 horses and examined by TMI for 
the presence of developing larvae. The mean mass of the combined biopsies was 0.5g 
+/- 0.2g. The tissue was subsequently digested and this digest examined for EL3. Of 
the 28 horses, encysted L3 were seen in one case (4%) (AB2) and DL in two (7%) 
(AB6 and DV3) (Figure 2.7). 
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Figure 2.7: Rectal mucosal larvae at varying stages of development. A: Encysted developing larvae 
from Transmural Illumination. B: Encysted third stage larvae released following tissue digest. C: 
Developing larvae released following tissue digest. 
 
It was also possible to take rectal mucosal sections from the horses sampled at the 
equine abattoir and these larger tissue sections were weighed and processed in the 
same manner as the rectal biopsies. The mean mass of the rectal mucosa sampled 
was 38.4 g +/- 12.0 g. Of the 16 horses sampled, DL, from TMI assessment, were 
found in five cases (31%) (AB2, AB6, AB8, AB12 and AB13) and EL3 from tissue 
digest assessment in four (25%) (AB2, AB6, AB7 and AB10). For analysis, the 
horses were grouped according to whether or not rectal larvae were found. The 
horses with evidence of larvae in the rectum had a significantly higher total mucosal 
burden, p=0.0003 (Figure 2.8). 

















Figure 2.8: Individual Value Plot of of log10+1 transformed CTMB grouped according to presence or 
absence of rectal mucosal larvae. The horses with evidence of larvae in the rectum had a significantly 
higher total mucosal burden, p=0.0003 (Test: Mann Whitney). The non-axis horizontal line indicates 
the median. (DL: Developing larvae; EL3: Encysted third stage larvae). 
   
A B C 
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2.3.3.4 Case of Larval Cyathostominosis 
 
Figure 2.9: Image of a clinical case of larval cyathostominosis, horse DV3, at post mortem. This horse 
was sampled at the R(D)SVS.  
 
Horse DV3 was confirmed at post mortem to have larval cyathostominosis. The 
horse was in poor body condition (Figure 2.9) and there was evidence of numerous 
adult cyathosomin larvae around the rectum and in the faeces. The intestinal tissue 
was inflamed, hyperaemic and oedematous (Figure 2.10). The FEC for this animal 
was negative. The luminal count was positive, with burdens of 800 and 1,140 larvae 
in the caecum and RVC respectively. On TMI assessment, numerous larvae were 
seen at various stages of development. Tissue digest revealed EL3 burdens of 
approximately 1.7 million and over 2 million in the caecum and RVC, respectively. 
Evidence of DL was seen on TMI of biopsied rectal tissue. 
 
Figure 2.10: Image of inflamed, hyperaemic and oedematous tissue from the right ventral colon of 
Horse DV3, a case of larval cyathostominosis. 
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2.3.4 Parasitology 
2.3.4.1 Faecal Egg Counts 
A negative FEC was observed in six cases (21 %) (AB3, AB5, DV1, DV3, DV5 and 
DV6). The median FEC was 16 EPG (range 0 - 396 EPG). Three horses (AB11, 
AB13 and DV8) had FEC greater than 200 EPG (Figure 2.11). Table 2.6 shows the p 
values for correlation between FEC and the cyathostomin counts using a Spearman 
rank correlation test for non-parametric data. The FEC significantly positively 
correlated with the luminal count in the caecum and RVC but not the EL3 and TMB 
in the caecum (Table 2.6). 
 
 
Figure 2.11: Barchart of average faecal egg count (FEC) of all horses sampled (AB1-16 and DV1-12). 
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 FEC 
 p-value rho 
Luminal Caecum 0.002 0.566 
Luminal RVC <0.001 0.675 
DL Caecum 0.018 0.442 
DL RVC 0.011 0.474 
EL3 Caecum 0.149 0.280 
EL3 RVC 0.031 0.409 
TMB Caecum 0.062 0.358 
TMB RVC 0.031 0.407 
 
Table 2.6: Table of p-values (italic) and rho values (bold) for correlations between FEC and 
cyathostomin burdens. Correlations performed using Spearman rank analysis. Significant correlations 
(p<0.05) are highlighted. (FEC: Faecal egg count; RVC: Right ventral colon; DL: Developing larvae; 
EL3: Encysted third stage larvae; TMB: Total Mucosal Burden). 
 
2.3.4.2 Luminal Counts 
Luminal counts were performed on the caecal and RVC contents. The visualisation 
of cyathostomin was greatly improved with the addition of iodine. Male and female 
cyathostomins were observed (Figure 2.12). Six horses (21%) had no evidence of 
luminal burdens (AB3, DV1, DV5, DV6, DV10 and DV11). Horses AB1, AB5, AB8 
and DV7 were negative in the caecum but had RVC luminal burdens. Conversely, 
horses AB2 and DV12 had burdens in their caecum only.  
 
 
Figure 2.12: Image of male (left) and female (right) luminal cyathostomins stained with iodine. 
Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Two: Investigation into Recruitment of Large Intestinal Mast Cells in 
























Figure 2.13: Scatterplot of log10+1 transformed RVC luminal (y-axis) versus caecal luminal (x-axis) 
counts coloured according to sample location (Abattoir (ab): black; R(D)SVS: red). p<0.001, 
rho=0.695. (Test: Spearman rank). (RVC: Right ventral colon). 
 
 
Luminal counts ranged from 0 to 9,780 (AB 12) in the caecum (median 118) and 0 to 
81,300 (AB 11) in the RVC (median 980). There was a strong correlation between 
the counts in the two organs, p<0.001 (Figure 2.13). In the majority of cases (86%) 
the luminal burden was greater in the RVC than the caecum and this was statistically 









Figure 2.14: A: Individual log10+1 transformed value plot of caecal and RVC luminal counts. The 
luminal count in the RVC was significantly greater than in the caecum, p=0.001 (Test: Wilcoxon 
signed rank test). The non-axis horizontal line indicates the median. B: Graph of individual values of 
log10+1 caecal and RVC luminal counts with lines connecting the values for each horse. (RVC: Right 
ventral colon). 
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2.3.4.3 Mucosal Counts 
2.3.4.3.1 Developing larvae 
Developing larvae were enumerated using the TMI method (Figure 2.15). Five 
horses were negative on TMI (AB3, DV1, DV5, DV6 and DV10). A further four 
horses were DL-negative in the caecum, but positive for these stages in the RVC 
(AB16, DV4, DV7 and DV11). There were no horses that were positive for DL in 
the caecum yet negative for these stages in the RVC.  
 
Figure 2.15: Image of evidence of developing larvae (DL) at various stages on Transmural 
Illumination (TMI) from the caecum of horse AB6. 
 
 
DL counts ranged from 0 to 96,928 (DV3) in the caecum (median 887) and 0 to 
88,919 (AB6) in the RVC (median 939). There was a strong correlation between the 
counts in the two organs, p<0.001 (Figure 2.16). In the majority of cases the DL 
burden was greater in the RVC than in the caecum and this difference was 
statistically significant, p=0.037 (Figure 2.17). 
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Figure 2.16: Scatterplot of log10+1 transformed RVC DL (x-axis) versus caecal DL (y-axis) counts 
coloured according to sample location (Abattoir (ab): black, R(D)SVS: red). p<0.001, rho=0.931. 














Figure 2.17: A: Individual value plot of log10+1 transformed caecal and RVC DL counts. The DL 
count in the RVC was significantly greater than that in the caecum, p=0.037 (Test: Wilcoxon signed 
rank test). The non-axis horizontal line indicates the median. B: Graph of individual values of log10+1 
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2.3.4.3.2 EL3 Count 
Early L3 were enumerated from tissue digest (Figure 2.18). Five horses had no 
evidence of EL3 burdens (AB3, DV1, DV5, DV6 and DV7). Horses AB16, DV2, 
DV4, DV8 and DV10 were negative in the caecum, but had evidence of EL3 in the 
RVC. Horse DV11 had evidence of EL3 in the RVC and not the caecum. 
 
Figure 2.18: Image of encysted third stage larvae (EL3) released from tissue through pepsin digest and 
stained with iodine. 
 
EL3 counts ranged from 0 to 1,676,119 (DV3) in the caecum (median 6,200) and 0 
to 2,002,927 (DV3) in the RVC (median 10,254). There was a strong correlation 
between EL3 counts in the two organs, p<0.001 (Figure 2.19). In the majority of 
cases, the EL3 burden was greater in the RVC than in the caecum and this difference 






















Figure 2.19: Scatterplot of log10+1 transformed caecal EL3 (x-axis) versus RVC EL3 (y-axis) counts 
coloured according to sample location (Abattoir (ab): black, R(D)SVS: red). p<0.001, rho=0.897. 
(Test: Spearman rank). (EL3: Encysted third stage larvae; RVC: Right ventral colon). 
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Figure 2.20: A: Individual value plot of log10+1 transformed caecal and RVC EL3 counts. The EL3 
count in the RVC was significantly greater than that in the caecum, p=0.025 (Test: Wilcoxon signed 
rank test). The non-axis horizontal line indicates the median. B: Graph of individual values of log10+1 




2.3.4.4 Comparison of Larval Recovery Techniques 
Caecal and RVC DL were enumerated in two ways: from TMI assessment and tissue 
digest analysis (DIG). In both organs, the two methods produced counts that were 
significantly correlated, p<0.001 (Figure 2.21). In the caecum, there was no 
significant difference between the two counting techniques, p=0.507 (Figure 2.22). 
However, in the RVC the TMI count was significantly different to those estimated by 
DIG, p=0.040 (Figure 2.23). Therefore, for all developing larval (DL) comparisons 
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Figure 2.21: A: Scatterplot of log10+1 transformed caecal DL from TMI (x-axis) versus caecal DL 
from DIG (y-axis) counts, p<0.001, rho=0.889. (Test: Spearman rank). B: Scatterplot of log10+1 
transformed counts of RVC DL from TMI (x-axis) versus RVC DL from DIG (y-axis). p<0.001, 
rho=0.888. (RVC: Right ventral colon; DL: Developing larvae; EL3: Encysted third stage larvae; 








Figure 2.22: A: Individual log10+1 transformed value plot of caecal DL from TMI and caecal DL 
from DIG counts. There was no significant difference between the caecal DL count from TMI or DIG, 
p=0.507 (Test: Wilcoxon signed rank test). The non-axis horizontal line indicates the median. B: 
Graph of individual values of log10+1 caecal DL from TMI and caecal DL from DIG counts with 
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Figure 2.23: A: Individual log10+1 transformed value plot of RVC DL from TMI and RVC DL from 
DIG counts. There were significantly more DL counted from TMI than from DIG, p=0.040 (Test: 
Wilcoxon signed rank test). The non-axis horizontal line indicates the median. B: Graph of individual 
values of log10+1 RVC DL from TMI and RVC DL from DIG counts with lines connecting the 
values for each horse. (RVC: Right ventral colon; DL: Developing larvae; TMI: Transmural 
Illumination; Dig: Digest). 
 
2.3.4.5 Total Mucosal Burdens 
The TMB for each organ was calculated from the combination of DL from TMI and 
EL3 populations from tissue digest. The TMB of the caecum ranged from 0-
1,773,047 encysted larvae with a median of 5,945. The RVC had a greater TMB 
range of 0–2,054,051 and a median of 7,028. The RVC had a significantly greater 
total population, p=0.006 (Figure 2.24). Using a Spearman rank correlation test for 
non-parametric data, Table 2.7 shows the p values for correlation between 
cyathostomin TMB in the caecum or RVC and the various cyathostomin 
developmental stages. The only non-significant correlation was between the FEC and 
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Figure 2.24: A: Individual log10+1 transformed value plot of caecal TMB and RVC TMB. The RVC 
had a significantly greater TMB than the caecum, p=0.006 (Test: Wilcoxon signed rank test) The non-
axis horizontal line indicates the median. B: Graph of individual values of log10+1 caecum and RVC 




 TMB Caecum TMB RVC 
 p-value rho p-value rho 
FEC 0.062 0.358 0.031 0.407 
Luminal C 0.001 0.594 0.001 0.601 
Luminal RVC <0.001 0.636 <0.001 0.649 
Total Luminal <0.001 0.693 <0.001 0.711 
DL Caecum <0.001 0.905 <0.001 0.862 
DL RVC <0.001 0.900 <0.001 0.927 
Total DL <0.001 0.909 <0.001 0.925 
EL3 Caecum <0.001 0.988 <0.001 0.910 
EL3 RVC <0.001 0.910 <0.001 0.980 
Total EL3 <0.001 0.949 <0.001 0.979 
TMB Caecum NA NA <0.001 0.927 
TMB RVC <0.001 0.927 NA NA 
CTMB <0.001 0.962 <0.001 0.984 
 
Table 2.7: Table of p-value (italic) and rho values (bold) for correlations between caecal and RVC 
TMB’s and parasitology data. Significant p values (<0.05) are highlighted. (Test: Spearman rank). 
(FEC: Faecal egg count; RVC: Right ventral colon; DL: Developing larvae; EL3: Encysted third stage 
larvae; TMB: Total Mucosal Burden; CTMB: Combined Total Mucosal Burden). 
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Of the cyathostomin-positive horses, in all but three cases (DV4, DV7 and DV8), the 
mucosal burden made up more than 50% of the total cyathostomin count. Mural 
counts were significantly higher than luminal counts in the both the caecum and 
RVC (p<0.001). Similarly, in all but two horses (DV6 and DV12) the EL3 
population made up more than 50% of the TMB and EL3 counts were significantly 
higher than DL counts in both organs (p<0.001). The matrix plot (Figure 2.25) 
graphically demonstrates the relationships between the combined (caecum and RVC) 
luminal, total DL, total EL3, combined total mucosal burden (CTMB) and average 
FEC. The corresponding p values can be found in Appendix Table 2.8. The CTMB 
displayed a strong correlation with the total EL3 (p<0.001, rho=0.990). The only 
non-significant correlations were between the average FEC and the EL3 count and 
TMB of the caecum (Table 2.8). 
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Figure 2.25: Matrix scatterplot of log10+1 transformed data for total (caecum and RVC combined) luminal, total DL, total EL3, CTMB and average FEC grouped 
according to sample location (Abattoir: black, R(D)SVS: red). (FEC: Faecal Egg Count; DL: Developing larvae; EL3: Encysted third stage larvae; CTMB: Combined 
Total Mucosal Burden). 
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Table 2.8: Table of p values (italics) and rho values (bold) for correlation matrix of parasite count data. Significant p values (<0.05) are highlighted. (FEC: Faecal Egg 
Count; RVC: Right ventral colon; DL: Developing larvae; EL3: Encysted third stage larvae; TMB: Total Mucosal Burden; CTMB: Combined Total Mucosal Burden).























FEC  0.566 0.675 0.707 0.442 0.474 0.472 0.280 0.409 0.401 0.358 0.407 0.405 
Luminal C 0.002  0.695 0.795 0.643 0.597 0.607 0.564 0.586 0.595 0.594 0.601 0.602 
Luminal RVC <0.001 <0.001  0.970 0.600 0.649 0.642 0.604 0.673 0.680 0.636 0.649 0.672 
Total Luminal <0.001 <0.001 <0.001  0.656 0.703 0.698 0.661 0.718 0.723 0.693 0.711 0.724 
DL Caecum 0.018 <0.001 0.001 <0.001  0.931 0.953 0.883 0.827 0.860 0.905 0.862 0.881 
DL RVC 0.011 0.001 <0.001 <0.001 <0.001  0.995 0.885 0.875 0.901 0.900 0.927 0.934 
Total DL 0.011 0.001 <0.001 <0.001 <0.001 <0.001  0.893 0.876 0.904 0.909 0.925 0.936 
EL3 Caecum 0.149 0.002 0.001 <0.001 <0.001 <0.001 <0.001  0.895 0.941 0.988 0.910 0.952 
EL3 RVC 0.031 0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001  0.983 0.910 0.980 0.963 
Total EL3 0.034 0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001  0.949 0.979 0.990 
TMB Caecum 0.062 0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001  0.927 0.962 
TMB RVC 0.031 0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001  0.984 
CTMB 0.033 0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001  
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2.3.5 Mast Cell Response 
2.3.5.1 Validation of Rectal Biopsy Technique 
To verify that rectal biopsies were representative of rectal tissue, cell counts of rectal 
tissue sections and rectal biopsy pilot data were compared as average cell count per 
field. Mucosal and submucosal mast cells were enumerated and the results are shown 
in Table 2.9. The mast cell counts from the rectal biopsy and tissue sections were 
significantly correlated in the case of the mucosa and the submucosa, p<0.001 
(Figure 2.26). There was no significant difference between the two methods of tissue 
sampling for mast cell counts in either the mucosa, p=0.128 (Figure 2.27), or 
submucosa, p=0.171 (Figure 2.28). 
 
 RS  
MMC 
(av cell count/field) 
RB  
MMC 
(av cell count/field) 
RS  
SMMC 
(av cell count/field) 
RB  
SMMC 
(av cell count/field) 
AB1 12 6 10 17 
AB2 28 26 18 15 
AB3 9 6 5 4 
AB4 34 29 18 14 
AB5 7 6 7 6 
AB6 26 20 12 13 
AB7 4 3 9 10 
AB8 26 18 11 20 
AB9 11 20 9 14 
AB10 33 26 12 15 
AB11 28 19 14 18 
AB12 31 34 19 21 
AB13 13 22 10 10 
AB14 11 9 12 13 
AB15 10 8 10 11 
AB16 12 13 9 8 
 
Table 2.9: Results of mucosal (MMC) and submucosal (SMMC) mast cell counts from the rectal 
sections (RS) and rectal biopsies (RB) of abattoir horses (AB1-16). Cells expressed as average cell 
count per field.  
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Figure 2.26: Scatterplot of average cell count per field of MMC from rectal sections (x-axis) versus rectal 
biopsies (y-axis), p<0.001, rho=0.850. (Test: Spearman rank). Scatterplot of average cell count per field of 
SMMC from rectal sections (x-axis) versus rectal biopsies (y-axis), p<0.001, rho=0.758. Note different y-axis 
scales. (Test: Spearman rank). (MMC: Mucosal mast cell; SMMC: Submucosal mast cell; RS: Rectal Section; 




Figure 2.27: A: Individual value plot of average cell count per field of RS and RB mucosal mast cell (MMC) 
counts. There was no significant difference between RS and RB MMC counts, p=0.128 (Test: Wilcoxon signed 
rank test). The non-axis horizontal line indicates the median. B: Graph of individual values of RS and RB 

















































































Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Two: Investigation into Recruitment of Large Intestinal Mast Cells in 
Response to Cyathostomin Infection   
62 
 
Figure 2.28: A: Individual value plot of average cell count per field of RS and RB submucosal mast cell counts, 
There was no significant difference between RS and RB SMMC counts, p=0.171 (Test: Wilcoxon signed rank 
test). The non-axis horizontal line indicates the median. B: Graph of individual values of RS and RB submucosal 
mast cell (SMMC) counts with lines connecting the values for each horse. (RS: Rectal Section; RB: Rectal 
biopsy). 
 
2.3.5.2 Mast Cell Counts 
Using Toluidine Blue mast cells stained blue (Figure 2.29). Mast cells in the 
submucosa had a greater staining intensity compared with the mucosal populations. 
Mast cells in the submucosa were also more distinct in their cell outline. The median 
and range of the mucosal and submucosal mast cell counts for the caecum, RVC and 
RB for all the horses (AB1-AB16 and DV1-DV12) are shown in Table 2.10. The 
mucosal and submucosal mast cell counts for the caecum, RVC and RB are shown in 
Table 7.1 of the appendix for the abattoir and R(D)SVS horses.  
 
 MMC        
Caecum 
(MC/mm2) 
SMMC   
Caecum 
(MC/mm2) 
MMC        
RVC 
(MC/mm2) 
SMMC      
RVC 
(MC/mm2) 
MMC           
RB  
(MC/mm2) 
SMMC         
RB  
(MC/mm2) 
Median 444 261 428 322 190 192 
Range 22-1,062 110-437 34-1,470 110-445 19-541 70-383 
 
Table 2.10: Median and range of MMC and SMMC from the caecum, RVC and rectum of all horses 
(AB1-16 and DV1-12). Cells expressed as MC per mm2. (MMC: Mucosal mast cell; SMMC: 
Submucosal mast cell; RVC: Right ventral colon; RB: Rectal biopsy). 
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Figure 2.29: Image of caecal tissue section from horse AB9 stained with Toluidine Blue. Mast cells in 
the mucosa and submucosa are stained blue. (M: Mucosa; SM: Submucosa). 
 
2.3.5.3 Histopathology of a Case of Larval Cyathostomniosis 
Tissue sections from Horse DV3 fixed in Carnoy’s and stained with Toluidine Blue 
can be seen in Figures 2.30 and 2.31. The submucosa was markedly expanded by 
increased clear space, consistent with oedema. Muscle bundles within the tunica 
muscularis are also separated by increased clear space. Multifocal to coalescing 
zones of the lamina propria and superficial submucosa were expanded and effaced 
by increased numbers of lymphocytes, plasma cells, eosinophils, macrophages and 
giant cells. Mucosal and submucosal larvae were present in the tissue surrounded by 
dense sheets of epithelioid macrophages, giant cells and outer halos of lymphocytes 
and fibroblasts (mature granulomas) (Pers Comm: Ms Helena Ferreira).  
 
Figure 2.30: Image of caecal tissue section from horse DV3 stained with Toluidine Blue. Mast cells in 
the mucosa and submucosa are stained blue. The arrows show larvae present in the centre of 
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Figure 2.31: Image of right ventral colon mucosal tissue from horse DV3 stained with Toluidine Blue. 
Mast cells are stained blue. The arrows show encysted larvae present in the centre of mucosal 
granulomas. 
 
2.3.6 Correlations between Mast Cell Counts at Different Mucosal 
Sites 
The mucosal and submucosal mast cells populations correlated significantly with one 
another in the caecum (Figure 2.32: p<0.001, rho=0.719) the RVC (Figure 2.33: 
p<0.001, rho=0.648) and the rectum (Figure 2.34: p<0.027, rho=0.417). All 
correlations are presented in Table 2.13. The mucosal mast cells counts were 
significantly correlated between organs (Table 2.11: p<0.001,), and this can be seen 
graphically in the matrix plot (Figure 2.35). The matrix plot in Figure 2.36 
demonstrates graphically that the submucosal mast cells counts were also 

















Figure 2.32: Scatterplot of caecal MMC (x-axis) versus caecal SMMC (y-axis). Cells expressed as MC per mm2, 
p<0.001, rho =0.719. (Test: Spearman rank). (MMC: Mucosal mast cell; SMMC: Submucosal mast cell). 
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Figure 2.33: Scatterplot of RVC SMMC (x-axis) versus RVC MMC (y-axis). Cells expressed as MC per mm2, 
p<0.001, rho=0.648. (Test: Spearman rank). (MMC: Mucosal mast cell; SMMC: Submucosal mast cell; RVC: 


















Figure 2.34: Scatterplot of RB SMMC (x-axis) versus RB SMMC (y-axis). Cells expressed as MC per 
mm2, p=0.027, rho=0.417. (Test: Spearman rank). (MMC: Mucosal mast cell; SMMC: Submucosal 
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Table 2.11: Correlations between caecal, RVC and RB mucosal mast cells (Test: Spearman rank). p 
values in italics, rho values in bold. Significant p values (<0.05) are highlighted. (MMC: Mucosal 
















Figure 2.35: Matrix scatterplot of counts for caecal, RVC and RB MMC. Cells expressed as MC per 




 Caecum SMMC RVC SMMC RB SMMC 
Caecum SMMC - 0.811 0.646 
RVC SMMC <0.001 - 0.488 
RB SMMC <0.001 0.008 - 
 
Table 2.12: Correlations between caecal, RVC and RB submucosal mast cells. (Test: Spearman rank). 
p values in italics, rho values in bold. Significant p values (<0.05) are highlighted. (SMMC: 
Submucosal mast cell; RVC: Right ventral colon; RB: Rectal biopsy). 
 
 Caecum MMC RVC MMC RB MMC 
Caecum MMC - 0.933 0.630 
RVC MMC <0.001 - 0.638 
RB MMC <0.001 <0.001 - 
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Table 2.13: Correlations between caecal, RVC and RB mucosal and submucosal mast cells. (Test: 
Spearman rank). p values in italics, rho values in bold. Significant p values (<0.05) are highlighted. 





Figure 2.36: Matrix scatterplot of counts for caecal, RVC and RB SMMC. Cells expressed as MC per 















MMC Caecum  0.719 0.933 0.732 0.630 0.422 
SMMC Caecum <0.001  0.664 0.811 0.563 0.646 
MMC RVC <0.001 <0.001  0.648 0.638 0.447 
SMMC RVC <0.001 <0.001 <0.001  0.655 0.488 
MMC Rectum <0.001 0.002 <0.001 <0.001  0.417 
SMMC Rectum 0.025 <0.001 0.017 0.008 0.027  
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2.3.7 Eosinophil Populations 
2.3.7.1 Effect of Tissue Fixation on Eosinophil Enumeration 
To enumerate mucosal eosinophil populations, Carnoy’s or formalin fixed tissue was 
stained with H&E. It was not possible to reliably count eosinophils on H&E stained 
Carnoy’s fixed tissue because it proved difficult to delineate individual eosinophils 
due to the high background pink staining and low eosinophil specific staining (Figure 
2.37A). In contrast, H&E staining of formalin fixed tissue sections stained 
eosinophils bright pink, and resulted in less background pink staining, allowing the 
accurate identification of eosinophils (Black arrow: Figure 2.37B). As Carnoy’s 
fixative was used for all tissue samples, but formalin was only used in a subset of 
samples, other methods of visualization of eosinophils on Carnoy’s fixed sections 
were attempted, such as examining sections for autofluorescence, DAB staining and 
carbol chromatrope staining; however none of these methods were sufficient to allow 











Figure 2.37: A: Image of a caecal tissue section fixed in Carnoy’s and stained with H&E. B: Image of 
a caecal tissue section fixed in formalin and stained with H&E. The arrow points to an eosinophil. 
(H&E: Haemotoxylin and eosin) 
 
2.3.7.2 Eosinophil Mucosal and Submucosal Counts 
Formalin fixed tissue from Horses DV6-DV12 were used to ascertain eosinophil 
counts (Table 7.2). Median and range of mucosal and submucosal eosinophil counts 
A B 
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from the caecum, RVC and rectum are shown in Table 2.14. Tissue stored in 
formalin was available for seven of the 28 horses and eosinophil counts were 
performed on this tissue (Table 2.14). However, this was deemed an insufficient 
sample size for further analysis.  
 


















Median 376 419 403 315 19 174 
Range 218-1,178 80-734 166-875 106-605 6-94 42-778 
 
Table 2.14: Median and range of mucosal and submucosal eosinophil counts from the caecum, RVC 
and rectum of horses DV6-12. Cells expressed as eosinophil count per mm2 (EC/mm2). (RVC: Right 
ventral colon). 
 
2.3.7.3 Tapeworm Status 
The presence of tapeworm was confirmed in nine of the 28 horses (32%) either on 
PM or from FEC; eight of which were from the abattoir and one from the R(D)SVS. 
Co-infection with A. perfoliata is associated with significantly higher TB mast cells 
in the caecal mucosa and submucosa (p=0.039 and p=0.004) (Figure 2.38), RVC 
mucosa and submucosa (p=0.019 and p<0.001) (Figure 2.39) and RB mucosa and 
submucosa (p=0.012 and p=0.046) (Figure 2.40). Due to this, ‘co-infection with A. 
perfoliata’ was added as a confounding variable for all analyses involving Toluidine 








Figure 2.38: Individual Value Plot of A: caecal MMC and B: caecal SMMC. Cells expressed as 
Toluidine Blue Mucosal mast cell per mm2 (TB MMC/mm2) and grouped according to presence or 
absence of Tapeworm, A: p=0.039 and B: p=0.004. (Test: Mann Whitney). Note different y-axis 
scales. The non-axis horizontal line indicates the median. 
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Figure 2.39: Individual Value Plot of A: RVC MMC and B: RVC SMMC Cells expressed as 
Toluidine Blue Mucosal mast cell per mm2 (TB MMC/mm2) or Toluidine Blue Submucosal mast cell 
per mm2 (TB SMMC/mm2) and grouped according to presence or absence of Tapeworm, A: p=0.019 
and B: p<0.001. (Test: Mann Whitney). Note different y-axis scales. The non-axis horizontal line 









Figure 2.40: Individual Value Plot of A: RB MMC and B: RB SMMC Cells expressed as Toluidine 
Blue Mucosal mast cell per mm2 (TB MMC/mm2) or Toluidine Blue Submucosal mast cell per mm2 
(TB SMMC/mm2) and grouped according to presence or absence of Tapeworm, A: p=0.012 and B: 
p=0.046 (Test: Mann Whitney). The non-axis horizontal line indicates the median. (RB: Rectal 
biopsy). 
 
2.3.8 Mast Cells and Cyathostomin Burdens 
Four horses, AB3, DV1, DV5 and DV6 were negative for cyathostomins on FEC, 
luminal content count, caecal and RVC TMI and caecal, RVC and rectal tissue 
digest. These horses were deemed cyathostomin-negative. The MMC and SMMC 
ranges and medians for these horses are shown in Table 2.15.
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Median 246 154 283 160 134 130 
Range 22-341 130-250 34-394 110-184 19-298 70-166 
 
Table 2.15: Median and range of MMC and SMMC from the caecum, RVC and rectum of all 
cyathostomin-negative horses (AB3, DV1, DV5 and DV6). Cells expressed as mast cell (MC) per 




To investigate whether age had an effect on MMC and SMMC and CTMB the 
R(D)SVS horses (DV1-DV12) were divided into two groups. Group 1 were those 
horses less than 15 years old (DV3, DV4, DV6, DV7, DV9, DV10, DV12) and 
Group 2 were those horses older than 15 years (DV1, DV2, DV5, DV8, DV11). 
There was no significant difference between the two groups with respect to CTMB or 
caecal, RVC and rectal MMC and SMMC (p>0.5).  
All horses were grouped into four groups according to their combined total mucosal 
burdens. Group 1 (n=4) were cyathostomin-negative, Group 2 (n=8) had a range of 
encysted burdens of 75 to 3,340, Group 3 (n=6) ranged from 6,289 to 47,753 and 
Group 4 (n=10) had a range of 115,077 to 3,827,097 (Figure 2.41). Boxplots of 
caecal TB MMC (Figure 2.42A), caecal TB SMMC (Figure 2.42B), RVC TB MMC 
(Figure 2.43A), RVC TB SMMC (Figure 2.43B), RB TB MMC (Figure 2.44A) and 
RB TB SMMC (Figure 2.44B) divided by these groups are shown below. Kruskal-
Wallis analysis revealed the only significant difference between groups to be in the 
case of RVC TB SMMC (Figure 2.43B: p=0.028). 
Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Two: Investigation into Recruitment of Large Intestinal Mast Cells in 


































































Figure 2.42: Boxplots: A: Caecal TB MMC counts (MC/mm2). Kruskal-Wallis analysis revealed no 
significant difference in Caecal TB MMC between groups (p=0.059). B: Caecal TB SMMC counts. 
Kruskal-Wallis analysis revealed no significant difference in Caecal TB SMMC between groups 
(p=0.066). (TB MMC: Toluidine Blue Mucosal mast cell; TB SMMC: Toluidine Blue Submucosal 










































Figure 2.43: Boxplots: A: RVC TB MMC counts (MC/mm2). Kruskal-Wallis analysis revealed no 
significant difference in RVC TB MMC between groups (p=0.190). B: RVC TB SMMC counts. 
Kruskal-Wallis analysis revealed a significant difference in RVC TB SMMC between groups 
(p=0.028). (TB MMC: Toluidine Blue Mucosal mast cell; TB SMMC: Toluidine Blue Submucosal 
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Figure 2.44: Boxplots: A: RB TB MMC counts (MC/mm2). Kruskal-Wallis analysis revealed no 
significant difference in RB TB MMC between groups (p=0.340). B: RB TB SMMC counts. Kruskal-
Wallis analysis revealed no significant difference in RB TB SMMC between groups (p=0.093). (TB 
MMC: Toluidine Blue Mucosal mast cell; TB SMMC: Toluidine Blue Submucosal mast cell; CTMB: 
Combined Total Mucosal Burden; RB: Rectal biopsy). 
 
Linear regression analysis of log10+1 transformed data, with A. perfoliata as a 
confounding variable showed a significant positive relationship between the CTMB 
and the caecal MMC (Figure 2.45: p=0.048, r2=16.9%). The caecal SMMC and 





















Figure 2.45: Relationship between log10+1 transformed CTMB (x-axis) and Caecal MMC (MC/mm2) 
(y-axis), p=0.048, r2=16.9% (MMC: Mucosal mast cell; CTMB: Combined Total Mucosal Burden).
A B 
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Figure 2.46: Relationship between log10+1 transformed CTMB (x-axis) and Caecal SMMC 
(MC/mm2) (y-axis), p=0.507, r2=26.9%. (SMMC: Submucosal mast cell; CTMB: Combined Total 
Mucosal Burden). 
 
Linear regression analysis of log10+1 transformed data, with A. perfoliata as a 
confounding variable showed a significant relationship between the CTMB and the 
RVC SMMC (Figure 2.48: p=0.005, r2=51.4%). The RVC MMC and CTMB 


















Figure 2.47: Relationship between log10+1 transformed CTMB (x-axis) and RVC MMC (MC/mm2) 
(y-axis), p=0. 211, r2=13.8%. (MMC: Mucosal mast cell; CTMB: Combined Total Mucosal Burden; 
RVC: Right ventral colon). 
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Figure 2.48: Relationship between log10+1 transformed CTMB (x-axis) and RVC SMMC (MC/mm2) 
(y-axis), p=0.005, r2=51.4%. (SMMC: Submucosal mast cell; CTMB: Combined Total Mucosal 
Burden; RVC: Right ventral colon). 
 
Linear regression analysis of log10+1 transformed data, with A. perfoliata as a 
confounding variable showed no significant relationship between the CTMB and the 



















Figure 2.49: Relationship between log10+1 transformed CTMB (x-axis) and RB MMC (MC/mm2) (y-
axis), p=0.366, r2=17.8%. (MMC: Mucosal mast cell; CTMB: Combined Total Mucosal Burden; RB: 
Rectal biopsy). 
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Figure 2.50: Relationship between log10+1 transformed CTMB (x-axis) and RB SMMC (MC/mm2) 
(y-axis), p=0.188, r2=11.5%. (SMMC: Submucosal mast cell; CTMB: Combined Total Mucosal 
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2.4 Discussion 
The aim here was to explore the relationship between mast cell numbers and 
cyathostomin burden throughout the large intestine to allow investigation of the 
potential for rectal biopsies as a diagnostic predictor of total cyathostomin burden. Of 
the 28 horses sampled, four were found to be cyathostomin-negative. The remaining 
24 (86%) had natural patent infections of varying severity with a combined mucosal 
total burden (CTMB), calculated from the caecum and RVC total burdens 
(EL3+DL), ranging from 75 to 3,827,097 larvae. Mucosal burdens to the order of 
several million have previously been reported (Dowdall, Matthews et al. 2002) and 
the horse with the greatest burden, DV3, was confirmed to be a case of larval 
cyathostominosis here. Those horses sampled from the abattoir had higher luminal 
and mucosal burdens than those sampled at the referral hospital. Although the 
clinical history of the abattoir horses was not available some of these horses were 
known to be feral and sourced from the New Forest, therefore they may never have 
been treated with anthelmintics. This may partially explain the higher parasite 
burdens seen in this population.  
To calculate the total mucosal cyathostomin burden, populations of EL3 and DL 
must be enumerated. Following the recommendations of Eysker and Klei (1999) 
TMI and tissue digest were used to determine the encysted larval count. TMI alone is 
of no use in enumerating EL3 because this larval stage is too small to visualise in 
tissue (Eysker, Boersema et al. 1997): using this method larvae cannot be classified 
by stage and hence must all be grouped as developing larvae (Eysker and Klei 1999). 
In contrast tissue digest allows enumeration of EL3 and also allows easier 
differentiation of encysted larval stages (Chapman, Kearney et al. 1999). However, 
there are disadvantages to this method in that there is concern about the damaging 
effects of digestion on larger developing larvae (LL3 and DL4) (Reinemeyer and 
Herd 1986). Preliminary studies using the digestion method here support this (Figure 
2.5). Significant structural damage to developing larvae was observed using the 
tissue digest method and this increased with digest time, similar to findings of 
Reinemeyer and Herd (1986). To limit potential damage to all cyathostomin stages, a 
‘milking’ process, first described by Murphy and Love (1997), was performed to 
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remove digested tissue and halt digestion of any larvae already released from tissue, 
which are thought to be more susceptible to damage. The RVC DL count from the 
tissue digest was significantly less than the TMI counts from the equivalent samples, 
supporting the need for both methods of enumeration. Therefore, in this study the 
total mucosal burden (TMB) for each organ was estimated from the EL3 count using 
the results from the tissue digest and the DL count using the results from TMI 
method. The combined TMB (CTMB) was calculated from the addition of the caecal 
and RVC TMBs. 
In this study larvae were found in the rectal wall of eight horses. This has been 
previously reported (Ricketts 1996) and it has been suggested that examination of 
rectal biopsies for encysted cyathostomins may be of diagnostic value (Church, Kelly 
et al. 1986). It was more common for larvae to be observed in the rectum when 
burdens were high: those horses with evidence of rectal larvae had a significantly 
higher CTMB. Four horses (14%) had CTMB (range 184,380 – 472,935) that were 
within the range of those with a positive rectal biopsy but were larval-negative at the 
rectum. This test has high specificity, with few false positive results i.e. positive 
rectal biopsy but low cyathostomin burden. However, the considerable number of 
false negative cases, negative rectal biopsies from horses with high cyathostomin 
burdens, demonstrates that cyathostomin identification from rectal biopsy alone is 
not a reliable indicator of cyathostomin mucosal burden. 
Here, in most cases (86%), luminal burdens were greater in the RVC than the 
caecum. Previous studies have found the greater part of the adult cyathostomin 
population concentrated in the ventral colon when compared to the caecum 
(Ogbourne 1976; Gawor 1995; Collobert-Laugier, Hoste et al. 2002). A similar 
finding was observed with respect to the distribution of larvae, both from the TMI 
and digest enumerations. Over 50 cyathostomin species have been described, 10 of 
which are highly represented (Reinemeyer, Smith et al. 1984; Lyons, Tolliver et al. 
1999). There is evidence (Ogbourne 1976; Gawor 1995; Collobert-Laugier, Hoste et 
al. 2002) to support the suggestion that cyathostomin species have preferential sites 
of infection. In a French study of 42 naturally infected horses, where 20 
cyathostomin species were identified, 12 of these species demonstrated a site 
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preference of the ventral colon compared to only one, Cyathostomum coronatum, in 
the caecum (Collobert-Laugier, Hoste et al. 2002). This supports the predominance 
of cyathostomin populations in the RVC demonstrated in this chapter, although 
species identification was out with the project scope. 
The phenomenon of over dispersion in strongyle FEC has been well demonstrated 
(Sangster 2003; Kaplan and Nielsen 2010; Lester, Bartley et al. 2013; Lester, 
Spanton et al. 2013) and is supported here: only three horses (AB11, AB13 and 
DV8) had FEC greater than 200 EPG. It has been demonstrated that using this 
threshold for anthelmintic treatment can reduce pasture contamination (Eysker, 
Bakker et al. 2008); however FEC does not correlate with mucosal encysted larvae 
levels (McWilliam, Nisbet et al. 2010). This is demonstrated most clearly here in the 
case of DV3, as this horse had a negative FEC but had the highest developing larval 
burden. The luminal count for DV3 was positive, with burdens of 800 and 1140 
larvae in the caecum and RVC, respectively. These luminal burdens, although 
positive, were lower than counts in over 50% of the samples collected. It is likely 
that this case was treated with an anthelmintic in the weeks prior to euthanasia. This 
would have eliminated anthelmintic sensitive nematodes, in particular adult stage 
worms in the lumen and would have had a significant impact on this horse’s FEC. 
The effect on the encysted larval population would depend on the anthelmintic used. 
Pyrantel salts are relatively ineffective against inhibited cyathostomin stages 
(Corning 2009) and ivermectin has been shown to have limited efficacy against 
encysted or developing larvae (Xiao, Herd et al. 1994). Benzimidazoles have a 
licensed efficacy against encysted cyathostomin larvae when administered as a 5 day 
course at 7.5 mg/kg (Duncan, Bairden et al. 1998) although efficacy of this product 
against cyathostomins in the UK and abroad is questionable due to anthelmintic 
resistance (Matthews 2008; Stratford, McGorum et al. 2011). In some cases, 
moxidectin has been demonstrated to be efficacious against encysted larvae (Bairden, 
Brown et al. 2001; Bairden, Davies et al. 2006) and is licensed for this use. On TMI 
of material from horse DV3 there was evidence of larval stages emerging from the 
mucosa and it is possible that the luminal larval population mainly comprised late 
L4. This case highlights the necessity for a diagnostic test that provides information 
Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Two: Investigation into Recruitment of Large Intestinal Mast Cells in 
Response to Cyathostomin Infection   
80 
on the quantity of mucosal stages as FECs do not correlate with encysted burden 
(Table 2.6). 
Significant correlations were observed between mucosal mast cells and submucosal 
mast cells within the caecum, RVC and rectal biopsy (RB) tissue. Encouragingly, 
there was no significant difference in rectal mast cell counts in either rectal mucosal 
tissue sections or rectal biopsies for either the mucosa or the submucosa of the 
rectum, indicating the reliability of the rectal biopsy technique used here to 
enumerate mast cells. In the mouse it has been demonstrated that mast cells migrate 
through intestinal tissue from the submucosa to the tips of the villi, therefore the 
submucosal population are contributing to that of the mucosa (Friend, Ghildyal et al. 
1996; Friend, Ghildyal et al. 1998). Also, in the mouse, it has been demonstrated that 
intestinal infection with schistosomiasis causes the expansion of both mucosal and 
submucosal mast cell populations (De Jonge, Van Nassauw et al. 2002). These 
processes previously described in rodents could be responsible for the correlations 
seen in these results in the horse. Significant correlations were also observed between 
mucosal mast cells across intestinal sites within individual horses. This supports the 
theory of the common mucosal system which is based on observations that 
stimulation of one mucosal region can lead to activation of mucosal immune 
responses at sites distant to the initial region of exposure (van Ginkel, Nguyen et al. 
2000). In the lamina propria, mast cells act to identify the presence of antigen 
through IgE bound to high affinity IgE receptor (FcRI) expressed on the mast cell 
surface, and initiate a defensive inflammatory response (Wallace and Granger 1996). 
Mast cell mediators can be differentially released depending on the stimulus applied 
(Theoharides, Patra et al. 2000). Mast cells are ideally situated at interfaces to the 
external environment and are hypothesised to have a key function in surveillance 
with a role in initiating the host immune response (Welle 1997; Knight, Wright et al. 
2000).  
Pronounced hyperplasia, differentiation, and activation of mucosal mast cells occurs 
in the intestine during nematode infections in rodents (Woodbury, Miller et al. 1984; 
Miller 1996). Linear regression analysis of log10+1 transformed data showed a 
significant relationship between the CTMB and the caecal mucosal mast cell (MMC) 
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(p=0.048, r2=16.9%), although the relationship between CTMB and caecal 
submucosal mast cells (SMMC) was not significant. Conversely, there was a 
significant relationship between the CTMB and the RVC SMMC (p=0.005, 
r2=51.4%). The relationship between the CTMB and RVC MMC was not significant 
(p=0.211, r2=13.8%). A difference in correlations at various sites of the large 
intestine has been demonstrated previously with an association described between 
the percentage of EL3 with MMC and SMMC counts in the ventral colon, but not the 
caecum or dorsal colon in a study in 42 horses (Collobert-Laugier, Hoste et al. 2002). 
The study by Collobert-Laugier et al. (2002) found no significant variations 
according to breed but horses over 10 years-old had significantly more mucosal mast 
cells in their caecum, dorsal and ventral colon. Conversely age was not found to 
affect MC counts or cyathostomin burden in Pickles et al. (2010). It was not feasible 
to record the ages of the horses sampled from the abattoir (AB1-16) here so the 
findings cannot be compared with this population in the current study. When 
R(D)SVS horses were divided into two age categories (Group 1 <15 years, Group 2 
>15 years), no significant differences in caecal, RVC or rectal MMC and SMMC 
were identified between the two age categories. There was also no significant 
difference in CTMB or FEC between the age groups. Although in the French study 
64% of horses were co-infected with A. perfoliata, the relevance of this was not 
investigated (C. Collobert-Laugier et al. 2002). From here, significantly higher levels 
of Toluidine Blue-stained mast cells were associated, both in the mucosa and 
submucosa in the caecum, RVC and RB, when there was co-infection with A. 
perfoliata. This result is corroborated by previous studies that have shown A. 
perfoliata to be a confounding variable for Toluidine Blue-stained mast cell numbers 
(Pickles, Mair et al. 2010).  
The relationship between CTMB and MC in the caecum here was not as strong as 
that seen in a previous study by Pickles et al. (2010). In their study, a statistically 
significant positive linear relationship was observed between cyathostomin burden 
and both mucosal and submucosal log10 transformed caecal Toluidine Blue-stained 
MC counts (Pickles et al. 2010). This previous work was performed using caecal 
material only. These horses (Thoroughbred horses, n=25) displayed a lower range in 
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their caecal luminal (0–2,400) and their caecal encysted (200–2,690) larval burdens. 
All horses were positive for cyathostomin infection and the sampling frame was 
relatively short (four months). In comparison, the samples obtained here over 23 
months represent a more diverse population from horses of different breeds, 
husbandry and from diverse environments, with caecal luminal burdens of 0–9,780 
and caecal encysted burdens of 0–1,773,047. It is possible that the horses here 
sampled over a longer time frame had a more complex relationship between mast cell 
populations and cyathsotomin burden as the immune response may vary depending 
on the stage of infection (Monahan, Chapman et al. 1998). This could contribute to 
the weaker relationships observed here when compared to those in Pickles et al. 
(2010). Also, the presence of cyathostomin larval-negative horses with evidence of 
recent anthelmintic treatment or larval expulsion in the current study, may have an 
effect on mast cell count data, as recruited mast cells may still remain in the tissue 
after worm death (du Toit, McGorum et al. 2007). Methods for mast cell staining and 
enumeration and tissue sample collection were similar among these studies but there 
were some differences in sample processing. Here, EL3 cyathostomins comprised the 
majority of the mucosal population and, as previously reported by Pickles et al. 
(2010) and Collobert-Laughier et al. (2002), the mucosal population was 
significantly greater than in the lumen, however Pickles et al. 2010 did not describe a 
separate method for enumerating DL, such as TMI. DL enumerated were released 
following tissue digestion and there was no ‘milking’ process to preserve later stage 
mucosal larvae in the digestion fluid. This is similar in the methodologies described 
by Collobert-Laugier et al. (2002) and the previously described technique on which 
this method was based (Monahan, Chapman et al. 1998). This could affect integrity 
of a proportion of the larvae, in particular the L4 and late L3. These factors may 
contribute to an underestimation of mucosal burden which could affect the 
relationship between cyathostomin burdens and mast cell numbers.  
No significant relationship between the CTMB and RB MMC or RB SMMC was 
observed. Similar observations were reported by Collobert-Laughier et al. (2002), 
who found that total worm burdens and total larval counts did not correlate with mast 
cell densities in any of the intestinal sites assessed. Although every effort was made 
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to produce as representative a count as possible, there will always be some error due 
to the nature of tissue cell count methods. Although 10 fields were chosen at random, 
as in previous studies (Collobert-Laugier, Hoste et al. 2002; du Toit, McGorum et al. 
2007; Pickles, Mair et al. 2010) this may not provide an accurate representation of 
the whole organ. Other mast cell studies have also assessed this number of fields 
(Strobel, Miller et al. 1981; Sarin, Malhotra et al. 1987; Sonti 2012). However, for 
more accuracy, some studies have used as many as 1,000–1,800 fields to describe the 
mast cell distribution in camels (Al-Zghoul, Al-Rukibat et al. 2009), bovines 
(Küther, Audigé et al. 1998), canines (Kube, Audigé et al. 1998) and in the equine 
endometrium (Welle, Audige et al. 1997). Also, due to the limitations of these 
equine-based investigations with a lack of experimentally controlled infections, 
interpretations of the results is rendered more difficult as only one time point is 
studied. Future rectal biopsy studies, including a greater number of examined fields, 
would be an obvious way of examining the dynamics of this response.  
The superiority of Carnoy’s fixed tissue for mast cell staining and identification has 
been well described (Strobel, Miller et al. 1981; Irani, Schechter et al. 1986; Küther, 
Audigé et al. 1998; Al-Zghoul, Al-Rukibat et al. 2009). The recommended standard 
technique for processing human biopsies of the intestine, specifically to ensure the 
preservation of mucosal mast cell information is fixation in Carnoy’s or basic lead 
acetate (BLA) and the use of Toluidine Blue or astra-blue/safranin as a subsequent 
stain (Strobel, Miller et al. 1981). For equine mast cell preservation and 
staining/labelling Carnoy’s fixed tissues are superior to formalin fixed tissue, even 
with antigen retrieval techniques, (K. Dacre 2005). The fixing of tissue in Carnoy’s 
is optimal for mast cell enumeration (with Toluidine Blue staining); however it is 
suboptimal for eosinophil enumeration (with H&E staining) when compared to 
formalin fixed, H&E stained tissue, as was demonstrated in Figures 2.37 A and B. 
Because of this, it was not possible to enumerate mast cells and eosinophils within 
the same sample to directly compare these two cell populations in the tissues 
collected. Associations have been demonstrated between eosinophil numbers and 
cyathostomin burdens in the caecum and colon of naturally infected horses 
(Collobert-Laugier, Hoste et al. 2002); however, as formalin fixed tissue was only 
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available for seven of the 28 horses this relationship could not be investigated further 
here due to inadequate sample size.  
Toluidine Blue stains the metachromotic granules of mast cells (Strobel, Miller et al. 
1981): this method requires that these granules are present. Once degranulated, mast 
cells are difficult to stain (Sonti 2012) due to the loss of their staining granules. Also, 
immature mast cells may not contain these granules rendering them unidentifiable 
using this stain (Khatri, Desai et al. 2013). Mast cells have been demonstrated to be 
immature at the time of maximal enzyme release (Woodbury, Miller et al. 1984). 
These immature mast cells may not have been well stained or enumerated by the 
staining method used here. For these reasons, exploration of mast cell proteinase 
production and expression will provide a more accurate picture of this complex 
relationship (see Chapters 3 and 4). Those horses in Group 4, with the highest CTMB 
range (115,077 and 3,827,097), are more likely to be demonstrating an active mast 
cell response and hence have a greater proportion of immature or degranulated mast 
cells which are difficult to stain. This could contribute to the lower mast cell numbers 
for this group than might be expected. In 10 out of the 28 horses studied here, 
evidence of previous larval damage was observed on TMI as areas suggestive of 
empty cysts. AB3 is of particular interest as this horse was negative for 
cyathostomins on TMI yet had numerous fibrous capsules observed in the mucosa: it 
is thought that these might represent previous larval encystment sites (Davidson et al. 
2005). Such horses, whilst having a low or negative cyathostomin mucosal burden, 
may have relatively high residual mast cell counts. Previous studies have also 
demonstrated mast cell populations in equine cyathostomin larval-negative sections 
which were suggested to relate to prior helminth exposure (du Toit, McGorum et al. 
2007). In the rodent, there are negligible mast cell numbers in helminth free 
individuals (du Toit, McGorum et al. 2007; Xing, Austen et al. 2011). As the 
majority of grazing horses are exposed to cyathostomins (Matthews 2008), it is likely 
that those classified as cyathostomin-negative at the time of death may have been 
previously infected. This is supported by the fact that although the mast cell 
populations enumerated in Group 1, the cyathostomin-negative horses, were lower 
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than in Groups 2, 3 and 4 they still demonstrated significant mast cell populations, 
particularly in the rectum (Figures 2.44 A and B).  
In summary, these results demonstrate a positive relationship between mast cells 
numbers throughout the intestine. However, a complex relationship between mast 
cells and cyathostomin burdens exists and this is affected by a number of variables. 
Some of these were measureable here, such as the presence or absence of A. 
perfoliata. Differences in horse management existed, for example some of the horses 
in this study from the abattoir were sourced from the New Forest where they are kept 
extensively and are unlikely to have ever been treated with anthelmnitics. This is 
vastly different to the majority of privatively owned horses sampled from the referral 
hospital. The phase of immune response may also be a factor. Cyathostomin larvae 
are pathogenic on their entry into the mucosa (Murphy and Love 1997) and their 
development is associated with a fibroblastic response and a marked inflammatory 
cellular reaction (Giles, Urquhart et al. 1985; Church, Kelly et al. 1986; Love, 
Murphy et al. 1999). Therefore, the level of mast cell involvement and the dynamics 
of the response may be affected by the stage of infection and also, the number of 
larvae at each stage within the mucosal wall. The results may also have been 
confounded by age, particularly as older horses have demonstrated an acquired 
immune response (Love and Duncan 1992) which during its maturation targets 
increasing numbers of parasite stages (Monahan, Chapman et al. 1998). Variations in 
levels of pasture contamination, frequency of anthelmintic treatment and nutrition, 
travelling or concurrent diseases may also act as confounding factors (Collobert-
Laugier, Hoste et al. 2002). For mucosal mast cells and their proteinases to be 
considered for use as a diagnostic there is a requirement that they are associated with 
cyathostomin burden regardless of season, age, breed and common history. As this is 
such a complex picture the relationships will be further explored in Chapter 3 in 
conjunction with the immunolabelling of mast cells for proteinase expression and the 
use of immunoassays to measure mast cell serine proteinase concentration in the 
tissue and serum. 
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3 Characterisation of Large Intestinal Mast Cell Activation in 
Response to Cyathostomin Infection 
3.1 Introduction 
Mast cells comprise a heterogeneous population that is species and tissue specific 
and this heterogeneity can be expressed as differences in functional, biochemical and 
histochemical characteristics (Welle 1997). Like humans (Irani and Schwartz 1994), 
rats (Le Trong, Neurath et al. 1987) and mice (Miller and Pemberton 2002), horses 
have mast cell subpopulations that differ in neutral proteinase content (Pickles, Mair 
et al. 2010). These proteinases have been demonstrated to play an important role in 
the host response to helminth infection in other species (Friend, Ghildyal et al. 1996; 
Miller 1996; Scudamore, McMillan et al. 1997; Wastling, Scudamore et al. 1997; 
Knight, Wright et al. 2000; McDermott, Bartram et al. 2003). 
Mast cells contain many potent mediators including serine proteinases, biological 
amines, prostaglandins, leukotrienes and cytokines (Metcalfe, Baram et al. 1997). 
Mast cell subsets have been described in the rat (Gibson, Mackeller et al. 1987), 
mouse (Friend, Ghildyal et al. 1996; Tchougounova, Pejler et al. 2003), human 
(Caughey, Raymond et al. 2000), sheep (Sture, Huntley et al. 1995), cow (Küther, 
Audigé et al. 1998) and camel (Al-Zghoul, Al-Rukibat et al. 2009). Mucosal mast 
cells (MMCs) in the gastrointestinal tract are distinct from mast cells in other tissues 
in their biochemical and functional properties and also in their neutral granule serine 
proteinases content (Miller, Huntley et al. 1988; Stevens, Friend et al. 1994; Knight, 
Wright et al. 2000). During gastrointestinal nematode challenge MMCs undergo a 
pronounced T-cell dependent hyperplasia, differentiation, and activation (Woodbury, 
Miller et al. 1984; Miller 1996). In the sheep, mouse and rat this is associated with 
the systemic release of mucosal mast cell granule chymases (chymotrypsin-like 
serine proteinases) at the time of worm expulsion (Miller 1996). The detection of 
tryptase released from mast cells is recognised as the most reliable indicator of mast 
cell activation (Hogan and Schwartz 1997). In the human, mast cells expressing 
tryptase are the predominant cell type in the intestinal mucosa (Irani, Schechter et al. 
1986). Two serine proteinases, one tryptase-like referred to as equine Tryptase 
(eqTRYP) and the second, chymotrypsin-like (chymase), referred to as equine Mast 
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Cell Proteinase-1 (eqMCP-1), have previously been isolated from equine 
mastocytoma tissue (Pemberton, McEuen et al. 2001). Polyclonal antibodies raised in 
rabbits to both proteinases (Pemberton, McEuen et al. 2001) have been purified and 
validated to investigate the role of mast cells and their proteinases in equine heaves. 
(Dacre, McAleese et al. 2006). The eqTRYP antibody has also been used to 
investigate mast cell degranulation and tryptase release into the airways of horses 
flowing organic dust exposure (Dacre, McGorum et al. 2007). Both antibodies have 
been used to establish an immunohistochemical technique to demonstrate the 
involvement of mast cell proteinases in the large intestinal response to cyathostomin 
infection (du Toit, McGorum et al. 2007). These antibodies were also used to 
demonstrate a strong positive linear relationship between cyathostomin burden and 
the production of mast cell proteinases in the caecal wall of naturally infected horses 
(Pickles, Mair et al. 2010).  
In the equine caecum there appears to be a predominance of chymase-positive mast 
cells (eqMCP-1) compared to tryptase-labelled mast cells in the mucosa and 
submucosa (Pickles, Mair et al. 2010). A strong relationship has been observed 
between total cyathostomin burden and mucosal mast cells labelled with tryptase 
(eqTRYP) (Pickles, Mair et al. 2010) such that total cyathostomin burden accounted 
for 57% of the variation in eqTRYP-labelled mast cells. Immunohistochemical 
studies of Carnoys-fixed tissues (Pickles, Mair et al. 2010) demonstrated strong 
positive linear relationships between total or mucosal cyathostomin burden and the 
production of both eqTRYP and eqMCP-1 in the caecal wall of naturally infected 
horses. There were also significant positive linear relationships between total larval 
cyathostomin population, and individual mural and luminal counts, and the number 
of Toluidine Blue (TB) stained mast cells in the mucosa and submucosa of the 
caecum (Pickles, Mair et al. 2010). This association supports the basis of the second 
hypothesis of this thesis, that mast cell proteinase concentrations may have 
diagnostic potential for prediction of cyathostomin burden.  
Mast cells and their associated proteinases have been implicated in the protective 
host immune response against nematode infection in mammals (Friend, Ghildyal et 
al. 1996; Miller 1996; Scudamore, McMillan et al. 1997; Wastling, Scudamore et al. 
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1997; Knight, Wright et al. 2000; McDermott, Bartram et al. 2003). Chymase 
appears critical to Trichinella spiralis expulsion in mice: deletion of the murine mast 
cell proteinase-1 (mMCP-1) gene results in delayed nematode expulsion and 
increased deposition of larvae in the muscle (Knight, Wright et al. 2000). Mouse 
intestinal MCP-1 is expressed constitutively in mucosal tissue, but levels increase in 
the bloodstream and intestinal lumen of parasitised mice and are maximal at the time 
of worm expulsion (Huntley, Gooden et al. 1990). Sheep mast cell proteinase-1 
(SMCP-1) is expressed in abundance in gastrointestinal cells (Pemberton, McAleese 
et al. 2000) and demonstrates both chymase- and tryptase-like specificity 
(Pemberton, Huntley et al. 1997). There is a pronounced mucosal mastocytosis in 
response to Haemonchus contortus infection in sheep (Huntley, Newlands et al. 
1992) and ELISAs have demonstrated elevated serum concentrations of SMCP-1 
following infection with Trichostrongylus colubriformis (Douch, Green et al. 1996). 
As sheep, mouse and rat mast cell proteinases are released both systemically and into 
the gut lumen (Huntley, Gooden et al. 1990; Scudamore, Thornton et al. 1995; Miller 
1996) in response to intestinal nematode infections, it is hypothesised that they 
participate in the effector response (Knight, Wright et al. 2000). This Chapter aimed 
to investigate this response in the horse and focussed on examining the hypothesis 
that serum and tissue mast cell proteinase concentrations are positively associated 
with mast cell number and proteinase expression, and with cyathostomin burden, 
such that they have diagnostic potential for prediction of total cyathostomin burden. 
This chapter therefore explored the mast cell proteinases (MCPs), eqTRYP and 
eqMCP-1, in two different ways.  
1. Immunolabelling of large intestinal tissue sections to enumerate proteinase-
labelled mucosal mast cells (MMC) and submucosal mast cells (SMMC) in 
tissue sections. This allowed the relationship between Toluidine Blue (TB) 
stained mast cells (Chapter 2) and proteinase-labelled mast cells to be 
explored. Mast cell heterogeneity in the horse will be described further. The 
relationship between proteinase-labelled mast cells and cyathostomin burden 
will also be investigated. 
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2. An optimised ELISA, using the antibodies previously raised in rabbits against 
the two proteinases of interest, to measure the amount of each proteinase in 
large intestinal tissue homogenate and serum. This allowed the relationship 
between proteinase concentration and cyathostomin burden to be explored.
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3.2 Materials and Methods 
3.2.1 Purified Proteinase Verification and Validation 
To examine the integrity of the available, previously purified MCPs (Pemberton, 
McEuen et al. 2001), a sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE), using NuPage Novex Bis-Tris Mini gels (Invitrogen), was performed 
as per the manufacturer’s instructions. Four µl of each reduced proteinase (denatured 
by heating with a reducing agent) were loaded per well. This was equivalent to 0.56 
µg eqMCP-1 and 1 µg eqTRYP. The concentration of eqMCP-1 had been 
determined previously by Dr K. Pickles (Dacre 2005). To quantify the concentration 
of eqTRYP in the samples available a Bicinchoninic Acid Protein assay (BCA) was 
performed using a Pierce Micro BCA™ protein assay kit according to 
manufacturer’s instructions (Thermo Scientific). The gel was stained with Simply 
Blue TM Safe Stain (Invitrogen) for 1 h and destained overnight in ddH2O.  
 
3.2.2 IgG Purification from Rabbit Sera 
Rabbit antisera to eqMCP-1 and eqTRYP previously generated by Dr A. Pemberton 
was supplied by Dr K. Pickles. The rabbit antisera was raised by inoculating 50 µg 
protein/rabbit in Freund’s complete adjuvant, followed by two boosts of 50 µg 
protein/rabbit in Freud’s incomplete adjuvant and the rabbits bled 10 days after the 
final boost (Pemberton, McEuen et al. 2001). To purify rabbit IgG the antisera was 
diluted 1:5 in binding buffer (20 mM sodium phosphate, pH 7.0). A Protein G 
column for IgG purification (GE Healthcare) was washed with deionised H20 for five 
min and then equilibrated with binding buffer for 10 min. The rabbit antiserum was 
then circulated through the column for 30 min followed by binding buffer for 10 min 
to wash the column. Elution buffer (0.1 M glycine-HCL, pH 2.7) was circulated and 
samples collected in 1 ml aliquots in tubes containing 40 µl of Tris-HCL, pH 9. 
Collected samples were stored at -20 °C. SDS-PAGE was performed to ascertain the 
purity of the antibody eluted. A Western blot was performed to validate the 
specificity of the purified anti-eqMCP-1 and anti-eqTRYP rabbit IgG.  
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Previous work had shown that the eqMCP-1 preparation used to immunise rabbits in 
Section 3.2.2 also contained serum albumin and that as a result, the rabbit antisera 
was likely to contain anti-equine albumin IgG. Contamination of purified rabbit anti 
eqMCP-1 IgG generated in Section 3.2.2 with anti-equine albumin IgG was verified 
by Western blot using the antibody preparation (1 µg/ml) and equine albumin 
(Europa Bioproducts Ltd) at 0.5 μg and 1 μg per lane and purified eqMCP-1 at 1 µg 
per lane. To remove contaminating anti-equine albumin IgG, the purified rabbit anti-
eqMCP-1 IgG was cross-absorbed against equine albumin by circulating the 
antibody preparation through a previously validated column (HiTrap NHS-activated, 
1 ml, Pharmacia) (Pemberton, McEuen et al. 2001) to which 10 mg equine albumin 
had been conjugated, according to manufacturer’s instructions. The concentration of 
IgG in the unbound fraction was quantified using a BCA assay. To ensure the 
successful removal of anti-equine albumin IgG the Western blot was repeated with 
equine albumin and purified eqMCP-1 as described above.  
 
3.2.3 Biotinylation of anti eqMCP-1 Rabbit IgG  
For dual immunolabelling rabbit anti- eqMCP-1 IgG was biotinylated using the 
Lightning-LinkTM Biotin Conjugation Kit (Innova Biosciences) as per the 
manufacturer’s instructions. Rabbit IgG (Sigma-Aldrich) was biotinylated for use as 
a negative control. 
 
3.2.4 Tissue Samples for Parasite and Mast Cell Enumeration and 
Mast Cell Proteinase Quantitation 
The caecum and right ventral colon (RVC) were processed as described in Chapter 
2.2.8 and two 5 % by weight longitudinal samples harvested for transmural 
illumination (TMI) and pepsin digestion. Adjacent to this area, tissue samples 
(approximately 1 cm2) were taken in duplicate and placed in glass bijoux of Carnoy’s 
fixative for mast cell enumeration and immunolabelling. The tissue sections were 
kept in Carnoy’s solution at room temperature for 24 h prior to being transferred to 
70 % ethanol. Serial 8 µm sections were cut and processed for immunolabelling on 
Superfrost plus slides (Thermo Shandon). 
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3.2.5 Immunohistochemistry 
3.2.5.1 Single Immunofluorescent Labelling 
Tissue sections were stored at 4 °C and brought to room temperature for processing 
before dewaxing in xylene. The sections were rehydrated from xylene to water 
through graded alcohols. Sections were then placed in constantly stirred 3 % 
hydrogen peroxide in methanol for 20 min. The slides were washed and loaded into 
Sequenza chambers (Thermo Shandon) using phosphate buffered saline (PBS). The 
slides were incubated with 100 µl of 25 % normal goat serum in PBS for 30 min at 
room temperature. One hundred µl of diluted antibody (5 μg/ml in PBS of 
biotinylated rabbit IgG, biotinylated anti eqMCP-1 rabbit IgG, rabbit IgG (Sigma) or 
anti eqTRYP rabbit IgG) were applied directly and incubated overnight at 4 °C. The 
following day slides were washed three times in PBS. For rabbit IgG or anti-eqTRYP 
rabbit IgG slides 100 μl of goat anti-rabbit IgG conjugated to Alexa Fluor® 488 
(Invitrogen) at 2 μg/ml were added per slide and incubated for 2 h at 4 °C. 
Biotinylated rabbit IgG and biotinylated anti-eqMCP-1 rabbit IgG slides were 
processed using the TSA™ Kit #24, with Horse Radish Peroxidase (HRP) 
conjugated Streptavidin and Alexa Fluor® 568 Tyramide (Invitrogen) as per the 
manufacturer’s instructions. After incubating with 100 μl HRP-streptavidin 
(Invitrogen) (1:100 in 1 % blocking solution) for 30 min the slides were incubated 
for 10 min with tyramide working solution (1:100). After this incubation all slides 
were washed three times in PBS and mounted with Mowiol mounting medium 
(Calbiochem–Novabiochem; San Diego, CA). Slides were viewed using an Axiovert 
200M inverted fluorescence microscope (Carl Zeiss Ltd., Welwyn Garden City, UK) 
at x 400 magnification.  
 
3.2.5.2 Dual-Immunofluorescent Labelling 
To visualise mast cells expressing both eqTRYP and eqMCP-1 a dual-
immunofluoresecent labelling protocol was performed. Slides were prepared as 
above for single immunofluorescent labelling and incubated overnight at 4 °C with 
either rabbit IgG (5 μg/ml in PBS) or 100 μl of diluted anti-eqTRYP rabbit IgG (5 
μg/ml in PBS). The following day, slides were washed three times in PBS and 100 µl 
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of goat anti-rabbit IgG conjugated to Alexa Fluor® 488 at 2 μg/ml at 2 μg/ml were 
added per slide and incubated for 2 h at 4 °C. The slides were washed three times in 
PBS and incubated with 100 μl of 25 % normal rabbit serum in PBS. Slides were 
incubated at 4 °C in the dark for 4 h. Slides were then incubated with 100 μl diluted 
antibody (5 μg/ml in PBS) of biotinylated rabbit IgG or biotinylated anti-eqMCP-1 
rabbit IgG and stored at 4 °C in the dark overnight. On the third day, slides were 
processed using the TSA™ Kit #24, with HRP-Streptavidin and Alexa Fluor® 568 
Tyramide (Invitrogen) as per the manufacturer’s instructions. After incubation, all 
slides were washed three times in PBS and mounted with Mowiol® 4-88 mounting 
medium (Sigma-Aldrich). Slides were viewed using an Axiovert 200M inverted 
fluorescence microscope at x 400 magnification. Due to high background labelling, 
control experiments were performed with the addition of 100 μl Diaminobenzidine 
(DAB) (Envision kit, Dako Ltd) for 5 min to quench any endogenous peroxidise 
activity (Kingston and Pearson 1981) and 100 μl of biotin solution (Vector 
laboratories) for 15 min to block endogenous biotin.  
 
3.2.6 Single Immunohistochemistry using DAB Substrate 
Tissue sections were brought to room temperature and placed in xylene to dewax. 
The sections were rehydrated through graded alcohols, washed in water, and then 
placed in constantly-stirred 3% hydrogen peroxide in methanol for 20 min. The 
slides were washed and loaded into Sequenza chambers (Thermo Scientific) using 
PBS before incubation with 100 μl of 25 % normal goat serum in PBS for 30 min at 
room temperature. Slides were then incubated with 100 μl of primary antibody (anti-
eqMCP-1 rabbit IgG or anti-eqTRYP rabbit IgG) at 0.2 µg/ml in PBS and the slides 
incubated overnight at 4 °C. In each Sequenza rack one slide was incubated with 
rabbit IgG at 0.2 µg/ml as a negative control. The next day, slides were washed three 
times with PBS before incubating with 100 μl of goat anti-rabbit HRP (Envision) for 
30 min at room temperature. After a further three washes in PBS, the slides were 
incubated with DAB for 8 min at room temperature. The slides were washed in tap 
water then placed in an automated stainer (Thermo Scientific) where cell nuclei were 
stained with haematoxylin (Haematoxylin Z, Cellpath). Slides were dehydrated to 
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xylene through graded alcohols and mounted with Consul-mount (Shandon) using an 
automated coverslipper (Consul model, Shandon). 
 
3.2.6.1 Optimal Antibody Concentrations for Immunohistochemistry 
Pilot studies were performed to optimise the antibody concentrations for 
immunohistochemistry. Two tissue sections were chosen, AB9 caecum (high TB 
mast cell count; 1062 MMC/mm2) and AB5 caecum (low TB mast cell count; 181 
MMC/mm2). Serial sections were taken and four dilutions of each antibody were 
compared: 0.1 µg/ml, 0.2 µg/ml, 0.5 µg/ml and 1 µg/ml.  
 
3.2.6.2 Enumeration of Proteinase-Labelled Mast Cells 
All histological counts were performed without knowledge of cyathostomin burden 
or labelling antibody. Sections were observed using an Olympus BX50 microscope 
and photographed using an Olympus U-CMAD digital camera and AnalySIS Five 
software (Soft Imaging System GmbH, Münster, Germany). Positively-labelled cells 
were identified and enumerated using a calibrated graticule over 10 mucosal and 
submucosal fields of view per slide under x 400 magnification. The total area per 
graticule field at this magnification was 0.0625 mm2. Mast cells were expressed as 
mast cell (MC) per mm2. 
 
3.2.7 Serum Collection and Storage for ELISA 
Left or right colonic vein blood samples were collected post mortem as a source of 
local (L) serum draining the site of interest. Approximately 2 ml of blood was 
collected using a needle and syringe and left to clot overnight at 4 °C. Serum was 
harvested by centrifugation at 1730 x g for 10 min at 4 °C and stored in aliquots at     
-20 °C or -80 °C. Peripheral (P) blood samples were also collected from horses at the 
R(D)SVS. Due to the nature of the slaughter line process it was not logistically 
feasible to collect peripheral blood samples from the horses at the abattoir. A BCA 
assay was performed using a Pierce Micro BCA™ protein assay kit (Thermo 
Scientific) to estimate the concentration of protein in each serum sample. 
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3.2.7.1 Cyathostomin-Negative Serum 
Serum was pooled from four ponies from a previous study (Murphy and Love 1997). 
These ponies were reared indoors with their dams, weaned at 4 months of age and 
maintained on a high-fibre pelleted ration and bedded on wood shavings. The ponies 
were considered to be helminth-naive at the time of sampling.  
 
3.2.8 Tissue Preparation for ELISA 
3.2.8.1 Tissue Homogenisation and Protein Content Analysis 
Tissue was stored at -80 °C. Samples of 20-30 mg were weighed into Precellys 
CK28 tubes (Peqlab) and 500 μl of PBS containing 1M NaCl, 0.05% Tween 20 
(Sigma-Aldrich) and proteinase inhibitors (Complete Mini Proteinase inhibitor 
Cocktail [Roche]). The tissue was homogenised for five, 23-second cycles using a 
Precellys 24 tissue homogeniser (Precellys) at 6200 rpm, with 2 min on ice between 
cycles. Homogenised tissue was centrifuged at 5000 rpm for 5 min and the 
supernatant collected and stored at -80 °C. A BCA assay was performed to estimate 
the concentration of protein in each homogenate sample. 
 
3.2.9 Optimisation of Serum and Tissue ELISAs for eqTRYP and 
eqMCP-1 
3.2.9.1 Proteins for ELISA Standard Curves 
Previously-purified proteinases derived from equine mastocytoma tissue (Pemberton, 
McEuen et al. 2001) were available at concentrations of 0.14 mg/ml (eqMCP-1) and 
0.25 mg/ml (eqTRYP). These proteinases were aliquoted and stored at -80 °C prior 
to use. The integrity of these proteinases had been previously verified by SDS-PAGE 
and Simply Blue™ staining (Section 3.2.1). A standard curve using the appropriate 
proteinase (eqTRYP or eqMCP-1) diluted in PBS 0.05 % Tween20 was prepared 
from a new aliquot for each individual ELISA plate. 
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3.2.9.2 General ELISA Protocol 
High binding 96-well ELISA plates (Immulon 96W, Dynatech M 129B, Thermo Life 
Sciences) were coated with 50 µl polyclonal rabbit anti proteinase (anti-eqTRYP or 
anti-eqMCP-1) at an optimal concentration (µg/ml) in carbonate buffer (pH 9.6). 
Plates were sealed and incubated at 4 oC overnight. Plates were washed six times 
with ELISA wash buffer, PBS 0.05 % Tween20 (PBST20) and then incubated with 
blocking buffer (4 % BSA PBST20, 200 μl/well) for 2 hs at 37 °C. Plates were 
washed again six times with 4 % BSA PBST20 and 50 µl of test sample (diluted in 
blocking buffer where necessary) were added to each well. Plates were incubated for 
1 h at 37 °C. Samples were tested in duplicate. Following a further six washes, plates 
were incubated with 50 µl/well biotinylated rabbit polyclonal antibody at an optimal 
concentration (µg/ml) for 1 h at 37 °C. Plates were washed a final six times and then 
incubated for 30 min at 23 °C with 50 µl/well streptavidin-HRP conjugate (Sigma, 
1:1000). To each well, 50 µl Sure Blue TMB substrate (Insight Biotechnology Ltd) 
were added and plates incubated for 5-10 min. Reactions were stopped with the 
addition of 50 µl/well 0.18M H2SO4. The reaction was read within 10 min using an 
ELISA plate reader (Tecan Sunrise) at 450 nm. 
 
3.2.9.3 Optimal Concentrations of Capture and Detection Antibodies for 
eqMCP-1 ELISA 
A pilot ELISA was performed to determine the optimal antibody concentrations, 
using rabbit anti- eqMCP-1 as the capture antibody (C) and biotinylated rabbit anti- 
eqMCP-1 as the detection antibody (D). These antibodies have previously been used 
in a sandwich ELISA (Dacre 2005). Combinations of capture and detection antibody 
at concentrations of 1, 2 and 5 µg/ml were tested. The combination of capture 
antibody at 5 μg/ml and detection antibody at 5 μg/ml were selected as this gave the 
greatest range of OD (0.079 to 1.180) over the standard protein dilutions.  
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3.2.9.4 Optimal Concentrations of Capture and Detection Antibodies for 
eqTRYP ELISA 
As in Section 3.2.11.1, an ELISA was performed to determine the optimal 
concentrations of capture and detection antibodies. Rabbit anti-eqTRYP IgG was 
used as the capture antibody and biotinylated rabbit anti-eqTRYP as the detection 
antibody. The secondary antibody had previously been used in a sandwich ELISA 
(Dacre 2005). Standard curves of purified eqTRYP at a range of 2.5 - 40 ng/ml were 
prepared in duplicate to test combinations of capture and detection antibodies at 
concentrations 1, 2 and 5 µg/ml however the OD values with these concentrations 
were low (<0.55) resulting in a lack of sensitivity. Further optimisation was therefore 
required. The top eqTRYP standard was increased to 20 ng/ml. The combinations of 
concentrations of capture and detection antibody at 5 μg/ml and 10 μg/ml were 
assessed. Serum over a range of dilutions from 1:8 to 1:64 from horse DV2 was also 
tested on each combination of antibodies. The combination of capture antibody at 5 
μg/ml and detection antibody at 10 μg/ml was selected. This gave a satisfactory 
range of OD over the standard protein dilutions (0.030 to 1.079). There was minimal 
difference between the serum ODs when the capture antibody was used at either 5 
μg/ml or 10 μg/ml so to preserve the reagents the lower concentration of 5 μg/ml was 
selected. 
 
3.2.9.5 Optimal Serum Concentrations for eqMCP-1 ELISA 
Serum was selected from four horses (DV1, DV2, DV3 and DV8) with a range of 
eqMCP-1 mast cell burdens ascertained from immunohistochemistry counts (Table 
3.1) in order to assess the optimal serum concentration for the eqMCP-1 ELISA. 
Four serial dilutions (4 % BSA in PBST20) of each sample were prepared ranging 
from 1:2 to 1:16. The dilution curves were compared against an eight-point standard 
curve of purified eqMCP-1 which ranged from 0.04 to 5 ng/ml. The ELISA was 
performed as in Section 3.2.8.1 using a capture antibody at 5 μg/ml and a detection 
antibody at 5 μg/ml. 
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eqMCP-1     
MMC Caecum 
(MC/mm2) 












eqMCP-1     
SMMC RB 
(MC/mm2) 
DV 1 56 64 56 50 3 8 
DV 2 301 98 272 213 85 19 
DV 3 70 69 19 38 59 58 
DV 8 408 131 509 218 309 226 
 
Table 3.1: Table of eqMCP-1 mast cell counts from horses DV 1, DV2, DV3 and DV 8. Cells 
expressed as MC per mm2. (eqMCP-1: equine Mast Cell Proteinase-1; MMC: Mucosal mast cell; 
SMMC: Submucosal mast cell; RVC: Right ventral colon; RB: Rectal biopsy). 
 
ELISA determination of eqMCP-1 values in the four serial dilutions of equine 
peripheral serum (P) from these horses are shown in Figure 3.1. A dilution factor of 
1:2 (Figure 3.1: circled) was selected as it gave the greatest discrimination between 
samples.  
 
Figure 3.1: EqMCP-1 serum ELISA: Graph of serum dilution curves of four horses (DV1, DV2, DV3 
and DV8). The circle area represents the selected dilution factor, 2 (eqMCP-1: equine Mast Cell 
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3.2.9.6 Optimal Serum Concentrations for eqTRYP ELISA 
Serum was selected from two local serum samples, DV9 and AB16 in order to assess 
the optimal serum concentration for the eqTRYP ELISA. This serum had 
demonstrated consistently high optical density (OD) in the eqMCP-1 serum ELISA. 
These horses, AB16 and DV9, had also demonstrated low and high eqTRYP mucosal 
MMC and SMMC burdens respectively (Table 3.2). Five serial dilutions (4 % BSA 
in PBST20) of each sample and the cyathsotomin-negative serum were prepared 
ranging from 1:16 to 1:256. The dilution curves were compared against an eight -
point standard curve of purified eqTRYP which ranged from 0.04 to 20 ng/ml. The 
ELISA was performed as in Section 3.2.8.1 using a capture antibody at 5 μg/ml and a 
detection antibody at 10 μg/ml. 
 
Table 3.2: Table of eqTRYP mast cell counts from horses AB16 and DV 9. Cells expressed as MC per 
mm2. (eqTRYP: equine Tryptase; MMC: Mucosal mast cell; SMMC: Submucosal mast cell; RVC: 
Right ventral colon; RB: Rectal biopsy). 
Horse 
ID 



















AB 16 11 6 46 40 24 21 
DV 9 149 66 117 190 174 181 
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The five serial dilutions (PBST20) prepared ranging from 1:16 to 1:256 of the local 
serum sample from horses, DV9 and AB16 and the pooled cyathostomin-negative 
serum are shown in Figure 3.2. The ELISA was performed using the chosen 
concentrations of capture antibody at 5 μg/ml and detection antibody at 10 μg/ml. A 
dilution factor of 1:128, circled on Figure 3.2, was selected which gave a range of 
ODs from 0.775 (DV9 Local) to 0.105 (NEG: cyathostomin-negative serum). This 
dilution factor was selected as it gave good separation between the samples. The 
cyathostomin-negative serum (Figure 3.6: green line) had a markedly lower OD than 
the infected samples. 
  
Figure 3.2: EqTRYP serum ELISA: Graph of serum dilution curves from two horses (DV9 and AB16) 
and the pooled serum of cyathostomin-negative horses (NEG). (eqTRYP: equine Tryptase; L: Local; 
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3.2.9.7 Optimal Tissue Sample Concentrations for eqMCP-1 and 
eqTRYP ELISA 
Caecal tissue homogenates from three horses DV2, AB1 and DV9 were used to 
optimise homogenate dilution for ELISA assays. Serial dilutions of tissue 
homogenate (4 % BSA in PBST20) were performed ranging from 1:64 to 1:512. The 
capture and detection antibody concentrations for the eqMCP-1 ELISA were both 5 
μg/ml. The capture and detection antibody concentrations were 5 μg/ml and 10 μg/ml 
respectively for the eqTRYP ELISA. The dilution factor of 1:256 and 1:512 was 
chosen for the eqTRYP and eqMCP-1 tissue ELISAs respectively, circled on Figures 




Figure 3.3: EqMCP-1 caecal tissue ELISA: Graph of tissue homogenate dilution curves from three 
horses (DV2, AB1 and DV9). The circle represents the selected dilution factor, 512. (eqMCP-1: 
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Figure 3.4: EqTRYP tissue homogenate ELISA: Graph of caecal tissue homogenate dilution curves 
from three horses (DV2, AB1 and DV9). (eqTRYP: equine Tryptase; C: Caecal tissue homogenate; 
OD: Optical Density). 
 
3.2.9.8 Further Optimisation of eqTRYP ELISA 
As the capture antibody for the eqTRYP ELISA (rabbit anti-eqTRYP IgG) had not 
been previously validated, further experiments were performed to optimise this 
assay. 
3.2.9.8.1 Capture Antibody for eqTRYP ELISA 
To validate that the signal from the capture antibody rabbit anti-eqTRYP IgG was 
specific and not due to non-specific effects of rabbit IgG an experiment was 
performed using normal rabbit IgG at 5 μg/ml as the capture antibody. Tissue 
homogenate from four horses and serum from six horses with a range of OD from 
pilot studies were used to conduct further studies to ensure the capture antibody was 
specific. There was a significant difference between the ODs of each sample with the 
two capture antibodies, Figure 3.5 (p=0.004); the rabbit IgG capture antibody gave 
significantly lower OD values (generally <0.1) compared to the rabbit anti eqTRYP 
IgG capture antibody. This suggested that the OD signal from the capture anti-
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Figure 3.5: Graph of OD readings at 492nm for serum and tissue samples for eqTRYP ELISA with 
two different capture antibodies, rabbit anti eqTRYP IgG and rabbit IgG. The red symbols represent 
tissue samples and the black symbols represent serum samples. The ODs observed with rabbit anti 
eqTRYP IgG were significantly greater than those with rabbit IgG, p=0.004. (eqTRYP: equine 
Tryptase; OD: Optical Density; Ab: Antibody). 
 
3.2.9.8.2 Optimal Block for eqTRYP ELISA 
A pilot study was performed to ascertain the optimal blocking solution. An ELISA 
was performed using three different blocks for comparison, 4 % BSA in PBST20, 10 
% normal rabbit serum (NRS) in PBST20 and 10 % NRS in 4 % BSA PBST20. A 
positive control of eqTRYP (80 ng/ml), tissue from the equine mastocytoma (diluted 
1:40), tissue from DV3 RVC (diluted 1:40) and serum from DV7 P and DV9 L 
(diluted 1:64) were used to compare the effects of the blocking solution. These 
results are displayed in Figure 3.6. There was no significant difference between the 
blocking solutions. 
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Figure 3.6: Barchart of samples for eqTRYP ELISA with three different blocking solutions. There 
was no significant difference between the ODs observed (Test: Friendman Test) (p=0.271). (eqMCP-
1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; L: Local; P: Peripheral; OD: Optical 
Density; RVC: Right ventral colon; BSA: Bovine Serum Albumin. NRS: Normal Rabbit Serum. 
PBST20: Phosphate Buffered Saline Tween 20). 
 
3.2.9.9 Serum Storage Conditions 
The serum storage conditions did not have a consistent effect on the proteinase 
concentration measured in the sample. The -20 °C stored serum concentrations of 
eqMCP-1 were significantly higher than the concentration in the -80 °C stored serum 
in the local, (p<0.001), and peripheral, (p=0.016), samples. However, the -20 °C 
stored serum samples containing significantly lower eqTRYP concentrations than the 
-80 °C stored local serum, (p=0.021) whereas there was no significant difference in 
eqTRYP concentrations between the two storage temperatures for the peripheral 
serum samples (p=0.424). The -20 °C and -80 °C serum results significantly 
correlated for the eqMCP-1 local and peripheral samples and also the eqTRYP local 
and peripheral samples. As these results demonstrated no consistent advantage for 
storage at -80 °C, further analysis was performed on the -20 °C stored serum values. 
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3.2.9.10 Final ELISA Protocols 
3.2.9.10.1 Final eqMCP-1 ELISA Protocol 
All serum and tissue samples were run in the optimised ELISA protocol in duplicate, 
on three separate occasions, using 5 µg/ml capture and detection antibodies. Serum 
samples were diluted 1:2 in 4 % BSA in PBST20. There was insufficient peripheral 
serum from horse DV4 stored at -20 °C to obtain an eqMCP-1 concentration. Tissue 
samples were diluted to 1:512 in 4 % BSA in PBST20.  
 
3.2.9.10.2 Final eqTRYP ELISA Protocol 
All serum and tissue samples were run in the optimised ELISA protocol in duplicate, 
on three separate occasions, with concentrations of capture and detection antibodies 
at 5 and 10 µg/ml, respectively. Serum samples were diluted 1:128 in 4 % BSA in 
PBST20. There was insufficient peripheral serum from horse DV4 stored at -20 °C 
and -80 °C to obtain an eqTRYP concentration. Tissue samples were diluted to 1:256 
in 4 % BSA in PBST20.  
 
3.2.9.11 Intra- and Inter- assay Coefficients of Variation (CV) for 
ELISAs 
To determine intra-assay variability the proteinase concentration was measured in 
duplicate for each ELISA (eqMCP-1 serum, n=28), (eqMCP-1 tissue, n=36), 
(eqTRYP serum, n=35), (eqTRYP tissue, n=35). The coefficients of variation (CVs) 
were determined by expressing the standard deviation as a percentage of the mean 
for each group of values. Inter-assay variability was determined by running the same 
sample on different ELISA plates on three separate occasions. For this CV one 
sample from a horse with a high proteinase concentration and one from a horse with 
a low proteinase concentration measured by ELISA was selected for both the serum 
and tissue ELISAs. The inter- and intra-assay CVs are shown in Table 3.3. The 
serum assays and the tissue eqMCP-1 assay had intra-assay CVs less than 10% and 
that of the tissue eqTRYP was 11.2%. The inter-assay CVs for all four ELISAs were 
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greater than 25%. Wherever possible samples were run on the same day, to minimise 
the effect of the high inter-assay variation. 
 
  Inter-assay CV (%) Intra-assay CV (%) 
eqMCP-1 Serum 34.0 8.4 
 Tissue 25.5 7.9 
eqTRYP Serum 32.9 8.0 
 Tissue 32.9 11.2 
Table 3.3: Inter- and Intra-assay Coefficients of Variation (CV) for the eqMCP-1 and eqTRYP serum 
and tissue ELISAs. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase). 
 
3.2.10 Data Analysis 
As data were not normally distributed, non-parametric tests were selected. For 
optimal graphical representation, log transformed (log10+1) data is sometimes 
presented. Statistical analyses and graphical displays were performed using the 
statistical computer package R Studio (V 0.97.551), Minitab 15 statistical software 
and GraphPad Prism5. For investigating the relationships between mast cell 
measures, including TB-stained mast cell counts, eqMCP-1- and eqTRYP-labelled 
mast cell counts, ELISA serum and tissue values correlations were assessed using the 
Spearman rank test. For comparison of paired data the Wilcoxon Signed rank test 
was selected and for unpaired, the Mann-Whitney test using GraphPad Prism5. 
Standard linear regression analyses were used to explore the relationships between 
log10+1 transformed mast cell measures and log10+1 transformed combined total 
mucosal burdens. Bland-Altman analysis was used to assess agreement between the 
local and peripheral serum proteinase levels. The presence of A. perfoliata was 
investigated and added as a confounding variable. Results were considered 
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3.3 Results 
3.3.1 Validation of eqTRYP and eqMCP-1 
SDS-PAGE of eqMCP-1 and eqTRYP followed by Simply Blue staining was 
performed to validate the integrity of the proteinases. EqMCP-1 gave a single band 
of approximately 32 kDa (Figure 3.7: lane 1, green arrow). EqTRYP gave a triple 
band complex at approximately 33-36 kDa (Figure 3.7: lane 2, three black arrows). 
These results are characteristic of these proteinases (Pemberton, McEuen et al. 
2001).  
 
                           


























Figure 3.7: Validation of equine mast cell proteinases. Scanned image of a Simple Blue stained SDS-
PAGE gel. MW: broad range molecular weight markers; 1: eqMCP-1; 2: eqTRYP. (eqMCP-1: equine 
Mast Cell Proteinase-1; eqTRYP: equine Tryptase). 
 
3.3.1.1 Validation of rabbit anti eqTRYP IgG and Rabbit Anti eqMCP-1 
IgG from Rabbit Sera 
A Western blot was performed to confirm that the rabbit anti-eqTRYP IgG and rabbit 
anti-eqMCP-1 IgG purified from rabbit sera bound to eqTRYP and eqMCP-1, 
respectively. Probing eqMCP-1 with anti-eqMCP-1 IgG resulted in a single band of 
reactivity at approximately 32 kDa (Figure 3.8: lane 2). Probing eqTRYP with anti-
eqTRYP IgG gave a triple band of reactivity at approximately 33-36 kDa (Figure 
3.8: lane 4). These results are consistent with Figure 3.7 and characteristic of these 
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proteinases (Pemberton, McEuen et al. 2001). No reactivity was observed when the 











Figure 3.8: Validation of equine mast cell proteinases. Scanned image of a Western blot. Lane 1 and 2 
contained 0.5 μg of eqMCP-1 and lanes 3 and 4 contained 1 μg of eqTRYP. Lanes 1 and 3 were 
treated with rabbit IgG (1 μg/ml), lane 2 treated with rabbit IgG anti eqMCP-1 (1 μg/ml) and lane 4 
treated with rabbit IgG anti eqTRYP (1 μg/ml).  MW: broad range molecular weight markers. 
(eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase).  
 
 
3.3.1.2 Removal of Anti-Equine Albumin from Rabbit IgG Anti eqMCP-1 
Sera 
The purified rabbit IgG anti-eqMCP-1 antisera was suspected by Dr A. Pemberton to 
be contaminated with anti-equine albumin antibodies (Pemberton, McEuen et al. 
2001). This contamination was verified by Western blot performed using equine 
serum albumin and purified eqMCP-1 (Figure 3.9). A band was observed in lane 2 
and 3 at approximately 67 kDa which is consistent with the size of equine albumin 
(Fjeldsgaard and Paulsen 1993). The purified rabbit IgG anti eqMCP-1 was therefore 
cross-absorbed against equine albumin by passing through a previously generated 
column (Pemberton, McEuen et al. 2001) to which 10 mg equine albumin had been 
conjugated. The Western blot was repeated and confirmed the successful removal of 
anti-equine albumin IgG as the band at approximately 67 kDA was no longer present 







kDa 1 2 3 4 MW 
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Figure 3.9: Validation of anti-equine albumin removal from anti eqMCP-1 antiserum. Scanned image 
of Western blots. Lanes 1 and 4 contained purified eqMCP-1 (1 μg), lanes 2, 3, 5 and 6 contained 
equine serum albumin (0.5 μg in lanes 2 and 5, 1 μg in lanes 3 and 6). Lanes 1, 2 and 3 were treated 
with rabbit IgG anti-eqMCP-1 before cross-absorption with albumin. Lanes 4, 5 and 6 were treated 
with rabbit IgG anti-eqMCP-1 IgG after cross-absorption with albumin. (MW: broad range molecular 




Dual-labelled immunofluorescence was performed on caecal material from horse 
AB9 with a high TB mast cell count (1062 MMC/mm2) to optimise the procedure. 
Figure 3.10 shows a slide that has been dual-labelled with immunofluorescent 
polyclonal rabbit antibodies, with eqTRYP-labelled green (AlexaFluor® 488, Figure 
3.10A) and eqMCP-1-labelled red (AlexaFluor® 568, Figure 3.10B). Pilot studies 
showed that there was significant background signal with biotinylated rabbit IgG 
which acted as the negative control for eqMCP-1 (Figure 3.11). A control experiment 
was performed using slides incubated omitting primary antibody, streptavidin-HRP 
and tyramide separately. Significant background signal was still apparent with 
tyramide only in the absence of HRP. Further control experiments were performed 
using a biotin blocking step prior to addition of the primary antibody, HRP-
streptavidin and Alexa Fluor® 568 Tyramide but this did not have a significant effect 
on the background signal. These results suggested that the background was due to 
endogenous peroxidase activity reacting with the Alexa Fluor® 568 Tyramide and 







1 2 3 4 5 6 MW 
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(DAB) to quench any endogenous eosinophil peroxidise activity. However, 
significant background was still observed and it was concluded that eqMCP-1 








Figure 3.10: Image of caecal mucosa demonstrating immunolabelled cells. A: eqTRYP at 2µg/ml 





Figure 3.11: Image of caecal tissue dual-immunolabelled with negative control antibodies. A: Rabbit 
IgG at 2µg/ml labelled with goat anti -rabbit IgG-alexafluor 488. B: biotinylated rabbit IgG at 2µg/ml 
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3.3.3.1 Optimal Antibody Concentrations for Immunohistochemistry 
Antibody concentrations of 0.5 µg/ml and 1 µg/ml produced too much background 
staining to reliably count labelled mast cells. This was particularly apparent in 
sections from horse AB9. These sections had a high MMC count from TB staining 
(1062 MMC/mm2). The optimal concentration was 0.2 µg/ml for both rabbit        
anti-eqMCP-1 IgG (Figure 3.12) and rabbit anti- eqTRYP IgG (Figure 3.13). The 
staining was more intense with eqMCP-1. Some mast cells appear to be 
degranulating in the tissue sections from this horse (Figure 3.12: black arrow). 
   
 
 
Figure 3.12: Image of a section of caecal tissue from horse AB9 at x 400 magnification labelled with 
A: rabbit anti eqMCP-1 IgG at 0.2µg/ml. Positive cells are labelled brown. Some labelled cells appear 
to be in the process of degranulating (black arrow). B: rabbit IgG at 0.2µg/ml. (eqMCP-1: equine Mast 
Cell Proteinase-1). 
 
   
 
 
Figure 3.13: Image of a section of caecal tissue from horse AB9 at x 400 magnification labelled with 
A: rabbit anti eqTRYP IgG at 0.2µg/ml. B: rabbit IgG at 0.2µg/ml. Positive cells are labelled brown. 
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3.3.3.2 Proteinase-Labelled Mast Cell Counts 
The median and range of the eqMCP-1- and eqTRYP-labelled MMC and SMMC 
counts for the caecum, RVC and RB for all horses (AB1-AB16 and DV1-DV12) are 
shown in Table 3.4 and 3.5, respectively. The widest range of eqMCP-1 MMC was 
in the RVC (19 – 1323 MC/mm2) and the widest range of eqTRYP MMC was 
observed in the caecum (6 – 432 MC/mm2). MMC and SMMC counts for the 
caecum, RVC and RB of the abattoir (AB) and R(D)SVS (DV) horses are shown in 




















Median 374 146 363 172 111 50 
Range 54-1027 14-230 19-1323 38-288 3-613 0-258 
 
Table 3.4: Median and range of MMC and SMMC eqMCP-1-labelled cells from the caecum, RVC 
and rectum of all horses (AB1-16 and DV1-12). Cells expressed as MC per mm2. (eqMCP-1: equine 
Mast Cell Proteinase-1; MMC: Mucosal mast cell; SMMC: Submucosal mast cell; RVC: Right ventral 





















Median 98 44 72 51 32 17 
Range 6-432 2-214 8-261 6-245 2-174 0-181 
 
Table 3.5: Median and range of MMC and SMMC eqTRYP-labelled cells from the caecum, RVC and 
rectum of all horses (AB1-16 and DV1-12). Cells expressed as MC per mm2. (eqTRYP: equine 
Tryptase; MMC: Mucosal mast cell; SMMC: Submucosal mast cell; RVC: Right ventral colon; RB: 
Rectal biopsy). 
 
3.3.3.3 Comparison of Proteinase-Labelled Mast Cell Counts 
There were significantly more eqMCP-1-labelled MMC and SMMC than eqTRYP-
labelled MMC and SMMC in the caecum (Figure 3.14) (MMC: p<0.0001. SMMC: 
p<0.0001), RVC (Figure 3.15) (MMC: p<0.0001. SMMC: p<0.0001) and rectum 
(Figure 3.16) (MMC: p<0.0001. SMMC: p<0.001).  
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Figure 3.14: A: Graph of individual values of caecal mucosal eqMCP-1- counts and eqTRYP-labelled 
mast cell counts with lines connecting the values for each horse. There were significantly more 
eqMCP-1+ caecal MMC, than eqTRYP+ caecal MMC p<0.0001. B: Graph of individual values of 
caecal submucosal eqMCP-1 counts and eqTRYP-labelled mast cell counts with lines connecting the 
values for each horse. There were significantly more eqMCP-1+ caecal SMMC, than eqTRYP+ caecal 
SMMC p<0.0001. Note different y-axis scales. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: 
equine Tryptase; MMC: Mucosal mast cell; SMMC: Submucosal mast cell).  
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Figure 3.15: A: Graph of individual values of RVC mucosal eqMCP-1- and eqTRYP-labelled mast 
cell counts with lines connecting the values for each horse. There were significantly more eqMCP-1 
RVC MMC, than eqTRYP+ RVC MMC p<0.0001. B: Graph of individual values of RVC submucosal 
eqMCP-1+ and eqTRYP-labelled mast cell counts with lines connecting the values for each horse. 
There were significantly more eqMCP-1+ RVC SMMC, than eqTRYP+ RVC SMMC p<0.0001. Note 
different y-axis scales. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; MMC: 
Mucosal mast cell; SMMC: Submucosal mast cell; RVC: Right ventral colon).  
A B 
A B 
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Figure 3.16: A: Graph of individual values of rectal mucosal eqMCP-1- and eqTRYP-labelled mast 
cell counts with lines connecting the values for each horse. There were significantly more eqMCP-1+ 
rectal MMC, than eqTRYP+ rectal SMMC p<0.0001. B: Graph of individual values of rectal 
submucosal eqMCP-1- and eqTRYP-labelled mast cell counts with lines connecting the values for 
each horse. There were significantly more eqMCP-1+ rectal SMMC, than eqTRYP+ rectal SMMC 
p<0.001. Note different y-axis scales. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine 




3.3.3.4 Comparison of Proteinase-Labelled Mast Cell Counts with TB 
Mast Cell Counts 
The proteinase-labelled mast cell and TB mast cell counts were compared to ensure 
that the staining methods used here produced comparable results and to provide 
confidence in the enumeration of the labelled cells. In the caecum and RVC there 
were significantly more TB MMC than eqMCP-1-labelled MMC (Figure 3.17A, 
p=0.0024 [caecum] and Figure 3.18A, p=0.030 [RVC]) and also significantly more 
TB stained SMMC than eqMCP-1-labelled SMMC mast cells (Figure 3.17B, 
p<0.0001 [caecum] and Figure 3.18B, p<0.0001 [RVC]). In the case of the rectum 
there was no significant difference between TB and eqMCP-1-labelled MMC 
numbers counted (Figure 3.19A: p=0.085); however there were significantly more 
TB stained SMMC than eqMCP-1-labelled SMMC (Figure 3.19B: p<0.0001).
A B 
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Figure 3.17: A: Graph of individual values from caecal mucosal TB counts and eqMCP-1 counts with lines 
connecting the values for each horse. There were significantly more TB caecal MMC, than eqMCP-1+ caecal 
MMC p=0.0024. B: Graph of individual values from caecal submucosal TB counts and eqMCP-1 counts with 
lines connecting the values for each horse. There were significantly more TB caecal SMMC, than eqMCP-1+ 
caecal SMMC p<0.0001. Note different y-axis scales. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: 
equine Tryptase; MMC: Mucosal mast cell; SMMC: Submucosal mast cell).  
T B e q M C P -1  
0
5 0 0
1 0 0 0
1 5 0 0




















































Figure 3.18: A: Graph of individual values from RVC mucosal TB counts and eqMCP-1 counts with 
lines connecting the values for each horse. There were significantly more TB RVC MMC, than 
eqMCP-1+ RVC MMC p=0.030. B: Graph of individual values from RVC submucosal TB counts and 
eqMCP-1 counts with lines connecting the values for each horse. There were significantly more TB 
RVC SMMC, than eqMCP-1+ RVC SMMC p<0.0001. Note different y-axis scales. (eqMCP-1: 
equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; RVC: Right ventral colon; MMC: Mucosal 
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Figure 3.19: A: Graph of individual values from rectal mucosal TB counts and eqMCP-1 counts with 
lines connecting the values for each horse. There was no significant difference between TB and 
eqMCP-1 rectal MMC counts, p=0.085. B: Graph of individual values from rectal submucosal TB 
counts and eqMCP-1 counts with lines connecting the values for each horse. There were significantly 
more TB rectal SMMC, than eqMCP-1+ rectal SMMC p<0.0001. Note different y-axis scales. 
(eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; MMC: Mucosal mast cell; 
SMMC: Submucosal mast cell).  
 
3.3.3.5 Relationship between Mast Cell Counts 
A correlation matrix of the counts of TB stained, eqTRYP-labelled and eqMCP-1-
labelled MMC and SMMC of the caecum, RVC and rectum is shown in Table 3.6. 
Individual scatter plot matrices of the log10+1 data for each organ are shown in 
Figures 3.20 (caecum), 3.21 (RVC) and 3.22 (rectum). Caecal eqMCP-1-labelled 
MMC counts were positively correlated with caecal TB and with eqTRYP MMC 
counts (p<0.001 and p<0.001, respectively). In the case of the RVC, similar positive 
correlations were observed between eqMCP-1-labelled and TB populations 
(p<0.001) and also eqMCP-1- and eqTRYP-labelled MMC populations (p=0.001). 
The relationships were also similar between these cell populations in the rectum with 
positive correlations between eqMCP-1-labelled and TB populations (p=0.026) and 
eqMCP-1- and eqTRYP-labelled MMC populations (p<0.001). The relationships 
between submucosal populations were less clear. Caecal eqMCP-1-labelled SMMC 
levels correlated with the caecal TB SMMC counts (p=0.004) but not with the caecal 
eqTRYP SMMC counts (p=0.719). In the case of the RVC and rectum, no 
significant correlations were found between the eqMCP-1-labelled SMMC counts 
and the TB-stained SMMC counts or with the local eqTRYP SMMC counts.
B A 
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MMC and SMMC eqMCP-1-labelled cell counts correlated positively in the caecum 
(p=0.002), RVC (p<0.001) and rectum (p=0.002). These correlations were of a 
similar magnitude to those observed between MMC and SMMC eqTRYP-labelled 
counts in the same organs (p=0.014), (p=0.034) and (p=0.001), respectively. Across 
different sites caecal eqMCP-1-labelled MMC counts correlated with RVC eqMCP-
1- MMC (p<0.001) and with the rectal eqMCP-1-labelled MMC counts (p=0.004). 
Similarly caecal eqTRYP-labelled MMC counts correlated with the RVC eqTRYP-
labelled MMC counts (p<0.001) but the correlation was not significant when the 
caecal eqTRYP-labelled MMC was compared with the rectal eqTRYP MMC counts 
(p=0.068). Caecal eqMCP-1-labelled SMMC counts correlated with the RVC 
eqMCP-1-labelled SMMC counts (p=0.003), but not with the rectal eqMCP-1-
labelled SMMC (p=0.762). Similarly, caecal eqTRYP-labelled SMMC counts 
correlated with the RVC eqTRYP-labelled MMC counts (p<0.001) but again the 
correlation was not significant when caecal eqTRYP-labelled SMMC counts were 
compared with those obatined in the rectal samples (p=0.184).  
The rectal proteinase-labelled mast cell populations were further examined. The RB 
eqMCP-1-labelled MMC correlated significantly with 11 of the possible 17 cell 
count measures (Table 3.6): caecal TB MMC (p=0.004), caecal TB SMMC 
(p=0.011), caecal eqMCP-1 MMC (p=0.004), caecal eqTRYP MMC (p=0.008), 
RVC TB MMC (p=0.008), RVC TB SMMC (p=0.004), RVC eqTRYP MMC 
(p=0.001), RB TB MMC (p=0.026), RB TB SMMC (p=0.036), RB eqMCP-1 
SMMC (p=0.002) and RB eqTRYP MMC (p<0.001). In contrast, RB counts of 
eqTRYP-labelled MMC correlated significantly with only four of the 17 possible cell 
count measures (Table 3.6): RB TB SMMC (p=0.010), RB eqMCP-1 MMC 
(p<0.001), RB eqMCP-1 SMMC (p=0.002) and RB eqTRYP SMMC (p=0.001).
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Table 3.6: Correlation matrix of p values (italic) and rho values (bold) for Toluidine blue (TB), eqMCP-1 and eqTRYP-labelled mast cell count data. Significant 
correlations are highlighted in yellow. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; MMC: Mucosal mast cell; SMMC: Submucosal mast cell; 























































Caecal TB MMC - 0.719 0.684 0.508 0.636 0.171 0.933 0.732 0.641 0.606 0.639 0.191 0.630 0.422 0.532 0.130 0.258 0.126 
Caecal TB SMMC <0.001 - 0.412 0.523 0.343 -0.071 0.664 0.811 0.447 0.380 0.367 -0.063 0.563 0.646 0.474 0.148 0.194 -0.096 
Caecal eqMCP-1 MMC <0.001 0.029 - 0.565 0.846 0.201 0.726 0.399 0.635 0.463 0.765 0.212 0.469 0.443 0.533 0.155 0.357 0.261 
Caecal eqMCP-1 SMMC 0.006 0.004 0.002 - 0.481 0.314 0.609 0.347 0.418 0.539 0.315 0.181 0.341 0.450 0.196 0.060 0.226 0.014 
Caecal eqTRYP MMC <0.001 0.074 <0.001 0.010 - 0.459 0.694 0.426 0.480 0.468 0.790 0.461 0.460 0.429 0.489 0.161 0.350 0.365 
Caecal eqTRYP SMMC 0.384 0.719 0.305 0.104 0.014 - 0.170 0.096 0.053 0.347 0.185 0.700 0.209 0.010 -0.067 0.034 0.285 0.259 
RVC TB MMC <0.001 <0.001 <0.001 0.001 <0.001 0.387 - 0.648 0.621 0.588 0.653 0.111 0.638 0.447 0.490 0.019 0.221 0.023 
RVC TB SMMC <0.001 <0.001 0.035 0.071 0.024 0.627 <0.001 - 0.268 0.351 0.417 0.016 0.655 0.488 0.525 0.173 0.329 0.172 
RVC eqMCP-1 MMC <0.001 0.018 <0.001 0.027 0.010 0.788 <0.001 0.169 - 0.644 0.598 0.138 0.399 0.374 0.362 -0.050 0.065 -0.057 
RVC eqMCP-1 SMMC <0.001 0.046 0.013 0.003 0.012 0.071 0.001 0.068 <0.001 - 0.510 0.399 0.255 0.350 0.264 0.080 0.201 0.318 
RVC eqTRYP MMC <0.001 0.055 <0.001 0.102 <0.001 0.346 <0.001 0.027 0.001 0.006 - 0.402 0.506 0.315 0.593 0.155 0.226 0.313 
RVC eqTRYP SMMC 0.331 0.751 0.279 0.358 0.014 <0.001 0.572 0.936 0.485 0.035 0.034 - 0.179 -0.005 -0.027 0.177 0.130 0.441 
RB TB MMC <0.001 0.002 0.012 0.076 0.014 0.286 <0.001 <0.001 0.035 0.191 0.006 0.363 - 0.417 0.419 0.130 0.212 -0.044 
RB TB SMMC 0.025 <0.001 0.018 0.016 0.023 0.961 0.017 0.008 0.050 0.068 0.102 0.980 0.027 -  0.399 0.301 0.477 0.253 
RB eqMCP-1 MMC 0.004 0.011 0.004 0.317 0.008 0.734 0.008 0.004 0.058 0.175 0.001 0.891 0.026 0.036 - 0.567 0.660 0.350 
RB eqMCP-1 SMMC 0.508 0.454 0.432 0.762 0.413 0.865 0.925 0.379 0.800 0.686 0.432 0.366 0.511 0.120 0.002 - 0.555 0.583 
RB eqTRYP MMC 0.185 0.323 0.063 0.247 0.068 0.141 0.258 0.087 0.742 0.305 0.249 0.509 0.279 0.010 <0.001 0.002 - 0.582 
RB eqTRYP SMMC 0.524 0.627 0.181 0.943 0.057 0.184 0.910 0.382 0.772 0.099 0.104 0.019 0.826 0.194 0.068 0.001 0.001 - 
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TB SMMC eqMCP-1 MMC eqMCP-1 SMMC eqTRYP MMC eqTRYP SMMC  
Figure 3.20: Matrix scatterplot of log10+ 1 transformed counts for caecal Toluidine blue (TB), eqMCP-1 and eqTRYP MMC and SMMC. Cells expressed as MC per 
mm2. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; MMC: Mucosal mast cell; SMMC: Submucosal mast cell). 
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TB SMMC eqMCP-1 MMC eqMCP-1 SMMC eqTRYP MMC eqTRYP SMMC  
Figure 3.21: Matrix scatterplot of log10+ 1 transformed counts for RVC Toluidine blue (TB), eqMCP-1 and eqTRYP MMC and SMMC. Cells expressed as MC per 
mm2. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; MMC: Mucosal mast cell; SMMC: Submucosal mast cell; RVC: Right ventral colon). 
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TB SMMC eqMCP-1 MMC eqMCP-1 SMMC eqTRYP MMC eqTRYP SMMC  
Figure 3.22: Matrix scatterplot of log10+ 1 transformed counts for Rectal Toluidine blue (TB), eqMCP-1 and eqTRYP MMC and SMMC. Cells expressed as MC per 
mm2. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; MMC: Mucosal mast cell; SMMC: Submucosal mast cell). 
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3.3.3.6 Co-infection with Anoplocephala perfoliata 
The presence of tapeworm was confirmed in nine of the 28 horses (32 %) either on 
post mortem by gross examination, paying particular attention to the caecal base and 
ileocaecal valve, or from FEC analysis. As evaluated in Chapter 2 and shown in 
Table 3.7, co-infection with A. perfoliata was associated with significantly higher TB 
mast cell counts in both the caecal mucosa and submucosa (p=0.039 and p=0.004), 
RVC mucosa and submucosa (p=0.019 and p<0.001) and RB mucosa and 
submucosa (p=0.012 and p=0.046). The presence or absence of A. perfoliata also 
had a significant effect on eqTRYP-labelled SMMC in the RVC (p=0.037) and 
eqMCP-1-labelled MMC in the rectum (p=0.006). Due to this, co-infection with A. 
perfoliata was added as a confounding variable for all analyses involving mast cell 
counts.  






TB MMC 0.039 0.019 0.012 
TB SMMC 0.004 <0.001 0.046 
EqMCP-1 MMC 0.219 0.731 0.006 
EqMCP-1 SMMC 0.623 0.961 0.658 
EqTRYP MMC 0.403 0.268 0.085 
EqTRYP SMMC 0.460 0.037 0.902 
 
Table 3.7: Table of p-values for the significance of co-infection with A. perfoliata on TB, eqMCP-1 
and eqTRYP-labelled MMC and SMMC in the caecum, RVC and rectum. Significant p-values are 
highlighted in yellow. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; TB: 
Toluidine Blue; MMC: Mucosal mast cell; SMMC: Submucosal mast cell; RVC: Right ventral colon).
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3.3.3.7 Relationship between Mast Cell Counts and Cyathostomin 
Burden 
Standard linear regression analyses were performed to investigate the relationship 
between log10+1 transformed mucosal and submucosal eqMCP-1- and eqTRYP-
labelled mast cell counts and log10+1 transformed combined total mucosal burden 
(CTMB). Linear regression was also performed on the mast cell populations and 
log10+1 transformed combined total luminal burden (CTLB). There were no 
significant relationships between the CTMB and the caecal or RVC eqMCP-1- or 
eqTRYP-labelled mast cell counts (Table 3.8). There was however, a significant 
positive linear relationship between the eqMCP-1-labelled MMC in the rectal biopsy 
tissue and CTMB (Figure 3.23: p=0.018, r2=38.5%). There was also a significant 
positive linear relationship between the eqTRYP-labelled MMC in the rectal biopsies 
and CTMB (Figure 3.24: p=0.048, r2=18.4%). Similar significant positive 
relationships were seen in the rectal MMC with CTLB (eqMCP-1: p=0.009, r2=41.5; 
eqTRYP: p=0.007, r2=28.9%). The relationships between CTMB or CTLB and 
proteinase-labelled MC populations in the Rectal biopsy submucosa were not 
statistically significant (Table 3.8).  
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  CTMB CTLB 
 Mast Cell Population p-value r2 (%) p-value r2 (%) 
Caecum eqMCP-1 MMC  0.972 0.0 0.910 0.0 
 eqMCP-1 SMMC  0.718 0.0 0.703 0.0 
 eqTRYP MMC  0.135 3.4 0.477 0.0 
 eqTRYP SMMC 0.803 0.0 0.884 0.0 
RVC eqMCP-1 MMC  0.972 0.0 0.749 0.0 
 eqMCP-1 SMMC  0.204 0.0 0.109 3.2 
 eqTRYP MMC  0.211 2.8 0.305 0.7 
 eqTRYP SMMC  0.485 13.7 0.630 12.8 
RB eqMCP-1 MMC  0.018 38.5 0.009 41.5 
 eqMCP-1 SMMC  0.403 0.0 0.137 4.7 
 eqTRYP MMC  0.048 18.4 0.007 28.9 
 eqTRYP SMMC  0.119 2.2 0.125 1.9 
 
Table 3.8: Table of p-values and r2 values for the relationships between log10+1 transformed MMC 
and SMMC Toluidine blue (TB), eqMCP-1 and eqTRYP-labelled mast cell counts and log10+1 
transformed combined total mucosal burden (CTMB) or combined total luminal burden (CTLB). 
Significant p-values are highlighted in yellow. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: 
equine Tryptase; MMC: Mucosal mast cell; SMMC: Submucosal mast cell; RVC: Right ventral colon. 
RB: Rectal biopsy). 
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Figure 3.23: Relationship between log10+1 transformed CTMB (x-axis) and RB eqMCP-1 MMC 
(MC/mm2) (y-axis), p=0.018, r2=38.5%. (eqMCP-1: equine Mast Cell Proteinase-1; MMC: Mucosal 
























Figure 3.24: Relationship between log10+1 transformed CTMB (x-axis) and RB eqTRYP MMC 
(MC/mm2) (y-axis), p=0.048, r2=18.4%. (eqTRYP: equine Tryptase; MMC: Mucosal mast cell; 
CTMB: Combined Total Mucosal Burden; RB: Rectal biopsy). 
Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Three: Characterisation of Large Intestinal Mast Cell Activation in  
Response to Cyathostomin Infection 
126 
3.3.3.8 Serum eqMCP-1 ELISA results 
The mean results for the serum eqMCP-1 ELISA from the two different collection 
sites (Local [L] or Peripheral [P]), where available, and the two different storage 
conditions (-20 °C and -80 °C) are shown in Table 7.5 along with the standard error 
of the mean (SEM). Where possible samples were run on the same day, with the aim 
of minimising the effect of the high inter-assay variation. ELISA results for the 
different storage conditions were compared to assess stability of the proteinases and 
determine optimal storage conditions. Peripheral and local serum results were 
compared to determine whether peripherally sourced serum was representative of the 
proteinase concentrations from serum obtained from a vascular site local to 
cyathostomin infection i.e. the colonic vein. The serum eqMCP-1 values are 
displayed graphically in the barchart, Figure 3.25. . 
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Figure 3.25: Barchart of eqMCP-1 concentrations of serum samples stored at -20 °C (red) and -80 °C (black). Error bars show standard error of the mean. (eqMCP-1: 
equine Mast Cell Proteinase-1; neg: serum from cyathostomin-negative ponies). 
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The median eqMCP-1 concentrations for local and peripheral serum samples were 
1.75 ng/ml and 1.55 ng/ml, respectively, and these were not significantly different 
from one another (Figure 3.27A: p=0.288). However, no significant correlation was 
observed between the eqMCP-1 levels in the serum collected from the local or 
peripheral sites (Figure 3.26A: p=0.203, rho=0.418), indicating that within each 
individual animal concentrations of eqMCP-1 in one site were not associated with 
concentrations in the other site (Figure 3.27B). In addition, considering the relatively 
small range of eqMCP-1 concentration in the samples from both sites (0.5 - 5.21 
ng/ml), the limits of the agreement between sample sites (limits of agreement: 0.402 







Figure 3.26: A: Scatterplot of eqMCP-1 concentrations from local (x-axis) and peripheral (y-axis) 
serum (p=0.203, rho=0.418). B: Bland-Altman plot of the average of the local and peripheral serum 
eqMCP-1 measures (x-axis) vs. the difference of the local and peripheral serum eqMCP-1 measures 
(y-axis), bias=0.402, sd of bias=1.33. Upper and lower 95% limits of agreement are indicated by the 







Figure 3.27: A: Individual value plot of eqMCP-1 serum concentrations (ng/ml) from local and 
peripheral sites, p=0.288 (Test: Wilcoxon signed rank test). The non-axis horizontal line indicates the 
median. (Test: Wilcoxon signed rank test) B: Graph of individual values of eqMCP-1 serum 
concentrations (ng/ml) from local and peripheral sources with lines connecting the values for each 
horse. (eqMCP-1: equine Mast Cell Proteinase-1). 
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3.3.3.9 Serum eqTRYP ELISA 
3.3.3.9.1 ELISA results 
The mean results for the serum eqTRYP ELISA from the different sites where 
available (Local, L or Peripheral, P) and the two different storage conditions (-20° C 
and -80 °C) are shown in Table 7.6 along with the standard error of the mean (SEM). 
Samples were run on the same day where possible. The serum eqTRYP 
concentrations are displayed graphically in the barchart, Figure 3.28. 
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Figure 3.28: Barchart of eqTRYP concentrations of serum samples stored at -20 °C (red) and -80 °C (black). Error bars show standard error of the mean. (eqTRYP: 
equine Tryptase; P: Peripheral; L: Local; NEG: serum from cyathostomin-negative ponies). 
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As was observed with the eqMCP-1 ELISA, there was no significant correlation 
between the eqTRYP levels the-serum from the local or peripheral sampling sites, 
Figure 3.29A (p=0.539, rho=-0.210). In addition, the limits of agreement are 
clinically significant (-0.759 +/- 5.282) and the variability is inconsistent; as the 
average increases the magnitude of the differences between the methods tends to 
increase and the scatter around the bias line is greater (Figure 3.29B). In a similar 
finding to the eqMCP-1 ELISA, there was no significant difference in eqTRYP 
concentrations between the sampling sites. Neither site demonstrated significantly 
greater eqTRYP concentrations, Figure 3.30 (p=0.240). The median eqTRYP 
concentration for the local serum samples was 3.16 µg/ml and 1.37 µg/ml for the 






Figure 3.29: A: Scatterplot of eqTRYP concentrations from local (x-axis) and peripheral (y-axis) 
serum (p=0.539, rho=-0.210). B: Bland-Altman plot of the average of the local and peripheral serum 
eqTRYP measures (x-axis) vs. the difference of the local and peripheral serum eqTRYP measures (y-
axis), bias=-0.759, sd of bias=5.282. Upper and lower 95% limits of agreement are indicated by the 








Figure 3.30: A: Individual value plot eqTRYP serum concentration (µg/ml) from local and peripheral 
sites, p=0.240. The non-axis horizontal line indicates the median (Test: Wilcoxon signed rank test) B: 
Graph of individual values of eqTRYP serum concentrations (µg/ml) from local and peripheral 
sources with lines connecting the values for each horse. (eqTRYP: equine Tryptase). 
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3.3.3.10 Serum Concentrations of eqMCP-1 and eqTRYP 
The concentrations of eqMCP-1 and eqTRYP in local serum samples were 
significantly positively correlated, Figure 3.31A (p=0.006, rho=0.665). In contrast, 
concentrations of eqMCP-1 and eqTRYP in peripheral serum did not significantly 












Figure 3.31 A: Scatterplot of local serum results eqMCP-1 (ng/ml) (x-axis) and eqTRYP (µg/ml) (y-
axis) serum (p=0.006, rho=0.665) (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine 
Tryptase). B: Scatterplot of peripheral serum results eqMCP-1 (ng/ml) (x-axis) and eqTRYP (µg/ml) 




3.3.3.10.1 Relationship Serum Concentration of eqMCP-1 and 
eqTRYP with Mast Cell Counts 
 
The Spearman rank test was used to calculate p and rho values for the correlations 
between the MMC and SMMC in the caecum, RVC and RB with the local (Table 
3.9) and peripheral (Table 3.10) serum eqMCP-1 and eqTRYP concentrations. There 
were no significant correlations between the MMC and SMMC in the caecum, RVC 
and RB with local serum eqMCP-1 or eqTRYP levels (Table 3.9). Similarly, there 
were no significant correlations between the MMC and SMMC in the caecum, RVC 
and RB with peripheral serum eqMCP-1 or eqTRYP levels (Table 3.10).  
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 Local  











Caecal TB MMC 0.065 0.472 0.093 0.434 
Caecal TB SMMC 0.673 0.115 0.746 0.088 
Caecal eqMCP-1 MMC 0.520 0.174 0.294 0.280 
Caecal eqMCP-1 SMMC 1.000 0.000 0.534 0.168 
Caecal eqTRYP MMC 0.456 0.200 0.477 0.191 
Caecal eqTRYP SMMC 0.991 -0.003 0.498 0.183 
RVC TB MMC 0.064 0.477 0.120 0.406 
RVC TB SMMC 0.415 0.219 0.212 0.330 
RVC eqMCP-1 MMC 0.891 0.038 0.908 -0.032 
RVC eqMCP-1 SMMC 0.538 0.166 0.110 0.415 
RVC eqTRYP MMC 0.064 0.474 0.072 0.461 
RVC eqTRYP SMMC 0.291 0.281 0.162 0.367 
RB TB MMC 0.119 0.406 0.117 0.408 
RB TB SMMC 0.204 -0.335 0.755 -0.085 
RB eqMCP-1 MMC 0.068 0.468 0.083 0.446 
RB eqMCP-1 SMMC 0.527 0.171 0.421 0.216 
RB eqTRYP MMC 0.896 0.035 0.288 0.283 
RB eqTRYP SMMC 0.753 0.086 0.363 0.244 
Table 3.9: Table of p and rho values for correlations of local serum ELISA eqMCP-1 and eqTRYP 
concentrations with mast cell counts. (Test: Spearman rank) (eqMCP-1: equine Mast Cell Proteinase-
1; eqTRYP: equine Tryptase; L: Local; MMC: Mucosal mast cell; SMMC: Submucosal mast cell; 
RVC: Right ventral colon; RB: Rectal biopsy). 
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 eqTRYP  
conc  
  Caecal TB MMC 0.649 -0.155 0.392 -0.287 
Caecal TB SMMC 0.503 -0.227 0.694 0.136 
Caecal eqMCP-1 MMC 0.755 -0.109 0.451 -0.255 
Caecal eqMCP-1 SMMC 0.989 -0.009 0.356 0.309 
Caecal eqTRYP MMC 0.341 -0.318 0.203 -0.418 
Caecal eqTRYP SMMC 0.769 -0.100 0.719 0.123 
RVC TB MMC 0.860 -0.064 0.356 -0.309 
RVC TB SMMC 0.121 -0.500 0.214 -0.409 
RVC eqMCP-1 MMC 0.451 0.255 0.776 0.100 
RVC eqMCP-1 SMMC 0.749 -0.109 1.000 0.000 
RVC eqTRYP MMC 0.821 0.077 0.811 -0.082 
RVC eqTRYP SMMC 0.946 0.027 0.818 0.082 
RB TB MMC 0.797 0.091 0.903 0.046 
RB TB SMMC 0.386 -0.291 0.968 0.018 
RB eqMCP-1 MMC 0.137 -0.482 0.066 -0.582 
RB eqMCP-1 SMMC 0.079 -0.551 0.416 -0.273 
RB eqTRYP MMC 0.179 -0.437 0.189 -0.428 
RB eqTRYP SMMC 0.228 -0.396 0.098 -0.524 
Table 3.10: Table of p and rho values for correlations of peripheral serum ELISA eqMCP-1 and 
eqTRYP concentrations with mast cell counts. (Test: Spearman rank) (eqMCP-1: equine Mast Cell 
Proteinase-1; eqTRYP: equine Tryptase; P: Peripheral; MMC: Mucosal mast cell; SMMC: 
Submucosal mast cell; RVC: Right ventral colon; RB: Rectal biopsy). 
 
 
3.3.3.10.2 Serum Concentrations of eqMCP-1 and eqTRYP and 
Cyathostomin Burden 
To investigate the relationship between cyathostomin burden and serum proteinase 
concentrations, linear regression analysis of log10+1 transformed data, with A. 
perfoliata as a confounding variable, was explored. There was no significant positive 
relationship observed between local serum eqMCP-1 concentrations and the 
combined total mucosal burden (CTMB) (Figure 3.32A: p=0.414, r2=0.0%). 
Similarly, there was no significant positive relationship between local serum 
eqTRYP concentrations and the CTMB (Figure 3.32B: p=0.321, r2=0.0%). There 
was no significant positive relationship between CTLB and local serum eqMCP-1 
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(Figure 3.33A: p=0.875, r2=0.0%) or eqTRYP (Figure 3.33B: p=0.113, r2=6.0%) 
concentrations. In the case of peripheral serum proteinase (eqMCP-1 and eqTRYP) 
concentrations, all relationships with CTMB and CTLB were negative, only one of 
which was statistically significant. This statistically significant negative relationship 
was between peripheral serum eqMCP-1 concentrations and the combined total 
mucosal burden (CTMB) (Figure 3.34A: p=0.019, r2=44.5%). The relationship with 
eqTRYP and CTMB was not significant (Figure 3.34B: p=0.150, r2=19.6%). There 
was no significant relationship between CTLB and peripheral serum eqMCP-1 















































Figure 3.32: A: Relationship between log10+1 transformed CTMB (x-axis) and local serum eqMCP-1 
concentrations (ng/ml) (y-axis), p=0.414, r2=0.0%. B: Relationship between log10+1 transformed 
CTMB (x-axis) and local serum eqTRYP concentrations (µg/ml) (y-axis), p=0.321, r2=0.0% (eqMCP-



















































Figure 3.33: A: Relationship between log10+1 transformed CTLB (x-axis) and local serum eqMCP-1 
concentrations (ng/ml) (y-axis), p=0.875, r2=0.0%. B: Relationship between log10+1 transformed 
CTLB (x-axis) and local serum eqTRYP concentrations (µg/ml) (y-axis), p=0.113, r2=6.0% (eqMCP-
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Figure 3.34: A: Relationship between log10+1 transformed CTMB (x-axis) and peripheral serum 
eqMCP-1 concentrations (ng/ml) (y-axis), p=0.019, r2=44.5%. B: Relationship between log10+1 
transformed CTMB (x-axis) and peripheral serum eqTRYP concentrations (µg/ml) (y-axis), p=0.150 
























































Figure 3.35: A: Relationship between log10+1 transformed CTLB (x-axis) and peripheral eqMCP-1 
concentrations (ng/ml) (y-axis), p=0.137, r2=14.7%. B: Relationship between log10+1 transformed 
CTLB (x-axis) and peripheral serum eqTRYP concentrations (µg/ml) (y-axis), p=0.154, r2=22.1% 
(eqMCP-1: equine Mast Cell Proteinase-1; CTLB: Combined Total Luminal Burden). 
 
To investigate whether there was a significant difference in local serum eqTRYP and 
eqMCP-1 concentrations between horses with low and high cyathostomin burdens, 
all horses for which there were local serum samples (AB13, AB14, AB15, AB16 and 
DV1-DV12) were grouped according to their CTMB (Figure 3.36). These groupings 
were different to those described in Chapter 2 as there were no local serum values 
available for horses AB1-AB12. Group 1 (n=3) were cyathostomin-negative, Group 
2 (n=4) had a range of encysted burdens of 75-680, Group 3 (n=4) ranged from 
1,029-8,355 and Group 4 (n=5) had a range of 23,219 to 3,827,097 (Figure 3.36). 
A B 
A B 
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Boxplots of eqMCP-1 serum concentrations (Figure 3.37), and eqTRYP serum 
concentrations (Figure 3.38) separated by these groupings are shown below. Kruskal-
Wallis analysis revealed no significant difference among groups in the case of either 





















Figure 3.36: Boxplot of the 16 horses with serum samples divided into four groups according to 
combined total mucosal burden (CTMB). Group 1 (n=3) were cyathostomin-negative, Group 2 (n=4) 
mucosal burden range of 75- 680, Group 3 (n=4) ranged from 1,029 to 8,355 and Group 4 (n=5) had a 






















Figure 3.37: Local eqMCP-1 serum concentrations (ng/ml) of the 16 horses with serum samples 
divided into four groups according to combined total mucosal burden (CTMB). Kruskal-Wallis 
analysis revealed no significant difference in local serum eqMCP-1 concentration between groups 
(p=0.553). (eqMCP-1: equine Mast Cell Proteinase-1). 
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Figure 3.38: Local eqTRYP serum concentrations (µg/ml) of the 16 horses with serum samples 
divided into four groups according to combined total mucosal burden (CTMB). Kruskal-Wallis 
analysis revealed no significant difference in local serum eqTRYP concentration between groups 
(p=0.251). (eqTRYP: equine Tryptase). 
 
3.3.3.11 Tissue Homogenate eqMCP-1 ELISA Analysis 
The tissue homogenate ELISA was performed in duplicate for each sample and 
repeated on at least three occasions. Where possible samples were run on the same 
day. The eqMCP-1 concentration for each organ is shown in Table 7.7 with the 
standard error of the mean (SEM) and as a barchart in Figure 7.1. The median and 
range for each organ are shown in Table 3.11. The RVC had the highest median 







Table 3.11: Median and range eqMCP-1 tissue concentrations (µg/g) from the caecum, RVC and 
rectum of all the horses (AB1-16 and DV1-12). (eqMCP-1: equine Mast Cell Proteinase-1; RVC: 












 Median 35.78 56.35 26.51 
Range 2.74 - 386.30 3.96 - 404.90 2.54 - 209.50 
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Table 3.12 shows the p and rho values for the correlations using the Spearman rank 
test in eqMCP-1 concentration between organs. There was a significant positive 
correlation between the eqMCP-1 concentrations in the three organs examined 
(caecum and RVC, p<0.001, rho=0.812), (caecum and RB, p=0.003, rho=0.544) 
(RVC and RB, p<0.001, rho=0.706). 
 
 
Table 3.12: Table of p and rho values for correlations of tissue homogenate eqMCP-1 concentration 
(µg/g) between organs. Significant p-values are highlighted in yellow. (Test: Spearman rank) 
(eqMCP-1: equine Mast Cell Proteinase-1; RVC: Right ventral colon; RB: Rectal biopsy). 
 
Table 3.13 shows correlations of eqMCP-1 tissue concentrations from the caecum, 
RVC and rectum of all horses (AB1-16 and DV1-12) with TB, eqMCP-1- and 
eqTRYP-labelled cell counts. Caecal eqMCP-1 concentrations were significantly 
positively correlated with the caecal TB MMC (p=0.008, rho=0.489) and SMMC 
numbers (p=0.008, rho=0.496). There were no significant correlations between the 
caecal eqMCP-1- or caecal eqTRYP-labelled mast cell populations and the caecal 
eqMCP-1 tissue concentrations. In the case of the RVC, tissue eqMCP-1 
concentrations positively correlated significantly with the RVC TB MMC (p=0.003, 
rho=0.549), RVC TB SMMC numbers (p<0.001, rho=0.702) and the RVC eqTRYP-
labelled MMC count (p=0.014, rho=0.459) but not with the eqMCP-1-labelled 
counts. As opposed to the observations made with the caecal and RVC material, RB 
tissue eqMCP-1 ELISA concentrations did not correlate with the RB TB MMC and 
SMMC counts. However, there were significant positive correlations between the RB 


























eqMCP1(µg/g) NA NA <0.001 0.812 0.003 0.544 
RVC eqMCP1 (µg/g) <0.001 0.812 NA NA <0.001 0.706 
RB eqMCP1 (µg/g) 0.003 0.544 <0.001 0.706 NA NA 
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RB eqTRYP-labelled MMC (p=0.011, rho=0.471) counts. The RB eqMCP-1 
concentration also significantly positively correlated with the caecal               
eqMCP-1-labelled MMC (p=0.016, rho=0.450) and eqTRYP-labelled MMC 
(p=0.012, rho=0.467) counts, as well as the eqTRYP-labelled MMC counts in the 


























Caecal TB MMC 0.008 0.489 0.001 0.573 0.137 0.288 
Caecal TB SMMC 0.008 0.496 0.011 0.476 0.347 0.184 
Caecal eqMCP-1 MMC 0.087 0.330 0.081 0.336 0.016 0.450 
Caecal eqMCP-1 SMMC 0.461 0.145 0.680 0.082 0.902 0.024 
Caecal eqTRYP MMC 0.185 0.258 0.016 0.453 0.012 0.467 
Caecal eqTRYP SMMC 0.845 0.039 0.453 0.148 1.00 0.000 
RVC TB MMC 0.012 0.467 0.003 0.549 0.119 0.301 
RVC TB SMMC <0.001 0.677 <0.001 0.702 0.118 0.302 
RVC eqMCP-1 MMC 0.421 0.158 0.386 0.170 0.438 0.152 
RVC eqMCP-1 SMMC 0.320 0.195 0.318 0.196 0.791 -0.053 
RVC eqTRYP MMC 0.058 0.362 0.014 0.459 0.006 0.507 
RVC eqTRYP SMMC 0.250 -0.225 0.931 -0.017 0.979 -0.005 
RB TB MMC 0.029 0.412 0.023 0.428 0.230 0.234 
RB TB SMMC 0.150 0.280 0.094 0.323 0.095 0.322 
RB eqMCP-1 MMC 0.002 0.567 <0.001 0.640 0.002 0.564 
RB eqMCP-1 SMMC 0.517 0.128 0.295 0.205 0.082 0.334 
RB eqTRYP MMC 0.036 0.398 0.008 0.494 0.011 0.471 
RB eqTRYP SMMC 0.781 0.055 0.240 0.230 0.032 0.407 
 
Table 3.13: Table of p and rho values for correlations of eqMCP-1 concentrations (µg/g) from the 
caecum, RVC and rectum of all horses (AB1-16 and DV1-12) with TB, eqMCP-1 and eqTRYP cell 
counts. Significant p-values are highlighted in yellow. (eqMCP-1: equine Mast Cell Proteinase-1; 
eqTRYP: equine Tryptase; TB: Toluidine Blue; MMC: Mucosal mast cell; SMMC: Submucosal mast 
cell; RVC: Right ventral colon; RB: Rectal biopsy). 
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3.3.3.12 Tissue Homogenate eqTRYP ELISA Analysis 
The eqTRYP concentrations measured in tissue homogenate for each organ are 
shown in Table 7.8 with the SEM and as a barchart in Figure 7.2. The median and 
range of eqTRYP concentrations for each organ are shown in table 3.14. As was 
observed with the levels of eqMCP-1, the RVC had the highest median (56.87 µg/g) 






Table 3.14: Median and range eqTRYP tissue concentration (µg/g) from the caecum, RVC and rectum 




Table 3.15: Table of p and rho values for correlations of tissue homogenate eqTRYP concentrations 
(µg/g) between organs. Significant p-values are highlighted in yellow (eqTRYP: equine Tryptase; 
RVC: Right ventral colon; RB: Rectal biopsy). 
 
There was a significant positive correlation between the eqTRYP concentrations 
measured in the three organs examined (caecum and RVC, p=0.003, rho=0.553), 
(caecum and RB, p=0.011, rho=0.480) (RVC and RB, p=0.001, rho=0.616) (Table 







Median 46.47 56.87 30.56 
Range 5.00 - 306.20 9.08 - 371.40 3.59 - 209.60 


























NA NA 0.003 0.553 0.011 0.480 
RVC eqTRYP 
(µg/g) 
0.003 0.553 NA NA 0.001 0.616 
RB eqTRYP 
(µg/g) 
0.011 0.480 0.001 0.616 NA NA 
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caecal TB MMC (p=0.016, rho=0.451) and SMMC population (p=0.005, rho=0.522) 
counts (Table 3.16). There was also a significant positive correlation observed 
between the caecal eqMCP-1-labelled mast cell population counts and the caecal 
eqTRYP tissue concentration (p=0.013, rho=0.464). In the case of the RVC, tissue 
eqMCP-1 concentrations measured positively correlated with the TB MMC 
(p<0.001, rho=0.697) and SMMC populations (p<0.001, rho=0.682). There was also 
a significant positive correlation with the RVC eqMCP-1-labelled SMMC (p=0.050, 
rho=0.374) and the RVC eqTRYP-labelled MMC counts (p<0.001, rho=0.731). 
Unlike in the caecum and RVC, RB tissue eqTRYP concentrations measured did not 
correlate with the RB TB MMC counts. However, there were significant positive 
correlations observed (Table 3.16) between the RB eqTRYP concentrations 
measured and all other rectal mast cell count parameters (RB TB MMC, RB TB 
SMMC, RB eqMCP-1 MMC, RB eqMCP-1 SMMC, RB eqTRYP MMC and RB 
eqTRYP SMMC). The RB eqTRYP concentration measured also significantly 
positively correlated with the caecum and RVC TB MMC (p=0.044, rho=0.384: 
p=0.017, rho=0.448 respectively), the caecum eqMCP-1-labelled MMC (p<0.001, 
rho=0.631) and eqTRYP MMC (p=0.002, rho=0.581) counts and the            
eqTRYP-labelled MMC counts in the RVC (p=0.002, rho=0.573). 
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Caecal TB MMC 0.016 0.451 <0.001 0.654 0.044 0.384 
Caecal TB SMMC 0.005 0.522 <0.001 0.639 0.018 0.448 
Caecal eqMCP-1 MMC 0.013 0.464 0.001 0.596 <0.001 0.631 
Caecal eqMCP-1 
SMMC 0.124 0.298 0.020 0.438 0.013 0.462 
Caecal eqTRYP MMC 0.066 0.353 <0.001 0.640 0.001 0.581 
Caecal eqTRYP SMMC 0.932 -0.017 0.636 0.094 0.865 -0.034 
RVC TB MMC 0.014 0.459 <0.001 0.697 0.017 0.448 
RVC TB SMMC 0.017 0.449 <0.001 0.682 0.050 0.374 
RVC eqMCP-1 MMC 0.088 0.329 0.175 0.263 0.108 0.310 
RVC eqMCP-1 SMMC 0.083 0.334 0.050 0.374 0.148 0.281 
RVC eqTRYP MMC 0.034 0.401 <0.001 0.627 0.002 0.573 
RVC eqTRYP SMMC 0.702 -0.076 0.632 0.095 0.986 0.004 
RB TB MMC 0.264 0.219 0.013 0.464 0.409 0.163 
RB TB SMMC 0.088 0.329 0.009 0.483 <0.001 0.650 
RB eqMCP-1 MMC 0.008 0.492 <0.001 0.731 <0.001 0.620 
RB eqMCP-1 SMMC 0.703 0.075 0.075 0.342 0.041 0.388 
RB eqTRYP MMC 0.283 0.210 0.005 0.517 0.012 0.467 
RB eqTRYP SMMC 0.849 0.038 0.172 0.266 0.010 0.478 
Table 3.16: Table of p and rho values for correlations of eqTRYP tissue concentration (µg/g) from the 
caecum, RVC and rectum of horses (AB1-16 and DV1-12) with TB, eqMCP-1 and eqTRYP cell 
counts. Significant p-values are highlighted in yellow (eqMCP-1: equine Mast Cell Proteinase-1; 
eqTRYP: equine Tryptase; TB: Toluidine Blue; MMC: Mucosal mast cell; SMMC: Submucosal mast 
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3.3.4 Analysis of Equine Tissue eqMCP-1 and eqTRYP 
Concentrations Measured by ELISA 
3.3.4.1 Comparison of eqMCP-1 and eqTRYP Concentrations between 
each Organ 
Within each organ, the eqMCP-1 and eqTRYP concentrations measured significantly 
positively correlated (caecum; p=0.002, rho=0.563. RVC; p<0.001, rho=0.790. RB; 
p=0.002, rho=0.577) (Table 3.17). Figure 3.39A demonstrates the relationship in the 
caecum (p=0.002, rho=0.563), Figure 3.39B shows the RVC (p<0.001, rho=0.790) 
and Figure 3.39C shows the rectum (RB, p=0.002, rho=0.577). There was no 
significant difference between the levels of the two proteinase concentrations 
measured in the caecum (Figure 3.40A, p=0.800), the RVC (Figure 3.40B, p=0.255) 
or in the rectum (Figure 3.40C, p=0.157). The RVC eqTRYP concentrations 
measured correlated significantly with the caecal eqMCP-1 concentrations (p<0.001, 
rho=0.651) and the RB eqMCP-1 concentrations (p=0.002, rho=0.577) (Table 3.17). 
 
 
Table 3.17: Table of p and rho values for correlations of tissue homogenate eqMCP-1 concentration 
(µg/g) with eqTRYP concentration (µg/g). Significant p-values are highlighted in yellow. (eqMCP-1: 
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Figure 3.39: Scatterplot of eqMCP-1(x-axis) and eqTRYP (y-axis) tissue concentration (µg/g). There 
was a significant positive correlation between eqMCP-1 and eqTRYP concentrations in the; Caecum: 
(p=0.002, rho=0.563); B: RVC: (p<0.001, rho=0.790); C: Rectum: (p=0.001, rho=0.577). Note 
different y-axis scales. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; RVC: 
Right ventral colon; RB: Rectal biopsy). 
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Figure 3.40: Graphs of individual horse eqMCP-1 and eqTRYP tissue concentrations (µg/g) with lines 
connecting the values for each horse. There was no significant difference between proteinase 
concentrations in the; A: Caecum: p=0.800; B: RVC: p=0.255; C: Rectum: p=0.157. Note different 
y-axis scales. (Test: Wilcoxon signed rank test). (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: 
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3.3.4.2 The Relationship of eqMCP-1 and eqTRYP Concentrations 
Measured in Tissue with those Measured in Serum  
The relationship between concentrations of eqTRYP and eqMCP-1 measured in 
caecal, RVC and rectal tissue and eqMCP-1 and eqTRYP levels measured in local 
serum are shown in Table 3.18 and 3.19. There was a significant positive relationship 
between the eqTRYP levels measured in serum and the eqMCP-1 measured in the 
caecal tissue (p=0.009, rho=0.641). 
 
Table 3.18: Table of p and rho values for correlations of tissue homogenate concentration (µg/g) of 
eqTRYP with local serum concentrations of eqTRYP (µg/ml) and eqMCP-1(ng/ml). Significant p-
values are highlighted in yellow (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine 
Tryptase; RVC: Right ventral colon; RB: Rectal biopsy). 
 
 
Table 3.19: Table of p and rho values for correlations of tissue homogenate concentration (µg/g) of 
eqMCP-1 with local serum concentrations of eqTRYP (µg/ml) and eqMCP-1(ng/ml).. Significant p-
values are highlighted in yellow (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine 
Tryptase; RVC: Right ventral colon; RB: Rectal biopsy). 
 
 






























0.822 0.062 0.080 0.453 0.822 0.062 
eqTRYP  
 (µg/ml) 
0.165 0.365 0.094 0.435 0.900 -0.035 






























0.096 0.432 0.089 0.441 0.310 0.271 
eqTRYP  
 (µg/ml) 
0.009 0.641 0.361 0.244 0.839 -0.056 
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3.3.4.3 Comparison of eqMCP-1 and eqTRYP Tissue Concentration 
According to Cyathostomin Burden 
All horses were grouped into four groups according to their CTMB as in Chapter 2 
Section 2.4.8. Boxplots showing the caecal eqMCP-1 tissue concentration (Figure 
3.41), caecal eqTRYP tissue concentration (Figure 3.42), RVC eqMCP-1 tissue 
concentration (Figure 3.43), RVC eqTRYP tissue concentration (Figure 3.44), RB 
eqMCP-1 tissue concentration (Figure 3.45) and RB eqTRYP tissue concentration 
(Figure 3.46) in these four groups are shown. There was a general trend of the group 
medians increasing across all three organs in relation to CTMB. The RVC was the 
only organ where eqMCP-1 and eqTRYP concentrations were observed to be 
significantly different among the different groups (p=0.009, p=0.019 respectively) 
with Groups 3 and 4 having the highest median proteinase concentrations and Group 























Figure 3.41: Caecal log10+1eqMCP-1 tissue concentrations (µg/g). Kruskal-Wallis analysis revealed 
no significant difference in caecal eqMCP-1 tissue concentration between groups (p=0.059). (eqMCP-
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Figure 3.42: Caecal log10+1 eqTRYP tissue concentrations (µg/g). Kruskal-Wallis analysis revealed 
no significant difference in caecal eqTRYP tissue concentration between groups (p=0.674). (eqTRYP: 























Figure 3.43: RVC log10+1 eqMCP-1 tissue concentrations (µg/g). Kruskal-Wallis analysis revealed a 
significant difference in RVC eqMCP-1 tissue concentration between groups (p=0.009). (eqMCP-1: 




























Figure 3.44: RVC log10+1 eqTRYP tissue concentrations (µg/g). Kruskal-Wallis analysis revealed a 
significant difference in RVC eqTRYP tissue concentration between groups (p=0.019). (eqTRYP: 
equine Tryptase; CTMB: Combined Total Mucosal Burden). 
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Figure 3.45: RB log10+1 eqMCP-1 tissue concentrations (µg/g). Kruskal-Wallis analysis revealed no 
significant difference in RB eqMCP-1 tissue concentration between groups (p=0.076). (eqMCP-1: 























Figure 3.46: RB log10+1 eqTRYP tissue concentrations (µg/g). Kruskal-Wallis analysis revealed no 
significant difference in RB eqTRYP tissue concentration between groups (p=0.298). (eqTRYP: 
equine Tryptase; CTMB: Combined Total Mucosal Burden; RB: Rectal biopsy). 
 
To investigate the relationship between the CTMB or CTLB and tissue proteinase 
concentrations, linear regression analysis of log10+1 transformed data (with A. 
perfoliata as a confounding variable) was explored. No significant relationship was 
observed between tissue proteinase concentrations and CTMB in the caecum or 
rectum (Table 3.20). However, there was a significant positive relationship between 
both RVC eqMCP-1 (Figure 3.47: p=0.005, r2=54.3%) and RVC eqTRYP (Figure 
3.48: p=0.023, r2=33.1%) concentrations and CTMB. A similar significant positive 
relationship was seen with RVC eqMCP-1 concentrations and CTLB (p=0.032, 
r2=47.7), but not with eqTRYP levels measured in the RVC (p=0.086, r2=26.7)
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Table 3.20: Table of p and r2 values for linear regression analysis of the tissue proteinase 
concentration of eqMCP-1 and eqTRYP in the caecum, RVC and RB and the combined total mucosal 
burden (CTMB) or combined total luminal burden (CTLB). Significant p-values are highlighted in 
yellow. (eqMCP-1: equine Mast Cell Proteinase-1; eqTRYP: equine Tryptase; RVC: Right ventral 























Figure 3.47: Relationship between log10+1 transformed CTMB (x-axis) and RVC eqMCP-1 tissue 
concentration (µg/g) (y-axis), p=0.005, r2=54.3% (eqMCP-1: equine Mast Cell Proteinase-1; CTMB: 




















Caecum eqMCP-1 0.302 46.0 0.134 48.5 
RVC eqMCP-1 0.005 54.3 0.032 47.7 
RB eqMCP-1 0.255 15.0 0.202 16.2 
Caecum eqTRYP 0.851 4.0 0.981 3.8 
RVC eqTRYP 0.023 33.1 0.086 26.7 
RB eqTRYP 0.927 1.6 0.653 2.4 
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Figure 3.48: Relationship between log10+1 transformed CTMB (x-axis) and RVC eqTRYP tissue 
concentration (µg/g) (y-axis), p=0.023, r2=33.1% (eqTRYP: equine Tryptase; CTMB: Combined 
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Here, the aim was to further explore the relationship between equine mast cell 
proteinases and cyathostomin burden. Proteinase-labelled mast cells were stained 
using immunohistochemistry and the populations of eqMCP-1 and eqTRYP 
expressing mast cells were enumerated. ELISAs were optimised to measure the 
concentrations of eqMCP-1 and eqTRYP in serum and tissue. The results were 
compared to the estimations of the cyathostomin burden from the cohort of horses 
studied in Chapter 2. 
Despite using additional blocking steps, the previously published dual-fluorescence 
immunohistochemistry technique used to simultaneously label both eqMCP-1 and 
eqTRYP (Dacre et al. 2010), was incapable of specifically labelling eqMCP-1-
positive cells. As a result it was not possible to explore the proportion of mast cells 
that were positive for both eqMCP-1 and eqTRYP. Thus, this method was replaced 
with single staining using DAB as a substrate, with eqMCP-1 and eqTRYP 
expressing cells labelled separately. The results from the enumeration of the single-
labelled mast cell populations demonstrated that there were more Toluidine Blue 
(TB) mast cells (enumerated in Chapter 2) than eqMCP-1-labelled mast cells, and 
this result was significant in the caecum and RVC. This provides confidence in the 
combination of labelling and enumeration techniques, as TB stains the total mast cell 
population and previous studies have indicated that a proportion of TB-stained 
equine mast cells are chymase-negative and tryptase-positive (du Toit, McGorum et 
al. 2007; Pickles, Mair et al. 2010). Different mammalian species have differing mast 
cell population compositions. These populations can either be defined by their 
location or, more preferably, their proteinase composition (Shimizu, Nagakui et al. 
2001). Three mast cell subtypes have previously been described in human (Weidner 
and Austen 1993), canine (Kube, Audigé et al. 1998), bovine (Küther, Audigé et al. 
1998) and equine (Pickles, Mair et al. 2010) tissue: mast cells that contain tryptase 
only, mast cells that contain chymase only and mast cells that contain both types of 
proteinases. The immunohistochemistry results here demonstrate a greater number of 
chymase- (eqMCP-1) compared to tryptase- (eqTRYP) labelled mast cells in the 
caecum, RVC and rectum. This predominance in chymase expression has also been 
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observed in parasite-infected intestinal tissues of sheep (Huntley, Gibson et al. 1987) 
and mice (Wastling, Scudamore et al. 1997; Friend, Ghildyal et al. 1998). The 
majority of mast cells were eqMCP-1 positive and this finding is in agreement with 
the most recent equine mast cell proteinase study (Pickles, Mair et al. 2010), which 
also demonstrated the caecal mast cell population to be predominantly chymase-
positive. The results from this study however differ from that reported by du Toit et 
al. (2007), who found significantly fewer eqMCP-1- compared to eqTRYP-labelled 
mast cells in the submucosa (p<0.024) and a similar (but non significant, p<0.123) 
trend in the mucosa (du Toit, McGorum et al. 2007). This discrepancy may be due to 
the fact that the tissue in the du Toit 2007 study was fixed in formalin and not the 
optimal fixation solution, Carnoy’s (Pickles, Mair et al. 2010). It has been 
documented in other studies that, despite antigen retrieval techniques, formalin 
fixation can comprise immunolabelling (Dacre 2005).  
There was a significant positive relationship between the numbers of mucosal and 
submucosal mast cells stained by TB in the three organs examined. This supports the 
theory of the common mucosal system (van Ginkel, Nguyen et al. 2000); in that 
stimulation at one mucosal site may provoke a similar immune response at mucosal 
sites distant to the initial site, and suggests that mast cell activation at one intestinal 
site results in recruitment of mast cells throughout the intestinal mucosa. EqMCP-1-
labelled cells followed a similar pattern to the TB-stained mast cells; caecal eqMCP-
1 mucosal cells significantly positively correlated with the right ventral colon (RVC) 
and rectal biopsy (RB) eqMCP-1 mucosal mast cell labelled populations. EqTRYP-
labelled cell numbers had a slightly different pattern; there was a significant positive 
correlation between the eqTRYP-labelled mucosal cell numbers in the caecum and 
RVC, but not in the rectum. In the caecum and RVC mucosa, TB MC counts 
correlated significantly with both eqMCP-1 and eqTRYP MMC counts. However, in 
the rectum only eqMCP-1-labelled MMC counts correlated with the TB stained 
MMC counts. EqMCP-1-labelled rectal mucosal mast cells correlated with 11 of the 
17 other mast cell populations enumerated. In comparison, rectal eqTRYP-labelled 
mucosal mast cells only correlated with four of these and these parameters were also 
measured in the rectum. One hypothesis is that equine intestinal mast cells express 
Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Three: Characterisation of Large Intestinal Mast Cell Activation in  
Response to Cyathostomin Infection 
 
155 
chymase constitutively and tryptase expression is more dynamic and responsive. The 
chymase expressing cells represent a more stable population. In support of this, 
caecal eqTRYP has previously demonstrated the strongest relationship with 
cyathostomin burden, despite the fact that the majority of the equine intestinal mast 
cell population measured was eqMCP-1-positive and eqTRYP-negative (Pickles, 
Mair et al. 2010). Measurement of tryptase in vivo serves as an overall indicator of 
mast cell activity (Miller and Schwartz 1988) and tryptase has been implicated as 
critical to the recruitment of eosinophils into nematode infected murine tissue (Shin, 
Watts et al. 2008). It has been speculated that tryptase may therefore be expressed in 
response to encysted cyathostomin larvae (Pickles, Mair et al. 2010). 
Rectal mucosal mast cell eqMCP-1 and eqTRYP-labelled cell counts were the only 
proteinase-labelled populations to correlate significantly with CTMB and CTLB. 
These results support the hypothesis that rectal tissue mast cell populations correlate 
with cyathostomin burden, such that they have diagnostic potential for prediction of 
total burden. Mast cells are resident within tissues that interface with the external 
environment, such as the rectum, and may play a sentinel role in host defence 
(Kumar and Sharma 2010). These relationships were not observed with the rectal 
submucosal proteinase-labelled population counts. The mucosal mast cells are more 
involved at the site of infection, particular with relation to luminal burden, therefore 
they are the predominant effector cell population. Differences in mast cell proteinase 
expression and subtype are linked to cell stage, maturation and activation (Aldenborg 
and Enerbäck 1994; de Souza, Toso et al. 2012). There is evidence to suggest that 
mast cells can transform phenotype depending on the local environment 
interchanging between connective tissue and mucosal mast cells and proteinase 
expression (Kitamura, Kanakura et al. 1987). Mast cells maturing in different tissue 
microenvironments can vary in the type and amount of tryptases and chymases 
expressed (Caughey 2007; Xing, Austen et al. 2011). This could explain the 
relationship observed here between CTMB and rectal mucosal proteinase-labelled 
mast cells but not the submucosal mast cell proteinase-labelled population. This is 
similar to murine mast cell response to T. spiralis infection, where the MMC subset 
undergoes massive hyperplasia but the CTMC population remains sparse (Shin, 
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Watts et al. 2008). Investigating individual mast cell proteinase expression at one 
time point may not be representative of current cyathostomin burden and may 
explain why no relationship was seen in the caecum or RVC. The rectum, with 
minimal cyathostomin burden, may represent a more stable mast cell population due 
to reduced local activation and degranulation. As previously mentioned in Chapter 2 
degranulated mast cells (such as those seen in Figure 3.12A) are difficult to stain 
(Sonti 2012) and enumerate, making activated mast cells challenging to quantify. For 
example, differential mast cell proteinase expression has been demonstrated in mast 
cells in mice during a defined period post infection (Friend, Ghildyal et al. 1996; 
Friend, Ghildyal et al. 1998). Thus further work to investigate the kinetics of equine 
mast cell proteinase expression is warranted and serum measurements of mast cell 
activation would be of great benefit to study the kinetics of proteinase expression and 
concentration. However, eqMCP-1 and eqTRYP proteinase concentrations in serum 
collected peripherally, from either the jugular vein or a vessel from a lower limb, did 
not correlate with the concentrations measured in local serum draining the site of 
interest. When examining this relationship further, through exploring the level of 
agreement between the sample sites, the limits of agreement for both proteinases 
were clinically significant. In addition, some individual horses had large differences 
in the proteinase concentrations measured at the two different sites. Therefore, 
measuring peripheral proteinase serum concentrations with the ELISA described 
here, cannot be used to reliably indicate the level of proteinase in serum local to the 
site of infection. Consistent with this observation, the concentrations of eqTRYP and 
eqMCP-1 measured in peripheral serum did not correlate with any of the TB, 
eqTRYP or eqMCP-1-labelled MMC or SMMC parameters. This is in comparison to 
studies in T. spiralis infected mice, which demonstrated a correlation between 
peripheral serum MCP concentration and MMC numbers and also the process of T. 
spiralis expulsion (Huntley, Gooden et al. 1990). Here, linear regression analysis 
demonstrated no significant relationship between the local eqMCP-1 concentrations 
measured and CTMB. The relationship was also not significant for local serum 
eqTRYP concentrations measured and CTMB. Peripheral serum concentrations of 
either proteinase did not have a significant positive correlation with CTMB or CTLB. 
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Therefore the results here indicate that serum MCP concentrations are not a good 
predictor of cyathostomin burden. When the serum proteinase concentrations were 
grouped according to the CTMB there was no significant difference between the 
groups for either eqMCP-1 or eqTRYP levels. The group with the highest CTMB 
(Group 4) had the highest range of proteinase concentrations and contained the 
highest proteinase concentration for both eqMCP-1 and eqTRYP, although the 
relationship was not significant. There was however a significant negative 
relationship between peripheral serum eqMCP-1 concentrations and the CTMB. An 
explanation for this could involve the activation and sequestering of proteinases 
within the gut lumen. During an active infection if proteinases are involved in the 
host response as hypothesised, they will be recruited to the region required, in this 
case the intestine, resulting in a potential decrease in peripheral serum 
concentrations. In mice the intestine is the primary source of peripheral mMCP-1 
(Huntley, Gooden et al. 1990; Wastling, Scudamore et al. 1997). MMCP-1 levels 
increase in the bloodstream and intestinal lumen of T. spiralis parasitised mice and 
are maximal at the time of worm expulsion (Huntley, Gooden et al. 1990). The 
differences in mast cell proteinase measurement observed here between the mouse 
and the horse could relate to variance physiology, differences between responses to 
infection or potentially the fact that proteinase measurements in this study were 
performed on naturally infected horses rather than synchronous experimental 
infections. In particular, the hypobiotic stage in which equine cyathostomins can 
reside for months to years (Gibson 1953; Murphy and Love 1997) could be an 
important factor in the measurement of mast cell response. As it was not possible to 
determine the level of cyathostomin infection activity it is difficult to relate the 
proteinase measurements with active infection. However, these results provide 
further support for the future investigation of equine mast cell proteinase expression 
kinetics and serum concentration at different timepoints and stages of infection. 
Concentrations of eqMCP-1 and eqTRYP measured locally in serum significantly 
positively correlated with each other. This demonstrates that the expression and 
release of these mast cell proteinases is related, which could be due to the fact that 
some mast cells express both proteinases or that the single mast cell proteinase 
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expressing populations are responding to the same stimuli and environment. There 
was no significant positive relationship between local serum proteinase 
concentrations and CTMB. A factor which may have resulted in this lack of 
relationship is that mast cell degranulation, causing release of serine proteinases, is 
not specific to gastrointestinal helminths. Mast cells can be activated in numerous 
ways, the most well documented of which is activation through IgE bound to high 
affinity IgE receptor (FcRI) expressed on the mast cell surface (Kinet 1990). Mast 
cells can also be stimulated by direct injury or activated complement proteins (Erdei, 
Andrásfalvy et al. 2004) and by pathogens through pattern recognition receptors (Urb 
and Sheppard 2012). Therefore many stimuli can theoretically increase tissue and 
serum eqTRYP and eqMCP-1 concentrations. An elevation in bronchial epithelial 
mast cells and evidence for mast cell degranulation causing tryptase release has been 
demonstrated in heaves susceptible horses following hay/straw challenge (Dacre, 
McGorum et al. 2007), however the ELISA used was optimised for BALF fluid and 
the levels in serum were not measured. Another common equine condition that can 
potentially cause an IgE mediated mast cell activation is sensitivity to Culicoides 
allergens (Wagner, Miller Jr et al. 2009). In this condition activated mast cells 
release histamine in the dermis (Morrow, Baker et al. 1987) and such degranuation 
may also result in the systemic release of serine proteinases, however this has not yet 
been measured in serum. These could be some of a number of concurrent conditions 
affecting systemic mast cell proteinase concentrations in the cohort of horses studied 
here. Concurrent disease is a potential area for further study as it has potential to 
have an effect on the systemic concentrations of MCPs.  
Although there was no significant positive relationship between local serum 
proteinase concentrations and CTMB for eqTRYP or eqMCP-1, cyathostomin- 
negative horses had consistently lower levels of eqMCP-1 (mean 0.45 ng/ml) and 
eqTRYP (mean 0.23 µg/ml). Studies in mice have demonstrated low serum levels of 
intestinal mast cell proteinase (IMCP) at 0.02 µg/ml in uninfected versus T. spiralis 
infected mice (Huntley, Gooden et al. 1990). The same study demonstrated low 
intestinal tissue concentrations of IMCP in non-parasitised mice which increased 
100-1000 fold in infected mice. Here, tissue from horses with a record of no previous 
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exposure to cyathostomins was not available. Neither local nor peripheral serum had 
statistically significant higher eqMCP-1 concentrations; the same was true of 
eqTRYP concentrations. However serum results were markedly different between 
the two proteinases; with eqMCP-1 and eqTRYP detected in nanograms and 
micrograms per millilitre respectively. This was unexpected in light of the 
significantly greater proportion of eqMCP-1 expressing intestinal mast cells 
enumerated using immunohistochemistry. The response of intestinal mast cell 
proteinase systemic release following nematode infection in mice with T. spiralis 
demonstrated peak concentrations of 9.48 µg/ml (Huntley, Gooden et al. 1990). 
Intravascular challenge of sensitised rats with soluble Nippostrongylus brasilensis 
antigen demonstrated vascular concentrations of rat mast cell proteinase-II of 6-10 
µg/ml after 1 min (Scudamore, Thornton et al. 1995). As eqTRYP was detected in 
µg/ml compared to ng/ml for eqMCP-1, it is possible that it is being differentially 
released or potentially differentially cleared, which has been demonstrated in mice 
(Pemberton, Wright et al. 2006). Mouse mast cell proteinases (mMCP) 1 and 2 have 
been shown to co-localise in similar quantities in intestinal mucosal mast cells; 
however, levels of these measured in peripheral blood during nematode infection is 
very different, with nanograms of mMCP-2 compared to micrograms of mMCP-1 
being detected (Pemberton, Wright et al. 2006). This difference is believed to be 
related to the fact that unlike mMCP-2, mMCP-1 forms complexes with serpins and 
this prevents its clearance and consequently substantially prolong its half-life 
(Pemberton, Wright et al. 2006). A similar situation could potentially be occurring 
here and further investigation in this respect is warranted. Despite the differences 
between the serum proteinase concentrations, there was no significant difference 
between the tissue proteinase concentrations in the caecum, RVC or rectum. This 
provides further evidence to suggest that there is a property of equine serum, such as 
differential clearance due to serpin complexes, that may be present and affecting the 
ELISA results here.                                                                                              
Different mast cell population compositions are also found in different tissues (Welle 
1997). Although the results here demonstrate eqMCP-1 expressing cells to be more 
numerous than those expressing eqTRYP in the intestine, this is not the case in all 
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equine tissues or organs (Pemberton, McEuen et al. 2001). Chymase-expressing cells 
were found to be scarce in the equine lungs, where tryptase-expressing mast cells 
predominate (Dacre 2005). This could have an effect on the concentrations of 
proteinases circulating in the serum. The rat beta chymase mast cell proteinase II is 
the predominant proteinase expressed in intestinal mucosal mast cells (Gibson, 
Mackeller et al. 1987; Sture, Huntley et al. 1995). In mice, the soluble beta chymase 
mouse MCP I is predominantly expressed by mucosal mast cells of the intestine 
(Wastling, Knight et al. 1998) and in helminth infections predominantly chymase-
positive phenotypes were observed (Friend, Ghildyal et al. 1996). However, tryptase 
expression has been demonstrated at higher levels than chymase in the human 
intestine (Aldenborg and Enerbäck 1994) and tryptase-positive mast cells have been 
found to be the most common subtype in bovine intestinal submucosa (Küther, 
Audigé et al. 1998). Sheep MCP I is abundantly expressed in ovine gastrointestinal 
cells; however, this proteinase has demonstrated both trypsin and chymotrypsin like 
activity (Pemberton, Huntley et al. 1997). Systemic concentrations of MCPs are 
higher in rodents compared to humans (Pemberton, Wright et al. 2006). Following 
nematode challenge, beta chymases have been detected in micrograms per millilitre 
in serum from mice (Pemberton, Brown et al. 2003) and rats (Miller, Woodbury et al. 
1983). In comparison, human serum levels of tryptase in response to allergic 
challenge have been measured in the order of nanograms per millilitre (Lin, Schwartz 
et al. 2000). In ovine studies concentrations of sheep MCP in serum were 
substantially less than the levels measured in rodents, however they were of a similar 
order of magnitude to those measured in humans (Huntley, Gibson et al. 1987). The 
relatively low concentrations of sheep MCP in serum (<1.0 ng/ml) is believed to be 
due to presence of proteinase inhibitors which interfere with its detection by ELISA 
(Huntley, Gibson et al. 1987). The binding of endogenous serum inhibitors to the 
serine proteinases could be masking epitopes and thus affecting their interaction with 
antibodies in the ELISA (Tate and Ward 2004). This could be a possible 
complication here and could potentially be responsible for the relatively low 
concentrations of eqMCP-1 measured in equine serum. The median local serum 
sample concentration of eqMCP-1 was 1.75 ng/ml compared to 3.16 µg/ml for 
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eqTRYP. However, using the same capture and detection antibodies for the tissue 
ELISAs the tissue concentrations were of the same order of magnitude, i.e. the 
median caecal eqMCP-1 concentrations was 35.78 µg/g compared to 46.47 µg/g for 
eqTRYP. This provides further evidence for the role of proteinase inhibitors in 
serum, but not in tissues and this property of equine serum requires further 
investigation.  
For the tissue MCP concentrations there was a significant correlation between the 
concentration of eqMCP-1 in the caecum, the RVC and the rectum. This was also 
observed with concentrations of eqTRYP in these organs. In addition, concentrations 
of eqTRYP significantly positively correlated with the concentrations of eqMCP-1 
within each organ. Furthermore, there was a significant relationship between both 
RVC eqMCP-1 and RVC eqTRYP concentrations and CTMB. Low RVC CTMB 
was associated with a low tissue proteinase concentration and high CTMB with high 
proteinase concentration, and this result was significant. Of the three organs 
examined, the RVC demonstrated the greatest range and highest median of eqMCP-1 
and eqTRYP proteinase concentrations. The RVC also had a greater total 
cyathostomin mucosal burden than the caecum (i.e. caecum: range 0–1,773,047; 
median 5945. RVC: range 0–2,054,051; median 7028). There were also significantly 
more luminal worms in the RVC compared to the caecum (Chapter 2). This could 
explain why the tissue ELISA results were more closely related to the cyathostomin 
burdens at this site, as the mast cells may be more active due to the higher levels of 
cyathsotomin present. In the case of CTLB, the only significant positive relationship 
was seen with RVC eqMCP-1 concentration (p=0.032, r2=47.7). The lack of 
relationship in the caecum and RB could also be related to the high assay coefficients 
of variation (CV). In particular the inter assay CVs for the serum ELISA were both 
above 30% despite additional optimisation procedures. This high CV could be 
contributed to by the use of polyclonal antibodies which may be binding non-
specifically to a number of epitopes (Lipman, Jackson et al. 2005). Also, the ELISA 
here used biotinylated versions of the capture antibody as the secondary antibody 
which is not ideal as these antibodies were raised in the same species (rabbit). As the 
capture and detections antibodies recognise the same epitopes it is likely that binding 
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of capture antibody to the proteinase interferes with binding of the detection 
antibody. This may have prevented antibody recognition and hence affected the level 
of signal recorded. Dilution errors for the standard curve may also have effected the 
variation between assays. As previously mentioned substances such as proteinase 
inhibitors, particularly in the serum, could also have been causing interference by 
interefering with antibody binding. The effect of this variation could be minimised in 
the future with the use of monoclonal antibody reagents, as they are produced by 
only one clone of B cells and therefore recognise only one epitope. Also, chymases 
are structurally very similar to granzymes and have similar specificities (Trapani 
2001). These granzymes are members of a chymotrypsin related family of serine 
proteinases produced by cytotoxic T-cells and NK cells (Trapani 2001). Due to 
similarities in the structure of related mast cell chymases and granzymes, it is 
therefore important to ensure the specificity of the antibodies utilised. The 
availability of the horse genome allows further investigation into the equine tryptase 
and chymase loci and this is the basis of Chapter 4. 
The work here has provided evidence to support further investigation in to equine 
mast cell proteinases and their use in diagnostic assays to estimate CTMB. The 
significant positive relationship demonstrated here between the proteinase-labelled 
rectal mast cells and CTMB has particular value as rectal biopsy is a viable and 
accessible sample source. The optimised ELISA demonstrated a significant 
relationship between both RVC eqMCP-1 and eqTRYP tissue concentrations and 
CTMB. Currently, in the case of equines, one mast cell chymase and one tryptase 
have been isolated from an equine mastocytoma (Pemberton, McEuen et al. 2001). 
However there is evidence for multiple equine chymases (Dacre 2005). Other species 
not only have varying mast cell population compositions, but express different 
numbers of both tryptase and chymase types (Caughey 2007). Given the diversity of 
mast cell proteinases in other species (Puente and López-Otín 2004; Gallwitz and 
Hellman 2006) there is potential for novel equine mast cell proteinases that have yet 
to be identified and may be more closely related to cyathostomin burden. 
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4 Exploration of Novel Equine Mast Cell Proteinases 
4.1 Introduction 
The recent generation of the horse genome map (Chowdhary and Raudsepp 2008) 
facilitates further investigation into equine mast cell proteinase sequences and their 
potential paralogs. This chapter had three broad aims. First to further extend the 
previous work here on equine mast cell proteinases, which demonstrated the possible 
existence for multiple equine chymases (Dacre 2005), and thus the aim here was to 
identify additional mast cell proteinase genes in the equine genome. Second to 
quantify transcription of four selected mast cell proteinases using quantitative 
polymerase chain reaction (qPCR). The sequences were chosen on the basis of their 
presence in equine intestinal tissue and amino acid (aa) at residue 226, an important 
residue for conferring substrate specificity (Smyth, O'Connor et al. 1996). Third to 
explore the relationship of the expression of selected proteinases with cyathostomin 
burden and other mast cell measurements. 
Mast cells comprise a heterogeneous population which can be expressed as 
differences in functional, biochemical and histochemical properties (Welle 1997). 
For example, there exist functionally distinct mast cell secretory granule subsets that 
define mast cell populations (Shimizu, Nagakui et al. 2001; Puri and Roche 2008) 
and like humans (Irani and Schwartz 1994), rats (Le Trong, Neurath et al. 1987) and 
mice (Miller and Pemberton 2002), horses have mast cell subpopulations that differ 
in neutral proteinase content (Pickles, Mair et al. 2010). Mast cells also express non-
specific proteinases, including granzymes, neurolysin and lysosomal cathepsins 
(Pejler, Åbrink et al. 2007; Pejler, Ronnberg et al. 2010). As previously mentioned 
(Chapter 1), the three main mast cell proteinases are tryptase, chymase and 
carboxypeptidase-A. Tryptase and chymase are classed as serine proteinases, because 
of the presence of a nucleophilic serine residue at the active site (Hedstrom 2002). 
The active site cleft is spanned by the catalytic triad with Ser195 on one side and 
Asp102 and His 57 on the other (Hedstrom 2002). Chymases, one of the major mast 
cell granule constituents, have chymotrypsin-like cleavage specificity and they 
cleave substrates on the C-terminal side of aromatic amino acids (Andersson, 
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Karlson et al. 2008). The chymase family can be subdivided into two groups, alpha 
and beta chymases, based on phylogenetic analyses (Chandrasekharan, Sanker et al. 
1996). Tryptases cleave peptide substrates on the carboxyl side of lysine and arginine 
residues (Caughey 2007) and are trypsin-like serine proteinases; however, they differ 
from trypsin in that they are resistant to natural inhibitors of trypsin and have little or 
no activity against denatured proteins such as casein (Little and Johnson 1995). As 
discussed in Chapter 3, two neutral serine proteinases have previously been extracted 
from equine mastocytoma tissue, equine tryptase (eqTRYP) and equine Mast Cell 
Proteinase-1 (eqMCP-1) which have trypsin-like and chymotrypsin-like specificities, 
respectively (Pemberton, McEuen et al. 2001). The antibodies used in Chapter 3 for 
immunolabelling and ELISAs were raised in rabbits using these two equine 
mastocytoma derived proteins (Pemberton, McEuen et al. 2001). The cloning and 
sequencing of these proteins has been described (Dacre 2005). The sequence for 
eqTRYP, referred to here as Tryptase-like Proteinase-1 (TLP1), shares >70 % aa 
identity with, and is the same length as other mammalian tryptases (Dacre, McAleese 
et al. 2006).  
The situation is more complicated with equine Mast Cell Proteinase-1 (eqMCP-1). 
When attempting to determine the nucleotide sequence for this chymase from equine 
intestinal tissue using molecular cloning techniques, the translated aa sequence for 
the putative eqMCP-1 had an N-terminal aa sequence that differed from that of the 
mastocytoma derived eqMCP-1 by two aa (Pemberton, McEuen et al. 2001; Dacre 
2005). Both sequences shared similar identities with human granzyme H (Pemberton, 
McEuen et al. 2001; Dacre 2005), however peptide masses of the two sequences, 
isolated by peptide mass fingerprinting, corresponded poorly with each other (Dacre 
2005). Fourteen peptide masses were determined for eqMCP-1 isolated from equine 
mastocytoma from peptide mass fingerprinting performed on two separate occasions 
(Dacre 2005). Only three of these corresponded with predicted peptides from 
putative eqMCP-1 (Dacre 2005). It was therefore hypothesised by Dr. K Pickles et 
al. (2005) that a similar but novel proteinase had been cloned and sequenced, rather 
than the original mastocytoma derived chymase that was purified and characterised 
by Dr A. Pemberton et al. 2001. This new chymase sequence was submitted to NCBI 
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as putative equine mast cell proteinase-1-like chymase by Dr. K Pickles et al. in 2005 
and is referred to as Chymase-like Proteinase-1 (CLP1) in this Chapter. 
Granzyme B is the best characterised granzyme and equine granzyme B has been 
recently isolated and identified (Piuko, Bravo et al. 2007). From preliminary 
examination of these sequences it is important to note that this sequence shares 
sequence homology (84% identity) with putative equine MCP-1, and 55% similarity 
with eqTRYP. Other species express multiple mast cell tryptase and chymase 
proteinases (Caughey 2007). In particular, the chymase locus has undergone 
significant evolutionary changes and multiple closely-related chymases are expressed 
in several mammalian species (McAleese, Pemberton et al. 1998; Miller and 
Pemberton 2002). The rat genome contains 28 closely related functional chymases 
(Puente and López-Otín 2004), compared to at least 14 in mice (Gallwitz and 
Hellman 2006). The finding by K. J Dacre (2005) provides evidence for the presence 
of multiple, closely related chymases in horses (Dacre 2005). In addition, the 
expression of specific mast cell proteinases has been demonstrated to correlate 
closely with intestinal nematode burdens in the mouse and rat (Woodbury, Miller et 
al. 1984; Huntley, Gooden et al. 1990). EqMCP-1 and eqTRYP tissue ELISA results 
from Chapter 3 demonstrated a significant positive relationship with cyathostomin 
burden in the right ventral colon (RVC). However, significant relationships between 
cyathostomin burden and eqMCP-1 and eqTRYP tissue concentrations were not 
observed in the caecum or rectum. As there is potential for novel equine mast cell 
proteinases there is also the potential that the expression of currently unidentified 
proteinases may be more closely related with cyathostomin burden. Therefore, this 
chapter aimed to explore this expression further and to examine the final hypothesis: 
 
There are novel equine mast cell proteinases that have not yet been identified. 
The release of these novel proteinases may be more closely related to worm 
burden than those previously investigated. 
To investigate the discrepancy in eqMCP-1 sequence and to determine whether other 
equine mast cell proteinases exist, proteomic analysis was performed on the 
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previously-purified protein products (eqTRYP and eqMCP-1), the equine 
mastocytoma tissue from which these proteinases were purified, equine intestinal 
tissue homogenate and serum with the aim of identifying other potential equine mast 
cell proteinases. Western blot analysis, using the polyclonal antibodies to both 
purified protein products (Pemberton, McEuen et al. 2001) used in Chapter 3, was 
performed to identify immunoreactive bands on one dimensional polyacrylamide 
gels and proteins within these areas were identified by mass-spectrometry with the 
aim of identifying other proteinases which may also be recognised by these 
polyclonal antibody reagents. The aa sequences obtained from this proteomic 
analysis were compared against known sequences for equine tryptase (TLP1) and 
putative equine Mast Cell Proteinase-1 (CLP1) and the NCBI database. This 
database includes the recently published equine genome, a bioinformatic resource 
that facilitates the investigation into predicted equine proteinase sequences. This 
approach identified seven additional proteinase sequences, of which two (granzyme 
B-like (GZMBL) and granzyme(BGH)-like GZM(BGH)L) were selected for further 
investigation. This selection was performed based on their aa residue at position 226, 
as this is important for conferring substrate specificity (Smyth, O'Connor et al. 
1996), and the presence of the proteinase in equine tissue from the Mascot results. 
Transcription analysis was then performed on four sequences, TLP1, CLP1 GZMBL 
and GZM(BGH)L, to investigate their expression in the equine cohort described in 
Chapter 2. Quantitative PCR was optimised and performed on cDNA from 14 horses 
at three different anatomical sites (the caecum, RVC and rectum) to determine 
transcript levels of the four proteinases. These results were then compared to mast 
cell counts and cyathostomin burden data and to immunohistochemistry and ELISA 
data generated on the two proteinases (eqMCP-1 and eqTRYP) to inform on the 
relationship of these proteinases with cyathostomin burden and immunological 
parameters. This work has the potential to provide additional information on equine 
mast cell proteinase genes and to further investigate their association with 
cyathostomin infection. 
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4.2 Materials and methods 
4.2.1 Sample Selection for Proteomic analysis 
To identify molecules bound by the anti-eqMCP-1 and anti-eqTRYP antibodies used 
in Chapter 3, serum and tissue homogenate samples were analysed. Sodium dodecyl 
sulphate polyacrylamide gel electrophoresis, using NuPage Novex Bis-Tris Mini gels 
(Invitrogen), was performed as per manufacturer’s instructions. Lanes containing 
homogenised equine mastocytoma and previously-purified eqTRYP and eqMCP-1 
(Pemberton, McEuen et al. 2001) were included for comparison. Sample ‘DV7 
Peripheral -80 °C’ serum and ‘DV12 RVC’ tissue homogenate were selected for 
analysis based on the presence of bands using antibody detection in pilot immunoblot 
studies. First, 6.5 µl of undiluted tissue homogenate from equine mastocytoma tissue, 
horse DV12 RVC and peripheral serum from horse DV7 (1:20 PBS) were loaded per 
lane. Two gels were run in parallel gel using NuPage MES Running Buffer 
containing 500 µl NuPage Antioxidant (Invitrogen) for 35 min at a constant 200 V. 
Samples were run in duplicate on two separate gels. One gel was washed three times 
in deionised water and stained overnight with Simply Blue™ Safe Stain (Invitrogen) 
to visualise protein bands. An immunoblot was performed on the second gel (see 
Appendix X) and the blot probed with rabbit anti-eqMCP-1 IgG or rabbit anti-
eqTRYP IgG (Chapter 3). Immunoreactive bands were visualised using ECL™ 
Western Blotting Detection Reagent (GE Healthcare). The blot was aligned with the 
protein stained gel to identify protein bands of similar size to the immunoreactive 
band(s). Three 1 mm wide gel slices were obtained for each lane: one slice at 
approximately the same size as the band, and one above and one below this slice. 
Each gel slice was analysed separately by mass spectrometry as described below. 
 
4.2.2 Liquid Chromatography- Electrospray Ionisation– Tandem 
Mass Spectrometry (LC-ESI-MS/MS) 
LC-ESI-MS/MS analysis of protein samples was carried out as described previously 
(Batycka et al. 2006). Briefly, the proteins within each gel slice excised from the 
sample lane were subjected to standard in-gel destaining, reduction, alkylation and 
trypsinolysis procedures (Shevchenko et al. 1996). Liquid chromatography (LC) was 
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then performed on samples of 4 μl from each gel slice, applied by direct injection to 
a monolithic reverse-phase column (5 cm × 200 μm; Dionex), using an Ultimate 
3000 nano-flow HPLC system (Dionex-LC Packings) maintained at 50 °C. Bound 
peptides were eluted by the application of a 15 min linear gradient of 8-45 % 
acetonitrile in 0.1 % formic acid and monitored by UV absorbance in a 3 nl UV 
detector flow cell. LC was interfaced with a 3-D high capacity ion trap mass 
spectrometer (Esquire HCTplusTM, Bruker Daltonics) via a low-volume (<50 
μl/min) stainless steel nebulizer (Agilent) and electrospray ionization. Digests were 
analysed for protein content by LC-ESI-MS/MS in ultrascan mode (26,000 amu/s). 
MS/MS analysis was initiated on a contact closure signal triggered by Chromeleon 
chromatography software (Dionex).  
 
4.2.3 Proteomic Analysis of MS/MS Data  
Deconvoluted MS/MS data in Mascot Generic Format (mgf) were imported into 
ProteinScape™ V2.1 (Bruker) proteomics data analysis software for searching 
against viral and mammalian subsections of the NCBI non-redundant protein 
sequence databases utilising the Mascot™ V2.2 search algorithm (Matrix Science). 
A second database containing the two sequences of interest, equine TLP1 and CLP1 
was created and the data also searched against this. Mascot search parameters were 
set in accordance with published guidelines (Taylor & Goodlett, 2005) and to this 
end, fixed and variable modifications selected were carbamidomethyl (C) and 
oxidation (M), respectively, while peptide (MS) and fragmentation (MS/MS) 
tolerance values were set at 1.5 Da and 0.5 Da, respectively. Individual protein 
candidates identified were inspected manually and considered significant only if: (a) 
a minimum of two peptides were matched for each protein, and (b) each peptide 
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4.2.4 MALDI-TOF-MS for Recombinant Protein Identification 
For identification of proteins by MALDI –TOF MS spots were excised from the gels 
and washed in 50 mM ammonium bicarbonate in 50% acetonitrile (ACN) three times 
for 15 min each at room temperature on a vortex mixer. The solution was removed 
and the gel pieces covered with 100 % ACN to dehydrate for 10 min. Supernatant 
was removed and the gel pieces vacuum-dried for 20 min. The gel spots were then 
rehydrated in trypsin digest solution (10 ng/µL sequencing grade modified trypsin) in 
25 mM ammonium bicarbonate and incubated at 37°C for at least 16 h. Tryptic 
peptides were applied to a steel MALDI target plate in a solution of 10mg/ml α-
cyano-4-hydroxycinnamic acid (CHCA) in 0.1 % TFA and 50 % ACN.  
 
4.2.5 Proteinase Sequence Analysis and Selection 
As previously mentioned, each lane was divided into three slices over the region of 
interest and each slice analysed separately. Two searches were performed using the 
Mascot™ V2.2 (Matrix Science) search algorithm. The first was performed against 
the database containing the two initial sequences of interest, TLP1 and CLP1. The 
second search used the NCBI non-redundant protein sequence databases and gave 
nine significant proteinase- or granzyme- related hits. After both searches, a database 
(GranzymeDB) was compiled of the nine protein candidates. From this database, 
four sequences of interest were selected; TLP1 (NP_001075344.1), GZMBL 
(XP_001488476.2), CLP1 (NP_001075345.1) and GZM(BGH)L (XP_001488616.3). 
The sequences were selected based on the aa residue at position 226 as this is 
important for conferring substrate specificity (Smyth, O'Connor et al. 1996) and the 
presence of the proteinase in equine tissue either from the Mascot results or, in the 
case of CLP1, the previous demonstration of this proteinase in equine tissue (Dacre 
2005). 
 
4.2.6 Processing and Storage of Tissue Material 
Sections were taken in duplicate from tissue adjacent to the samples processed for 
ELISA analyses and mast cell enumeration from the caecum, RVC and rectum of all 
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horses during the sampling process (Sections 2.2.6 and 2.2.8). These sections were 
placed immediately into at least 10 volumes of RNAlater (Invitrogen). The sections 
were less than 0.5 cm thick to ensure rapid and reliable stabilisation of RNA. 
Samples were stored for a minimum of 24 h at 4 oC, then transferred to -80 oC.  
 
4.2.7 RNA Extraction from Equine Tissue 
RNAlater-preserved tissue was homogenised using a Precellys®24 tissue 
homogeniser (Precellys) as follows: 30-40 mg of tissue were placed into a Precellys 
CK28 tube (Peqlab) together with 600 µl Buffer RLT Plus (Qiagen). The tissue was 
homogenised for five, 23-second cycles at 6200 rpm, with 2 min on ice between each 
cycle. The homogenised tissue was clarified by centrifugation at 14,000 × g for 10 
min at 4 °C. The homogenised lysate was passed through QIAshredder column 
(Qiagen) at 13,000 rpm for 2 min, then processed through a gDNA Eliminator spin 
column (Qiagen) at 11,000 rpm for 30 sec. RNA was extracted using an RNeasy Plus 
Mini Kit (Qiagen) with on-column digestion of DNA using an RNase-Free DNase 
Set (Qiagen) as per the manufacturer’s instructions.   
 
4.2.8 RNA Validation 
The quantity of the RNA was confirmed using a spectrophotometer (Nanodrop® 
ND-1000 UV-Vis Spectrophotometer) following the manufacturer’s instructions. 
The quality of RNA was assessed using the Agilent RNA 6000 Nano Assay protocol 
(2100 Bioanalyzer, Agilent Technologies). One μl of heat-treated RNA was added to 
each prepared well as per the manufacturer’s instructions. The ‘RNA Integrity 
Number’ for each sample was assessed. Samples with an RNA Integrity Number 
greater than 8 were accepted and any below this threshold were reprocessed. The 
mean RNA concentration using the Nanodrop spectrophotometer was 565.96 ng/ml 
+/- 277.25 (ng/ml +/- SD). The mean RNA concentration using the Agilent RNA 
6000 Nano Assay protocol was 803.10 ng/ml +/- 425.92 (ng/ml +/- SD).  
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4.2.9 Complementary DNA Production 
To produce complementary DNA (cDNA), 1 μg of RNA sample was used to 
synthesise single-stranded cDNA using Sprint™ Powerscript™ PrePrimed Single 
Shots with Oligo (dT)23 Primers (Sigma O4387). The cDNA was diluted 1:10 with 
molecular biology grade H2O before use, divided into aliquots and stored at -20 °C. 
 
4.3 Design of Primers 
Primers were designed manually for each of the four selected proteinase sequences; 
TLP1, GZMBL, CLP1, GZM(BGH)L. Sequences were searched against the equine 
genome using the NCBI standard nucleotide BLAST function (organism Equus 
caballus) and then aligned against all hits. Areas of unique nucleotide sequence were 
identified and primers designed to give an amplicon of 117 to 160 base pairs, a 
melting point of 62 °C and a GC content of between 40 and 65 % (Table 4.1). Once 
selected, the chosen amplicon sequences were re-verified, using the same BLAST 
function as above, against the equine NCBI database to ensure their specificity prior 
to cloning and sequencing. 
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Table 4.1: Primer sequences and product length for each of the four amplicons of interest. (bp: base pairs; TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-




Forward Primer Sequence 
 
 
Reverse Primer Sequence 
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Percentage of the 
amplicon sequence that 
the most similar hit 
covers  
Percentage identity 
with the most 
similar hit at the 
aa level 
TLP1 0 0 0 
GZMBL 11 97% 93% 
CLP1 1 99% 94% 
GZM(BGH)L 9 100% 89% 
 
Table 4.2: Table of results from a BLASTn search against the NCBI equine genome database using 
the PCR products for each gene of interest as the query sequence. The number of similar hits for each 
PCR product is shown is shown. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; 
CLP1: Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
 
4.3.1 Primer Validation and PCR Amplicon Sequencing 
Initial PCR was carried out using cDNA from caecal tissue from horse DV11 and 
RVC tissue from horse DV12. These horses were selected due to high eqTRYP- and 
eqMCP-1-labelled mast cell counts (DV11 Caecum: eqMCP-1 397 mucosal mast cell 
(MMC)/mm2 and eqTRYP 114 MMC/mm2; DV12 RVC: eqMCP-1 368 MMC/mm2 
and eqTRYP 162 MMC/mm2). The cDNA was used as a template with specific 
oligonucleotide primers (Table 4.2) for each of the genes of interest (TLP1, GZMBL, 
CLP1, GZM(BGH)L) to generate amplicons of 117-160 bp. PCR was performed 
under the conditions; 94 °C for 5 min, followed by 40 cycles of 94 °C for 30 sec, 55 
°C for 30 sec and 72 °C for 30 sec, with a final extension step of 7 min at 72 °C. The 
PCR products were purified using PCR purification kits (Qiagen), cloned into the 
pGEM-T easy vector system cloning kit (Promega) and the plasmids were 
transformed into JM109 High Efficiency Competent Cells (Promega). The 
transformed plasmids were incubated in SOC medium for 1 h at 37 °C, then spread 
onto Luria-Bertani (lb) medium plates containing ampicillin at 100 µg/ml. To enable 
alpha complementation to be used as a screening tool for the plasmids containing 
DNA, the plates contained 80 µg/ml X-Gal (5-bromo-4-chloro-3-indolyl-ß-D-
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galactoside, Promega) and 0.5 mM IPTG (Isopropyl ß-D-1-Thiogalactopyranoside; 
Promega). Colony PCR was performed on white colonies using SP6 and T7 primers, 
with positive colonies selected for culture. Selected plasmid colonies with amplicons 
of the correct approximate size were purified using the Wizard Plus Miniprep DNA 
Purification System (Promega) and the inserts sequenced (Eurofins MWG). The PCR 
was repeated with cDNA from four further horses selected at random (DV3, DV5, 
DV6, DV10), with cDNA from DV12 and DV11 amplified to act as positive 
controls. The PCR products from DV3, DV6 and DV10 were also ligated, 
transformed, purified and sequenced (as above) to examine any differences in 
nucleotide sequence in the genes of interest between horses and to confirm 
specificity of the primers. 
 
4.3.2 House Keeping Gene Selection 
The geNorm Reference Gene Selection Kit (Primerdesign) was used to establish the 
optimal reference genes utilising SYBR green detection chemistry. The six reference 
targets were; beta-actin (ACTβ), beta-2-microglobulin (B2M), hypoxanthine 
phosphoribosyltransferase (HPRT), glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), 18s ribosomal RNA (RN18S) and succinate dehydrogenase complex, 
subunit A, flavoprotein SDHA. Fifteen equine tissue samples were selected at 
random for preliminary analysis. The samples analysed represented a range of 
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Sample Number Horse Site Sex Age (yrs) 
1 DV12 C Male 1 
2 DV8 RVC Male >15 
3 DV6 C Female 4 
4 DV7 C Male 4 
5 DV3 C Female 3 
6 DV12 RB Male 1 
7 DV11 C Female 25 
8 DV7 RVC Male 4 
9 DV6 RB Female 4 
10 DV8 RB Male >15 
11 DV12 RVC Male 1 
12 DV7 RB Male 4 
13 DV6 RVC Female 4 
14 DV11 RVC Female 25 
15 DV8 C Male >15 
 
Table 4.3: Table of the 15 samples of equine tissue selected at random for geNorm analysis. (C: 
Caecum; RVC: Right ventral colon; RB: Rectal biopsy). 
 
 
SYBR green PrecisionTM 2X qPCR Mastermix (Primerdesign) was prepared as per 
manufacturer’s instructions. Lyophilised primer was re-suspended in 220 μl RNAse 
free water. A reaction mix (15 μl) containing 1 μl primer suspension, 10 μl 
PrimerDesign PrecisionTM 2X qPCR Mastermix and 4 μl RNAse-free water was 
added per well. The reactions were performed in quadruplicate. To each well, 5 ng of 
appropriate cDNA were added to give a final volume of 20 μl. The qPCR was 
performed using an ABI 7500 machine (Applied Biosystems) under cycling 
conditions of 10 min at 95 °C, followed by 50 cycles of 15 sec at 95 °C and 60 sec at 
60 °C. The geNorm analysis was performed using qbaseplus real-time PCR data 
analysis software (qbase+). 
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4.3.3 Probe Design for Quantitative PCR for Genes of Interest 
Probes were designed for qPCR for each of the four sequences (TLP1, GZMBL, 
CLP1, GZM(BGH)L) under investigation. Using the blastn suite in NCBI for the 
equine genome (organism E. caballus), each amplicon was aligned with its relevant 
related sequence results and target areas (highlighted in green) of difference 
identified (Figures 4.1-4). As the Blastn search for the TLP1 sequence returned no 
significant related hits, the similarity of TLP1 with the other three selected sequences 
was assessed (Figure 4.1). Dual-labelled hydrolysis probes (Table 4.4), Taqman 
(Eurofins MWG), were designed based on the parameters used by Beacon 
Designer™ and AlleleID®. To comply with these parameters, the probe for sequence 
GZM(BGH)L was reversed to ensure that the number of G’s and C’s at the 3’ end 
did not exceed two. Probes were labelled with the fluorescent dye 6-
carboxyfluorescein (FAM, Eurofins MWG) at the 3’ end and a non-fluorescent 
quencher, Black Hole Quencher 1 (Eurofins, MWG) at the 5’ end.  
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Table 4.4: Table of probe sequences and related information for each of the four genes of interest. The bolded sequence for the probe for GZM(BGH)L was reversed in 
accordance with optimal parameters. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-Like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: 
Granzyme(BGH)-like). 
Gene Probe Sequence 
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Figure 4.1: Alignment of the four amplicons of interest with primers (blue) and probe (green) for 
TLP1 highlighted. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-
like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
* - indicates positions which have a single, fully conserved residue.  
: - indicates conservation between groups of strongly similar properties - scoring > 0.5 in the Gonnet PAM 250 matrix.  


























Figure 4.2: Alignment of relevant equine proteinase predicted sequences from blastn of granzyme B-
like (GZMBL) amplicon (E. caballus) with highlighted primer sequences (blue) and selected probe 
sequence (green). The red areas are nucleotides that match the GZMBL sequence and the yellow are 
areas of difference.  
* - indicates positions which have a single, fully conserved residue.  
: - indicates conservation between groups of strongly similar properties - scoring > 0.5 in the Gonnet PAM 250 matrix.  
. - indicates conservation between groups of weakly similar properties - scoring = < 0.5 in the Gonnet PAM 250 matrix. 
GZMBL                                CAGCCTGCCCTGGGGAACAGCCCAGCTGAGGCCTGGAGAGGTGTGCAGTGTGGCAGGCTG 
gi|194238883|ref|XM_001488635.2      CCGCCTGCCCTGGTCCAAGGCCCAGGTGAGGCCCAGACAGGTGTGCAGTGTGGCGGGATG 
gi|194207238|ref|XM_001487881.2      CAGCCTGCCCTGGGGCACAGCCCAGGTGAGGCCTGGAGAGCTGTGCAGTGTGGCCGGCTG 
gi|194238887|ref|XM_001915613.1      CAGCCTGCCCTGGGGCACAGCCCAGGTGAGGCCCGGAGAGCTGTGCAGTGTGGCCGGCTG 
gi|194238000|ref|XM_001914653.1      CAGCCTGCCCTGGGGCACAGCCCAGGTGAGGCCCGGAGAGCTGTGCAGTGTGGCCGGCTG 
gi|194207240|ref|XM_001488315.2      CAGCCTGCCCTGGGGAACAGCCCAGGTGAGGCCTGGAGAGGTGTGCAGTGTGGCAGGCTG 
gi|126352429|ref|NM_001081881.1      AAGCCTGCCCAGGGCCAAGGCCCAGGTGAGGCCGCGACAGGTGTGCAGAGTGGCCGGATG 
gi|338717980|ref|XM_001488278.3      AAGCCTGCCCAGGGCCAAGGCCCAGGTGAGGCCGCGACAGGTGTGCAGAGTGGCCGGATG 
gi|338728626|ref|XM_001488566.3      CAACCTGCCCAGGGGCACAGCCCAGGTGAGGCCCGGAGAGGTGTGCCGTGTGGCTGGCTG 
gi|338717962|ref|XM_001488193.3      CAGCCTGCCCTGGGGCACAGCCCAGGTAAGGCCTGGAGAGGTGTGCAGTGTGGCTGGCTG 
gi|338717963|ref|XM_001488406.3      CAGCCTGCCCAGGGGCACAGCCCAGGTGAGGCCTGGAGAGGTGTGCAGTGTGGCGGGCTG 
gi|149692884|ref|XM_001488513.1      CAGCCTGCCCAGGGCCACAGCCCAGGTGAGGCCTGGAGAGGTGTGCAGTGTGGCTGGCTG 
                                    ...*******:**  .*..****** *.*****  ** ** *****.*:***** **.** 
 
 
GZMBL                                GGGGAGAGTCACCCCAAATGGCAGAGGGTCAGACACCCTGCAGGAGGTGGAGCTGACTGT 
gi|194238883|ref|XM_001488635.2      GGGGAAAGTCACCCCAATGGGCAGCTTCTCAGACACACTGCAGGAGGTGGAGCTGACTGT 
gi|194207238|ref|XM_001487881.2      GGGGAGAGTCACTCCAAATGGCACAGGGTCAGACACTCTGCAGGAGGTGGAGCTGACCGT 
gi|194238887|ref|XM_001915613.1      GGGGAGAGTCACCCCAAATGGCAGAGTGTCAAACACTCTGCAGGAGGTGGAGCTGACCGT 
gi|194238000|ref|XM_001914653.1      GGGGAGAGTCACCCCAAATGGCAGAGTGTCAAACACTCTGCAGGAGGTGGAGCTGACCGT 
gi|194207240|ref|XM_001488315.2      GGGGAGAGTCACTCCAAATGGCAGAGGGTCTGACACTCTGCAGGAGGTGGAGTTGACAGT 
gi|126352429|ref|NM_001081881.1      GGGGAGAGTCTCCCTGATGGGCAGCTTCTCAGACACGCTGCAGGAGGTGGAGCTGACTGT 
gi|338717980|ref|XM_001488278.3      GGGGATAGTCTCCCCGATGGGCAGCTTCTCAGACACGCTGCAGGAGGTGGAGCTGACCGT 
gi|338728626|ref|XM_001488566.3      GGGGAGAGTTGCCCTAAATGGCAGAGCGTCAGACACTCTGCAGGAGGTGGAGCTGACCGT 
gi|338717962|ref|XM_001488193.3      GGGGAGAGTCACCCGAAATGGCAGAGCATCAGTCACTCTGCAGGAGGTGGAGCTGACCGT 
gi|338717963|ref|XM_001488406.3      GGGGAGAGTCGCCCCAAATGGCAGAGGGTCAGACACCCTGCAGGAGGTGGAACTGACCGT 
gi|149692884|ref|XM_001488513.1      GGGAAGTGTCGCCCCATTCGGCAGAGCATCGGACACTCTGCAGGAGGTGGAGCTGACCGT 
                                     ***.* :**  * * .:: **** .   ** .:*** **************. **** ** 
 
GZMBL                                GCAGCAGGATCAGGTGTGCGAATCCTACTTTGGCAAT---TACAACCGTACCACTCAGCT 
gi|194238883|ref|XM_001488635.2      GCAGCAGGACAGGAAGCGTGAATCCTACTTACACAATTATCACAACAGTACCACTCAGCT 
gi|194207238|ref|XM_001487881.2      GCAGCAGGACCGGGTGTGCGAATCCTACTTACGCAGT---TACAACAGTAACACTCAGCT 
gi|194238887|ref|XM_001915613.1      GCAGCAGGACCGGGTGTGCGAATCCTACTTACGCAAT---TACAACAGTAACACGCAGTT 
gi|194238000|ref|XM_001914653.1      GCAGCAGGACCGGGTGTGCGAATCCTACTTACGCAAT---TACAACAGTAACACGCAGTT 
gi|194207240|ref|XM_001488315.2      GCAGCAGGACCAGGTGTGCAAATCCTACTTATGCAAT---TACAACAGTACCACTCAGCT 
gi|126352429|ref|NM_001081881.1      GCAGCAGGACCGGGAATGTGAATCTTACTTACGCAATTATTACAACAGTACCACTCAGCT 
gi|338717980|ref|XM_001488278.3      GCAGCAGGACCGGGAGTGCGAATCTTACTTACGCAATTATTACAATAGTACCACTCAGCT 
gi|338728626|ref|XM_001488566.3      GCAGCAGGACCAGGAGTGCGAATCCTACTTACAAAAG---TACAACAGTACCACTCAGCT 
gi|338717962|ref|XM_001488193.3      GCAGCAGGACCGCGTGTGCAAATCCTACTTACGCAAT---TACAACAGTACCACTCAGCT 
gi|338717963|ref|XM_001488406.3      GCAGCAGGACTGGGTGTGCGAATACTACTTTCACAAT---TACAACAGTACCACTCAGCT 
gi|149692884|ref|XM_001488513.1      GCAGCAGGACTGGGAGTGCGAGTTCCTATGGCACAAT---TACAACAAGACCACTCAGCT 
                                     *********  . .:. * .*.*   :.*   ..*.     **** .. *.*** *** * 
 
TLP1                                 GGGCGATGTCGACAATGGAGTCAGTCTGCCACCTCCGTTTCCCCTGAAGGAAGTAAAAGT 
CLP1                                 GGGGCAACTTGCCCCGAAGGGCAGGTTCCCAG------ACACACTGCAGGAGGTGGAACT 
GZMBL                                GGGGAGAGTCACCCCAAATGGCAGAGGGTCAG------ACACCCTGCAGGAGGTGGAGCT 
GZM(BGH)L                            GGGGAGAGTTGCCCTAAATGGCAGAGCGTCAG------ACACTCTGCAGGAGGTGGAGCT 
                                     ***  .: * ..*.  .. * ***     **       : .* ***.****.**..*. * 
 
TLP1                                 CCCCATTGTGGAAAACAGCGTTTGTGACAGGAAATACCACACTGGCGTGTCCACGGGGGA 
CLP1                                 GACTGTGCAGCAGGATGAGGTGTGCG------AATCCTACTTCCGCAATTA------TTT 
GZMBL                                GACTGTGCAGCAGGATCAGGTGTGCG------AATCCTACTTTGGCAATTA--------- 
GZM(BGH)L                            GACCGTGCAGCAGGACCAGGAGTGCG------AATCCTACTTACAAAAGTA--------- 
                                      .* .*  :* *..*  . *: ** *      ***.* **:   ...: *.          
 
TLP1                                 CAACATCCGGATTGTCCAGGCCGACATGCTGTGTGCAGGGAATAGGAGGCACGACA---- 
CLP1                                 CAACA---G-----T----ACCACTCAGCTGTGTGTAGGGGATCCGAAAGATAAGAAGTC 
GZMBL                                CAACC---G-----T----ACCACTCAGCTGTGTGTGGGGGACCCGAAGGAAAAGAAGTC 
GZM(BGH)L                            CAACA---G-----T----ACCACTCAGCTGTGTGTGGGGGACCCGAAGGAAAAGAAGTC 
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Figure 4.3: Alignment of both equine proteinase predicted sequences from blastn of Chymase-like 
Proteinase-1 (CLP1) amplicon (E. caballus) with highlighted primer sequences (blue) and selected probe 
sequence (green). The red areas are nucleotides that match the CLP1 sequence and the yellow are areas of 
difference.  
* - indicates positions which have a single, fully conserved residue.  
: - indicates conservation between groups of strongly similar properties - scoring > 0.5 in the Gonnet PAM 250 matrix.  






























Figure 4.4: Alignment of relevant equine proteinase predicted sequences from blastn of Granzyme(BGH)-
like (GZM(BGH)L) amplicon (E. caballus) with highlighted primer sequences (blue) and selected probe 
sequence (green). The red areas are nucleotides that match the GZM(BGH)L sequence and the yellow are areas of 
difference.  
* - indicates positions which have a single, fully conserved residue.  
: - indicates conservation between groups of strongly similar properties - scoring > 0.5 in the Gonnet PAM 250 matrix.  
. - indicates conservation between groups of weakly similar properties - scoring = < 0.5 in the Gonnet PAM 250 matrix. 
CLP1                                 AACAGTACCACTCAGCTGTGTGTAGGGGATCCGAAAGATAAGAAGTCTTCCTTTCAGGGT 
gi|338728628|ref|XM_001489068.3      AACAGTACCACTCAGCTGTGTGTAGGGGACCCGAAGGTTAAGAAGTCTTCCTTTCAGGGC 
                                    ***************************** *****.*:*********************  
 
CLP1                                 GACTCTGGGGGCCCTCTCATCTGTGAGAACGGGCTCCAGGGCATTGTCTCCTATGGACTA 
gi|338728628|ref|XM_001489068.3      GACTCTGGGGGCCCTCTCATCTGTGAGAACGGTCTCCAGGGCATTGTCTCCTATGGACTG 
                                     ******************************** **************************. 
 
CLP1                                 GATAACGGGAGTATTCCACAGGCCTTCACCAAAGTCTCGAGTTTCCTGCCCTGGATAAAG 
gi|338728628|ref|XM_001489068.3      GATAACGGGAGTCCTCCACGGGCCTTCACCAAAGTCTCGAGTTTCCTGCCCTGGATAAAG 
                                     ************  ***** **************************************** 
 
 
GZM(BGH)L                            CCACCCAGACTATAATTCTAAGAACTTCGCCAACGACATCATGTTACTAA  
gi|338717963|ref|XM_001488406        CCACCCAGACTATAATTCTAAGAAGATAGCCAACGACATCATGATACTAA  
gi|149692884|ref|XM_001488513        CAACCCACACTATAATTCTAAGAACCTCAACAATGACATCATGTTACTAA 
gi|126352429|ref|NM_001081881        ACACCCAGACTATAACCCTAAGAACTACTCCAACGACATCATGTTACTAA  
gi|338717980|ref|XM_001488278        ACACCCAGACTATAACCCTAAGAACTACTCCAACGACATCATGTTACTAA  
gi|338728628|ref|XM_001489068        CCACCCAGACTATAATCTTAAGAACCTCTCCAATGACATCATGTTACTAA  
gi|194238887|ref|XM_001915613        CCACCCAGACTATAAACGTAAGGAGTTCTCCAATGACATCATGTTACTAA  
gi|194238000|ref|XM_001914653        CCACCCAGACTATAAACGTAAGGAGTTCTCCAATGACATCATGTTACTAA  
gi|338728630|ref|XM_001489737        CCACCCAGACTATATTCCTAGTGAATACTTCAATGACATCATGATACTAA  
gi|338728709|ref|XM_003365684        CCACCCAGACTATATTCCTAGTGAATACTTCAGTGACATCATGATACTAA  
                                     ..***** ******:   **. .*  :.  **. *********:****** 
 
GZM(BGH)L                            AGCTGGAGAGAAGGGCCAAGCTTACCGAAGCTGTGTGGCCCCTCAACCTG 
gi|338717963|ref|XM_001488406        AGCTGGATAGAAAGGCCAAGCTGTCTGAAGCTGTGCAGCCCCTCAGCCTG  
gi|149692884|ref|XM_001488513        AGCTGGAGAGAAAGGCCCAGCAGACTGCAGCTGTGAGGCCCCTCAGCCTG  
gi|126352429|ref|NM_001081881        AGCTGGAGAGAAAGGCCAAGCTGACTGTAGCTGTGAGGACCCTAAGCCTG  
gi|338717980|ref|XM_001488278        AGCTGGAGAGAAAGGCCAAGCTGACTGCAGCTGTGAGGACCCTAAGCCTG  
gi|338728628|ref|XM_001489068        AGCTGGAGAGAAGGGCCAAGCTGTCTGCAGCTGTGTGGCCCCTCAGCCTG  
gi|194238887|ref|XM_001915613        AGCTGGAGAGAGAGGCCAAGCTGACTGCAGCTGTGAGGACCCTCAGCCTG 
gi|194238000|ref|XM_001914653        AGCTGGAGAGAGAGGCCAAGCTGACTGCAGCTGTGAGGACCCTCAGCCTG 
gi|338728630|ref|XM_001489737        AGCTAGAGAGAAAGGCCATGCGGACTGCAGCTGTGTGGCCCCTCATCCTG  
gi|338728709|ref|XM_003365684        AGCTAGAGGGAAAGGCCAAGCTGACTGCAGCTGTGTGGCCCCTCATCCTG  
                                     ****.** .**..****.:**  :* * ******* .*.****.* **** 
 
GZM(BGH)L                            CCCAGGGGCACAGCCCAGGTGAGGCCCGGAGAGGTGTGCCGTGTGGCTGG  
gi|338717963|ref|XM_001488406        CCCAGGGGCACAGCCCAGGTGAGGCCTGGAGAGGTGTGCAGTGTGGCGGG  
gi|149692884|ref|XM_001488513        CCCAGGGCCACAGCCCAGGTGAGGCCTGGAGAGGTGTGCAGTGTGGCTGG  
gi|126352429|ref|NM_001081881        CCCAGGGCCAAGGCCCAGGTGAGGCCGCGACAGGTGTGCAGAGTGGCCGG  
gi|338717980|ref|XM_001488278        CCCAGGGCCAAGGCCCAGGTGAGGCCGCGACAGGTGTGCAGAGTGGCCGG  
gi|338728628|ref|XM_001489068        CCCAGGGGCAAGACCCAGGTGAGGCCCGGAGAGGTGTGCAGTGTGGCCGG  
gi|194238887|ref|XM_001915613        CCCTGGGGCACAGCCCAGGTGAGGCCCGGAGAGCTGTGCAGTGTGGCCGG  
gi|194238000|ref|XM_001914653        CCCTGGGGCACAGCCCAGGTGAGGCCCGGAGAGCTGTGCAGTGTGGCCGG  
gi|338728630|ref|XM_001489737        CCCAGGGGCACAGCCCAGGTGAGGCCCGGAGAGGTGTGCCGTGTGGCAGG  
gi|338728709|ref|XM_003365684        CCCAGGGGCACAGCCCAGGTGAGGCCCAGAGAGGTGTGCCGTGTGGCCGG  
                                     ***:*** **...*************  ** ** *****.*:***** ** 
 
GZM(BGH)L                            CTGGGGGAGAGTTGCCCTAAATGGCAGAGCGTCAGACACTCTGCAGGAGG  
gi|338717963|ref|XM_001488406        CTGGGGGAGAGTCGCCCCAAATGGCAGAGGGTCAGACACCCTGCAGGAGG  
gi|149692884|ref|XM_001488513        CTGGGGAAGTGTCGCCCCATTCGGCAGAGCATCGGACACTCTGCAGGAGG  
gi|126352429|ref|NM_001081881        ATGGGGGAGAGTCTCCCTGATGGGCAGCTTCTCAGACACGCTGCAGGAGG  
gi|338717980|ref|XM_001488278        ATGGGGGATAGTCTCCCCGATGGGCAGCTTCTCAGACACGCTGCAGGAGG  
gi|338728628|ref|XM_001489068        CTGGGGGCAACTTGCCCCAAAGGGCAGGTTCCCAGACACACTGCAGGAGG  
gi|194238887|ref|XM_001915613        CTGGGGGAGAGTCACCCCAAATGGCAGAGTGTCAAACACTCTGCAGGAGG  
gi|194238000|ref|XM_001914653        CTGGGGGAGAGTCACCCCAAATGGCAGAGTGTCAAACACTCTGCAGGAGG  
gi|338728630|ref|XM_001489737        CTGGAGGCTAATCGGCCCCAATGGCATAATTTCCAACACACTGCGGGAGG  
gi|338728709|ref|XM_003365684        TTGGAGGCTAATGGCCCTAAAAGGCATAATTTCCAACACACTGTGGGAGG  
                                 ***.*.. : *   **  :: ****      * .**** *** .***** 
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4.3.4 Probe design for Quantitative PCR housekeeping genes 
Probes were designed for the two chosen housekeeping genes, selected from the 
geNORM results, GAPDH and SDHA (Primerdesign). Probes were verified using 
cDNA from samples DV8 C and DV12 RVC. For consistency, the housekeeping 
probes were also labelled with FAM and Black Hole Quencher1.  
 
4.3.5 Generation of Plasmid Standards for Quantitative PCR 
Plasmids containing inserts purified from amplicons of the four sequences of interest 
(TLP1, GZMBL, CLP1, GZM(BGH)L) were purified. A spectrophotometer was 
used to determine the concentration of DNA in preparations of the purified plasmids 
and, from this value, the number of copies calculated using the formula: 
Number of copies = quantity (ng) x 6.022 x 1023 
                                 length (bp) x 1 x 109 x 650  
 
The qPCR reaction was performed under the conditions; 94 °C for 5 min, followed 
by 45 cycles of 94 °C for 30 sec, 55 °C for 30 sec and a data collection step of 72 °C 
for 32 sec. 
 
4.3.6 Probe Verification 
Combinations of primers and probes were tested. Each primer set was tested in 
duplicate with each of the four different probes, 0.5 μl of the relevant forward and 
reverse primers (10 μM each), 0.25 μl of relevant probe (10 μM) and 5 μl of template 
(cDNA diluted 1:10). Because the experiment required a large amount of cDNA, 
samples from four horses were selected at random, one for each primer set. DV10 
RVC was used for TLP1, DV7 caecum for GZMBL, DV12 caecum for CLP1 and 
DV9 caecum for GZM(GBH)L. The qPCR was performed using a ABI 7500 cycler 
under conditions of 94 °C for 5 min, followed by 45 cycles of 94 °C for 30 sec, 55 
°C for 30 sec and a data collection step of 72 °C for 32 sec.  
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4.3.7 Quantitative PCR of Equine Tissue Samples 
Proteinase transcript levels were measured by relative qPCR using the standard curve 
method. For each plate standard curves were generated using plasmids containing the 
DNA sequence of the relevant genes of interest or the reference genes. 
Amplifications for the standard curve were performed in triplicate and diluted over a 
range of 105 copies/µl to 1 copy/µl. All cDNA samples were analysed in duplicate. 
Negative controls were prepared using an identical mastermix, but with 5 µl of PCR-
grade water instead of cDNA. Each qPCR reaction consisted of 6.2 µl PCR grade 
H20, 12.5 µl mastermix (Invitrogen), 0.05 µl reference dye (ROX), 0.5 μl of the 
relevant forward and reverse primers (10 µM each), 0.25 μl of relevant probe (10 
µM) and 5 µl of template (cDNA diluted 1:10). The qPCR was performed using the 
ABI 7500 cycler under conditions of 94 °C for 5 min, followed by 45 cycles of 94 °C 
for 30 sec, 55 °C for 30 sec and a data collection step of 72 °C for 32 sec. Levels of 
gene transcript in each sample were evaluated using ABI 7500 software (Applied 
Biosystems), and the results normalised to the two selected reference genes, GAPDH 
and SDHA. This was performed by calculating the geometric mean of the reference 
genes and, subsequently, deriving a normalisation coefficient for each cDNA sample 
by dividing the geometric mean of the reference genes by the average geometric 
mean from all the reference samples. The individual genes of interest were then 
normalised by dividing the copies/µl of cDNA by the normalisation coefficient for 
the same cDNA sample. All plates were run with a plasmid standard curve for 
absolute quantification. Samples were repeated if the difference between the 
duplicate results was greater than 1.5 Ct (threshold cycle). 
 
4.3.8 Re-annotation of Equine Genome  
The horse genome was re-annotated and this was made public in September 2013 
(version EquCab 2.0) (Personal Communication: Wayne Matten, PhD). The four 
mast cell proteinase sequences were assessed and compared with the re-annotated 
entries in order to assure their accuracy. 
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4.3.9 Data Analysis 
As the data were not normally distributed, non-parametric tests were selected. For 
optimal graphical representation, log transformed (log10+1) data is sometimes 
presented here. Statistical analyses and graphical displays were performed using R 
Studio (V 0.97.551), Minitab 15 statistical software and GraphPad Prism5. To 
investigate the relationships between mast cell measures, including Toluidine blue 
stained mast cell counts, eqMCP-1- and eqTRYP-labelled mast cell counts, ELISA 
serum and tissue values and qPCR results, correlations were assessed using the 
Spearman rank test. Standard linear regression analysis was used to explore the 
relationships between log10+1 transformed normalised proteinase results and 
log10+1 transformed combined total mucosal burdens (CTMB). The presence of A. 
perfoliata was added as a confounding variable. The associations were considered as 
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4.4 Results 
4.4.1 Sequence Selection for Identification of Additional 
Proteinases 
Protein stained SDS PAGE gels and immunoblots were performed in parallel on 
mastocytoma tissue, serum and mucosal tissue to identify proteins within regions 
recognised by the anti-eqMCP-1 and anti-eqTRYP antibodies for subsequent mass 
spectrometry analysis. The images are shown in Figures 4.5A and B for eqTRYP and 
4.6A and B for eqMCP-1, respectively. Bands bound by the antibodies were used to 
guide excision of the protein bands of interest on the corresponding protein stained 
gel. Each lane was separated into three slices (Figures 4.5A and 4.6A), and each of 
these analysed separately. Two searches were performed on the deconvoluted 
MS/MS data, firstly using the NCBI non-redundant protein sequence databases and 
Mascot™ V2.2 (Matrix Science) search algorithm, followed by the second database 
containing the two initial sequences of interest, TLP1 and CLP1, which had 
previously been submitted to NCBI by Dacre et al. 2005. These searches identified 
seven novel predicted equine sequences and confirmed the presence of TLP1 and 
CLP1. After both searches a final database was compiled of nine candidates 
(GranzymeDB). This database included the proteins TLP1 and CLP1. The NCBI 
sequence identifiers for the nine sequences were gi126352403 (TLP1), gi126352661 
(CLP1), gi338728629, gi338728627, gi194238001, gi194207243, gi149692885, 
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Figure 4.5: A: EqTRYP SDS PAGE gel showing the three slices each lane was divided into. B: The 
corresponding Western blot probed with rabbit IgG anti-eqTRYP (1 µg/ml) and developed with ECL. 
Lane 1: Purified eqTRYP. Lane 2: Equine mastocytoma tissue homogenate. Lane 3: Equine serum. 
Lane 4: Equine right ventral colon tissue homogenate. 
 
Figure 4.6: A: EqMCP-1 SDS PAGE gel showing the three slices each lane was divided into. B: The 
corresponding eqMCP-1 western blot probed with rabbit IgG anti-eqMCP-1 (1 µg/ml) and developed 
with ECL.Lane 1: Purified eqMCP-1. Lane 2: Equine mastocytoma tissue homogenate. Lane 3: 
Equine serum. Lane 4: Equine right ventral colon tissue homogenate. 
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Figure 4.7: Alignment of the nine novel proteinase candidates in granzymeDB identified by Mascot 
database search. The areas highlighted in red are peptide sequences defined from the Mascot results 
that are unique to the proteins of interest. The pink highlighted area denotes the start and end of each 
unique sequence. The areas highlighted in yellow are peptide sequences that are not unique and match 
one or more of the granzymeDB protein sequences. 
 
 
gi|126352403|ref|NP_001075344.1|      ------------------------------------------------------------ 
gi|126352661|ref|NP_001075345.1|      ------------------------------------------------------------ 
gi|338728629|ref|XP_001489118.3|      MGLRHQAGKPGAAAQGHSPPTGEERGDLSRTFSPTARELAQSQEGLEGTDPICTSFLSSG 
gi|338728627|ref|XP_001488616.3|      ------------------------------------------------------------ 
gi|194238001|ref|XP_001914688.1|      ------------------------------------------------------------ 
gi|194207243|ref|XP_001488243.2|      ------------------------------------------------------------ 
gi|149692885|ref|XP_001488563.1|      ------------------------------------------------------------ 
gi|194207249|ref|XP_001488476.2|      ------------------------------------------------------------ 
gi|194207247|ref|XP_001488456.2|      ------------------------------------------------------------ 
                                                                                                   
gi|126352403|ref|NP_001075344.1|      -------------------MPNLLVLALALLVNLGHAAPAPGQALEREGIVGGQEASGSK 
gi|126352661|ref|NP_001075345.1|      -------------------MRPLLL-LLAFLLP---------PEAGTEDIIGGHEAKPHS 
gi|338728629|ref|XP_001489118.3|      LKEQGGSTSLPDLSNLPGKMQPLLL-LLAFLLS---------PGAEAGEIIGGHEAWPHS 
gi|338728627|ref|XP_001488616.3|      -------------------MQPLLL-LLAILVP---------PGA--EEIIGGHEARPHS 
gi|194238001|ref|XP_001914688.1|      -------------------MQPLLL-LLVFLLP---------PEAGTEDIIGGHEAKPHS 
gi|194207243|ref|XP_001488243.2|      -------------------MQPLLL-LLVFLLS---------PGTEAGEIIGGHEARPHS 
gi|149692885|ref|XP_001488563.1|      -------------------MQPLLL-LLAFLLS---------PGAEAGEIIGGHEAWPHS 
gi|194207249|ref|XP_001488476.2|      -------------------MQPLLF-LLAFLLS---------PGPEAGEIIGGHEARPHS 
gi|194207247|ref|XP_001488456.2|      -------------------MQPLLF-LLAFLLS---------PGPEAGEIIGGHEAWPHS 
                                                         *  **.  *.:*:                 *:**:**   . 
gi|126352403|ref|NP_001075344.1|      WPWQVSLRKNTEYWKHFCGGSLIHPQWVLTAAHCVGPDIEDFRDIRVQLREQHLYYRDQL 
gi|126352661|ref|NP_001075345.1|      RPYMALVQFLFEEILHSCGGVLVRQDIVLTAAHCWGRLMNVTLGAHNI---RRQEKTQQV 
gi|338728629|ref|XP_001489118.3|      RPYMALVQFLFEEILHSCGGVLVRHDIVLTAAHCWGRLMNVTLGAHNI---RKQEKTQQV 
gi|338728627|ref|XP_001488616.3|      RPYMAFVQFLVEEAKDGCGGVLVQQDFVLTAAHCWGSSIKVTLGAHNI---QKQERTQQV 
gi|194238001|ref|XP_001914688.1|      RPYMVFVQCLRGNKKKRCGGVLVQEDFVLTAAHCRGRLINVILGAHNI---RKQEKTQQV 
gi|194207243|ref|XP_001488243.2|      RPYMAFVQFLVEEKNHRCGGVLVQQDFVLTAAHCWGSSINVTLGAHNI---QKQERTQQV 
gi|149692885|ref|XP_001488563.1|      RPYMAFVLSLEKEKGKSCGGVLVRQDFVLTAAHCWGSSMMVTLGAHNI---EKQERTQQV 
gi|194207249|ref|XP_001488476.2|      RPYMAFVQILIEQKWKSCGGVLVRQDVVLTAAHCWGRSIKVALGAHNI---KKQERTQQV 
gi|194207247|ref|XP_001488456.2|      RPYMAFVQILVEEKWKSCGGVLLRRDIVLTAAHCWGSSIKVTLGAHNI---QKQERTQQV 
                                       *: . :        . *** *:: : ******* *  :      :     .:    :*: 
gi|126352403|ref|NP_001075344.1|      LPVSRILPHPYYYTVENGADIALLELQDPVNISSHVQVVTLPPASETFPPGTPCWVTGWG 
gi|126352661|ref|NP_001075345.1|      ITVRQAIHHPDYNPKSFSNDIMLLKLGRRAKLTAAVRPLSLPRGKTQVRPGEVCSVAGWG 
gi|338728629|ref|XP_001489118.3|      ITVRQAIRHPDYNLKNLSNDIMLLKLERRAKLSAAVWPLSLPRGKTQVRPGEVCSVAGWG 
gi|338728627|ref|XP_001488616.3|      IPVKEAIPHPDYNSKNFANDIMLLKLERRAKLTEAVWPLNLPRGTAQVRPGEVCRVAGWG 
gi|194238001|ref|XP_001914688.1|      ITVRQALRHPDYKRKEFSNDIMLLKLEREAKLTAAVRTLSLPWGTAQVRPGELCSVAGWG 
gi|194207243|ref|XP_001488243.2|      ISVKEAIPHPDYKRKKFSNDIMLLKLERKATQTAAVRPLSLPWGTAQVRPGEVCSVAGWG 
gi|149692885|ref|XP_001488563.1|      ISVKEAIPNPHYNSKNLNNDIMLLKLERKAQQTAAVRPLSLPRATAQVRPGEVCSVAGWG 
gi|194207249|ref|XP_001488476.2|      ISVKEAIPHPHYNSKKIANDIMILKLERKAELTAAVQPISLPWGTAQLRPGEVCSVAGWG 
gi|194207247|ref|XP_001488456.2|      ISVKEAIPHPDYNSKKIANDIMILKLDRKAKLSEAVQPLSLPRGTAQVRPGEVCSVAGWG 
                                      : * . : .* *   .   ** :*:*   .  :  *  :.** ..  . **  * *:*** 
gi|126352403|ref|NP_001075344.1|      DVDNGVSLPPPFPLKEVKVPIVENSVCDRKYHTGVSTGDNIRIVQADMLCAGNR--RHDS 
gi|126352661|ref|NP_001075345.1|      QLAPKGRFP--DTLQEVELTVQQDEVCESYFRNYFN--------STTQLCVGDPKDKKSS 
gi|338728629|ref|XP_001489118.3|      QLAPKGRFP--DTLQEVELTVQQDEVCESYFRNYYN--------STTQLCVGDPKVKKSS 
gi|338728627|ref|XP_001488616.3|      RVALNGRAS--DTLQEVELTVQQDQECESYLQKY-N--------STTQLCVGDPKEKKSS 
gi|194238001|ref|XP_001914688.1|      RVTPNGRVS--NTLQEVELTVQQDRVCESYLRNY-N--------SNTQLCVGDPKEEKSS 
gi|194207243|ref|XP_001488243.2|      RVTRNGRAS--VTLQEVELTVQQDRVCKSYLRNY-N--------STTQLCVGDPKEKKSS 
gi|149692885|ref|XP_001488563.1|      SVAPFGRAS--DTLQEVELTVQQDWECEFLWHNY-N--------KTTQLCVGDPKEKKSS 
gi|194207249|ref|XP_001488476.2|      RVTPNGRGS--DTLQEVELTVQQDQVCESYFGNY-N--------RTTQLCVGDPKEKKSS 
gi|194207247|ref|XP_001488456.2|      RVAPNGRGS--DTLQEVELTVQQDWVCEYYFHNY-N--------STTQLCVGDTKEKKSS 
                                       :           *:**:: : ::  *.    .  .            **.*:   .:.* 
gi|126352403|ref|NP_001075344.1|      CQGDSGGPLVCKVKGTWLQAGVVSWANSCAQPNRPGIYTRVTYYLDWIYQYVPKDS---- 
gi|126352661|ref|NP_001075345.1|      FQGDSGGPLICENG----LQGIVSYGLDNG--SIPQAFTKVSSFLPWIKKTMKRL----- 
gi|338728629|ref|XP_001489118.3|      FQGDSGGPLICENG----LQGIVSYGLDNG--SPPRAFTKVSSFLPWIKKTMKSL----- 
gi|338728627|ref|XP_001488616.3|      FKGDSRGTLVCKNV----IQGIVSYGRIGG--IPPQAFTKVSSFLPWIKKTMKGRALWQN 
gi|194238001|ref|XP_001914688.1|      FKGDSGGPLVCENV----IQGLVSYGRRDG--TPPQAFTKVSSFLPWIKETMKKL----- 
gi|194207243|ref|XP_001488243.2|      FKGDSGGPLVCNNL----IQGLVSYGRCNG--TPPRAFTKVSSFLPWIKKTLKAT--WQS 
gi|149692885|ref|XP_001488563.1|      YKGDSGGPLVCKNV----IQGIVSYGRIGG--IPPQAFTKVLSFLPWIKKTMKGPAPWQR 
gi|194207249|ref|XP_001488476.2|      YKGDSGGPLVCKNV----IQGIVSYGRSGG--LPPRAFTKVSSFLPWIKKTMKGRAPWPR 
gi|194207247|ref|XP_001488456.2|      YKGDSGGPLMCKNM----IQGIVSYGRRGG--IPPGAFTKVSSFLPWIKKTRKGRPHGGV 
                                       :*** * *:*:        *:**:.   .    *  :*:*  :* ** :           
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The sequences within the GranzymDB database were aligned using Clustal Omega 
(Goujon, McWilliam et al. 2010; Sievers, Wilm et al. 2011) and examined to identify 
unique peptide sequences from the Mascot results (Figure 4.7). The nine sequences 
of GranzymeDB were also aligned and compared to ovine MCP1, and human and 
mouse GZMB (Figure 4.8) to identify aa residues at position 226 as this is important 
for conferring specificity (Smyth, O'Connor et al. 1996). GranzymeDB sequences 
were grouped according to this residue. Group 1 had a glycine at 226 (blue), Group 
2, like mouse and human GZMB, had an arginine (pink) and Group 3 had a 
glutamine (green). These proteins are listed in Table 4.5 and were classified as 
granzyme or mast cell proteinase related. The slices of gel (Figure 4.5 and 4.6) were 
analysed to identify the proteinase sequences in each lane. In lane 1 of the eqTRYP 
gel, which contained purified eqTRYP (Figure 4.5), the only identified sequence 
from the GranzymeDB database was TLP1. In lane 1 of the eqMCP-1 gel, containing 
purified eqMCP-1 (Figure 4.6), GZM(GBH)L was the only proteinase identified. The 
equine mastocytoma (Lanes 2: Figures 4.5 and 4.6) contained TLP1, GZMBL, 
GZM(BGH)L and CLP1 as well as two other sequences categorised alongside 
GZMBL in Group 2, gi338728629 and gi194207243. From the analysis of eqTRYP 
and eqMCP-1 slices derived from equine serum lanes (Lanes 3: Figures 4.5 and 4.6), 
no significant matches against any of the sequences in the GranzymeDB sequences 
in any slices were identified. The most abundant equine protein in all six slices from 
lanes in which serum was loaded was immunoglobulin lambda light chain. GZMBL, 
GZM(BHG)L, TLP1 and gi194207247 (Group 2) were confirmed in the lanes 
containing equine intestinal tissue (Lanes 4: Figures 4.5 and 4.6). CLP1 was not 
confirmed in any of the equine intestinal tissue sections however its presence in 
equine tissue (bronchus, bronchiole, colon, liver and skin) has been previously 
confirmed (Dacre 2005). In addition, the equine genome was investigated using the 
NCBI and ensemble databases. The chymase locus was found to be situated on 
chromosome 1 and the tryptase locus on chromosome 13. 
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Four sequences were selected for further analyses (Table 4.5: highlighted in yellow) 
on the following basis. First, Tryptase-like Proteinase-1 (TLP1) was the tryptase 
sequence previously sequenced from equine tissue (Dacre, McAleese et al. 2006) and 
was selected due to its presence in equine mastocyoma and tissue. Chymase-like 
Proteinase-1 (CLP1) was the sequence of the putative eqMCP-1 cloned and 
characterised previously (Dacre 2005). This sequence was selected also due to its 
previously confirmed presence in equine tissue (Dacre 2005). Due to a combination 
of identification of unique peptides not identified in the other proteinase sequences 
and presence, identified here, in equine tissue, two further sequences were identified 
and selected. One of these was a sequence from Group 2, Granzyme B-like 










Figure 4.8: Alignment of the nine sequences in the granzymeDB. The sequences were grouped 
according to the residue at 226 (highlighted). Group 1 (Blue: glycine), Group 2 (Pink: arginine), 
Group 3 (Green: glutamine). Results are compared to the sequences for MCP1 Ovis Aries, GZMB 
Mus Muscularis and GZMB Homo Sapiens (Yellow) with known specificity. (TLP1: Tryptase-like 










Group 1 gi|126352403|ref|NP_001075344.1 TLP1      CQGDSGGPLVCKVKGTWLQAGVVSWANSCAQPNRPGIYTRVTYYLDW 
Group 1 gi|194207247|ref|XP_001488456.2           YKGDSGGPLMCKNM----IQGIVSYGRRGG--IPPGAFTKVSSFLPW 
Group 2 gi|338728629|ref|XP_001489118.3           FQGDSGGPLICENG----LQGIVSYGLDNG--SPPRAFTKVSSFLPW 
Group 2 gi|194207243|ref|XP_001488243.2           FKGDSGGPLVCNNL----IQGLVSYGRCNG--TPPRAFTKVSSFLPW 
Group 2 gi|194207249|ref|XP_001488476.2 GZMBL     YKGDSGGPLVCKNV----IQGIVSYGRSGG--LPPRAFTKVSSFLPW 
  Group 3 gi|126352661|ref|NP_001075345.1 CLP1      FQGDSGGPLICENG----LQGIVSYGLDNG--SIPQAFTKVSSFLPW 
Group 3 gi|338728627|ref|XP_001488616.3 GZMBGHL   FKGDSRGTLVCKNV----IQGIVSYGRIGG--IPPQAFTKVSSFLPW 
Group 3 gi|194238001|ref|XP_001914688.1           FKGDSGGPLVCENV----IQGLVSYGRRDG--TPPQAFTKVSSFLPW 
Group 3 gi|149692885|ref|XP_001488563.1           YKGDSGGPLVCKNV----IQGIVSYGRIGG--IPPQAFTKVLSFLPW 
        MCP1 ovis aries                           FSGDSGGPLVCNGV----AQGIVSYGKDDG--TTPDVYTRISSFLSW 
        GZMB Mus muscularis                       FRGDSGGPLVCKKV----AAGIVSYGYKDG--SPPRAFTKVSSFLSW 
        GZMB Homo Sapiens                         FKGDSGGPLVCNKV----AQGIVSYGRNNG--MPPRACTKVSSFVHW 
                                                    *** * *:*:        *:**:.   .    *   *::  :: *        
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Table 4.5: Table of the nine GranzymeDB sequences grouped according to their aa at residue 226. 
Group 1 (G: glycine), Group 2 (R: arginine), Group 3 (Q: glutamine). The number of unique peptides 
from the MASCOT results are shown. The presence or absence of each sequence in purified eqMCP-
1, equine mastoctoma, equine tissue and purified eqTRYP are also shown. The four sequences 
highlighted in yellow were selected for further analysis. (TLP1: Tryptase-like Proteinase-1; GZMBL: 
Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
 
The four sequences selected for subsequent analyses are aligned in Figure 4.9 with 
the sequences for sheep mast cell proteinase-1, mouse GZMB and human GZMB for 
comparison. These were selected for sequence comparison due to their known 
specificity. All seven sequences share the conserved catalytic triad, with a histidine 
at residue 57, aspartic acid at 102 and serine at 195 (highlighted in red). Equine 
TLP1 contains an aspartate at residue 189 (shown in blue), whereas in the equine 
other sequences, (CLP1, GZMBL and GZM(BGH)L) there is a serine at this site 
(shown in green). The sheep, mouse and human sequences all differ at residue 189 
(shown in yellow). At residue 216, six of the sequences have a glycine (shown in 
pink and yellow); however, TLP1 differs here as it has an alanine. At residue 226 
TLP1 has a glycine, where CLP1 and GZM(BGH)L both have a glutamine, GZMBL 
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and the human and murine sequences have an arginine. The TLP1 sequence has 
identity of about 50% identical amino acids across the entire granzyme-like and 
CLP1 sequences. CLP1, GZMBL and GZM(BGH)L are more similar and have 
approximately 80% sequence identity across their entire sequence. 
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Figure 4.9: Alignment of the four selected sequences, TLP1, CLP1, GZMBL and GZM(BGH)L with MCP1 ovis aries, GZMB Mus Muscularis and GZMB Homo 
Sapiens for comparison and highlighted residues and important bases. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-
1; GZM(BGH)L: Granzyme(BGH)-like). 
 
TLP1                                 GGSLIHPQWVLTAAHCVGPDIEDFRDIRVQLREQHLYYRDQLLPVSRILPHPYYYTVENG 
CLP1                                 GGVLVRQDIVLTAAHCWGRLMNVTLGAHNI---RRQEKTQQVITVRQAIHHPDYNPKSFS 
GZMBL                                GGVLVRQDVVLTAAHCWGRSIKVALGAHNI---KKQERTQQVISVKEAIPHPHYNSKKIA 
GZM(BGH)L                            GGVLVQQDFVLTAAHCWGSSIKVTLGAHNI---QKQERTQQVIPVKEAIPHPDYNSKNFA 
MCP1 ovis aries                      GGFLVHEDFVLTAAHCLGSSISVTLGAHNI---VDRERTQQVIQVRRAIPHPHYNDKTLA 
GZMB Mus muscularis                  GGFLIREDFVLTAAHCEGSIINVTLGAHNI---KEQEKTQQVIPMVKCIPHPDYNPKTFS 
GZMB Homo Sapiens                    GGFLIQDDFVLTAAHCWGSSINVTLGAHNI---KEQEPTQQFIPVKRAIPHPAYNPKNFS 




TLP1                                 ADIALLELQDPVNISSHVQVVTLPPASETFPPGTPCWVTGWGDVDNGVSLPPPFPLKEVK 
CLP1                                 NDIMLLKLGRRAKLTAAVRPLSLPRGKTQVRPGEVCSVAGWGQLAPKG--RFPDTLQEVE 
GZMBL                                NDIMILKLERKAELTAAVQPISLPWGTAQLRPGEVCSVAGWGRVTPNG--RGSDTLQEVE 
GZM(BGH)L                            NDIMLLKLERRAKLTEAVWPLNLPRGTAQVRPGEVCRVAGWGRVALNG--RASDTLQEVE 
MCP1 ovis aries                      NDIMLLQLTRKAEMSDAVSPINLPRSLEKVKPGMMCSVAGWGQLGVNM--PSADKLQEVN 
GZMB Mus muscularis                  NDIMLLKLKSKAKRTRAVRPLNLPRRNVNVKPGDVCYVAGWGRMAPMG--KYSNTLQEVE 
GZMB Homo Sapiens                    NDIMLLQLERKAKRTRAVQPLRLPSNKAQVKPGQTCSVAGWGQTAPLG--KHSHTLQEVK 





TLP1                                 VPIVENSVCDRKYHTGVSTGDNIRIVQADMLCAGNR--RHDSCQGDSGGPLVCKVKGTWL 
CLP1                                 LTVQQDEVCESYFRNYF--------NSTTQLCVGDPKDKKSSFQGDSGGPLICENG---- 
GZMBL                                LTVQQDQVCESYFGNY---------NRTTQLCVGDPKEKKSSYKGDSGGPLVCKNV---- 
GZM(BGH)L                            LTVQQDQECESYLQKY---------NSTTQLCVGDPKEKKSSFKGDSRGTLVCKNV---- 
MCP1 ovis aries                      LEVQSEEECIARFKNY---------IPITQICAGDSTKRKNSFSGDSGGPLVCNGV----                
GZMB Mus muscularis                  LTVQKDRECESYFKNRY--------NKTNQICAGDPKTKRASFRGDSGGPLVCKKV---- 
GZMB Homo Sapiens                    MTVQEDRKCESDLRHYY--------DSTIELCVGDPEIKKTSFKGDSGGPLVCNKV---- 




TLP1                                 QAGVVSWANSCAQPNRPGIYTRVTYYLDWIYQYVPKDS---------------------- 
CLP1                                 LQGIVSYGLDNG--SIPQAFTKVSSFLPWIKKTMKRL----------------------- 
GZMBL                                IQGIVSYGRSGG--LPPRAFTKVSSFLPWIKKTMKGRAPWPRVNGHSSFGSSILPAAQNP 
GZM(BGH)L                            IQGIVSYGRIGG--IPPQAFTKVSSFLPWIKKTMKGRALWQNSGSSVNLGEGKGIHV--- 
MCP1 ovis aries                      AQGIVSYGKDDG--TTPDVYTRISSFLSWIQRTMRRY----------------------- 
GZMB Mus muscularis                  AAGIVSYGYKDG--SPPRAFTKVSSFLSWIKKTMKSS----------------------- 
GZMB Homo Sapiens                    AQGIVSYGRNNG--MPPRACTKVSSFVHWIKKTMKRY----------------------- 
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4.4.1.1 Comparison of N-terminal Amino Acid Sequence  
The N-terminal aa sequences for each of the nine sequences in the GranzymeDB 
were aligned (Figure 4.10) to facilitate comparison between these sequences and 
those previously generated by Pemberton et al. (Pemberton, McEuen et al. 2001). 
This region was compared here as it had been previously described and determined 
to 20 residues (Pemberton, McEuen et al. 2001). As mentioned, two proteolytic 
components from equine mastocytoma tissue were previously purified and 
characterised (Pemberton, McEuen et al. 2001). The N-terminal aa sequence of TLP1 
(Pemberton, McEuen et al. 2001), was found to be very similar to human beta and 
bovine tryptase (85% - 17 out of 20 aa) and to a lesser extent, to sheep tryptase 1 and 
tryptase 2 (75% - 15 out of 20 aa) (Figure 4.11). In these studies eqMCP-1 was found 
to be 95% identical to human granzyme H and 84% identical to bovine duodenase 
and SMCP-1. In the case of N-terminal aa sequencing for eqMCP-1 (Pemberton, 
McEuen et al. 2001), residue number 10 could not be assigned unambiguously, 
indicating both Pro and His (Table 4.12). It is probable that this ambiguity was due to 
carry-over from incomplete hydrolysis at residue 9 which would indicate that residue 
10 is a His, similar to other MCP enzymes (Pemberton, McEuen et al. 2001). The N-
terminal aa sequence of the mastocytoma derived eqMCP-1 differed from that of 
cloned putative eqMCP-1 (CLP1) by 2 aa (highlighted in yellow: Figure 4.12). This 
was hypothesised to be a similar but novel equine chymase (Dacre 2005). The N-
terminal aa sequence for GZM(BGH)L (annotated by NCBI) has a matching 
sequence to that of the mastocytoma derived sequence, eqMCP-1 published 
previously (Pemberton, McEuen et al. 2001). As it is the most abundant granzyme 
from the purified equine chymase (Section 4.4.1) it is possible that GZM(GBH)L is 
the same protein (eqMCP-1) characterised previously (Pemberton, McEuen et al. 
2001). 
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Figure 4.10: N terminal aa sequence of the 9 proteins in the granzymeDB database. (TLP1: Tryptase-
like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: 
Granzyme(BGH)-like). 
 
 1         10          20 
TLP1 I V G G Q E A S G S K W P W Q V S L R K 
Human Tryptase-β I V G G Q E A P R S K W P W Q V S L R V 
Sheep Tryptase-1 I I G G K E A P G S R W P W Q V S L R V 
Bovine Tryptase I V G G Q E A P G S Q W P W Q V S L R V 
Figure 4.11: N terminal aa sequences from TLP1 compared with the sequences from human tryptase- 
β (Miller, Moxley et al. 1990), sheep tryptase-1(Pemberton, McAleese et al. 2000) and bovine tryptase 




 1         10          20 
EqMCP-1 I I G G H E A R P X S R P Y M A F V Q F 
CLP1 I I G G H E A K P H S R P Y M A L V Q F 
GZMBL I I G G H E A R P H S R P Y M A F V Q I 
GZM(BGH)L I I G G H E A R P H S R P Y M A F V Q F 
Human granzyme H I I G G H E A K P H S R P Y M A F V Q F 
SMCP-1 I I G G H E A K P H S R P Y M A F L Q I 
Bovine duodenase I I G G H E A K P H S R P Y M A F L L F 
Figure 4.12: N terminal aa sequences from EQMCP-1, CLP1 and predicted sequences for GZMBL 
and GZMBGHL compared with the sequences human granzyme H (Haddad, Jenne et al. 1991), sheep 
mast cell proteinase-1 (McAleese, Pemberton et al. 1998) and bovine duodenase(Zamolodchikova, 




TLP1                                 IVGGQEASGSKWPWQVSLRK 
CLP1                                 IIGGHEAKPHSRPYMALVQF 
GZMBL                                IIGGHEARPHSRPYMAFVQI 
GZM(BGH)L                            IIGGHEARPHSRPYMAFVQF 
gi|338728629|ref|XP_001489118.3      IIGGHEAWPHSRPYMALVQF 
gi|194238001|ref|XP_001914688.1      IIGGHEAKPHSRPYMVFVQC 
gi|194207243|ref|XP_001488243.2      IIGGHEARPHSRPYMAFVQF 
gi|149692885|ref|XP_001488563.1      IIGGHEAWPHSRPYMAFVLS 
gi|194207247|ref|XP_001488456.2      IIGGHEAWPHSRPYMAFVQI 
                                     *:**:**   . *: . : 
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4.4.2 Sequence Analysis of PCR Products 
PCR was performed using cDNA from caecal tissue from horse DV11 and RVC 
tissue from horse DV12 as template with specific oligonucleotide primers for each 
gene of interest (TLP1, GZMBL, CLP1 and GZM(BGH)L) designed from nucleotide 
sequences derived proteomic analysis to generate amplicons of 100-170 bp. The gel 
(Figure 4.13) shows amplicons at the expected length for each of the four sequences: 




Figure 4.13: Agarose gel image showing the PCR products using the four primer sets generated from 
cDNA from horses DV11 and DV12 The size of the 1kb plus ladder (Invitrogen) is shown in bp. 1: 
DV11 Caecum; 2: DV12 RVC; 3: Negative Control. (RVC: Right ventral colon; TLP1: Tryptase-like 
Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: 
Granzyme BGH LikeGranzyme(BGH)-like).  
 
 
To ensure that the primers were able to amplify specific sequences from tissue 
derived from different horses, PCR was performed using cDNA from additional 
horses DV3, DV5, DV6, DV10, DV11 and DV12. The specific oligonucleotide 
primers were used for each of the genes of interest; TLP1 (Figure 4.14A), GZMBL 
(Figure 4.14B), CLP1 (Figure 4.14C), and GZM(BGH)L) (Figure 4.14D). These 
figures show the PCR products generated. Amplicons of the expected size were 
produced from each of the six horses for all four genes. No PCR product was present 




1 2 1 1 1 2 2 2 3 3 3 3 
 
TLP1 GZMBL CLP1 GZM(BGH)L 
400 
500 
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Figure 4.14: A-D: Agarose gel image showing the PCR products from caecal tissue from horse DV3, 
DV5, DV6, DV10, DV12 and DV11. The size of the 1kb plus ladder (Invitrogen) is shown in bp. A: 
TLP1 B: GZMBL C: CLP1 D: GZM(BGH)L. 1: DV3 caecum; 2: DV12 caecum; 3; DV6 caecum; 4: 
DV11 caecum; 5: DV10 caecum; 6: DV5 caecum; 7: Negative control. (TLP1: Tryptase-like 
Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: 
Granzyme(BGH)-like.)  




















1 2 4 3 5 6 
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PCR products (two clones) from each horse, representing each of the four genes were 
submitted for sequencing. Sequences derived from these PCR products were 
compared with the original sequences used to design the primers, referred to here as 
‘query’ sequences. The TLP1 amplicon nucleotide (Figure 4.15) and protein 
sequence (Figure 4.16) were identical to the query TLP1 sequence for all five horses. 
There were a number of differences in the nucleotide sequences between the five 
horses and the query GZMBL sequence. These were mainly seen in sequences from 
DV10 and DV12 which each had the same five single nucleotide polymorphisms 
(SNPs) when compared to the query sequence (Figure 4.17). Only two of these 
differences altered the translated sequence (Figure 4.18) resulting in the substitution 
of a glutamine from a glycine and an arginine from a glutamine (Fig 4.18). The 
CLP1 nucleotide sequences (Figure 4.19) showed two differences (highlighted in 
pink). Sequences from all horses had a cytosine in place of a thymidine at amplicon 
nucleotide position 32 which did not translate to any difference in the derived aa 
sequence (Figure 4.20). Sequence from horse DV3 had a SNP: a cytosine in place of 
a thymidine, which translated to a change from a serine to a proline at residue 214 
(Figure 4.20). The GZM(BGH)L amplicon nucleotide sequences (Figure 4.21) 
showed two differences (highlighted in pink). Both were seen in sequences from 
horse DV3. There was cytosine in place of a thymidine, which translated to a 
difference in the aa sequence as a change from isoleucine to threonine at residue 103 
(Figure 4.22). Sequence from horse DV3 also had a SNP at the end of the reverse 
primer sequence, an adenine in place of a guanine. This did not alter the protein 
sequence (Figure 4.22). 
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Figure 4.15: Alignment of nucleotide sequence of TLP1 amplicons from DV3 Caecum, DV6 Caecum, 
DV10 Caecum, DV11 Caecum and DV12 RVC. The primer sequences are highlighted in yellow and 










Figure 4.16: Alignment of predicted protein sequence of TLP1 amplicons from DV3 Caecum, DV6 


























Figure 4.17: Alignment of nucleotide sequence of GZMBL amplicons from DV3 Caecum, DV6 
Caecum, DV10 Caecum, DV11 Caecum and DV12 RVC. The primer sequences are highlighted in 
yellow and the probe sequence in green. Nucleotides that differ from the query sequence are 
highlighted in pink. (GZMBL: Granzyme B-like). 
QueryTLP1     AGTCAGTCTGCCACCTCCGTTTCCCCTGAAGGAAGTAAAAGTCCCCATTGTGGAAAACAG 
DV3TLP1       AGTCAGTCTGCCACCTCCGTTTCCCCTGAAGGAAGTAAAAGTCCCCATTGTGGAAAACAG 
DV6TLP1       AGTCAGTCTGCCACCTCCGTTTCCCCTGAAGGAAGTAAAAGTCCCCATTGTGGAAAACAG 
DV10TLP1      AGTCAGTCTGCCACCTCCGTTTCCCCTGAAGGAAGTAAAAGTCCCCATTGTGGAAAACAG 
DV11TLP1      AGTCAGTCTGCCACCTCCGTTTCCCCTGAAGGAAGTAAAAGTCCCCATTGTGGAAAACAG 
DV12TLP1      AGTCAGTCTGCCACCTCCGTTTCCCCTGAAGGAAGTAAAAGTCCCCATTGTGGAAAACAG 
              ************************************************************ 
 
QueryTLP1     CGTTTGTGACAGGAAATACCACACTGGCGTGTCCACGGGGGACAACATCCGGATTGTCCA 
DV3TLP1       CGTTTGTGACAGGAAATACCACACTGGCGTGTCCACGGGGGACAACATCCGGATTGTCCA 
DV6TLP1       CGTTTGTGACAGGAAATACCACACTGGCGTGTCCACGGGGGACAACATCCGGATTGTCCA 
DV10TLP1      CGTTTGTGACAGGAAATACCACACTGGCGTGTCCACGGGGGACAACATCCGGATTGTCCA 
DV11TLP1      CGTTTGTGACAGGAAATACCACACTGGCGTGTCCACGGGGGACAACATCCGGATTGTCCA 
DV12TLP1      CGTTTGTGACAGGAAATACCACACTGGCGTGTCCACGGGGGACAACATCCGGATTGTCCA 
              ************************************************************ 
 
QueryTLP1     GGCCGACATGCTGTGTGCA 
DV3TLP1       GGCCGACATGCTGTGTGCA 
DV6TLP1       GGCCGACATGCTGTGTGCA 
DV10TLP1      GGCCGACATGCTGTGTGCA 
DV11TLP1      GGCCGACATGCTGTGTGCA 
DV12TLP1      GGCCGACATGCTGTGTGCA 
              ******************* 
 
QueryTLP1     VSLPPPFPLKEVKVPIVENSVCDRKYHTGVSTGDNIRIVQADMLCA 
DV3TLP1       VSLPPPFPLKEVKVPIVENSVCDRKYHTGVSTGDNIRIVQADMLCA 
DV6TLP1       VSLPPPFPLKEVKVPIVENSVCDRKYHTGVSTGDNIRIVQADMLCA 
DV10TLP1      VSLPPPFPLKEVKVPIVENSVCDRKYHTGVSTGDNIRIVQADMLCA 
DV11TLP1      VSLPPPFPLKEVKVPIVENSVCDRKYHTGVSTGDNIRIVQADMLCA 
DV12TLP1      VSLPPPFPLKEVKVPIVENSVCDRKYHTGVSTGDNIRIVQADMLCA 




QueryGZMBL       AGCTGAGGCCTGGAGAGGTGTGCAGTGTGGCAGGCTGGGGGAGAGTCACCCCAAATGGCA 
DV10GZMBL        AGCTGAGGCCTGGAGAGGTGTGCAGTGTGGCAGGCTGGGGGAGAGTCACCCCAAATGGCA 
DV12GZMBL        ------GGCCTGGAGAGGTGTGCAGTGTGGCAGGCTGGGGGAGAGTCACCCCAAATGGCA 
DV3GZMBL         TGCTGAGGCCTGGAGAGGTGTGCAGTGTGGCAGGCTGGGGGAGAGTCACCCCAAATGGCA 
DV11GZMBL        AGCTGAGGCCTGGAGAGGTGTGCAGTGTGGCAGGCTGGGGGAGAGTCACCCCAAATGGCA 
DV6GZMBL         AGCTGAGGCCTGGAGAGGTGTGCAGTGTGGCAGGCTGGGGGAGAGTCACCCCAAATGGCA 
                       ****************************************************** 
 
QueryGZMBL       GAGGGTCAGACACCCTGCAGGAGGTGGAGCTGACTGTGCAGCAGGATCAGGTGTGCGAAT 
DV10GZMBL        GAGAGTCAGACACTCTGCAGGAGGTGGAGCTGACCGTGCAGCAGGACCGGGTGTGCGAAT 
DV12GZMBL        GAGAGTCAGACACTCTGCAGGAGGTGGAGCTGACCGTGCAGCAGGACCGGGTGTGCGAAT 
DV3GZMBL         GAGGGTCAGACACCCTGCAGGAGGTGGAGCTGACCGTGCAGCAGGATCAGGTGTGCGAAT 
DV11GZMBL        GAGGGTCAGACACCCTGCAGGAGGTGGAGCTGACTGTGCAGCAGGATCAGGTGTGCGAAT 
DV6GZMBL         GAGGGTCAGACACCCTGCAGGAGGTGGAGCTGACCGTGCAGCAGGATCAGGTGTGCGAAT 
                 ***.********* ******************** *********** *.*********** 
 
QueryGZMBL       CCTACTTTGGCAATTA 
DV10GZMBL        CCTACTTTGGCAATTA 
DV12GZMBL        CCTACTTTGGCAATTA 
DV3GZMBL         CCTACTTTGGCAATTA 
DV11GZMBL        CCTACTTTGGCAATTA 
DV6GZMBL         CCTACTTTGGCAATTA 
                 **************** 
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Figure 4.18: Alignment of predicted protein sequence of GZMBL amplicons from DV3 Caecum, DV6 Caecum, 
DV10 Caecum, DV11 Caecum and DV12 RVC using reading frame 3 direct. Aa that differ from the query 




















Figure 4.19: Alignment of nucleotide sequence of CLP1 amplicons from Horse samples DV3 
Caecum, DV6 Caecum, DV10 Caecum, DV11 Caecum and DV12 RVC. The primer sequences are 
highlighted in yellow and the probe sequence in green. Nucleotides that differ from the query 











Figure 4.20: Alignment of predicted protein sequence of CLP1 amplicons from Horse samples DV3 
Caecum, DV6 Caecum, DV10 Caecum, DV11 Caecum and DV12 RVC using reading frame 2 direct. 
Aa that differ from the query sequence are highlighted in pink. (CLP1: Chymase-like Proteinase-1). 
QueryGZMBL     LRPGEVCSVAGWGRVTPNGRGSDTLQEVELTVQQDQVCESYFGN 
DV3GZMBL       LRPGEVCSVAGWGRVTPNGRGSDTLQEVELTVQQDQVCESYFGN 
DV6GZMBL       LRPGEVCSVAGWGRVTPNGRGSDTLQEVELTVQQDQVCESYFGN 
DV11GZMBL      LRPGEVCSVAGWGRVTPNGRGSDTLQEVELTVQQDQVCESYFGN 
DV10GZMBL      LRPGEVCSVAGWGRVTPNGRESDTLQEVELTVQQDRVCESYFGN 
DV12GZMBL      --PGEVCSVAGWGRVTPNGRESDTLQEVELTVQQDRVCESYFGN 
                 ****************** **************:******** 
 
QueryCLP1     TCCGAAAGATAAGAAGTCTTCCTTTCAGGGTGACTCTGGGGGCCCTCTCATCTGTGAGAA 
DV3CLP1       TCCGAAAGATAAGAAGTCTTCCTTTCAGGGCGACTCTGGGGGCCCTCTCATCTGTGAGAA 
DV6CLP1       TCCGAAAGATAAGAAGTCTTCCTTTCAGGGCGACTCTGGGGGCCCTCTCATCTGTGAGAA 
DV10CLP1      TCCGAAAGATAAGAAGTCTTCCTTTCAGGGCGACTCTGGGGGCCCTCTCATCTGTGAGAA 
DV11CLP1      TCCGAAAGATAAGAAGTCTTCCTTTCAGGGCGACTCTGGGGGCCCTCTCATCTGTGAGAA 
DV12CLP1      TCCGAAAGATAAGAAGTCTTCCTTTCAGGGCGACTCTGGGGGCCCTCTCATCTGTGAGAA 
              ****************************** ***************************** 
 
QueryCLP1     CGGGCTCCAGGGCATTGTCTCCTATGGACTAGATAACGGGAGTATTCCACAGGCCTT 
DV3CLP1       CGGGCTCCAGGGCATTGTCCCCTATGGACTAGATAACGGGAGTATTCCACAGGCCTT 
DV6CLP1       CGGGCTCCAGGGCATTGTCTCCTATGGACTAGATAACGGGAGTATTCCACAGGCCTT 
DV10CLP1      CGGGCTCCAGGGCATTGTCTCCTATGGACTAGATAACGGGAGTATTCCACAGGCCTT 
DV11CLP1      CGGGCTCCAGGGCATTGTCTCCTATGGACTAGATAACGGGAGTATTCCACAGGCCTT 
DV12CLP1      CGGGCTCCAGGGCATTGTCTCCTATGGACTAGATAACGGGAGTATTCCACAGGCCTT 
              ******************* ************************************* 
 
QueryCLP1     PKDKKSSFQGDSGGPLICENGLQGIVSYGLDNGSIPQA 
DV6CLP1       PKDKKSSFQGDSGGPLICENGLQGIVSYGLDNGSIPQA 
DV10CLP1      PKDKKSSFQGDSGGPLICENGLQGIVSYGLDNGSIPQA 
DV11CLP1      PKDKKSSFQGDSGGPLICENGLQGIVSYGLDNGSIPQA 
DV12CLP1      PKDKKSSFQGDSGGPLICENGLQGIVSYGLDNGSIPQA 
DV3CLP1       PKDKKSSFQGDSGGPLICENGLQGIVPYGLDNGSIPQA 
              ************************** *********** 
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Figure 4.21: Alignment of nucleotide sequence of GZMBGHL amplicons from DV3 Caecum, DV6 
Caecum, DV10 Caecum, DV11 Caecum and DV12 RVC. The primer sequences are highlighted in 
yellow and the probe sequence in green. Nucleotides that differ from the query sequence are 















Figure 4.22: Alignment of predicted protein sequence of GZMBGHL amplicons from DV3 Caecum, 
DV6 Caecum, DV10 Caecum, DV11 Caecum and DV12 RVC using reading frame 1 direct. Aa that 






4.4.2.1 Re-annotation of the equine genome 
The horse genome was re-annotated (version EquCab 2.0) and this was made public 
in September 2013 after the primer and probe design and qPCR analysis here. The 
NCBI annotation for TLP1 and CLP1 was not altered; the sequences entered by K. J 
Dacre (2005) remained the same. After reannotation GZMBL sequence 
(XP_001488476.2), was replaced with XP_005603467.1 (XM_005603410.1) and 
XP_005603468.1 (XM_005603411.1). These two predicted proteins have been 
QueryGZMBGHL     AATTCTAAGAACTTCGCCAACGACATCATGTTACTAAAGCTGGAGAGAAGGGCCAAGCTT 
DV6GZMBGHL       AATTCTAAGAACTTCGCCAACGACATCATGTTACTAAAGCTGGAGAGAAGGGCCAAGCTT 
DV10GZMBGHL      AATTCTAAGAACTTCGCCAACGACATCATGTTACTAAAGCTGGAGAGAAGGGCCAAGCTT 
DV11GZMBGHL      AATTCTAAGAACTTCGCCAACGACATCATGTTACTAAAGCTGGAGAGAAGGGCCAAGCTT 
DV12GZMBGHL      AATTCTAAGAACTTCGCCAACGACATCATGTTACTAAAGCTGGAGAGAAGGGCCAAGCTT 
DV3GZMBGHL       AATTCTAAGAACTTCGCCAACGACACCATGTTACTAAAGCTGGAGAGAAGGGCCAAGCTT 
                 ************************* ********************************** 
 
QueryGZMBGHL     ACCGAAGCTGTGTGGCCCCTCAACCTGCCCAGGGGCACAGCCCAGGTGAGGCCCGGAGAG 
DV6GZMBGHL       ACCGAAGCTGTGTGGCCCCTCAACCTGCCCAGGGGCACAGCCCAGGTGAGGCCCGGAGAG 
DV10GZMBGHL      ACCGAAGCTGTGTGGCCCCTCAACCTGCCCAGGGGCACAGCCCAGGTGAGGCCCGGAGAG 
DV11GZMBGHL      ACCGAAGCTGTGTGGCCCCTCAACCTGCCCAGGGGCACAGCCCAGGTGAGGCCCGGAGAG 
DV12GZMBGHL      ACCGAAGCTGTGTGGCCCCTCAACCTGCCCAGGGGCACAGCCCAGGTGAGGCCCGGAGAG 
DV3GZMBGHL       ACCGAAGCTGTGTGGCCCCTCAACCTGCCCAGGGGCACAGCCCAGGTGAGGCCCGGAGAG 
                 ************************************************************ 
 
QueryGZMBGHL     GTGTGCCGTGTGGCTGGCTGGGGGAGAGTTGCCCTAAATG 
DV6GZMBGHL       GTGTGCCGTGTGGCTGGCTGGGGGAGAGTTGCCCTAAATG 
DV10GZMBGHL      GTGTGCCGTGTGGCTGGCTGGGGGAGAGTTGCCCTAAATG 
DV11GZMBGHL      GTGTGCCGTGTGGCTGGCTGGGGGAGAGTTGCCCTAAATG 
DV12GZMBGHL      GTGTGCCGTGTGGCTGGCTGGGGGAGAGTTGCCCTAAATG 
DV3GZMBGHL       GTGTGCCGTGTGGCTGGCTGGGGGAGAGTTGCCCTAAATA 
                 ***************************************. 
 
QueryGZMBGHL     NSKNFANDIMLLKLERRAKLTEAVWPLNLPRGTAQVRPGEVCRVAGWGRVALN 
DV6GZMBGHL       NSKNFANDIMLLKLERRAKLTEAVWPLNLPRGTAQVRPGEVCRVAGWGRVALN 
DV10GZMBGHL      NSKNFANDIMLLKLERRAKLTEAVWPLNLPRGTAQVRPGEVCRVAGWGRVALN 
DV11GZMBGHL      NSKNFANDIMLLKLERRAKLTEAVWPLNLPRGTAQVRPGEVCRVAGWGRVALN 
DV12GZMBGHL      NSKNFANDIMLLKLERRAKLTEAVWPLNLPRGTAQVRPGEVCRVAGWGRVALN 
DV3GZMBGHL       NSKNFANDTMLLKLERRAKLTEAVWPLNLPRGTAQVRPGEVCRVAGWGRVALN 
                 ******** ******************************************** 
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annotated as granzyme H-like isoform X1 and granzyme H-like isoform X2 
respectively. The nucleotide sequence over the amplicon area used for qPCR for 
GZMBL, is identical to the same area of sequence for granzyme H-like isoform X1 
and granzyme H-like isoform X2. The sequence GZM(BGH)L (XP_001488616.3), 
was removed during the re-annotation process and replaced with XM_005613502.1: 
XP_005613559.1. This protein has been annotated as granzyme H-like. The 
nucleotide sequence over the amplicon area used for qPCR for GZM(BGH)L was 
also identical to the same area of granzyme H-like. 
Granzyme specificity is determined by the aa residue at 226. Figure 4.23 shows an 
alignment of the two re-annotated sequences of interest (GZMBL and GZM(BGH)L) 
with the residue at 226 highlighted. The sequences are aligned with human and rat 
granzyme H, both of which have a glycine at 226. The equine sequences did not 
share this residue. Which suggests that the original nomenclature of granzyme B-like 






Figure 4.23: Alignment of GZMB(L), GZM(BGH)L and human and rat granzyme H. Residue 226 is 
highlighted. (GZMBL: Granzmye B-like; GZM(BGH)L: Granzyme(BGH)-like). 
 
 
4.4.3 Reference Gene Selection 
GeNorm analysis was performed on 15 samples using the six available equine 
reference targets. These targets were ACTβ, B2M, HPRT, GAPDH, RN18S and 
SDHA. Reference target stability was high (average geNorm M ≤ 0.5) as indicated 
by the average expression stability value (M) of reference genes at each step during 
stepwise exclusion of the least stably expressed reference gene. Starting with the 
least stable gene at the left, RN18S, the genes are ranked according to increasing 
expression stability; with SDHA and GAPDH appearing as the most stable (Figure 
4.24).
GZMBL                               ---IQGIVSYGRSGG--LPPRAFTKVSSFLPWIKKTMKGRAPWP 
GZM(BGH)L                           ---IQGIVSYGRIGG--IPPQAFTKVSSFLPWIKKTMKGRALWQ 
Granzyme H (brown rat)              ---AYGVVSYGKNGT--ISSGVFTKVVYFLPWISRNMKLL----
Granzyme H precursor (Human)        ---AQGILSYGNKKG--TPPGVYIKVSHFLPWIKRTMKRL---- 
                                                                                                      *::*:            : :*  :* ** : :       
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Figure 4.24: Graph of average expression stability of reference target genes. (ACTβ: beta-actin; B2M: 
beta-2-microglobulin; HPRT: hypoxanthine phosphoribosyltransferase;GAPDH: glyceraldehyde 3-
phosphate dehydrogenase; RN18S: 18s ribosomal RNA; SDHA: succinate dehydrogenase complex, 
subunit A, flavoprotein) 
 
The bar chart (Figure 4.25), geNorm V, shows the optimum number of reference 
genes required as it illustrates the variation in average stability of each. The chart 
demonstrates sequential addition of each reference gene beginning on the left with 
the two most stably-expressed genes (SDHA and GAPDH) then moving to the right 
with the inclusion of a third, fourth and fifth gene respectively. The optimal number 
of reference genes is observed when V(n/n+1), the pairwise variation, drops below 
the threshold 0.15 (Vandesompele, De Preter et al. 2002). The optimal number of 
reference targets in this experimental situation is two (geNorm V <0.15, when 
comparing a normalisation factor based on the two or three most stable targets). As 
such, the optimal normalisation factor can be calculated as the geometric mean of the 
reference targets, SDHA and GAPDH.  
Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Four: Exploration of Novel Equine Mast Cell Proteinases   201 
 
Figure 4.25: Bar chart to determine optimal number of reference targets. The chart demonstrates 
sequential addition of each reference gene beginning on the left with the two most stably expressed 




4.4.4 Probe Validation 
Combinations of primers and probes were tested. Each primer set was tested in 
duplicate with each of the four different probes. The probes were specific to the 
amplicons produced from the PCR reaction. For each of the four genes of interest a 
positive result in the form of a measureable Ct value (cycle threshold defined as the 
number of cycles required for the signal to exceed the background level (Vargas and 
Vivas-Mejia 2013)) was only observed with the correct combination of primer and 
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Primers Probe cDNA Ct 
TLP1 TLP1  DV10 RVC 32.3 
TLP1 GZMBL DV10 RVC >40.0 
TLP1 CLP1 DV10 RVC >40.0 
TLP1 GZM(BGH)L DV10 RVC >40.0 
GZMLBL TLP1  DV7 Caecum >40.0 
GZMLBL GZMBL DV7 Caecum 37.8 
GZMLBL CLP1 DV7 Caecum >40.0 
GZMLBL GZM(BGH)L DV7 Caecum >40.0 
CLP1 TLP1  DV12 Caecum >40.0 
CLP1 GZMBL DV12 Caecum >40.0 
CLP1 CLP1 DV12 Caecum 32.8 
CLP1 GZM(BGH)L DV12 Caecum >40.0 
GZM(BGH)L TLP1  DV9 Caecum >40.0 
GZM(BGH)L GZMBL DV9 Caecum >40.0 
GZM(BGH)L CLP1 DV9 Caecum >40.0 
GZM(BGH)L GZM(BGH)L DV9 Caecum 33.3 
 
Table 4.6: Table of Ct values from Primer/Probe combinations. The assay used 40 cycles and a 
positive Ct result was only obtained from the correct combination of primer set and probe. (TLP1: 
Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; 
GZM(BGH)L: Granzyme(BGH)-like). 
 
                
4.4.5 Quantitative PCR Efficiency 
The qPCR reactions were optimised and the range of efficiencies from each of the 
assays is shown in Table 4.7.The primary step of every qPCR is the extraction and 
purification of RNA. The quality of template is very important for the reproducibility 
and reliability of assay results (Bustin and Nolan 2004). The qPCR efficiency is also 
dependent on the assay, the master mix performance, and sample quality. It is 
important that assays are reliable and of optimum efficiency for comparison of the 
data. Efficiency between 90 and 110% is generally considered optimal (D’haene, 
Vandesompele et al. 2010). Figure 4.26 shows the standard curves for each of the 
four genes of interest. 
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Gene Efficiency Range (%) 
TLP1 96 - 103 
GZMBL 91 - 110 
CLP1 94 - 104 
GZM(BGH)L 88 - 94 
GAPDH 93 - 102 
SDHA 88 - 99 
 
Table 4.7: Table of the range of efficiencies for each qPCR reaction. (TLP1: Tryptase-like Proteinase-
1; GZMBL: Granzyme-B-like; CLP1: Chymase-like Proteinase1; GZM(BGH)L: Granzyme (BGH) 






Figure 4.26: Plasmid standard curves from qPCR for each of the four genes of interest. (TLP1: 
Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; 
GZM(BGH)L: Granzyme(BGH)-like). 
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4.4.6 Tissue Transcript Levels from Quantitative PCR 
The levels of transcript in the 42 tissue samples were evaluated using ABI 7500 
software, normalising all results to the two selected reference genes, GAPDH and 
SDHA. The normalised number of copies per µl of TLP1, GZMBL, CLP1, 
GZM(BGH)L in each of the organs sampled are shown (Figure 4.27A-C). The levels 
of the four proteinases in each of the three organs were compared. Although the 
range of proteinase levels varied by organ, there was no significant difference when 
comparing the expression of each gene individually in the three different organs 




Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Four: Exploration of Novel Equine Mast Cell Proteinases   205 
AB 1 3 AB 1 4 AB 5 AB 1 6 D V3 D V4 D V5 D V6 D V7 D V8 D V9 D V1 0 D V1 1 D V1 2
0
5 0 0














T L P 1
G Z M B L
C L P 1
G Z M (B G H )L
 
 

















T L P 1
G Z M B L
C L P 1
G Z M (B G H )L
 
















T L P 1
G Z M B L
C L P 1
G Z M (B G H )L
 
 
Figure 4.27: Bar charts of the normalised number of copies per µl of TLP1, GZMBL, CLP1, 
GZM(BGH)L in each of the organs sampled. A: Caecum. B: RVC. C: RB. (RVC: Right ventral colon; 
RB: Rectal biopsy; TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-Like; CLP1: Chymase-
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Figure 4.28. Box plots of individual proteinase transcript levels divided by organ. 
A: Friedman analysis revealed no significant difference in CLP1 copies/µl between organs (p=0.146). B: Friedman analysis revealed no significant difference in TLP1 
copies/µl between organs (p=0.103). C: Friedman analysis revealed no significant difference in GZMBL copies/µl between organs (p=0.410). D: Friedman analysis 
revealed no significant difference in GZM(BGH)L copies/µl between organs (p=0.411) . (RVC: Right ventral colon; RB: Rectal biopsy; TLP1: Tryptase-like 
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4.4.6.1 Transcript Levels in the Caecum 
The median and range of transcript levels in the caecum are shown in Table 4.8. 
Friedman analysis revealed a significant difference in caecal copies/µl between 
proteinases (p<0.001). CLP1 had the highest median (118.7) and the greatest range 
(13.2 – 1057.0) of copies/µl. The relationships between caecal transcript levels are 
displayed as a matrix scatter plot in Figure 4.29, and the p and rho values for each 
correlation in Table 4.9. There was a significant correlation between the levels of 
TLP1 and GZMBL (p<0.001, rho=0.860), and the levels of CLP1 and GZM(BGH)L 
(p=0.033, rho=0.578). 
 
Caecum TLP1 GZMBL CLP1 GZM(BGH)L 
Median 47.8 68.9 118.7 19.9 
Range 19.6 - 167.5 18.8 - 634.7 13.2 - 1057.0 2.3 - 173.0 
 
Table 4.8: Median and range of Caecal TLP1, GZMBL, CLP1 and GZM(BGH)L transcript levels 
expressed as copies/µl. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: 
Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
 
Figure 4.29: Matrix scatter plot of caecal transcript levels of TLP1, GZMBL, CLP1 and 
GZM(BGH)L. (C: Caecum; TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: 
Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
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Caecum TLP1 GZMBL CLP1 GZM(BGH)L 
TLP1 - 0.860 0.310 0.376 
GZMBL <0.001 - 0.220 0.301 
CLP1 0.280 0.450 - 0.578 
GZM(BGH)L 0.185 0.295 0.033 - 
 
Table 4.9: Table of rho values (bold) and p values (in italics) for correlations between genes of interest 
in the caecum. Significant p-values are highlighted in yellow. (TLP1: Tryptase-like Proteinase-1; 





4.4.6.2 Transcript Levels in the RVC 
The median and range of transcript levels in the RVC are shown in Table 4.10. For 
the RVC, Friedman analysis showed a significant difference in RVC copies/µl 
between the proteinases (p<0.01). The proteinase with the highest median was CLP1 
(112.6 copies/µl) and CLP1 also had the greatest range (6.4 – 792.4 copies/µl). The 
relationships between RVC transcript levels are displayed as a matrix scatter plot in 
Figure 4.30, and the p and rho values for each correlation in Table 4.11. As in the 
caecum, there were significant correlations between the levels of TLP1 and GZMBL 
(p=0.003, rho=0.754), and the levels of CLP1 and GZM(BGH)L (p=0.032, 
rho=0.582). 
 
RVC TLP1 GZMBL CLP1 GZM(BGH)L 
Median 66.4 79.2 112.6 21.1 
Range 18.4 - 208.1 18.0 - 452.4 6.4 - 792.4 1.8 - 182.4 
 
Table 4.10: Median and range of RVC TLP1, GZMBL, CLP1 and GZM(BGH)L transcript levels 
expressed as copies/µl. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: 
Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
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Figure 4.30: Matrix scatter plot of RVC transcript levels of TLP1, GZMBL, CLP1 and GZM(BGH)L. 
(RVC: Right ventral colon; TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: 
Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
RVC TLP1 GZMBL CLP1 GZM(BGH)L 
TLP1 - 0.754 0.697 0.371 
GZMBL 0.003 - 0.486 0.090 
CLP1 0.007 0.081 - 0.582 
GZM(BGH)L 0.192 0.762 0.032 - 
 
Table 4.11: Table of rho values (bold) and p values (in italics) for correlations between genes of 
interest in the RVC. Significant p-values are highlighted in yellow. (TLP1: Tryptase-like Proteinase-1; 
GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-
like). 
 
4.4.6.3 Transcript Levels in the Rectum 
The median and range of transcript levels in the rectum are shown in Table 4.12. 
Friedman analysis revealed a significant difference in RB transcript copies/µl 
between proteinases (p<0.05). Levels of CLP1 had the highest median (58.6 
copies/µl) and the greatest range (5.6 – 464.2 copies/µl). The relationships between 
rectal transcript levels for the four different proteinases is displayed as a matrix 
scatter plot in Figure 4.31, and the p and rho values for each correlation in          
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Table 4.13. There was a significant correlation between the levels of TLP1 and 
GZMBL (p<0.001, rho=0.7925) at this site. 
 
RB TLP1 GZMBL CLP1 GZM(BGH)L 
Median 27.8 46.0 58.6 12.3 
Range 11.5 - 140.2 6.0 - 325.2 5.6 - 464.2 1.2 - 99.5 
 
Table 4.12: Median and range of RB TLP1, GZMBL, CLP1 and GZM(BGH)L transcript levels 
expressed as copies/µl. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: 
Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
 
Figure 4.31: Matrix scatter plot of RB transcript levels of TLP1, GZMBL, CLP1 and GZM(BGH)L. 
(RB: Rectal biopsy; TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-
like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
RB TLP1 GZMBL CLP1 GZM(BGH)L 
TLP1 - 0.925 0.077 -0.055 
GZMBL <0.001 - 0.090 -0.169 
CLP1 0.797 0.762 - 0.530 
GZM(BGH)L 0.856 0.563 0.054 - 
 
Table 4.13: Table of rho values (bold) and p values (in italics) for correlations between genes of 
interest in the rectum from rectal biopsy (RB). Significant p-values are highlighted in yellow. (TLP1: 
Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; 
GZM(BGH)L: Granzyme(BGH)-like). 
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4.4.7 Relationship between Mast Cell Proteinase Transcripts and 
Mucosal Cyathostomin Burdens 
4.4.7.1 Caecum Transcript Levels and Combined Total Mucosal Burden 
The relationship between caecal transcript levels and combined total mucosal burden 
(CTMB) are displayed in Figures 4.32A-D. Standard linear regression analysis with 
the presence of A. perfoliata as a confounding variable showed that there was no 
significant relationship between the log10+1 transformed CTMB and the caecal 









































































Figure 4.32.A: Relationship between log10+1 transformed Caecal TMB (x-axis) and Caecal TLP1 (y-
axis), p=0.093, r2=34.0%. B: Relationship between log10+1 transformed Caecal TMB (x-axis) and 
Caecal GZMBL (y-axis), p=0.419, r2=28.3%. C: Relationship between log10+1 transformed Caecal 
TMB (x-axis) and Caecal CLP1 (y-axis), p=0.534, r2=0.0%. D: Relationship between log10+1 
transformed Caecal TMB (x-axis) and Caecal GZM(BGH)L (y-axis), p=0.698, r2=0.0%. (CTMB: 
Combined Total Mucosal Burden; TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; 
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4.4.7.2 RVC Transcript Levels and Combined Total Mucosal Burden 
The relationship between transcript levels of proteinases in the RVC and CTMB is 
shown in Figures 4.34A-D. Standard linear regression analysis with the presence of 
A. perfoliata as a confounding variable showed a significant relationship between 
log10+1 transformed CTMB and log10+1 transformed RVC TLP1 levels (p=0.007, 






































































Figure 4.33.A Relationship between log10+1 transformed RVC TMB (x-axis) and RVC TLP1 (y-
axis), p=0.007, r2=51.2% . B: Relationship between log10+1 transformed RVC TMB (x-axis) and 
RVC GZMBL (y-axis), p=0.042, r2=45.4%. C: Relationship between log10+1 transformed RVC 
TMB (x-axis) and RVC CLP1 (y-axis), p=0.336, r2=0.0%. D: Relationship between log10+1 
transformed RVC TMB (x-axis) and RVC GZM(BGH)L (y-axis), p=0.385, r2=0.0%. (CTMB: 
Combined Total Mucosal Burden; TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; 
CLP1: Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
4.4.7.3 Rectal Transcript Levels and Combined Total Mucosal Burden 
The relationship between proteinase transcript expression in the rectum and CTMB is 
shown in Figure 4.34A-D. Standard linear regression analysis with the presence of A. 
perfoliata as a confounding variable showed that there was no significant 
relationship between the log10+1 transformed CTMB and expression of any of the 
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Figure 4.34: A: Relationship between log10+1 transformed CTMB (x-axis) and Rectal TLP1 (y-axis), 
p=0.344, r2=9.5% . B: Relationship between log10+1 transformed CTMB (x-axis) and Rectal 
GZMBL (y-axis), p=0.862, r2=3.5% . C: Relationship between log10+1 transformed CTMB (x-axis) 
and Rectal CLP1 (y-axis), p=0.685, r2=0.0% . D: Relationship between log10+1 transformed CTMB 
(x-axis) and Rectal GZM(GBH)L (y-axis), p=0.781, r2=0.0%. (CTMB: Combined Total Mucosal 
Burden; TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like 
Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
4.4.8 Relationship between Tissue Transcript Expression and Mast 
Cell Populations 
The relationships between caecal transcript levels and mast cell populations 
(Toluidine Blue (TB), eqMCP-1-labelled and eqTRYP-labelled mucosal mast cells 
(MMC) and submucosal mast cells (SMMC)) in the caecum are displayed as a matrix 
scatter plot in Figure 4.35. The p and rho values for each correlation are in Table 
4.14. There were significant correlations between the levels of CLP1 transcripts and 
TB MMC, eqMCP-1 MMC and eqTRYP MMC (Table 4.14) in the caecum. No other 
significant correlations were seen in the caecum. 
A B 
C D 
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Figure 4.35: Matrix scatter plot of log10+1 transformed counts for caecal mast cell counts (x-axis) and 
caecal transcript levels (y-axis). Significant relationships are circled. (TLP1: Tryptase-like Proteinase-
















TLP1 rho 0.473 0.343 0.019 -0.268 0.040 -0.225 
 p 0.088 0.230 0.949 0.354 0.893 0.440 
GZMBL rho 0.184 0.213 -0.080 -0.422 -0.141 -0.288 
 p 0.529 0.464 0.785 0.132 0.631 0.319 
CLP1 rho 0.623 -0.051 0.748 0.226 0.793 0.187 
 p 0.017 0.868 0.002 0.436 0.001 0.522 
GZM(BGH)L rho 0.464 -0.081 0.506 -0.055 0.393 0.084 
 p 0.095 0.785 0.065 0.856 0.165 0.776 
 
Table 4.14: Table of rho values (bold) and p values (in italics) for correlations between genes of interest in the 
caecum and caecal TB, eqMCP-1 and eqTRYP MMC and SMMC. Significant p-values are highlighted in yellow. 
(TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; 
GZM(BGH)L: Granzyme(BGH)-like). 
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The relationships between proteinase transcript levels and mast cell populations in 
the RVC are displayed as a matrix scatter plot in Figure 4.36. The p and rho values 
for each correlation are shown in Table 4.15. There was a significant correlation 
between the levels of CLP1 and TB MMC (p=0.024, rho=0.609) at this site. No other 
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Figure 4.36: Matrix scatter plot of log10+1 transformed counts for RVC mast cell counts (x-axis) and 
RVC transcript levels (y-axis). Significant relationships are circled. (TLP1: Tryptase-like             
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TLP1 rho 0.191 0.191 -0.218 -0.086 0.191 -0.026 
 p 0.512 0.512 0.454 0.771 0.512 0.929 
GZMBL rho -0.059 0.077 -0.332 -0.271 -0.227 -0.095 
 p 0.844 0.797 0.246 0.349 0.436 0.747 
CLP1 rho 0.609 0.147 0.020 0.178 0.491 0.322 
 p 0.024 0.616 0.952 0.542 0.075 0.262 
GZM(BGH)L rho 0.292 0.020 0.222 0.051 0.147 0.077 
 p 0.310 0.952 0.445 0.864 0.615 0.793 
Table 4.15: Table of rho values (bold) and p values (in italics) for correlations between genes of 
interest in the RVC and RVC TB, eqMCP-1 and eqTRYP MMC and SMMC. Significant p-values are 
highlighted in yellow. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: 
Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
The relationships between proteinase transcript levels and mast cell populations in 
the rectum are displayed as a matrix scatter plot in Figure 4.37. The p and rho values 
for each correlation are shown in Table 4.16. There was a significant correlation 
between the levels of GZM(BGH)L and eqMCP-1 MMC and eqTRYP SMMC 
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Figure 4.37: Matrix scatter plot of log10+1 transformed counts for RB mast cell counts (x-axis) and 
RB transcript levels (y-axis). Significant relationships are circled.  (TLP1: Tryptase-like Proteinase-1; 
GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like. 
RB: Rectal biopsy). 
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TLP1 rho 0.154 0.270 0.150 0.235 -0.086 -0.040 
 p 0.599 0.349 0.610 0.418 0.770 0.893 
GZMBL rho 0.112 0.174 0.123 0.182 -0.203 -0.200 
 p 0.703 0.553 0.675 0.532 0.486 0.493 
CLP1 rho -0.033 0.095 0.282 -0.029 -0.016 0.240 
 p 0.911 0.750 0.329 0.928 0.958 0.409 
GZM(BGH)L rho 0.251 -0.160 0.581 0.446 0.471 0.574 
 p 0.387 0.584 0.029 0.112 0.089 0.032 
 
Table 4.16: Table of rho values (bold) and p values (in italics) for correlations between genes of 
interest in the rectum and rectal TB, eqMCP-1 and eqTRYP MMC and SMMC from rectal biopsy. 
Significant p-values are highlighted in yellow. (TLP1: Tryptase-like Proteinase-1; GZMBL: 
Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like. RB: 
Rectal biopsy). 
 
4.5 Relationship between Tissue Transcript Levels and Tissue 
Proteinase Concentration 
The relationships between caecal transcript levels and caecal tissue proteinase 
concentrations are displayed as a matrix scatter plot in Figure 4.38. The p and rho 
values for each correlation are in Table 4.17. There was no significant correlation 
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Figure 4.38: Matrix scatter plot of log10+1 transformed data for the amount of caecal eqMCP-1 and 
eqTRYP from Tissue ELISA (x-axis) and caecal transcript levels (y-axis). (TLP1: Tryptase-like 
Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: 
Granzyme(BGH)-like).
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Caecum  TLP1 GZMBL CLP1 GZM(BGH)L 
eqMCP-1(µg/g) rho 0.169 -0.088 0.103 0.086 
 p 0.563 0.765 0.727 0.773 
eqTRYP(µg/g) rho -0.229 -0.326 -0.002 -0.371 
 p 0.431 0.256 1.000 0.192 
 
Table 4.17: Table of rho values (bold) and p values (in italics) for correlations between Caecal genes 
of interest and Caecal eqMCP-1 and eqTRYP Tissue ELISA results. (TLP1: Tryptase-like Proteinase-
1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-
like). 
 
The relationships between RVC transcript levels and RVC tissue proteinase 
concentrations are displayed as a matrix scatter plot in Figure 4.40. The p and rho 
values for each correlation are shown in Table 4.18. There was a significant 
correlation between the levels of TLP1 transcript and eqMCP-1 tissue concentrations 
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Figure 4.39: Matrix scatter plot of log10+1 transformed data for the amount of RVC eqMCP-1 and 
eqTRYP from Tissue ELISA (x-axis) and RVC transcript levels (y-axis). Significant relationships are 
circled. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like 
Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
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RVC  TLP1 GZMBL CLP1 GZM(BGH)L 
eqMCP-1 (µg/g) rho 0.582 0.451 0.512 0.451 
 p 0.032 0.186 0.064 0.108 
eqTRYP (µg/g) rho 0.306 0.130 0.451 0.174 
 p 0.288 0.660 0.108 0.553 
 
Table 4.18: Table of rho values (bold) and p values (in italics) for correlations between RVC genes of 
interest and RVC eqMCP-1 and eqTRYP Tissue ELISA results. Significant p-values are highlighted 
in yellow. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like 
Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
The relationships between rectal transcript levels and rectal tissue proteinase 
concentrations are displayed as a matrix scatter plot in Figure 4.40. The p and rho 
values for each correlation are displayed in Table 4.19. There was a significant 
correlation between levels of GZM(BGH)L transcript and the eqMCP-1 tissue 
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Figure 4.40: Matrix scatter plot of log10+1 transformed data for the amount of RB eqMCP-1 and 
eqTRYP from Tissue ELISA (x-axis) and RB transcript levels (y-axis). Significant relationships are 
circled. (TLP1: Tryptase-like Proteinase-1. GZMBL: Granzmye B-like. CLP1: Chymase-like 
Proteinase-1. GZM(BGH)L: Granzyme(BGH)-like. RB: Rectal biopsy). 
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RB  TLP1 GZMBL CLP1 GZM(BGH)L 
eqMCP-1(µg/g) rho 0.160 -0.055 0.187 0.723 
 p 0.584 0.856 0.522 0.005 
eqTRYP(µg/g) rho 0.112 0.042 0.499 0.468 
 p 0.704 0.892 0.072 0.094 
 
Table 4.19: Table of rho values (bold) and p values (in italics) for correlations between RB genes of 
interest and RB eqMCP-1 and eqTRYP Tissue ELISA results. Significant p-values are highlighted in 
yellow. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like 
Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like. RB: Rectal biopsy). 
 
4.6 Relationship between Tissue Transcript Levels and Serum 
Proteinase Concentration 
The relationships between caecal transcript levels and local serum eqMCP-1 and 
eqTRYP concentrations were explored and are displayed as a matrix scatter plot in 
Figure 4.41. The p and rho values for each correlation are shown in Table 4.20. 
There was a significant correlation between the caecal levels of CLP1 transcript and 
the local serum concentration of eqMCP-1 (Table 4.20: p=0.028, rho=0.596). There 
was also a significant correlation between the caecal levels of GZM(BGH)L 
transcript and the concentration of eqMCP-1 in the local serum (Table 4.20: 
p=0.044, rho=0.552). 
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Figure 4.41: Matrix scatter plot of log10+1 transformed data for the amount of caecal eqMCP-1 and 
eqTRYP from -20°C Serum ELISA (x-axis) and caecal transcript levels (y-axis). Significant 
relationships are circled. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: 
Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
 
Caecum  TLP1 GZMBL CLP1 GZM(BGH)L 
eqMCP-1 (ng/ml) (-20°C) rho 0.462 0.209 0.596 0.552 
 p 0.096 0.473 0.028 0.044 
eqTRYP (µg/ml) (-20°C) rho 0.152 -0.097 0.521 0.152 
 p 0.604 0.742 0.059 0.605 
 
Table 4.20: Table of rho values (bold) and p values (in italics) for correlations between genes of 
interest from Caecal tissue and eqMCP-1 and eqTRYP serum ELISA results. Significant p-values are 
highlighted in yellow. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: 
Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
The relationships between RVC transcript levels local serum eqMCP-1 and eqTRYP 
concentrations are displayed as a matrix scatter plot in Figure 4.42. The p and rho 
values for each correlation are shown in Table 4.21. There was a significant 
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correlation between the RVC levels of CLP1 transcript and the concentration of 


































Figure 4.42: Matrix scatter plot of log10+1 transformed data for the amount of RVC eqMCP-1 and 
eqTRYP from -20°C Serum ELISA (x-axis) and RVC transcript levels (y-axis). Significant 
relationships are circled. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: 
Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
 
 
RVC  TLP1 GZMBL CLP1 GZM(BGH)L 
eqMCP-1 (ng/ml) (-20°C) rho 0.525 0.332 0.732 0.411 
 p 0.057 0.246 0.004 0.146 
eqTRYP(µg/ml) (-20°C) rho 0.328 0.160 0.446 -0.046 
 p 0.253 0.584 0.112 0.880 
 
Table 4.21: Table of rho values (bold) and p values (in italics) for correlations between genes of 
interest from RVC tissue and eqMCP-1 and eqTRYP serum ELISA results. Significant p-values are 
highlighted in yellow. (TLP1: Tryptase-like Proteinase-1; GZMBL: Granzmye B-like; CLP1: 
Chymase-like Proteinase-1; GZM(BGH)L: Granzyme(BGH)-like). 
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The relationships between rectal transcript levels and local serum eqMCP-1 and 
eqTRYP serum proteinase concentrations are displayed as a matrix scatter plot in 
Figure 4.43. The p and rho values for each correlation are shown in Table 4.22. 
There were no significant correlations between the levels of transcript of each of the 
proteinases and serum concentrations of either eqMCP-1 or eqTRYP. 
 
RB  TLP1 GZMBL CLP1 GZMBGHL 
eqMCP-1 (ng/ml) (-20°C) rho 0.011 -0.099 0.253 0.499 
 p 0.976 0.739 0.383 0.072 
eqTRYP (µg/ml) (-20°C) rho 0.112 0.108 0.262 0.332 
 p 0.704 0.716 0.366 0.246 
 
Table 4.22: Table of rho values (bold) and p values (in italics) for correlations between genes of 
interest from rectal biopsy and eqMCP-1 and eqTRYP -20°C serum ELISA results. (TLP1: Tryptase-
like Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: 


































Figure 4.43: Matrix scatter plot of log10+1 transformed data for the amount of rectal eqMCP-1 and 
eqTRYP from -20 °C Serum ELISA (x-axis) and RB transcript levels (y-axis). (TLP1: Tryptase-like 
Proteinase-1; GZMBL: Granzmye B-like; CLP1: Chymase-like Proteinase-1; GZM(BGH)L: 
Granzyme(BGH)-like. RB: Rectal biopsy). 
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4.7 Discussion 
The first aim here was to investigate the ambiguity surrounding previous work on 
equine mast cell proteinases. The equine genome was utilised as a tool to further 
clarify the situation and to explore novel equine mast cell proteinases. Observations 
were made using the archetypal chymotrypsinogen numbering system based on the 
alignment of amino acid sequences with chymotrypsinogen (Hartley and Neurath 
1970; Hedstrom 2002). The second aim was quantitative analysis for further 
investigation into proteinase expression and the relationship of these proteinases with 
cyathostomin burden and mast cell response.  
The two neutral serine proteinases previously extracted from equine mastocytoma 
tissue, equine tryptase (eqTRYP) and equine Mast Cell Proteinase-1 (eqMCP-1), had 
been used to raise antibodies in rabbits. The cloning and sequencing of these equine 
mastocytoma derived proteins has been previously investigated. EqTRYP has been 
cloned and sequenced (Dacre, McAleese et al. 2006) and is referred to in this chapter 
as Tryptase-like Proteinase-1 (TLP1). At the time of study, exploration into the 
equine genome did not demonstrate any further predicted tryptase-like equine mast 
cell proteinase sequences. TLP1 was also the only tryptase-like sequence identified 
from the MASCOT results. Therefore the results here suggest that there is only one 
equine tryptase gene, however full mapping of the equine tryptase locus would be 
necessary to confirm this.  
Enzymic activity of granzymes depends on the presence of three highly conserved 
aa: His57, Asp102 and Ser195 (chymotrypsinogen numbering), otherwise known as 
the catalytic triad (Hedstrom 2002). Other highly conserved sites include aa residues 
189, 216 and 226, which are important in determining the specificity pocket, and 
cysteine residues required for disulphide bridge formation (Hedstrom 2002). The S1 
site, a polypeptide biding site adjacent to Ser195, is formed by residues 189-192, 
214-216 and 224-228 (Hedstrom 2002). Granzyme specificity is determined by the 
aa residue at 226. This is in contrast to tryptase enzymes, in which the residue of 
primary importance for specificity is at position 189 (Zamolodchikova, Sokolova et 
al. 2003). Ser195 is the catalytic residue in all serine proteinases and is adjacent to 
the S1 substrate recognition site (Hedstrom 2002).  
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Equine TLP1, like all trypsin-like proteinases, contains an aspartate at residue 189 
(Dacre, McAleese et al. 2006). Other conserved trypsin-like proteinase features 
present in the TLP1 sequence are the activation site region IVGG (residues 31-34) 
and cysteine residues at 191 and 220 (Dacre 2005). Unusually for a trypsin-like 
proteinase, equine tryptase contains an alanine, rather than glycine, at residue 216, as 
seen here (Figure 4.9) and in previous studies (Dacre, McAleese et al. 2006). This is 
of importance because this forms part of the substrate binding pocket wall and is 
considered a critical determinant of substrate specificity (Perona, Hedstrom et al. 
1995). This substitution may alter substrate specificity as alanine has a larger side 
chain (CH3) than glycine (H) and will therefore protrude further into the substrate-
binding pocket. The biological significance of this substitution could be that it may 
restrict fibrinogenolysis (Dacre, McAleese et al. 2006) as, unlike equivalents in 
humans (human ß tryptase) (Thomas, Wheeless et al. 1998) and sheep (sheep mast 
cell proteinase-1) (Pemberton, Huntley et al. 1997), equine tryptase lacks the ability 
to cleave fibrinogen (Dacre, McAleese et al. 2006). This theory is supported by the 
fact that the aspartate substitution at residue 216 (Fiorucci and Ascoli 2004) in 
human alpha tryptase is implicated in this proteinase’s reduced activity (Selwood, 
Wang et al. 2002) and inability to cleave substrates including fibrinogen (Huang, Li 
et al. 1999). Further work is required to confirm the relevance of this substitution.  
Multiple closely related chymases are expressed by many mammalian species 
(McAleese, Pemberton et al. 1998; Miller and Pemberton 2002). The genome of the 
rat contains 28 closely related functional chymases (Puente and López-Otín 2004), 
compared to at least 14 in the mouse (Gallwitz and Hellman 2006) and four in the 
human (Caughey, Schaumberg et al. 1993; Gallwitz and Hellman 2006). When 
Pickles et al. (2005) attempted to obtain the chymase nucleotide sequence from 
equine tissue, the deduced aa sequence for the putative equine Mast Cell Proteinase-1 
had an N-terminal aa sequence that differed from the mastocytoma derived eqMCP-1 
sequence by two aa. The peptide mass fingerprints of these chymases were poorly 
matched and it was hypothesised that a similar, but novel, proteinase was cloned and 
sequenced (CLP1), rather than the original mastocytoma derived chymase    
(eqMCP-1) (Dacre 2005). Proteomic analysis in this chapter demonstrated that the 
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most abundant proteinase in the purified eqMCP-1 was in fact GZM(BGH)L. In 
addition this sequence also had the highest number of unique peptide hits (6). Also, 
the predicted N-terminal aa sequence of GZM(GBH)L was identical to the N-
terminal aa sequence of eqMCP-1 (Pemberton, McEuen et al. 2001). Due to this 
sequence similarity and the abundance of this proteinase it is hypothesised that the 
sequence GZM(BGH)L is the original sequence of mast cell chymase characterised 
and isolated by Pemberton et al. (2001) and that the chymase measured in previous 
chapters is in fact GZM(BGH)L. The NCBI annotation GZM(BGH)L is potentially 
misleading as there is no official gene nomenclature for equids, hence gene and 
protein names originate from a number of sources including annotation on GenBank 
(INSDC) records, literature, and Swiss-Prot. Both CLP1 and GZM(BGH)L have a 
glutamine at residue 226 which suggests that they have a similar activity. This 
provides further evidence of the presence of multiple equine mast cell chymases as 
the predicted nucleotide sequence of GZM(BGH)L shares <85% identity with the 
NCBI entry for putative equine mast cell proteinase-1 (CLP1). Full sequence 
analysis of the proteinase GZM(BGH)L would be necessary to confirm this in 
conjunction with experiments to deduce its biological activity and functional 
specificity.  
Investigation into the equine genome here has shown that the mast cell chymase 
locus is situated on equine chromosome 1. This locus contains one or two alpha 
chymases and additional serine proteinases including lymphocyte-derived granzymes 
(Gallwitz, Enoksson et al. 2007). Granzymes can be grouped according to their 
specificity; their subfamilies have tryptase-like, chymotrypsin-like and elastase-like 
properties (Smyth, O'Connor et al. 1996). In humans and mice, granzymes are 
grouped into three clusters among three different chromosomes; GrA, GrB and GrM 
(Ewen, Kane et al. 2012). The subfamily with chymotrypsin-like specificity (GrB) is 
grouped on the chymase locus and includes mouse granzyme B, C, D, E, F and G 
and granzyme B and H in the human (Trapani 2001). Equine granzyme B (eqGrzmB) 
has been identified and characterized (Piuko, Bravo et al. 2007) and is also located 
on equine chromosome 1. At the time of this study, eqGrzmB was the only 
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sequenced equine granzyme in the NCBI database; TLP1 and CLP1 were the only 
previously identified equine mast cell proteinases.  
The database GranzymeDB was compiled of nine protein candidates selected from 
the MASCOT results from the equine mastocytoma and tissue homogenate and 
comprised eqTRYP/TLP1, CLP1 and an additional seven predicted sequences. Two 
of the predicted sequences were selected for further analysis and quantification, 
granzyme B-like (GZMBL) and Granzyme(BGH)-like (GZM(BGH)L). Although 
these sequences were termed granzyme B-like and Granzyme(BGH)-like, as 
previously mentioned there is no official gene nomenclature for equids. Therefore, 
for these predicted sequences their assigned ‘granzyme-like’ names are potentially 
misleading as their cellular origin is yet to be determined. Also, these sequences were 
re-named when the equine genome was re-annotated. The re-annotated gene and 
protein name for both sequences, granzyme H-like, was generated automatically by 
NCBI’s genome annotation pipeline. The sequences were aligned with human and rat 
granzyme H, both of which have a glycine at 226. This glycine has a critical role for 
substrate specificity of human granzyme H (Wang, Zhang et al. 2012). The 
sequences do not share this residue, with GZMBL displaying an arginine and 
GZM(BGH)L displaying a glutamine. This suggests that they do not share the same 
specificity and hence their re-annotation as granzyme H-like is potentially inaccurate. 
Interestingly, like human, mouse and rat granzyme B, GZMBL has an arginine at 
residue 226 (Cullen, Adrain et al. 2007) suggesting that the original NCBI 
nomenclature is more accurate. Despite the significant similarities in sequence, 
human and murine granzyme B have been demonstrated to have divergent substrate 
preferences (Cullen, Adrain et al. 2007). Full sequence analysis and specificity 
studies on these proteins would be necessary to confirm the correct annotation for 
these proteinases. Furthermore, as the RNA was extracted from a tissue homogenate 
with a mixed cell population, it is not possible to definitively state the cellular origin 
of the proteinases. It is possible that they may be lymphocyte derived; granzymes are 
members of a chymotrypsin related family of serine proteinases produced by 
cytotoxic T-cells and NK cells (Trapani 2001). However, granzymes are not always 
limited to a single cellular origin. In mice, granzyme D is expressed by both mucosal 
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mast cells and T cells (Rönnberg, Calounova et al. 2013). In situ hybridisation would 
be necessary to confirm the cellular locations of these proteinases in equine tissue.  
Here, cDNA created from RNA extracted from the intestinal tissue of five horses, 
was used to compare the nucleotide and translated protein sequences of TLP1, 
GZMBL, CLP1 and GZM(BGH)L across a region of interest unique to that gene. 
The RNA quality of all horses, even those in a known diseased state, such as horse 
DV3, was high; all RIN values were greater than 8. Full sequence analysis was not 
performed as it was outwith the scope of the project. Due to the highly conserved 
nature of the proteinase sequences it was necessary to design the primer and probes 
manually to ensure that selected regions were specific to the sequences of interest. 
The primers were verified using cDNA from five horses and the amplicons from 
samples compared to ensure that the primers were specific. Due to the highly similar 
nucleotide sequences of the genes of interest, probes were used to increase the 
reaction specificity. The primers and probes were also tested in a matrix; this 
experiment was successful in demonstrating specificity, as all probes were specific to 
their designed primer set. All TLP1 sequences were identical to the query TLP1 
sequence. Although there were a number of differences in the nucleotide sequences 
between the five horses and the query GZMBL sequence, only two differences 
altered the derived aa sequence. The CLP1 amplicon nucleotide sequences 
demonstrated only one translated difference between the query sequence and 
sequences derived from the equine tissue here. The GZM(BGH)L amplicon 
nucleotide sequences showed two differences, both of which were seen in a single 
horse. Only one of these translated to a difference in the derived protein sequence.  
Although it was outwith the scope of this project to analyse the full sequences it is 
interesting to observe that horse DV3, a case of larval cyathostominosis, had a 
number of sequence polymorphisms over the area compared in the protein sequence 
of both CLP1 and GZM(BGH)L. This could potentially have an effect on protein 
structure and function (Ng and Henikoff 2001). In the case of GZM(BGH)L this 
difference was at residue 103. The aspartate residue at position 102 is of importance 
because as mentioned above, along with His57 and Ser195, it is part of the catalytic 
triad which is a complex network of hydrogen bonds (Hedstrom 2002). In the case of 
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CLP1, the difference in protein sequence was at residue 214. Residue 216 is of 
importance because, along with residues 189 and 226, it forms the substrate 
specificity pocket. Potentially of greater importance is that Ser214 (replaced with a 
proline in horse DV3) forms a hydrogen bond with Asp102 (Hedstrom 2002). Ser214 
has been considered the fourth member of the catalytic triad (McGrath, Vasquez et 
al. 1992; Krem and Di Cera 2001; Hedstrom 2002). Although some studies have 
suggested it is non-essential for enzyme catalytic function (Epstein and Abeles 1992; 
McGrath, Vasquez et al. 1992) Ser214 is highly conserved due to its role in substrate 
recognition (Krem, Prasad et al. 2002) and contributes to the S1 binding pocket 
(Perona, Hedstrom et al. 1995). As these two substitutions in horse DV3 for the 
CLP1 (residue 214) and GZM(BGH)L (residue 103) sequences are closely related to 
residues affecting proteinase specificity, further work is warranted to explore the full 
protein sequences and the enzymic activity of the derived enzymes. 
In mice the absence of the chymase mMCP-1 gene has been demonstrated to affect 
the kinetics of Nippostrongylus brasilensis infection (Wastling, Knight et al. 1998) 
and this knockout also had a negative effect on the clearance of Trichinella spiralis 
worms from the intestine (Knight, Wright et al. 2000). A hypothesis that requires 
further investigation is that alterations in mast cell proteinase aa sequence has a 
deleterious effect on the proteinase structure and function. SNPs are the most 
abundant and widespread form of genetic sequence variation (Marth, Korf et al. 
1999). An equine SNP genotyping array has been developed and evaluated (Wade, 
Giulotto et al. 2009; McCue, Bannasch et al. 2012). Exploring the chymase locus on 
equine chromosome 1, particularly investigating the minority of horses that are 
carrying high cyathostomin burdens, would be valuable way of determining the 
significance of these SNPs. The results from this Chapter provide a preliminary 
framework for this: however, further sequence analysis at the genetic and functional 
levels must be performed. 
It is becoming increasingly important to analyse the appropriate housekeeping gene 
as it has been shown that commonly used housekeeping genes are not always suitable 
choices due to variation in their own expression profiles (Dheda, Huggett et al. 2004; 
Barber, Harmer et al. 2005; Cappelli, Felicetti et al. 2008). In the case of the horse, a 
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number of studies have utilised different housekeeping genes in BALF (Beekman, 
Tohver et al. 2011), peripheral blood mononuclear cells (Cappelli, Felicetti et al. 
2008; Figueiredo, Salter et al. 2009) and colon, heart, kidney, liver, lung, lymph 
node, small intestine and spleen (Zhang, Davis et al. 2009), skin and sarcoid tissue 
(Bogaert, Van Poucke et al. 2006). Also, of relevance here, intestinal regions have 
been shown to differ in their gene expression (Comelli, Lariani et al. 2009). The 
computer programme geNorm, minimises errors caused by inappropriate reference 
gene selection by enabling analysis of a selection of reference genes and providing 
information on the best possible combination for the experimental conditions 
(Vandesompele, De Preter et al. 2002). GeNorm provides a gene expression 
normalisation factor that can be calculated for each sample based on the geometric 
mean of a defined number of reference genes. The optimal normalisation factor for 
this study was calculated as the geometric mean of reference targets SDHA and 
GAPDH. GAPDH is a commonly used reference gene in intestinal samples of horses 
(Hjertner, Olofsson et al. 2013 ; Southwood, Lindermann et al. 2006; Woodward, 
Holcombe et al. 2010; Fossum, Hjertner et al. 2012). GAPDH is also used as an 
intestinal reference gene in rats (Bulut, Felderbauer et al. 2008) and humans (Pizarro, 
Michie et al. 1999). There are fewer reports of SDHA as a reference gene; however 
SDHA was the optimal small intestinal housekeeping gene in sheep infected with 
gastrointestinal nematodes (Zaros, Coutinho et al. 2010). Efficiency between 90 and 
110% is generally considered optimal (D’haene, Vandesompele et al. 2010) and 
encouragingly, all the reactions were within an efficiency range of 88 to 110%.  
There was a significant difference in the levels of transcript of TLP1, GZMBL, CLP1 
and GZM(BGH)L in each organ. Transcript levels of CLP1 consistently displayed 
the highest median and greatest range at all sites. The elevated levels of CLP1 
supports the previous immunolabelled-cell counts (Chapter 3) as the majority of mast 
cells enumerated were chymase-positive. The level of transcript of each protein 
between organs was not significantly different. In the caecum, RVC and rectum, 
transcript levels of TLP1 and GZMBL were significantly positively correlated. 
Levels of CLP1 and GZM(BGH)L positively correlated significantly in the caecum 
and RVC, and approached significance (p=0.054, rho=0.530) in the rectum. This 
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could be due to two predominant subsets of mast cells; one that is producing TLP1 
and GZMBL and another subset generating CLP1 and GZM(BGH)L. Alternatively, 
production of these proteinases could be from individual cell populations that are 
responding to the environment, including the cyathostomin burden, in a similar way. 
As mentioned, the GZMBL sequence contains an arginine at residue 226 as do 
human, mouse and rat granzyme B (Cullen, Adrain et al. 2007). This strict 
requirement at this residue confers specificity at the P1 site (Waugh, Harris et al. 
2000; Hedstrom 2002; Ruggles, Fletterick et al. 2004). As previously mentioned, 
granzymes can be expressed by more than one cell type; murine granzyme D is 
expressed by both T cells and mucosal mast cells (Rönnberg, Calounova et al. 2013) 
and mast cells have the ability to both express multiple chymases and adjust their 
proteinase phenotype to their environment (Friend, Ghildyal et al. 1998). 
Furthermore, granzyme and chymase sequences show high identity at the nucleotide 
level; hence it would be necessary to perform in situ hybridisation to confirm the 
cellular origin of these genes and further characterise the intestinal mast cell 
populations at these sites. 
The results presented here provide evidence that serum concentrations of eqMCP-1, 
measured by ELISA (Chapter 3), correlate with transcript expression of certain 
chymases in the large intestine. The closest relationship was observed with CLP1. 
Caecal transcript levels of CLP1 and GZM(GBH)L significantly positively correlated 
with the eqMCP-1 measured in serum from veins draining the large intestine. In the 
RVC, a similar correlation was observed between CLP1 transcript levels and 
eqMCP-1 serum concentrations. There were no significant correlations between local 
serum proteinase concentrations and any of these transcripts measured in the rectum. 
The conclusions that can be drawn from this data are limited without full knowledge 
of the specificity of the antibodies utilised in the ELISA. As the sequences are 
homologous and the antibodies polyclonal there is potential for the recognition of 
multiple epitopes leading to cross-reactivity. Further studies are warranted, such as 
immunoaffinity chromatography, to assess the specificity of the rabbit anti-eqMCP-1 
and -eqTRYP IgG reagents used earlier in this study.  
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When comparing transcript levels and mast cell counts, significant positive 
correlations were seen between mucosal TB-stained mast cell levels, eqMCP-1- 
positive and eqTRYP positive cells with CLP1 transcript levels in the caecum. In the 
RVC, significant positive correlations were observed only between CLP1 transcript 
levels and TB-stained mucosal mast cells levels (p=0.024, rho=0.609). In the rectum 
relationships were seen between GZM(BGH)L transcript levels and eqMCP-1- 
positive mucosal mast cell (p=0.029, rho=0.581) and eqTRYP positive submucosal 
mast cells (p=0.032, rho=0.574). The relationships between GZM(BGH)L and 
chymase measures could be explained by the proteomic results here. These have 
demonstrated that the previously purified chymase was predominantly GZM(BGH)L, 
and therefore the antibodies raised against this chymase used here may actually be 
largely recognising GZM(BGH)L. There was a significant positive correlation 
between tissue transcript levels of GZM(BGH)L and eqMCP-1 tissue concentrations 
in the rectum (p=0.005, rho=0.723). This relationship is further supported by the 
ELISA results which demonstrated a significant positive relationship between rectal 
eqMCP-1 mucosal mast cell counts and rectal eqMCP-1 concentration, (p=0.002, 
rho=0.564). This is of interest due to the significant positive linear relationship 
between the eqMCP-1-labelled MMC in the rectal biopsy tissue and the combined 
CTMB (p=0.018, r2=43.1%). However, there was no significant relationship between 
the log10+1 transformed CTMB and any of the four transcript levels in the rectum.  
In the mouse the constitutive expression of the chymase mast cell proteinase-1 
(mMCP-1) in the jejunum has been demonstrated, as well as the up-regulation of this 
proteinase during N. brasiliensis infection (Wastling, Scudamore et al. 1997). The 
altered expression of this proteinase has also been demonstrated to delay expulsion 
of T. spiralis (Knight, Wright et al. 2000). Linear regression analysis here 
demonstrated a statistically significant positive relationship between transcript levels 
of TLP1 and the CTMB, (p=0.007, r2=51.2%) in the RVC. In this organ, there was 
also a statistically significant positive relationship between transcript levels of 
GZMBL and the CTMB, (p=0.042, r2=45.4%). This result supports the relationship 
observed between tissue eqTRYP concentrations and the RVC CTMB in Chapter 3. 
It also provides support for the hypothesis that there are previously unidentified 
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novel equine mast cell proteinases. The cellular origin of GZMBL requires 
verification; however the fact that its presence was identified in equine mastocytoma 
tissue is support for the hypothesis that this novel equine proteinase is mast cell 
derived. The strong relationship between GZMBL and TLP1 expression in all three 
organs examined provides further support for this. 
The relationship between TLP1 and RVC CTMB also supports previous equine 
studies which demonstrated that tryptase-labelled mast cells had the strongest 
relationship with cyathostomin burden, with total cyathostomin burden accounting 
for 57% of the variation in tryptase-labelled mast cell counts in the caecal mucosa 
(Pickles, Mair et al. 2010). Although in the cohort studied here these relationships 
were not verified in the caecum and rectum the results from the RVC are 
encouraging. As was demonstrated here, the equine genome provides a valuable tool 
for further investigation. Preliminary investigation using this resource has shown that 
the equine chymase expressing genes are located around chromosome 1. The work 
described here has provided evidence of multiple equine mast cell proteinase-like 
gene sequences that are expressed in equine intestinal tissue and a foundation for 
their characterisation. Two transcripts that were analysed here, GZMBL and 
GZM(BGH)L, have close homology to the putative equine Mast Cell Proteinase-1 
sequence (CLP1). There was strong evidence to suggest that the predicted sequence 
GZM(BGH)L is the same as the initial equine mast cell proteinase originally purified 
from an equine mastocytoma. This proteinases was used to generate many of the 
immunological reagents used in this study (Pemberton, McEuen et al. 2001). This 
requires further verification but it may mean that the antibodies used in the ELISAs 
and immunohistochemistry in Chapter 3 were predominantly picking up signals for 
GZM(BGH)L.  
This chapter has therefore provided useful insight into the potential for novel equine 
mast cell proteinases. The previous ambiguity surrounding equine mast cell 
proteinase-1 has been clarified through the proteomic work and the identification of 
GZM(BGH)L as the previously isolated and characterised eqMCP-1 proteinase.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
Full sequence analysis is required to investigate the four sequences examined in this 
chapter further, in conjunction with in situ hybridisation to examine the cellular 
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origin of these proteinases. The expression of TLP1 was closely correlated with 
GZMBL expression, and linear regression analysis has demonstrated a statistically 
significant positive relationship between both TLP1 and GZMBL transcript levels 
and total mucosal cyathostomin in the RVC. This work has therefore provided a 
good foundation for further exploration into the role of equine mast cell proteinases 
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5 General Discussion 
As a result of their prevalence and pathogenicity cyathstomins are considered the 
most important equine nematode (Matthews 2014; Love, Murphy et al. 1999; 
Matthews 2008). With the growing concern over the development of anthelmintic 
resistance, and no new therapeutic options on the horizon, it is important to 
investigate the potential for diagnostic assays to facilitate targeted treatment 
(Matthews 2014; McWilliam, Nisbet et al. 2010). In particular, encysted larvae play 
an important role in the epidemiology and pathogenesis of cyathostominosis (Giles, 
Urquhart et al. 1985) and to date there is no accurate way to assess an individual’s 
infection status. An increase in caecal mast cells expressing proteinases has been 
demonstrated during cyathostomin infection (du Toit, McGorum et al. 2007; Pickles, 
Mair et al. 2010) and ELISAs have been used with some success to measure the 
systemic release of mast cell proteinases into blood during nematode infections in 
other species (Miller, Woodbury et al. 1983; Woodbury, Miller et al. 1984; Huntley, 
Gibson et al. 1987; Huntley, Gooden et al. 1990). By increasing the knowledge of the 
relationship between immune effector cells, such as mast cells, and cyathostomins 
the potential for their use as predictors of burden can be explored. This thesis has 
further investigated the involvement of mast cells and their proteinases, equine mast 
cell proteinase-1 (eqMCP-1) and equine tryptase (eqTRYP) in natural equine 
cyathostomin infection, and evaluated the potential for mast cell proteinase assays to 
be used in minimally invasive diagnostic tests to estimate encysted cyathostomin 
larval burden. Knowledge of an individual’s larval cyathostomin status would be 
beneficial to inform strategic and targeted treatments, especially in young horses that 
are more susceptible to clinical disease (Traversa, Milillo et al. 2010). Prerequisites 
for a cyathostomin diagnostic assay include identification of cyathostomins at their 
encysted and pathogenic stage and an assay that quickly becomes negative following 
effective therapy to allow the monitoring of treatment protocols (Andersen, Howe et 
al. 2013). A diagnostic assay for clinical use must be robust and practically 
applicable in the field (Matthews 2014), hence the focus here was on serum and 
rectal tissue biopsy samples. A diagnostic IgG(T) serum ELISA using recombinant 
versions of cyathostomin gut associated larval antigen (Cy-GALA) generated for a 
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number of common cyathostomin species is currently being assessed (Matthews 
2011). However, the dynamics of antigen specific IgG(T) responses, particularly 
following treatment, are a concern when considering this assay’s utility. Mast cell 
proteinase tissue expression and concentrations in serum and tissue were therefore 
investigated in this study as potential biomarkers of active infection. The usefulness 
of a diagnostic assay can be described by its sensitivity, specificity, and positive and 
negative predictive value (Akobeng 2006). This study was limited in its ability to 
assess these factors, as the horses examined were carrying natural infections. A 
complete history of anthelmintic treatment and cyathostomin burden was not 
available. Due to this, horses could not be reliably placed into positive and negative 
groups, limiting the assessment of the aforementioned properties. Whilst these 
factors could not be assessed here at this stage, due to the limitiations in study 
design, the relationship between proteinase expression and cyathostomin burden was 
explored here as a necessary step in the process of evaluating the potential for these 
proteinase to be used as biomarkers for active infection.  The requirment for a 
diagnostic test that will provide information on an individual’s cyathostomin larval 
infection status has been illustrated here. Only three of the 28 horses (11%) had 
faecal egg counts (FEC) above the commonly used treatment cut off of 200 eggs per 
gram (Nielsen, Haaning et al. 2006; Larsen, Ritz et al. 2011); however 50% of the 
horses had combined total mucosal burdens (CTMBs) greater than 20,000 encysted 
larvae. Furthermore, the case of larval cyathostominosis here had caecal and right 
ventral colon (RVC) mucosal burdens to the order of several million, yet the FEC 
was negative.  
The common mucosal immune system has the potential to evoke mucosal immune 
responses throughout the gut, including the rectum (Lycke 2012) and is a key 
determinant of the success of rectal biopsies and mast cell activity at this site as 
diagnostic tests. This thesis provided evidence to support the theory of mast cell 
recruitment as part of the common mucosal system in equines. The Toluidine blue 
(TB) mast cell mucosal and submucosal populations significantly correlated at each 
site and significant correlations were also observed between mucosal and 
submucosal mast cells across sites: the caecum and RVC, the caecum and the rectum, 
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and the rectum and RVC. This result is supported by a previous study which 
examined the mast cell response in naturally cyathostomin infected horses and 
demonstrated correlations between the large intestinal (caecum, ventral and dorsal 
colon) mast cell counts (Collobert-Laugier, Hoste et al. 2002). The rectum was not 
investigated in the latter study; therefore the results from this thesis are novel in their 
explorations of this anatomical location. These results support the theory that mast 
cells are recruited throughout the intestinal mucosa so that stimulation at one site, 
such as the caecum, has potential to provoke a response at a distant site. 
A more complex relationship was observed when examining the composition of the 
mast cell serine proteinase-labelled populations. The majority of mast cells were 
eqMCP-1-positive, a finding in agreement with Pickles et al. 2010 and the eqMCP-1-
labelled mast cell populations followed a similar pattern to the TB stained cells. The 
eqTRYP-labelled mast cell enumerations were less consistent; for example, the rectal 
eqTRYP-labelled mucosal mast cells only correlated with other rectal based cell 
counts. Mast cells maturing in different tissue microenvironments can vary in the 
type and amount of the proteinases they express (Caughey 2007; Xing, Austen et al. 
2011). One hypothesis to explain the findings here is that the chymase-like 
expressing cells comprise the majority of the mast cell population and therefore their 
numbers are more closely related throughout the intestinal tract. The expression of 
eqTRYP may be more dependent on the local environment. This hypothesis is 
supported by the fact that caecal eqTRYP has previously demonstrated the strongest 
relationship with cyathostomin burden, despite the majority of the equine intestinal 
mast cell population being eqMCP-1-positive and eqTRYP-negative (Pickles, Mair 
et al. 2010).  
Previous work has demonstrated strong positive linear relationships between 
cyathostomin burden and the production of both equine tryptase and eqMCP-1 within 
the caecal wall of naturally infected horses (Pickles, Mair et al. 2010). In this thesis 
the rectal mucosal populations of both eqTRYP- and eqMCP-1-labelled cells were 
significantly positively correlated with both CTMB and combined total luminal 
burden (CTLB). Standard linear regression analysis, performed with the presence of 
A. perfoliata as a confounding variable, demonstrated a significant positive linear 
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relationship between both eqMCP-1- and eqTRYP-labelled MMC in the rectal 
biopsy tissue and CTMB (p=0.018, r2=43.1% and p=0.048, r2=24.4% respectively). 
Similar significant positive relationships were also seen with CTLB (eqMCP-1: 
p=0.009, r2=41.5; eqTRYP: p=0.007, r2=28.9). These results provide support for 
rectal biopsy and determination of proteinase-labelled mast cells as a diagnostic 
predictor of total cyathostomin burden.  
Of the three anatomical sites explored, the RVC demonstrated the most consistent 
relationship with cyathostomin larval burden. This may have future diagnostic value 
for investigation of weight loss during exploratory laparotomy. Significant results in 
the RVC included a positive relationship between TB submucosal mast cells 
(SMMC) and CTMB, and between CTMB and eqMCP-1 and eqTRYP tissue 
concentrations. The RVC was the only organ in which linear regression analysis 
demonstrated a statistically significant positive relationship between transcript levels 
of tryptase-like proteinase-1 (TLP1) and the CTMB, and in this anatomical location 
there was also a statistically significant positive relationship between transcript levels 
of granzme B-like (GZMBL) and the CTMB. Of the three locations examined, the 
RVC demonstrated the greatest range and highest median of both eqMCP-1 and 
eqTRYP proteinase concentration. Interestingly, the RVC (range 0 – 2,054,051; 
median 7028) had a greater total cyathostomin mucosal burden than the caecum 
(range 0 – 1,773,047; median 5945). There were also significantly more luminal 
worms in the RVC compared to the caecum. This increased cyathostomin challenge 
could possibly explain the more consistent relationship with cyathostomin burden in 
the RVC seen here. 
Larval cyathostominosis is associated with diarrhoea and colic; however these are 
common gastrointestinal symptoms and present the veterinarian with a clinical 
challenge (Ricketts 1996). Additional clinical signs ascribed to this condition include 
weight loss, anorexia, oedema and pyrexia (Love, Murphy et al. 1999; Smets, Shaw 
et al. 1999; Bodecek, Jahn et al. 2010). Here, and in previous studies (Pickles, Mair 
et al. 2010), mast cell proteinase expression has been linked to cyathostomin 
infection. However, it is unclear as to the exact nature of the relationship. The 
association between intestinal pathology and immune expulsion of gastrointestinal 
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helminths has yet to be elucidated and remains controversial in other species 
(Lawrence, Paterson et al. 2004). Altered gastrointestinal motility is considered an 
important feature of equine colic and it is thought that the inflammatory changes 
within the mucosa due to encysted larvae may be the cause (Love, Murphy et al. 
1999). Despite the fact that mast cells were discovered over a century ago, there is no 
consensus regarding their physiologic role (Abraham and Malaviya 1997). Whilst the 
classic mastocytosis and systemic release of chymase is a hallmark of infection, mast 
cells have also been shown to play a role in the amplification of the T helper 2 (Th2) 
associated immune response, which is required for parasite loss but also results in an 
associated enteropathy (Lawrence, Paterson et al. 2004). In equines, the findings to 
date are supportive of a Th2 type immune response to cyathostomin challenge (du 
Toit, McGorum et al. 2007), however the precise role of Th2 derived cytokines in the 
horse has not been defined. Whilst it is hypothesised that they are protective in the 
host immune response to parasites the factors driving these Th2 cytokines and their 
downstream mechanisms have yet to be thoroughly investigated (Davidson, 
Hodgkinson et al. 2005). In the mouse Th2 responses have been demonstrated to 
generate muscle hypercontractility with the roles of individual cytokines differing 
according to the type of nematode infection (Khan, Richard et al. 2003). Increases in 
interleukin-9 (IL-9) levels accelerate worm clearance and are required for optimal 
response to Trichuris muris infection; in contrast IL-9 is not required for the 
hypermotility associated with Trichinella spiralis infection, as IL-3 and Il-4 are 
sufficient (Khan, Richard et al. 2003). In addition, mouse mMCP1 has been 
demonstrated to induce intestinal inflammation (Lawrence, Paterson et al. 2004) and 
it may be the case that the release of mast proteinases is partly responsible for the 
clinical signs ascribed to larval cyathostominosis. As such, mast cell proteinases may 
be a measure of immunity as opposed to a marker of infection. Further studies are 
warranted to investigate the role of mast cells in immunity to nematodes in horses; 
these may provide information about those animals that harbour high burdens. 
Mast cells appear to have a dual role in the innate immune system, as both sentinels 
for invading pathogens and also regulatory cells through the course of acute 
inflammation (St. John and Abraham 2013). There is also evidence to support the 
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role of mast cell activation in response to chronic pathogen infection (Shin, Watts et 
al. 2008), although this is not well understood. In the mouse, tryptase has been 
demonstrated to be involved in the modulation of the immune response to the chronic 
colonisation phase of T. spiralis infection. This role has also been demonstrated to be 
mast cell subset and proteinase specific, as it is the tryptase mouse mast cell 
proteinase-6 (mMCP-6), not mMCP-7 (another murine tryptase), that has been 
shown to be critical to eosinophil recruitment in this chronic infection phase (Shin, 
Watts et al. 2008). This highlights the importance of the effector role for mast cells in 
the adaptive immune system. The host/parasite interaction in equine 
cyathostominosis is complicated by the lengthy period of encystment, thought to last 
for months to years (Gibson 1953; Murphy and Love 1997). An improved 
understanding of the mechanism controlling encystment would be beneficial to gain 
a better understanding of the role of mast cells in this chronic phase of infection. 
Serum mast cell proteinase concentrations in mice, rats and sheep, measured by 
ELISA have been demonstrated to be associated with gastrointestinal mastcocytosis 
and intestinal nematode infections (Woodbury, Miller et al. 1984; Huntley, Gibson et 
al. 1987; Huntley, Gooden et al. 1990; Miller 1996). Encouragingly in this study, 
local serum concentrations of eqTRYP and eqMCP-1 were significantly positively 
correlated (p=0.006, rho=0.665) and serum from cyathostomin-negative horses gave 
consistently low readings for eqMCP-1 (mean 0.45 ng/ml) and eqTRYP (mean 0.23 
µg/ml) serum ELISA. Peripheral serum is relatively easy to obtain and would be a 
more accessible sample for diagnostic assay than serum sourced from the intestinal 
tract. However, both eqMCP-1 and eqTRYP proteinase concentrations in peripheral 
serum did not correlate with concentrations in local serum suggesting that they 
cannot be used to indicate the level of proteinase in the serum local to the site of 
infection, and thus limiting the diagnostic potential of this assay in horses. There was 
a significant negative relationship observed between peripheral serum eqMCP-1 
concentrations and the CTMB, which could be a result of activation and sequestering 
of proteinases within the gut lumen. However, linear regression analysis 
demonstrated no significant relationship between local proteinase concentrations 
measured in these tests with the CTMB. This could relate to the differences in the 
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exact cyathostomin stage of infection between animals, which may have affected the 
local responses at the time of assay. In addition, proteinases may have been released 
and sequestered into the gut lumen as occurs in other species (Huntley, Gooden et al. 
1990; Scudamore, Thornton et al. 1995; Miller 1996), which was not measured here. 
With the antibodies currently available this serum assay is of little diagnostic value in 
cyathostomin infection.  
With regards to assessing the clinical application of a diagnostic assay, biological 
markers should be robust enough to be unaffected by season, breed and common 
history. However, as this was a study of natural infection, the analysis of the 
relationships between all mast cell measures and cyathostomin burden was limited by 
a lack of knowledge of infection and treatment history of the horses studied. 
Differences in horse management, particularly between the two sampling locations, 
stage of infection and also the phase of immune response may be confounding 
factors and could explain why the relationships observed here in the caecum were not 
as significant when compared to previous studies performed by K. Dacre et al. 2010. 
The results here may also have been affected by age, variations in levels of pasture 
contamination, treatment frequency and external stresses such as nutrition, travelling 
or concurrent diseases (Collobert-Laugier, Hoste et al. 2002). In addition, the 
antibodies previously validated and used in this study and by Dacre et al (2010) were 
polyclonal. This may have resulted in a loss of sensitivity, particularly when 
considering the sequence homology between chymases and granzymes, and may also 
have contributed to the high coefficients of variation seen in the optimised ELISA. 
Although the serum levels of eqTRYP and eqMCP-1 correlated with each other there 
was no correlation between local serum proteinase and CTMB. A lack of specificity 
may have caused a lack of sensitivity due to cross-reactivity, as the polyclonal 
antibodies may have been binding to a number of epitopes (Lipman, Jackson et al. 
2005). This may have resulted in subtle relationships being missed and could explain 
why the results were more significant in the RVC where the cyathostomin larval 
burden in individuals was greater. Previous work has highlighted the potential for 
other equine mast cell proteinases (Dacre 2005) and that expression of these 
proteinase may be more related to cyathostomin burden, or a lack of sensitivity to 
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specific proteinases may be hindering analysis. In an attempt to address the 
limitations of the antibodies available, this thesis explored previously undescribed 
mast cell proteinases using the equine genome as a bioinformatic resource. In 
addition, the proteinases recognised by the previously purified antibodies were 
investigated. The results provided evidence for the presence of multiple equine 
chymases isoforms. Subsequently, the transcription of three such chymases was 
explored and a further five potential chymase sequences were identified here. It was 
outside the scope of this project to investigate all related predicted sequences, but the 
results provided encouraging preliminary data. Results from the qPCR experiments 
demonstrated that CLP1 was the most abundant of the four proteinase transcripts 
measured in the caecum, RVC and in rectal tissue. This result was supported by the 
significant positive correlations between the caecal and RVC CLP1 transcript levels 
and the eqMCP-1 concentrations in the local serum. The antibodies that were used in 
the serum ELISA were purified from equine mastocytoma tissue (Pemberton, 
McEuen et al. 2001). Granzyme(BGH)-like (GZM(BGH)L) was the most abundant 
chymase-like proteinase in the equine mastocytoma and also had an identical N-
terminal aa sequence to the previously described equine mast cell proteinase-1 
sequence (Pemberton, McEuen et al. 2001; Dacre 2005). This suggests that the 
predicted sequence (GZM(BGH)L) is the same as the original equine mast cell 
proteinase that was purified from equine mastocytoma (Pemberton, McEuen et al. 
2001), although full sequence analysis and assessment of substrate specificity are 
required to confirm this.  
There are many elements of the research presented here that would be beneficial to 
continue exploring. One interesting area would be clarification of the heterogeneity 
of mast cell expression in the horse. The initial mast cell proteinase expression 
results described provides the basis for this work. To take this further would require a 
thorough examination of the equine genome, with a particular focus on chromosome 
1 where the mast cell chymase locus is situated (Chapter 4). As mentioned above, 
this thesis has provided further evidence for multiple, closely-related equine 
chymases. Full sequence analysis on all identified sequences alongside in situ 
hybridisation to confirm their cellular origin would clarify the level of heterogeneity 
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further. This would provide an insight into the correlation between the proteinases 
(TLP1 with GZMBL, CLP1 with GZM(BGH)L) identified here. There could 
potentially be a number of mast cell subsets expressing various combinations of 
serine proteinases. A greater understanding of the origin of these sequences would 
aid in interpreting their expression and defining equine mast cell heterogeneity. 
Following confirmation of the cellular origin of all identified potential mast cell 
sequences, a further step of great benefit would be the production of monoclonal 
antibodies that are specific to an individual proteinase. Monoclonal antibodies would 
produce less background signal and less cross-reactivity as they target a single 
epitope (Lipman, Jackson et al. 2005). This would allow the development of 
optimised ELISAs that could reliably measure concentrations of known sequences 
for direct comparison. This would be valuable due to the high sequence homology 
between serine proteinases, especially chymases. The chymase-like sequences 
investigated in this study, CLP1, GZMBL and GZM(BGH)L, are highly homologous 
and this may cause cross reactivity in the ELISA. There is also potential for other 
closely related proteinases expressed by mast cells or lymphocytes that may be 
recognised by the polyclonal antibody available. It would be very interesting to 
optimise an ELISA specific to CLP1 in equine serum using a monoclonal anitbody. 
As this proteinase has been demonstrated to be more abundant in the tissue, this may 
also be the case in serum. This would allow investigation into which proteinases are 
at higher concentrations in serum to assess the potential for differential release, as 
noted in other species, and also to further investigate the relationship between tissue 
transcript proteinase levels and cyathostomin infection. A further benefit of specific 
monoclonal antibodies would be to assess mast cell labelled populations in detail 
according to their specific proteinase expression and allow exploration of the kinetics 
of mast cell response. Differential mast cell proteinase expression has been 
demonstrated in the mouse during the inflammatory response to nematode infection 
(Friend, Ghildyal et al. 1996; Friend, Ghildyal et al. 1998) and it would be interesting 
to investigate this in the equine. Here, immunolabelled mast cells in sections of rectal 
tissue taken using rectal biopsy demonstrated significant positive relationships with 
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CTMB. Rectal biopsies may be a practical method for investigating the dynamics of 
the mast cell response to cyathostomin infection. 
In summary, this thesis has further explored and characterised large intestinal mast 
cell recruitment and proteinase expression in response to cyathostomin infection in 
naturally infected horses. Serum and tissue mast cell proteinase concentrations have 
been estimated using optimised ELISAs. The ambiguity surrounding the previously 
purified mastocytoma-derived proteinases and the antibodies raised against them 
have been investigated. Additionally, the identification and quantification of novel 
equine mast cell proteinase-related sequences has been successfully performed, 
providing a foundation for future exploration and investigation.  
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7  Appendix A: Additional Data 
 












AB 1  397 254 467 320 93 266 
AB 2  518 299 704 373 420 235 
AB 3  208 130 317 110 99 70 
AB 4  794 286 749 405 461 229 
AB 5  181 194 157 158 98 93 
AB 6  407 275 429 389 314 200 
AB 7  398 224 381 254 40 166 
AB 8  592 317 546 326 288 318 
AB 9  1,062 355 789 357 315 218 
AB 10  795 437 738 413 414 242 
AB 11  787 413 832 349 307 283 
AB 12  637 312 731 387 541 330 
AB 13  386 184 382 304 352 163 
AB 14  448 269 437 299 144 200 
AB 15  240 216 120 170 134 182 
AB 16 
  




DV 1 22 158 34 170 19 102 
DV 2 594 293 517 445 395 206 
DV 3 285 110 197 296 122 94 
DV 4 336 268 101 328 170 243 
DV 5 285 150 250 150 170 166 
DV 6 341 250 394 184 298 157 
DV 7 390 315 350 325 59 383 
DV 8 526 195 423 193 174 150 
DV 9 440 229 428 281 354 355 
DV 10 473 162 473 196 96 166 
DV 11 1,035 331 1,470 364 467 183 
DV 12 874 248 738 334 131 118 
Table 7.1: Results of mucosal and submucosal mast cell counts from the caecum, RVC and rectum of 
all horses (AB1-16, DV1-12). Cells expressed as MC per mm2. (MMC: Mucosal mast cell; SMMC: 
Submucosal mast cell; RVC: Right ventral colon; RB: Rectal biopsy) 
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DV6 270 144 166 134 8 83 
DV7 928 734 624 605 94 778 
DV8 218 80 237 106 6 42 
DV9 355 405 302 315 19 248 
DV10 501 606 570 510 34 435 
DV11 376 552 403 270 8 174 
DV12 1178 419 875 389 88 106 
 
Table 7.2: Results of mucosal and submucosal eosinophil cell counts (EC/mm2) from the caecum, 
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Horse  
















eqMCP-1   
MMC    
RB 
(MC/mm2) 




AB 1 333 179 211 160 125 50 
AB 2 542 146 432 165 328 186 
AB 3 290 98 250 107 30 35 
AB 4 395 152 344 213 106 74 
AB 5 70 14 118 56 19 2 
AB 6 632 178 565 224 613 32 
AB 7 96 14 483 246 136 128 
AB 8 363 230 442 222 392 158 
AB 9 1027 224 966 205 136 25.6 
AB 10 638 192 634 179 256 78 
AB 11 627 171 366 149 371 40 
AB 12 507 77 621 138 558 46 
AB 13 371 150 117 187 115 90 
AB 14 205 187 450 262 11 0 
AB 15 70 54 400 110 46 24 
AB 16 54 38 43 43 395 155 
DV 1 56 64 56 50 3 8 
DV 2 301 98 272 213 85 19 
DV 3 70 69 19 38 59 58 
DV 4 264 146 176 107 11 86 
DV 5 376 94 360 62 26 8 
DV 6 339 210 320 125 51 72 
DV 7 419 160 346 218 96 141 
DV 8 408 131 509 218 309 226 
DV 9 464 125 354 189 381 258 
DV 10 598 122 418 146 101 54 
DV 11 397 173 1323 288 24 5 
DV 12 686 165 368 259 171 42 
 
Table 7.3: Table of eqMCP-1 labelled mast cells in the mucosa (MMC) and submucosa (SMMC) in 
the caecum, RVC and rectum from horses sampled from the abattoir and the R(D)SVS. Cells 
expressed as MC per mm2. (eqMCP-1: equine mast cell proteinase-1. MMC: mucosal mast cell. 
SMMC: submucosal mast cell. RVC: Right ventral colon. RB: Rectal biopsy). 
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Table 7.4: Table of eqTRYP labelled mast cells in the mucosa (MMC) and submucosa (SSMC) in the 
caecum, RVC and rectum from horses sampled from the abattoir and the R(D)SVS. Cells expressed as 
MC per mm2. (eqTRYP: equine tryptase. MMC: mucosal mast cell. SMMC: Submucosal mast cell. 
RVC: Right ventral colon. RB: Rectal biopsy). 
Horse  



















AB 1 29 11 38 13 154 38 
AB 2 118 37 77 37 59 13 
AB 3 24 21 34 30 11 6 
AB 4 130 106 219 171 40 80 
AB 5 21 2 34 50 2 0 
AB 6 218 93 235 51 85 56 
AB 7 35 8 94 34 19 32 
AB 8 102 27 45 43 83 38 
AB 9 150 11 220 45 22 3 
AB 10 93 3 94 27 27 5 
AB 11 181 51 98 6 64 3 
AB 12 230 75 261 72 83 8 
AB 13 112 66 202 88 29 50 
AB 14 72 115 43 99 6 2 
AB 15 18 11 40 40 34 11 
AB 16 11 6 46 40 24 21 
DV 1 6.4 37 19 21 14 2 
DV 2 69 37 21 14 26 11 
DV 3 78 109 21 78 59 30 
DV 4 38 86 8 66 62 69 
DV 5 35 24 59 35 6 11 
DV 6 102 115 43 77 18 0 
DV 7 126 74 94 179 34 90 
DV 8 40 107 67 94 122 42 
DV 9 149 66 117 190 174 181 
DV 10 432 34 144 66 8 80 
DV 11 114 96 160 197 6 10 
DV 12 256 214 162 245 107 98 
Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 
Chapter Seven: Appendix A                                                                                     273 
Sample Serum at 
-20°C 
 





SEM     
(+/- ng/ml) 
AB13 L 2.25 0.13 1.64 0.37 
AB14 L 1.32 0.05 1.07 0.19 
AB15 L 0.93 0.13 0.93 0.11 
AB16 L 4.18 0.29 3.86 0.34 
DV1 L 2.26 0.22 1.99 0.20 
DV1 P 2.27 0.25 2.04 0.29 
DV2 L 1.33 0.15 1.32 0.42 
DV2 P 1.00 0.08 0.93 0.20 
DV3 L 1.26 0.14 0.96 0.33 
DV3 P 1.25 0.12 0.96 0.33 
DV4 L 0.75 0.13 0.58 0.18 
DV5 L 1.01 0.25 0.70 0.13 
DV5 P 2.77 0.19 2.02 0.60 
DV6 L 1.40 0.10 1.65 0.90 
DV6 P 1.60 0.68 0.81 0.22 
DV7 L 0.54 0.05 0.54 0.27 
DV7 P 0.98 0.32 0.53 0.20 
DV8 L 1.82 0.20 1.34 0.28 
DV8 P 1.45 0.02 1.62 0.37 
DV9 L 5.21 0.63 3.84 0.36 
DV9 P 1.55 0.05 1.60 0.31 
DV10 L 1.75 0.17 1.35 0.16 
DV10 P 1.31 0.07 1.15 0.13 
DV11 L 3.54 1.68 1.74 0.27 
DV11 P 2.15 0.50 1.65 0.14 
DV12 L 2.68 0.61 1.92 0.21 
DV12 P 2.05 0.50 1.31 0.03 
NEG 0.45 0.02 0.56 0.12 
 
Table 7.5: Table of mean serum eqMCP-1 ELISA concentration results from serum collected from a 
local (L) or peripheral site (P) and stored at -20 °C or -80 °C. (eqMCP-1: equine mast cell proteinase-
1. NEG: serum from cyathostomin negative ponies. SEM: Standard Error of the Mean). 
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SEM          
(+/-µg/ml) 
AB13 L 12.14 5.29 17.43 4.29 
AB14 L 2.42 0.72 5.74 0.34 
AB15 L 0.91 0.18 1.08 0.09 
AB16 L 3.02 0.95 7.29 0.87 
DV1 L 3.55 1.31 1.98 0.21 
DV1 P 1.64 0.40 1.44 0.16 
DV2 L 3.91 1.40 5.62 0.80 
DV2 P 0.51 0.11 0.39 0.05 
DV3 L 1.89 0.71 2.01 0.55 
DV3 P 0.73 0.11 0.88 0.13 
DV4 L 1.33 0.37 1.11 0.15 
DV5 L 2.05 0.61 3.06 0.27 
DV5 P 14.25 4.42 14.84 3.48 
DV6 L 1.83 0.43 2.61 0.17 
DV6 P 5.77 0.70 4.89 1.23 
DV7 L 2.07 0.71 2.40 0.27 
DV7 P 2.38 0.97 2.10 0.20 
DV8 L 5.54 2.08 4.11 0.98 
DV8 P 1.37 0.37 2.10 0.37 
DV9 L 8.31 2.96 10.03 1.06 
DV9 P 0.53 0.06 0.76 0.18 
DV10 L 1.22 0.41 1.43 0.17 
DV10 P 0.42 0.12 0.47 0.03 
DV11 L 3.16 0.98 3.53 0.89 
DV11 P 2.63 1.05 4.50 1.35 
DV12 L 6.27 1.96 19.62 5.24 
DV12 P 1.22 0.33 1.46 0.13 
NEG  0.23 0.04 0.21 0.04 
 
Table 7.6: Table of mean serum eqTRYP ELISA concentration results from serum collected from a 
local (L) or peripheral site (P) and stored at -20 °C or -80 °C (eqTRYP: equine tryptase. P: Peripheral. 
L: Local. NEG: serum from cyathostomin negative ponies. SEM: Standard Error of the Mean).
Mast Cell Recruitment and Activation as Measures of Cyathostomin Burden 














AB1 115.73 33.39 81.47 15.83 54.01 9.97 
AB2 220.90 35.61 200.02 37.87 50.57 10.54 
AB3 21.75 5.04 7.59 3.89 25.84 4.38 
AB4 34.13 8.08 229.26 36.40 93.37 21.70 
AB5 4.97 0.68 3.96 0.82 3.52 0.56 
AB6 167.07 33.43 206.03 43.05 108.46 32.57 
AB7 61.98 11.14 87.03 19.74 46.18 7.68 
AB8 10.79 2.48 9.28 1.66 7.83 2.50 
AB9 63.66 9.23 63.23 11.19 27.18 7.71 
AB10 39.71 11.36 60.49 9.13 33.06 4.53 
AB11 386.26 69.52 404.85 62.84 209.49 45.62 
AB12 248.54 42.34 313.26 67.72 121.43 26.39 
AB13 46.27 8.07 33.46 6.01 22.54 2.45 
AB14 37.43 4.58 52.20 6.44 8.86 2.97 
AB15 2.74 0.59 25.65 7.82 20.42 5.67 
AB16 328.09 38.07 404.14 33.09 100.04 19.57 
DV1 13.80 1.70 9.10 2.74 6.30 1.53 
DV2 68.46 8.61 68.81 10.46 2.54 0.35 
DV3 13.56 1.79 62.05 11.27 11.21 1.79 
DV4 43.11 4.36 47.27 6.07 106.24 19.13 
DV5 13.88 1.49 4.83 1.75 19.30 1.48 
DV6 12.00 2.10 18.38 3.27 9.74 0.55 
DV7 11.03 0.95 6.80 1.56 8.12 1.90 
DV8 31.75 4.82 14.10 1.14 15.27 1.50 
DV9 29.83 3.42 190.90 30.46 152.36 38.44 
DV10 8.76 2.07 41.17 6.15 137.28 16.25 
DV11 23.31 6.82 34.17 4.04 9.43 0.82 
DV12 113.72 43.09 312.75 46.05 53.25 7.04 
Table 7.7: Table of mean eqMCP-1 ELISA results from caecal, RVC and RB tissue (eqMCP-1: 
equine mast cell proteinase-1. SEM: Standard Error of the Mean. RVC: Right ventral colon. RB: 
Rectal biopsy). 
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Horse  Caecum 
(μg/g) 




SEM     
(+/-μg/g) 
RB      
(μg/g) 
SEM      
(+/-μg/g) 
AB1 71.44 22.72 77.02 9.18 49.85 10.58 
AB2 224.22 46.30 185.40 26.62 31.57 6.96 
AB3 30.88 3.22 24.95 5.00 21.49 6.09 
AB4 15.89 3.98 113.54 27.37 47.25 11.59 
AB5 24.92 6.23 19.08 4.39 3.59 6.79 
AB6 77.69 25.82 97.31 15.76 113.34 44.01 
AB7 53.86 7.16 59.66 0.42 26.44 7.72 
AB8 90.00 1.15 70.41 28.80 56.11 4.39 
AB9 89.70 11.79 140.44 32.11 30.57 6.72 
AB10 41.83 5.74 73.44 3.73 39.96 5.47 
AB11 120.11 17.01 215.95 1.68 54.25 11.25 
AB12 120.54 14.07 91.79 6.37 39.80 3.58 
AB13 42.17 16.15 54.07 13.54 23.74 7.05 
AB14 31.92 6.82 32.60 6.19 9.73 4.04 
AB15 5.00 0.87 20.76 6.31 8.93 2.52 
AB16 82.03 25.38 94.89 32.08 30.54 6.17 
DV1 10.83 1.31 13.21 1.69 6.36 2.30 
DV2 50.77 3.01 39.71 5.20 6.31 0.42 
DV3 21.50 2.63 37.50 2.63 8.68 0.95 
DV4 19.83 2.41 23.84 2.91 24.34 2.15 
DV5 93.89 30.07 9.08 1.02 34.63 5.09 
DV6 24.68 6.43 44.52 9.86 20.63 4.32 
DV7 187.11 115.71 64.71 27.13 209.55 126.94 
DV8 25.62 3.08 18.87 3.70 13.48 5.20 
DV9 14.68 3.80 112.51 49.74 38.72 5.23 
DV10 12.32 2.43 26.59 3.77 40.42 4.85 
DV11 60.81 12.94 41.07 17.73 20.07 5.27 
DV12 306.19 223.65 371.40 187.99 33.81 6.53 
 
Table 7.8: Table of mean eqTRYP ELISA results from caecal, RVC and RB tissue. (eqTRYP: equine 
tryptase. SEM: Standard Error of the Mean. RVC: Right ventral colon. RB: Rectal biopsy). 
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Figure 7.1: Barchart of mean eqMCP-1 tissue concentrations (µg/g). Error bars show standard error of the mean. (eqMCP-1: equine Mast Cell Proteinase-1; C: 
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Figure 7.2: Barchart of mean eqTRYP tissue concentrations (µg/g). Error bars show standard error of the mean. (eqTRYP: equine Tryptase; C: Caecum; RVC: Right 
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8 Appendix B: Nucleotide and Protein Sequences 
8.1 Nucleotide Sequences  
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8.2 Protein Sequences 
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9 Appendix C: General Laboratory Solutions and 
Procedures 
9.1.1 Carnoy’s Solution 
150 ml chloroform 
300 ml absolute alcohol 
50ml glacial acetic acid 
 
9.1.2 Peptic Digestion Solution 
10 g pepsin (Fisher) 
15ml HCL 
1L warm water 
 
The pepsin was dissolved in a small volume of the warm water before being added to 
the acid and the rest of the water.  
 
9.1.3 0.5% Toluidine Blue Solution 




The Toluidine blue stain was prepared by adding Toluidine blue powder to distilled 
water, concentrated hydrochloric acid was added to give an acidity of pH 0.5. The 
solution was made up to final volume with distilled water to give a 0.5% w/v 
solution. It was left overnight on a magnetic stirrer and filtered before use. 
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9.1.5 ELISA Coating buffer 
5.3g Na2CO3 (anhydrous) 
4.2g NaHCO3  
The above were combined and made up to 1 L with dH2O and the pH adjusted to 9.6 
using HCl. 
 
9.1.6 Western Transfer Buffer  
850 ml Distilled water 
100 ml Methanol 
50 ml NuPAGE transfer buffer (20 x; Invitrogen) 
The above were combined and stored at room temperature. 
 
9.1.7 TNTT 
50 ml 1 M Tris 
146.1 g NaCl 
2.5 ml Tween 20 
0.5 g Thimerasol 
The above were combined and made up to 5 litres with dH2O and the pH adjusted to 
7.4 using HCl. 
 
9.1.8 Tris-acetate-EDTA (TAE) Buffer (50X) 
242 g Tris base 
57.1 ml Glacial acetic acid 
100 ml 0.5M EDTA (pH 8) 
The above were combined and made up to 1 L with dH2O to make a 50 X solution. 
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9.1.9 1 % Agarose Gel 
2 g agar 
4 ml 50 x TAE  
20 μL 10,000 x Gel Red  
The above were combined and the volume made up to 200ml with dH2O. The 
solution was heated in a microwave on full power for approximately 3 min and then 
allowed to cool to 45 °C. The gel was then poured into a gel electrophoresis tank 
with a comb pre-positioned to give the correct number and size of wells. Once the 
gel had set, the comb was removed and 1 x TAE poured over to submerge the gel. 
The samples were loaded alongside a Ready-Load™ 1 kb DNA Ladder (Invitrogen) 
and the tank attached to a power supply. 100 V were applied for approximately 40 
mins and the gel visualised using UV. 
 
9.1.10  DNA Loading Buffer 
0.25 % Bromophenol blue 
0.25 % Xylene cyanol FF 
40 % (w/v) Sucrose in water 
A 6 X gel loading buffer was made by combining the above and stored at 4 °C. 
 
9.1.11 Western Blot 
The gel was transferred to a nitrocellulose membrane using the Iblot blotting system 
as per the manufacturer’s instructions (Thermo Fisher). After removal of the ladder 
(which was placed in distilled water) TNTT was used to block the membrane 
overnight at room temperature. The primary antibody was diluted 1/100 in TNTT, 
poured onto the membrane and left to rock gently. After 1 h the antibody was washed 
off and three 10 min washes with TNTT were performed. The secondary antibody 
was also diluted 1/1000 TNTT and the same process was repeated. The bands were 
visualised using the ECL system (GE Healthcare) followed by the SigmaFast 3,3’-
diaminibenzidine tablet set (Sigma) as per the manufacturers’ instructions and the 
reaction stopped with distilled water. 
